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1
general introduCtion
Adult congenital heart disease
Congenital heart disease (CHD) is the most common type of birth defect with a 
prevalence of 8.0 per 1000 births.1 The eight most common heart defects at birth 
are ventricular septal defect (VSD, 34%), atrial septal defect (ASD, 13%), persistent 
ductus arteriosus (10%), pulmonary stenosis (8%), tetralogy of Fallot (ToF, 5%), 
coarctation of the aorta (CoA, 5%), transposition of the great arteries (TGA, 5%) 
and aortic stenosis (4%).2 With the introduction of and improvements in diagnostic 
procedures, cardio-thoracic surgery, anaesthesia, intensive care and specialised 
pediatric and adult cardiology care, life expectancy has increased enormously. 
Nowadays, about 90% of patients with CHD, often after successful surgery at 
young age, reach adulthood. This results in a growing number of adults with CHD 
with an estimation of 35,000 in the Netherlands.3
Although survival has improved, morbidity is still substantial. The most com-
mon complications in adult CHD are arrhythmias and heart failure. In the Nether-
lands, the estimated incidence of heart failure in adults with CHD is 1.2 per 1,000 
patient-years and differs amongst the various congenital lesions.4 Heart failure is 
less often observed in patients with simple lesions, e.g. ASD and VSD, while higher 
incidences are reported in patients with more complex lesions, e.g. ToF and TGA. 
Chronic heart failure is often the result of ventricular dysfunction and is the main 
cause of mortality: 26% of all deaths.4
Early detection of ventricular dysfunction
Adequate assessment of ventricular function is essential to identify patients at 
risk for complications or adverse outcome. Echocardiography remains the first-
line investigation and continues to evolve, with improved functional assessment. 
Echocardiography can provide information on the basic cardiac anatomy, venous 
return, connection of the atria and ventricles, and origin of the great arteries. It 
allows evaluation of the morphology of cardiac chambers, ventricular function, 
and evaluation of shunt lesions. Assessment of ventricular volume overload and 
pressure overload is of major importance. Although echocardiography is easy to 
perform, inexpensive and patient-friendly, and can provide comprehensive infor-
mation, its limitations must also be taken into consideration. With conventional 
two-dimensional (2D) echocardiography, complex cardiac anatomy can be difficult 
to visualise and a reliable and reproducible method for ventricular function as-
sessment is lacking. These issues apply especially to the right ventricle (RV) that 
is positioned closely behind the sternum and is important to evaluate in CHD.5 
Moreover, the currently used conventional echocardiographic technique fails to 
14 Chapter 1
detect early (subclinical) ventricular dysfunction. Early recognition of ventricu-
lar dysfunction could result in a more adequate medical treatment regimen and 
better timing of cardiac (re)intervention. These improvements in treatment may 
avoid further deterioration in cardiac function with subsequent development of 
heart failure, and will ultimately result in a better survival. Therefore, novel echo-
cardiographic techniques for quantitative assessment of ventricular function, and 
techniques for better visualisation of the RV are warranted.
Cardiac anatomy
In the left ventricle (LV), fi bres in the subepicardium run in a left-handed direction, 
fi bres in the mid layer run circumferentially, and fi bres in the subendocardium run 
in a right-handed direction (Figure 1A). These myocardial fi bres are connected 
to each other, with a smooth transition from subendocardium to mid layer, and 
then to subepicardium, along the long-axis. Contraction of these three layers of 
myocardial fi bres causes besides longitudinal, circumferential, and radial move-
ments of the heart, also a rotational movement (Figure 1B).6
Leonardo da Vinci already described the rotational movement of the LV in the 
16th century,7 and in 1669 Richard Lower described this movement as “the wring-
ing of a linen cloth to squeeze out the water”.8 Over the past three centuries, the 
twisting movement of the LV has continued to intrigue clinicians and researchers 
in their quest to understand the performance of the human heart.9 The subepicar-
dium and subendocardium rotate in opposite directions during contraction. When 
both layers contract simultaneously, the larger radius for the outer subepicardium 
results in a mechanical advantage of the epicardial fi bres in dominating the overall 
direction of rotation.10 Therefore, the base rotates in clockwise direction and the 
apex in counterclockwise direction. The twisting movement is necessary because 
Α Β
Figure 1 Fibre orientation of the left ventricle
Fibres in the subepicardium run in a left-handed direction, fi bres in the mid layer run circumferentially, and 
fi bres in the subendocardium run in a right-handed direction (A). Contraction of these fi bres causes a rotational 
movement of the heart (B).
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shortening of the myocardial fibres is about 15-20%, whereas the actual ejection 
fraction of the human heart is 60 to 70%.6, 11 This ejection fraction could be reached 
with the involvement of twisting.
Although it has been customary to consider LV function and RV function as 
separate entities, this approach is flawed. The continuity between the myocardial 
fibres of the LV and RV functionally binds the ventricles together. This continuity, 
together with the common interventricular septum and pericardium, contributes 
to ventricular interaction.12, 13
Speckle-tracking echocardiography
Speckle-tracking echocardiography (STE) is a novel echocardiographic technique 
that enables to quantify regional and global myocardial function, relatively inde-
pendently of angle and ventricular geometry.14 Grey-scale 2D-echocardiographic 
images consist of a speckled pattern which is unique for each region of the 
myocardium. The geometric position of the speckles changes from frame-to-frame 
with the surrounding tissue motion. With the use of STE, these ultrasonic speckles 
can be tracked and subsequently myocardial-deformation parameters, such as 
strain and rotation, can be calculated (Figure 2). Strain describes the deforma-
tion of an object normalised to its original shape and size and can be measured 
in longitudinal, radial and circumferential directions. Rotational deformation 
enables the analysis of complex LV motion patterns.15 Increasing data suggest that 
STE may provide useful clinical measurements for detection of subtle ventricular 
dysfunction that is likely to progress into heart failure.16, 17 Information about the 
use of STE for LV and RV function in adults with CHD is limited, especially the LV 
twist in CHD is not completely elucidated. The relatively angle- and geometry inde-
pendence of STE could be a useful advantage in adults with CHD, who often have 
complex ventricular geometry and varying intrathoracic positions and orientation 
of the heart.
The use of iRotate for visualising the right ventricle
There is an increased recognition of assessing RV function in the acute phase and 
during follow up as a prognostic factor in a variety of disease states such as CHD, 
left-sided heart failure and pulmonary hypertension.13 However, unlike the LV that 
can be completely visualised from one apical window, a multi-view approach is 
needed for a comprehensive evaluation of RV size and function because of its 
complex geometry and retrosternal position.18, 19 Serial follow-up of RV dimensions 
and function measures results in considerable inaccuracies from oblique plane 
acquisitions due to the lack of anatomic landmarks used as reference points.19 A 
standardised multi-view echocardiographic approach for the assessment of RV, 
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based on anatomic landmarks and taken from one echocardiographic window, 
could increase the accuracy of RV dimensions and function measures in routine 
follow-up. The iRotate mode is a new visualisation tool developed by Philips20, 
which consists of a transducer that rotates electronically to obtain the required 
view within the acoustical window, rather than manually rotating the transducer. 
Therefore, iRotate provides a multiplane echocardiographic approach from the 
Figure 2 Speckle-tracking echocardiography
With this echocardiographic technique, the motion of the ventricular walls can be analysed by tracking the 
speckled pattern of the myocardium during the cardiac cycle. Various myocardial-deformation parameters can 
be measured in different directions, such as longitudinal strain of the left ventricle from the apical four-chamber 
view (A) and two-chamber view (B); and rotation of the base (C) and apex (D) from the short-axis view.
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same window without moving the transducer. Whether this new echocardio-
graphic modality is feasible and reproducible for the evaluation of the RV has to 
be investigated.
Types of congenital heart defects
Tetralogy of Fallot
Tetralogy of Fallot is the most prevalent form of cyanotic CHD. This disease com-
prises four cardiac anomalies: VSD, overriding of the aorta, variable forms of RV 
outflow obstruction and RV hypertrophy (Figure 3).21 The technique of surgical 
repair has remained largely unchanged in its basic principles since the original 
description.22 The repair consists of VSD closure and the relief of RV obstruction, 
usually with a transannular patch, and usually resulting in free pulmonary regur-
gitation.23 However, progress in circulatory support, surgical techniques and pre-
operative and postoperative care have enabled an important reduction in the age 
at which this operation can be performed. This may influence long-term results, 
which should be considered a factor in interpretation of current data on long-term 
outcome. In general, the survival of these patients has remarkably improved: 90% 
of patients are currently alive 30 years after successful surgical repair in early 
childhood.24-26 Despite these satisfactory results, survival is lower than in the nor-
mal population, and little is known about long-term functional outcome and life 
expectancy beyond 30 years.26, 27 Although anatomic repair has been achieved, 
complications such as pulmonary regurgitation, RV dysfunction, arrhythmias, 
R L
Figure 3 Tetralogy of Fallot
Tetralogy of Fallot consists of a ventricular septal defect with an overriding aorta, pulmonary narrowing and a 
hypertrophied right ventricle.
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and sudden death are found in late survivors.21, 28, 29 RV dysfunction may affect LV 
function resulting in more attention for the LV in this patient group.30 Although the 
influence of RV dilatation on LV shape and function has not been studied in detail, 
LV dysfunction is a strong independent determinant of clinical outcome.31, 32 This 
makes early detection of both RV and LV dysfunction important.
Ventricular septal defect
A VSD (Figure 4) is by far the most common type of CHD in children.2 A VSD can be 
an isolated cardiac lesion but can also be associated with other congenital cardiac 
malformations.33 Small VSDs may remain without hemodynamic consequences, 
but a significant left-to-right shunt will cause LV overload, pulmonary arterial hy-
pertension, ventricular dysfunction and aortic regurgitation.33, 34 Surgical closure 
at young age is the method of choice and often results in good long-term survival 
with low morbidity.35 Therefore, most such patients have been discharged from 
routine cardiological follow-up. For both patients and their treating physicians, 
it is essential to know whether the pre-operative left-to-right shunt and the VSD 
patch affect biventricular function in the long term. However, information on mor-
tality and morbidity beyond 30 years after surgical VSD closure is scarce.
Atrial septal defect
An ASD (Figure 5) is the most common CHD at adult age.36 Most children with 
an isolated ASD are free of symptoms, but the rates of complaints increase with 
advancing age.37 Before closure, patients with an ASD have right-sided volume 
R L
Figure 4 Ventricular septal defect
A ventricular septal defect is a defect in the wall between the left and the right ventricles.
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overload caused by left-to-right shunting. Some patients also have anomalous 
pulmonary venous return which will result in right-heart overload. The RV volume 
overload is well tolerated for many years,38 but eventually diminished RV function 
and heart failure tend to occur resulting in an increased morbidity, e.g. arrhythmia 
and exercise intolerance, and higher mortality.37, 39After successful surgical repair 
at young age, the life expectancy up to 30 years is similar to that of the general 
population.40, 41 Transcatheter closure offers a less invasive alternative for patients 
with a suitable ASD.5, 37 Even when ASD repair is performed in childhood, RV dilata-
tion or impaired RV function could be found in a substantial part of the patients.42 
The effect of preoperative chronic volume loading on RV function in later life is 
still not completely elucidated.
Transposition of the great arteries
Transposition of the great arteries means that the aorta arises from the morpho-
logic RV and the pulmonary artery from the morphologic LV (Figure 6). The first 
surgical option for patients born with TGA was the atrial switch procedure as 
described by Senning in 1959 and Mustard in 1964.43 In patients with TGA repaired 
by Mustard operation and in patients with congenitally corrected TGA, the mor-
phologic RV supports the systemic circulation. The RV geometry is not suitable to 
encounter this chronic pressure overload.13 Therefore, the main concern regard-
ing the long-term outcome of these patients is dysfunction of the systemic RV.
R L
Figure 5 Atrial septal defect
An atrial septal defect is a defect in the wall between the left and the right atria.
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Coarctation of the aorta
Coarctation of the aorta is defined as a condition with a constricted aortic seg-
ment in the area where the ductus arteriosus inserts (Figure 7). There are known 
associated lesions, such as a bicuspid aortic valve and mitral valve stenosis.5 CoA 
causes LV pressure overload which can lead to increased myocardial wall stress, 
LV dysfunction, and the development of arterial collaterals. Despite successful 
repair, late cardiovascular problems can occur including systemic hypertension in 
R L
Figure 6 Transposition of the great arteries
Transposition of the great arteries is a heart defect in which the two main arteries, the aorta and the pulmonary 
artery, are reversed.
R L
Figure 7 Coarctation of the aorta
Coarctation of the aorta is a narrowing of the aorta at about the level of the ductal structure.
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up to 75% of patients and heart failure in 15%.44-47 Early detection of LV dysfunction 
is important for risk stratification and early initiation of treatment.
Aims
The aim of this thesis is to investigate the long-term outcome in adult patients 
with CHD and to evaluate novel, non-invasive echocardiographic techniques in a 
healthy adult population and in adult patients, which can contribute to an accurate 
quantitative assessment of LV and RV function. With the more precise assessment 
of early ventricular dysfunction, we aim for a better outcome for patients with 
CHD.
outline of the thesis
Novel echocardiographic techniques and measurements have been applied to a 
healthy population of 147 volunteers from 20 to 72 years old and equally distributed 
in sex. First, in Chapter 2, we establish normal adult longitudinal strain values for 
the LV using 2D-STE and identify associations with anthropometrics. In Chapter 
3, we investigate whether there are unique anatomical landmarks in the RV that 
could be used as reference points to accurately depict the entire RV from one 
standard echocardiographic view. We evaluate the feasibility of this multi-plane 
imaging mode in the healthy volunteers. Additionally, we examine the feasibility 
of this imaging technique in a cohort of patients with RV volume overload or RV 
pressure overload.
The second part of this thesis focuses on the clinical outcome and early de-
tection of ventricular dysfunction in patients with repaired ToF. Results on very 
long-term outcome of patients after ToF repair are scarce. In Chapter 4, we de-
scribe the survival and clinical outcome up to 40 years after surgical repair in a 
uniquely designed, prospective study, where the patients underwent a thorough 
in-hospital examination in 1990, 2001 and again in 2012. In patients with ToF, RV 
as well as LV dysfunction are of major concern at adult age. Other complications, 
such as arrhythmias and reinterventions, are also described. Additionally, the 
subjective health status is assessed. In Chapter 5, we investigate the feasibility of 
strain imaging with STE for the assessment of RV and LV function in this patient 
group. We evaluate the ventricular interaction and determine the relationship of 
these strain measurements with clinical parameters. In Chapter 6, we examine the 
use of STE to assess LV rotation and twist, and determine relationships with con-
ventional echocardiography, cardiac magnetic resonance imaging, and exercise 
capacity in patients with ToF. The use of N-terminal pro-B-type natriuretic peptide 
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(NT-proBNP), a laboratory cardiac biomarker released from cardiomyocytes in 
response to ventricular stretch and volume overload, and its association with 
cardiac function in adults with ToF is described in Chapter 7.
The third part of this thesis provides information on the clinical outcome and 
early detection of ventricular dysfunction in adult patients with other types 
of CHD. We report the survival and clinical outcome in longitudinally followed 
patient cohorts 30 to 40 years after surgical VSD closure in Chapter 8 and after 
ASD closure in Chapter 9. Additionally, we detect determinants of clinical out-
come and we evaluate the present subjective health status of these patients. In 
Chapter 10, we delineate the feasibility and measurements of RV and LV strain 
imaging using STE in patients with a surgically repaired ASD at young age. We 
evaluate the mechanical interaction between the ventricles and we determine as-
sociations between strain measurements and clinical parameters. The feasibility 
to assess longitudinal strain for quantification of systolic RV function in patients 
with a systemic RV (Mustard patients and congenitally corrected TGA) will be 
discussed in Chapter 11. In Chapter 12, we focus on the feasibility of STE-derived 
strain in patients with repaired CoA, a left-sided outflow tract anomaly. We study 
relationships between LV strain measurements and patient characteristics such 
as smoking, interventions, hypertension, aortic valve morphology, and other as-
sociated congenital cardiac lesions, but also with conventional echocardiographic 
measurements and the biomarker NT-proBNP.
Finally, in Chapter 13 we will reflect on and discuss the most important findings 
of this thesis. Concluding remarks and future perspectives are provided for clini-
cal practice and research.
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abstraCt 
Aims
Evaluation of left ventricular (LV) myocardial deformation by speckle-tracking 
echocardiography (STE) is useful for clinical and research purposes. However, 
strain measurements depend on the used software. Normative data for QLAB 10 
(Philips) are scarce. Additionally, little is known about the influence of anthropo-
metric factors. We aimed to establish normal adult STE-derived strain and strain 
rate values, and to evaluate associations with anthropometrics.
Methods 
Hundred-and-fifty-five healthy subjects aged 20 to 72 years (≥28 subjects per 
decile) were prospectively gathered and examined with electrocardiography and 
two-dimensional echocardiography. With STE, we assessed peak systolic global 
longitudinal strain (GLS), segmental longitudinal strain and strain rate from the 
three standard apical views. 
Results
We included 147 healthy subjects (age 44.6 ± 13.7 years, 50% female, LV GLS -20.8 
± 2.0%). Men had significantly lower LV GLS than women (-20.1 ± 1.8% vs. -21.5 ± 
2.0%, P<0.001), but no association was found with age. LV GLS was significantly 
lower with higher blood pressure, body surface area (BSA), LV volumes and some 
indices of diastolic function. Indexing absolute LV GLS for BSA, strengthened 
the correlations with systolic blood pressure (r=-0.44, P<0.001), QRS duration 
(r=-0.38, P<0.001), LV end-diastolic volume (r=-0.62, P<0.001), LV end-systolic vol-
ume (r=-0.70, P<0.001), E-wave (r=0.39, P<0.001), and E-prime (r=0.30, P<0.001). The 
systolic strain rates of most segments correlated with BSA.
Conclusions 
Our study resulted in normative LV GLS values assessed with QLAB 10. The val-
ues are independent of age, but male sex, higher BSA and higher blood pressure 
negatively influence GLS. Therefore, these factors should be taken into account for 
strain interpretation in clinical practice.
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introduCtion
The quantification of cardiac chamber dimensions and function is the cornerstone 
of cardiac imaging.1 Conventional two-dimensional (2D) and Doppler echocardiog-
raphy are the most commonly used noninvasive modalities and are valuable tools, 
especially for the assessment of global systolic and diastolic function. The most 
widely used measurement for left ventricular (LV) systolic function in a clinical set-
ting is ejection fraction. However, this parameter is limited in abnormally shaped 
or dilated LVs due to the geometric assumptions used in the 2D-biplane method. In 
addition, regional systolic dysfunction could be missed with this method.1 
During the last decade, 2D-speckle-tracking echocardiography (STE) has be-
come available which provides quantitative assessment of global and segmental 
ventricular function by measuring myocardial deformation, largely independent of 
angle and ventricular geometry.2,3 Strain in longitudinal direction, one of the mea-
sures of deformation, is the most widely used type of strain and is a robust index 
for clinical studies.4 With the use of myocardial deformation imaging, ventricular 
dysfunction may be detected in a pre-clinical phase.5
Although STE is widely used for the assessment of LV function, myocardial 
deformation parameters are dependent on the equipment that is used and there-
fore results of machines and software packages from different vendors are not 
interchangeable.4,6 However, there has been an improvement in between-vendor 
concordance in LV global longitudinal strain (GLS) since the work of the joint 
standardization task force.7 Erasmus MC routinely uses the Philips iE33 and EPIQ7 
ultrasound systems, and QLAB software for analyzing datasets (Philips Medical 
Systems, Best, the Netherlands). Normal reference values of STE-derived longitu-
dinal strain are scarce using QLAB software 8, especially strain values established 
with the software versions after the standardization initiative.7 Because of this lack 
of adequate normal data, the clinical value of STE data in patients is suboptimal. 
In addition, little is known about the influence of anthropometric factors on these 
strain values. 
The aim of this prospective cohort study was to obtain normal LV longitudinal 
strain and strain rate values in healthy volunteers aged from 20 to 72 years. Sec-
ondly, we wanted to identify the influence of age, sex, body mass index (BMI), 
body surface area (BSA), blood pressure, ECG findings and ventricular size and 
volumes on strain. 
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Methods
Study population
This prospective cohort study was conducted in 2014-2015 in 155 healthy volunteers 
aged 20 to 72 years, who were stratified into 5 age groups: 20 to 29, 30 to 39, 40 to 
49, 50 to 59, and 60 to 72 years (n≥28 in each group, equal distribution in sex). The 
subjects were recruited via an advertisement for healthy subjects. The inclusion 
criteria required that subjects had normal results on physical examination and elec-
trocardiography (ECG). Subjects were excluded when they met any of the following 
criteria: (prior) cardiovascular disease; cardiovascular risk factors consisting of 
hypertension, diabetes mellitus or hypercholesterolemia; systemic disease or medi-
cation known to influence cardiac function; or the finding of cardiac abnormalities 
during examination. Professional athletes, morbidly obese subjects (BMI >40 kg/
m2), pregnant women and women with breast implants were also excluded. 
All procedures were in accordance with the ethical standards of the institutional 
research committee and with the 1964 Helsinki declaration and its later amend-
ments. Informed consent was obtained from all participants.
Clinical assessment
The subjects’ visit consisted of physical examination, 12-lead ECG, venous blood 
sampling, and 2D-echocardiography. Physical examination included height, 
weight, blood pressure, saturation, and results of heart, lungs and abdominal find-
ings. Blood samples were taken to determine serum creatinine as an indicator for 
renal function.
Echocardiographic image acquisition 
All echocardiographic studies were performed by 2 experienced sonographers 
(JM, WV). Two-dimensional greyscale harmonic images were obtained in the left 
lateral decubitus position using an iE33 or EPIQ7 ultrasound system (Philips Medi-
cal Systems, Best, the Netherlands) equipped with a transthoracic broadband X5-1 
matrix transducer (composed of 3040 elements with 1-5 MHz). Standard apical 
4-chamber (A4C), 2-chamber (A2C) and 3-chamber (A3C) views were obtained for 
STE at frame rates of ≥50 frames/sec.9
Conventional echocardiographic measurements
For chamber measurements we used the current guidelines of the American Soci-
ety of Echocardiography  and the European Association of Cardiovascular Imag-
ing.1 From the A4C, pulsed-wave Doppler examination was performed to obtain 
peak mitral inflow velocities at early (E) and late (A) diastole and E deceleration 
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time. Tissue Doppler imaging was performed to obtain myocardial tissue velocity 
at the septal mitral annulus at early diastole (E’). LV end-diastolic, LV end-systolic 
and LV ejection fraction were derived with the biplane method of disks based on 
one cardiac cycle using QLAB software.
Speckle-tracking analysis
The data sets were blinded regarding the subject’s ID. Offline analyses were per-
formed by 2 independent observers (MM, JM) using QLAB 10 (Philips Medical 
Systems, Best, the Netherlands). Cardiac cycles were defined by the positioning 
of R-waves. Aortic valve closure time was used to define end-systole3 by selecting 
the frame of closure on the A3C view.
To assess peak systolic LV longitudinal strain and strain rate, the endocardial 
and epicardial borders were traced in the A4C, A3C and A2C on an end-diastolic 
frame. The program automatically divided the walls in several segments (LV algo-
rithm based on 17-segment model) and tracked these points on a frame-by-frame 
basis. When tracking was suboptimal, we readjusted the borders. Segments with 
persistently inadequate tracking were excluded from analysis. Peak systolic strain 
and strain rate values were defined as the peak values on the curves during the 
ejection phase of one cardiac cycle. Figure 1 shows examples of longitudinal strain 
analyses. Data were exported to a spreadsheet program (Excel; Microsoft Corpo-
ration, Redmond, WA, USA). All references to strain changes consider the absolute 
value of the number, so that higher or increase in longitudinal strain means a more 
negative number and lower or decrease means a less negative number.10
Statistical analysis
The data distribution was checked using histograms and the Shapiro-Wilk test. 
Depending on the distribution, continuous data are presented as mean±standard 
deviation (SD), or median with first and third quartile [Q1-Q3] or interquartile 
range [IQR]. Categorical data are presented as frequencies and percentages. For 
comparison of normally distributed continuous variables in one group we used 
the paired t-test and between two groups the Student’s t-test. In case of skewed 
distribution, the Mann-Whitney-U test was applied. For comparison of frequencies 
the χ2-test was used. Linear regression analysis was used to explore the relation-
ship between strain and baseline characteristics. Variables that reached P<0.001 
and did not show collinearity with other variables were included in a multivariable 
model. In case of collinear variables, the variable with the highest correlation coef-
ficient was included. All statistical analyses were performed using SPSS statistics 
version 21 (IBM Corp., Armonk, NY, USA). The statistical tests were two-sided and 
a P<0.05 was considered statistically significant. 
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Intraobserver agreement (MM) was assessed by repeated analysis in a sample 
of 20 subjects (n=4 per decile, randomly selected) >1 month after the initial 
analysis, in randomly mixed order, and blinded to the initial results. Assessment 
of interobserver agreement was performed by a second observer (JM) in the same 
sample. The agreement between 2 measurements was determined as the mean of 
Figure 1 Example of left ventricular longitudinal strain measurements in a healthy individual
The left ventricle was traced in the apical four-, three-, and two-chamber views at end-diastole. The walls were 
automatically divided into seven segments at each view and the global longitudinal strain at each view was 
calculated (A-C). The segmental strains were plotted in a bull’s eye and the left ventricular global longitudinal 
strain based on a 17-segment model was calculated (D).
AP2 = apical two-chamber; AP3 = apical three-chamber; AP4 = apical four-chamber; GL = global longitudinal.
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the differences ±1.96SD.11 Additionally, the coefficient of variation was provided 
(SD of the differences of 2 measurements divided by their mean).
results
Study population
Of the 155 subjects who came to our medical centre, 147 were included (age 44.6 ± 
13.7 years, 50% female). Table 1 shows the characteristics of the study population 
per age group. Eight subjects were excluded for various reasons: breast implants 
(n=2), valvular pathology (n=2), surgically closed patent ductus arteriosus (n=1), 
hypertension (n=1), morbid obesity (n=1), and right bundle branch block on ECG 
(n=1). Due to technological reasons, the echocardiographic images of 2 subjects 
had not been exported to the QLAB working station.
Left ventricular longitudinal strain 
Among the 145 remaining subjects, the feasibility of peak systolic LV GLS on A4C 
and A2C was 99%, on A3C 97%, and LV GLS based on all three apical views 97%. 
Figure 2 shows the feasibility per segment on each view. The mean LV GLS of 
the healthy subjects was -20.8 ± 2.0%. The mean global and segmental strains of 
the three apical views are summarized per age group in Table 2. LV GLS did not 
decrease significantly with advancing age (Figure 3). However, comparing GLS of 
subjects >55 years old (n=35) versus ≤55 years (n=106), resulted in a lower strain 
in the older subjects (-20.2 ± 2.0% vs. -21.0 ± 2.0%, P=0.029). In all age groups, the 
apical segments showed higher peak systolic strain than the basal segments. 
Apical four-chamber Apical three-chamber Apical two-chamber
99%
99%
99%99%
99% 99%
99%
septal lateral
97%
97%
97%
97%
97%
97%97%
anteroseptalinferolateral 99%
94%99%
99% 97%
99%98%
inferior anterior
Figure 2 The feasibility of strain calculation per segment
Each number reflects the percentage of possible strain measurements of that segment in our cohort.
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Relationships with left ventricular global longitudinal strain 
Males had significantly lower LV GLS than females (-20.1 ± 1.8% vs. -21.5 ± 2.0%, 
P<0.001). Figure 4 presents the median GLS for males and females stratified by age. 
Table 3 shows the results of univariable and multivariable regression analyses 
with GLS as dependent variable. There was a linear decrease in GLS with increas-
ing blood pressure and BSA, but no relationship was found with age as continuous 
Table 1 Characteristics of the study population
  Age group (yrs)
20-29 30-39 40-49 50-59 60-72
Characteristic n=32 n=28 n=28 n=31 n=28
Sex, female 16 (50%) 14 (50%) 14 (50%) 16 (52%) 14 (50%)
Age (years) 26 ± 3 35  ±  3 44  ±  3 55  ±  3 64  ±  3
Current smoker  2 (6%) 1 (4%) 4 (14%) 5 (16%) 1 (4%)
Physical examination
Body mass index (kg/m2) 22.3  ±  2.1 24.1  ±  3.4 24.6  ±  3.7 25.4  ±  2.8 25.8  ±  3.1
Body surface area (m2) 1.84  ±  0.17 1.89  ±  0.18 1.92  ±  0.22 1.92  ±  0.18 1.90  ±  0.19
Systolic blood pressure (mmHg) 124  ±  13 121  ±  10 123  ±  12 130  ±  15 137  ±  17
Diastolic blood pressure (mmHg) 76  ±  8 78  ±  7 80  ±  10 83 ± 11 83 ± 8
ECG
Sinus rhythm 32 (100%) 28 (100%) 28 (100%) 31 (100%) 28 (100%)
Heart rate (bpm) 61 ± 11 60 ± 8 61 ± 10 62 ± 9 65 ± 10
PR interval (ms) 156 ± 24 150 ± 21 156 ± 24 159 ± 16 173 ± 18
QRS duration (ms) 96 ± 8 97 ± 9 97 ± 9 95 ± 10 97 ± 10
Echocardiography, left ventricle
End-diastolic dimension (mm) 46.4 ± 3.2 46.9 ± 3.2 45.3 ± 3.9 44.8 ± 4.5 44.0 ± 5.1
End-systolic dimension (mm) 28.6 ± 3.2 28.3 ± 3.3 28.4 ± 4.6 28.2 ± 4.2 28.0 ± 6.2
E wave (m/s) 0.80 ± 0.16 0.75 ± 0.16 0.66 ± 0.15 0.65 ± 0.11 0.59 ± 0.13
A wave (m/s) 0.39 ± 0.14 0.43 ± 0.08 0.47 ± 0.10 0.56 ± 0.12 0.62 ± 0.17
Deceleration time (ms) 177 ± 29 181 ± 32 185 ± 29 194 ± 31 216 ± 64
E’ (cm/s) 12.5 ± 1.8 10.4 ± 1.6 9.2 ± 1.6 8.2 ± 1.8 6.8 ± 1.7
E/A-ratio 2.27 ± 0.77 1.80 ± 0.40 1.43 ± 0.38 1.21 ± 0.34 1.01 ± 0.32
E/E’-ratio 6.45 ± 1.35 7.27 ± 1.47 7.29 ± 1.71 8.11 ± 1.44 9.04 ± 2.42
End-systolic volume (mL) 47 ± 11 47 ± 13 51 ± 15 45 ± 12 48 ± 16
End-diastolic volume (mL) 117 ± 23 120 ± 23 125 ± 31 116 ± 21 116 ± 31
End-systolic volume / BSA (mL/m2) 25.4 ± 5.1 24.7 ± 6.2 26.2 ± 5.5 23.2 ± 5.1 25.0 ± 6.9
End-diastolic volume / BSA (mL/m2) 63.9 ± 9.5 63.1 ± 9.9 64.1 ± 10.9 60.5 ± 8.0 60.6 ± 12.2
Ejection fraction (biplane) (%) 60.4 ± 3.6 61.4 ± 5.0 59.2 ± 4.5 61.9 ± 5.3 59.2 ± 4.5
Values are presented as n (%) or mean ± SD. A = peak mitral inflow velocity at late diastole; E = peak mitral inflow 
velocity at early diastole; E’ = early diastolic annular myocardial velocity. 
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variable. A higher GLS was associated with more favourable indices of diastolic 
function and with smaller LV end-diastolic and end-systolic volumes. 
Because of the relationship between GLS and BSA, we additionally performed 
univariable regression analysis of GLS indexed for BSA. Indexing for BSA strength-
ened most of the significant correlations with the subjects’ characteristics (Table 
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Figure 3 Correlation between left ventricular peak systolic global longitudinal strain and age
This scatter plot represents one person’s left ventricular peak systolic global longitudinal strain value versus 
his/her age. No significant relationship could be observed between these two variables.
*To aid interpretation of the Pearson’s correlation coefficient, global longitudinal strain has been analyzed as 
positive number. LV = left ventricular.
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Figure 4 Median left ventricular global longitudinal strain stratified by sex and age
*P<0.05 Strain values are presented as median [IQR] by sex and age group. LV = left ventricular.
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3). In multivariable analysis, sex, systolic blood pressure, E wave and LV end-
systolic volume remained significant predictors for GLS indexed for BSA (Table 3).
Left ventricular longitudinal strain rate
LV peak systolic strain rates per age group are given in Table 4. Linear regression 
analysis showed lower strain rates on the A4C and A2C with increasing age. Strain 
rates were comparable between men and women. Correlation analysis between 
strain rate and BSA showed that on the A4C 6 out of 7 segments correlated signifi-
cantly, on the A3C 1 out of 7, and on the A2C 5 out of 7.
Table 2 Left ventricular peak systolic global and segmental longitudinal strain
Age (years) 20-29 30-39 40-49 50-59 60-72 P-value*
 n=31 n=28 n=27 n=30 n=27  
GLS (%) -20.8 ± 1.9 -21.3 ± 1.9 -20.7 ± 2.2 -21.1 ± 2.4 -20.0 ± 1.5 0.189
GLS apical 4-chamber -21.1 ± 2.0 -21.4 ± 2.1 -20.9 ± 2.5 -21.0 ± 2.9 -19.9 ± 1.7 0.068
Basal septal -16.4 ± 2.3 -16.9 ± 2.7 -16.5 ± 3.2 -15.8 ± 3.5 -14.1 ± 2.7 0.001
Mid septal -18.6 ± 3.1 -18.6 ± 2.7 -16.8 ± 3.7 -17.0 ± 3.3 -16.0 ± 2.8 0.001
Apical septal -27.0 ± 3.4 -27.3 ± 2.7 -27.4 ± 3.9 -28.4 ± 4.6 -27.1 ± 3.6 0.377
Apex -25.2 ± 2.5 -25.1 ± 2.5 -24.5 ± 3.2 -25.2 ± 3.9 -23.9 ± 2.6 0.349
Apical lateral -23.4 ± 2.5 -23.1 ± 3.1 -21.8 ± 3.7 -22.0 ± 3.8 -20.7 ± 2.4 0.003
Mid lateral -18.9 ± 3.4 -20.2 ± 2.7 -20.5 ± 3.0 -20.1 ± 3.4 -18.5 ± 2.8 0.883
Basal lateral -19.1 ± 2.5 -19.3 ± 3.0 -19.3 ± 3.3 -19.3 ± 3.6 -19.1 ± 2.1 0.961
GLS apical 3-chamber -20.2 ± 2.5 -21.5 ± 2.4 -21.4 ± 2.5 -21.4 ± 3.3 -20.8 ± 2.7 0.264
Basal inferolateral -17.3 ± 3.7 -18.5 ± 3.1 -19.8 ± 3.6 -18.9 ± 3.5 -19.9 ± 4.0 0.016
Mid inferolateral -21.2 ± 3.6 -22.8 ± 4.1 -22.3 ± 3.2 -21.9 ± 4.4 -21.2 ± 4.2 0.748
Apical lateral -21.4 ± 3.2 -22.2 ± 3.2 -21.5 ± 3.6 -22.3 ± 4.5 -20.6 ± 2.8 0.684
Apex -22.4 ± 3.2 -23.4 ± 3.0 -23.4 ± 4.4 -23.4 ± 4.7 -22.2 ± 3.5 0.586
Apical anterior -23.3 ± 4.1 -24.7 ± 4.1 -25.3 ± 5.7 -24.4 ± 6.2 -24.3 ± 4.4 0.273
Mid anteroseptal -19.7 ± 3.1 -20.4 ± 3.7 -20.0 ± 4.3 -20.8 ± 4.6 -19.8 ± 2.9 0.449
Basal anteroseptal -17.4 ± 3.2 -19.4 ± 3.2 -18.2 ± 2.8 -19.4 ± 3.7 -18.4 ± 3.8 0.131
GLS apical 2-chamber -20.9 ± 2.1 -21.0 ± 2.1 -20.1 ± 2.6 -20.8 ± 2.5 -19.3 ± 1.9 0.015
Basal inferior -16.8 ± 2.9 -16.9 ± 3.0 -17.1 ± 3.5 -16.5 ± 3.7 -15.2 ± 3.2 0.087
Mid inferior -19.3 ± 2.9 -18.7 ± 3.0 -18.1 ± 3.3 -18.3 ± 3.2 -17.0 ± 2.6 0.006
Apical inferior -25.5 ± 3.0 -25.9 ± 2.7 -24.5 ± 3.4 -26.2 ± 3.3 -24.4 ± 2.8 0.258
Apex -23.4 ± 2.7 -24.0 ± 2.6 -22.3 ± 3.0 -24.0 ± 3.3 -21.9 ± 2.3 0.155
Apical anterior -21.7 ± 3.0 -22.0 ± 3.2 -20.6 ± 3.3 -22.5 ± 3.9 -19.5 ± 2.7 0.084
Mid anterior -21.1 ± 3.2 -20.9 ± 3.1 -19.2 ± 3.3 -19.8 ± 3.9 -19.4 ± 3.4 0.006
Basal anterior -19.1 ± 2.9 -19.4 ± 4.3 -19.7 ± 3.8 -19.3 ± 3.1 -18.6 ± 3.2 0.359
Values are presented as mean ± SD. *Using linear regression analysis. GLS = global longitudinal strain.
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Intra-observer and inter-observer agreement
The intra-observer agreement for LV GLS was 0.01 ± 0.57%, and the inter-observer 
agreement -0.67 ± 0.91%. Figure 5 presents the linear correlation and Bland-Altman 
plots for the intra-observer and inter-observer measurements.  
disCussion
To our best knowledge, this prospective cohort study consisting of 147 healthy 
volunteers and who are stratified per age decade, is the first study reporting nor-
mal LV longitudinal strain values after the strain standardization initiative of the 
Table 4 Left ventricular peak systolic strain rates per age group
Age (years) 20-29 30-39 40-49 50-59 60-72 P-value*
 n=31 n=28 n=27 n=30 n=27  
Apical 4-chamber
Basal septal (s-1) -0.79 ± 0.12 -0.84 ± 0.11 -0.81 ± 0.18 -0.77 ± 0.14 -0.69 ± 0.13 0.002
Mid septal -0.92 ± 0.15 -0.92 ± 0.15 -0.85 ± 0.18 -0.87 ± 0.17 -0.78 ± 0.13 0.002
Apical septal -1.26 ± 0.18 -1.26 ± 0.16 -1.25 ± 0.19 -1.25 ± 0.16 -1.16 ± 0.20 0.134
Apex -1.22 ± 0.17 -1.16 ± 0.13 -1.12 ± 0.18 -1.12 ± 0.19 -1.02 ± 0.14 <0.001
Apical lateral -1.22 ± 0.22 -1.11 ± 0.16 -1.01 ± 0.23 -1.04 ± 0.23 -0.90 ± 0.13 <0.001
Mid lateral -1.00 ± 0.13 -1.03 ± 0.14 -0.98 ± 0.17 -0.99 ± 0.15 -0.91 ± 0.13 0.026
Basal lateral -1.00 ± 0.16 -0.97 ± 0.17 -0.99 ± 0.16 -0.90 ± 0.16 -0.91 ± 0.12 0.008
Apical 3-chamber
Basal inferolateral -0.93 ± 0.15 -1.01 ± 0.17 -0.98 ± 0.18 -0.94 ± 0.14 -0.93 ± 0.23 0.733
Mid inferolateral -1.03 ± 0.18 -1.09 ± 0.19 -1.06 ± 0.17 -1.05 ± 0.15 -1.02 ± 0.20 0.547
Apical lateral -1.00 ± 0.17 -1.05 ± 0.13 -1.00 ± 0.14 -1.02 ± 0.21 -0.93 ± 0.15 0.097
Apex -1.01 ± 0.13 -1.06 ± 0.11 -1.05 ± 0.17 -1.04 ± 0.21 -0.99 ± 0.19 0.948
Apical anterior -1.05 ± 0.16 -1.11 ± 0.15 -1.12 ± 0.24 -1.09 ± 0.26 -1.09 ± 0.24 0.405
Mid anteroseptal -0.97 ± 0.13 -0.99 ± 0.16 -0.99 ± 0.20 -0.97 ± 0.16 -0.94 ± 0.20 0.873
Basal anteroseptal -0.84 ± 0.16 -0.95 ± 0.16 -0.92 ± 0.15 -0.92 ± 0.18 -0.87 ± 0.19 0.595
Apical 2-chamber
Basal inferior -0.80 ± 0.15 -0.79 ± 0.09 -0.80 ± 0.15 -0.77 ± 0.13 -0.71 ± 0.12 0.013
Mid inferior -0.92 ± 0.15 -0.87 ± 0.11 -0.89 ± 0.16 -0.89 ± 0.13 -0.83 ± 0.13 0.053
Apical inferior -1.17 ± 0.14 -1.17 ± 0.12 -1.12 ± 0.15 -1.13 ± 0.11 -1.06 ± 0.16 0.004
Apex -1.08 ± 0.14 -1.07 ± 0.10 -1.01 ± 0.15 -1.03 ± 0.11 -0.96 ± 0.13 0.001
Apical anterior -1.01 ± 0.17 -1.00 ± 0.12 -0.95 ± 0.16 -0.99 ± 0.16 -0.91 ± 0.15 0.028
Mid anterior -0.98 ± 0.17 -0.98 ± 0.16 -0.92 ± 0.14 -0.91 ± 0.17 -0.91 ± 0.16 0.005
Basal anterior -0.89 ± 0.17 -0.89 ± 0.15 -0.90 ± 0.17 -0.87 ± 0.13 -0.84 ± 0.14 0.088
Values are presented as mean ± SD. *Using linear regression analysis.
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task force.10 Sex, BSA and blood pressure were the most important anthropometric 
factors that influence LV GLS assessed with QLAB, whereas age did not. Strain 
rates were lower with increasing age and did not differ between men and women. 
Left ventricular longitudinal strain
LV GLS was feasible in 97% of the subjects, and GLS on A4C and A2C even in 99%, 
which is an important amenity for the wider use of GLS on a daily basis in the 
clinical setting. The mean GLS of our study cohort was -20.8 ± 2.0%, which is 
COV = 2.7%
-0.67
1.11
-2.45
0.01
1.12
-1.10
COV = 4.2%
Figure 5 Linear correlation and Bland-Altman plots for intra-observer and inter-observer mea-
surements of left ventricular global longitudinal strain
First row (A) refers to intra-observer agreement with one observer analyzing the same dataset twice. Second 
row (B) refers to inter-observer agreement with two observers analyzing the same dataset. In the Bland-Altman 
plots on the right side, the striped lines depict the mean difference of two measurements, and the dashed lines 
depict the limits of agreement (1.96SD). COV = coefficient of variation.
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comparable with the reported -19.7% in a meta-analysis.8 However, the majority of 
included studies in that meta-analysis used software of another vendor. Moreover, 
the included studies are dated and therefore newer versions of the software are 
already in use. 
We observed LV segmental strain heterogeneity: longitudinal strain gradually 
increased from the basal to apical segments in all age groups, which is in line 
with the results reported by Sun et al.12 Nowadays, analyzing regional ventricular 
function becomes more-and-more important. An increasing number of studies 
state that it is especially the function of some of the regions that are impaired 
in different types of heart diseases, for example decreased basal strain in hyper-
trophic cardiomyopathy and aortic stenosis.13,14 Even in patients with primarily 
right-heart pathology, evaluating regional LV deformation could be of particular 
importance. Patients with repaired tetralogy of Fallot had a decreased LV septal 
strain indicating that right ventricular dysfunction negatively affects LV function, 
which is called ventricular-ventricular interaction.15
Relationships with sex, age and body surface area 
The cut-off value for normal LV ejection fraction is higher in women than men.1 
The same should be applied for longitudinal strain, because we found significant 
greater values in women, which corroborates with previous STE studies12,16 and 
a recent study with feature-tracking cardiovascular magnetic resonance (CMR).17 
In a relatively large sample of the general population, where longitudinal strain 
was measured with colour Doppler myocardial imaging,18 no sex differences were 
found, neither in a meta-analysis by Yingchoncharoen et al.8 The different vendors 
that have been included might have had an influence. 
We did not observe a clear relationship between age and GLS, neither per age 
decade, nor as linear correlation. This might be explained by our relatively low 
sample size. On the other hand, the absence of a relationship was also reported on 
GLS assessed with feature-tracking CMR.17 However, we did find a significant differ-
ence in strain between subjects ≤55 years old and subjects >55. Dividing subjects 
in groups younger and older than 55 years has also been performed by Sun et al. 
resulting in a slightly lower strain in the older patients.12 In a study including over 
1,200 healthy individuals with a maximum age of 89 years, systolic strain was also 
lower with increasing age.19 Due to the fact that age often goes along with higher 
blood pressure and BSA, it seems plausible that at a certain age, decrease in strain 
could occur. After adjustment for various anthropometric variables, GLS did not 
associate with age as continuous variable in a meta-regression analysis.8 There-
fore, we postulate that age itself is not the most important and clinical relevant 
factor for interpreting strain results. However, we did not include subjects >72 
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years. Those subjects may have a lower GLS than the subjects of our cohort, but 
this assumption has to be investigated. It is however, not easy to include subjects 
above 72 years of age without history of or risk factors for cardiovascular disease.
We found a weak to moderate positive correlation between GLS and BSA. 
Such correlation had also been described with the use of feature-tracking CMR 
in healthy controls,17 and, though weaker, with STE.12 Because of this correlation 
and the possible interaction between BSA and other anthropometric and echo-
cardiographic measurements, we decided to index GLS for BSA. This indexation 
resulted in stronger correlations regarding systolic and diastolic blood pressure, 
some diastolic function indices and LV end-diastolic and end-systolic volumes. 
Additionally, the sex-difference in strain became larger. That is why we advise to 
correct for BSA and sex.
Relationship with blood pressure
Even though all our subjects were healthy and did not have hypertension, we 
still observed a moderate correlation between higher blood pressure and lower 
GLS. A similar correlation was also found in a meta-analysis with a larger sample 
of healthy subjects.8 In patients with hypertension, decreased GLS was reported 
in the presence of a normal or even supranormal LV ejection fraction.20 As a com-
pensatory mechanism for preserving the ejection fraction, these patients had an 
increased twist compared to normal controls.20 It is generally known that, besides 
aging,21 hypertension is associated with alterations in diastolic LV function.22 
In our healthy cohort, some of the diastolic function indices, such as E wave, 
deceleration time, E prime and E/A ratio showed significant relationships with 
GLS. Even after implementation the ‘E wave’ in a multivariable regression model, 
it remained a significant determinant for GLS. A recently published paper of the 
CARDIA study described that higher cumulative exposure to blood pressure over 
25 years from young adulthood to middle age was associated with lower LV longi-
tudinal strain and diastolic dysfunction, but not with LV ejection fraction.23 These 
findings reflect that GLS is a load dependent parameter and that a relatively small 
increase in afterload will result in lower longitudinal strain. The fact that GLS cor-
relates with blood-pressure values at the time of echocardiography in our cohort, 
makes no distinction whether GLS is just a pure reflection of the current degree of 
afterload or a reasonable and sensitive marker for incipient LV dysfunction caused 
by chronic hypertension. The definition of hypertension is traditionally based on 
office blood-pressure measurements.24 However, blood pressure could be elevated 
in the office and normal out of the office which is termed white-coat hypertension, 
whereas masked hypertension refers to a normal blood pressure in the office and 
abnormally high out of the medical environment.22 Hence, out-of-office blood-
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pressure measurements play an important role in hypertension management,22,24 
but home and ambulatory blood-pressure monitoring both have their limitations. 
It would be helpful if STE-derived strain can serve, already in a preclinical state, 
as an objective diagnostic tool to determine the severity of hypertension without 
the interference of overestimation (white-coat hypertension) or underestimation 
(masked hypertension). Whether decreased strain really can serve as an early 
marker and reasonable predictor of hypertension and future heart failure in this 
patient population has to be investigated in a follow-up study.  
Left ventricular longitudinal strain rate
In contrast to strain, longitudinal strain rates of most of the segments did signifi-
cantly decrease over the age decades, but regarding sex no clear differences were 
found. Studies evaluating the effects of age on strain rate are scarce, and studies 
reporting strain rates measured with the newer STE software versions even more. 
Although not measured with STE but with Doppler imaging, strain rate showed 
significant dependence on age in some studies.18,19,25 It has been supposed that 
slower calcium cycling with age leads to longer systolic contraction periods. This 
physiological mechanism may be an explanation for the fact that decrease in tis-
sue displacement is less age-related than decrease in velocity.25,26 Therefore, peak 
systolic strain could be preserved despite lower peak strain rate.
Intra-observer and inter-observer agreement
The intra-observer and inter-observer agreement were excellent and evidently 
better than previously reported by others.12,16 The improvement is probably a re-
sult of the more automated software that now have been used and is an important 
finding making GLS more sound for clinical use. 
Study limitations
Between-vendor variability is often mentioned as a limitation to the clinical appli-
cation of strain imaging. In this study, we only used Philips ultrasound equipment 
and QLAB software. However, after the implementation of the standardization pro-
cess, the variability of GLS in the later developed software versions between two 
leading ultrasound manufactures have been reduced 7 making the values reported 
by us more widely applicable nowadays. Due to the relatively small sample size, 
the conclusions should be interpreted with caution.
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ConClusions
Our study resulted in normative LV GLS values assessed with QLAB 10 in a healthy 
population aged 20 to 72 years. Sex, BSA and blood pressure influence LV GLS, 
whereas age does not. Indexation of GLS for BSA results in stronger correlations 
regarding blood pressure and sex. For interpretation of strain results in clinical 
practice, it is crucial to take these factors into account. That is why we advise to 
correct strain measurements for BSA and sex. 
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abstraCt
Aims
The aim of this study was to evaluate the feasibility of transthoracic two-dimen-
sional (2D) iRotate, a new echo modality, to assess the whole right ventricle (RV) 
from a single transducer position based on anatomic landmarks.
Methods and Results
The anatomic landmarks were first defined based on three-dimensional echo-
cardiographic datasets using multiplane reconstruction analyses. Thereafter, 
we included 120 healthy subjects (51% male, age range 21-67 years). Using 2D 
iRotate, four views of the RV could be acquired based on these landmarks. The 
anterior, lateral, inferior wall (divided into three segments: basal-mid-apical), and 
right ventricular outflow tract (RVOT) anterior wall of the RV were determined. 
The feasibility of visualization of RV segments and Tricuspid annular plane sys-
tolic excursion (TAPSE) and TDI measurements were assessed. To evaluate this 
model for diseased RVs, a small pilot study of 20 patients was performed. In 98% 
of healthy subjects and 100% of patients, iRotate mode was feasible to assess the 
RV from one single transducer position. In total, 86% and 95%, respectively, of the 
RV segments could be visualized. The visualization of the RVOT anterior wall was 
worse 23% and 75%, respectively. TAPSE and TDI measurements on all four views 
were feasible 93% and 92%, respectively, of the healthy subjects and in 100% of 
the patients.
Conclusion
With 2D iRotate, a comprehensive evaluation of the entire normal and diseased RV 
is feasible from a fixed transducer position based on anatomic landmarks. This is 
less time-consuming than the multiview approach and enhances accuracy of RV 
evaluation. Imaging of the RVOT segment remains challenging.
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introduCtion
Assessment of right ventricular (RV) function is increasingly recognized as a prog-
nostic factor in a variety of diseases such as left-sided heart failure, pulmonary 
hypertension and congenital heart disease in the acute phase and during follow 
up.1 In everyday clinical practice, two-dimensional (2D) transthoracic echocar-
diography (TTE) remains the technique that is most often used for the assess-
ment of ventricular function. Unlike the left ventricle (LV) that can be completely 
visualized from one apical window, for a comprehensive evaluation of RV size and 
function, a multiview approach is necessary.2-6 However, this multiview approach 
is impractical in a routine setting: it is time-consuming, operator dependent, and 
inaccurate due to the complex RV geometry. Current echocardiographic meth-
odologies do not provide a robust assessment of RV function. Serial follow-up of 
RV measurements and function parameters result in significant inaccuracies from 
oblique plane acquisitions due to the lack of fixed landmarks.2, 4 A standardized 
echocardiographic approach taken from one acoustic window where an anatomic 
landmark in the image plane can be used to identify a specific RV wall could in-
crease the accuracy of assessment of RV function in routine follow-up. The aim of 
this study was: (1) to investigate whether there are unique anatomic landmarks 
that could be used as a reference point to depict a specific RV wall from one 
standard acoustic window, the apical window, (2) to evaluate the feasibility of 2D 
transthoracic iRotate mode, a new echo modality, to comprehensively assess the 
RV based on these anatomic landmarks, and (3) to demonstrate in a small pilot 
group of patients with a diseased RV the feasibility of this technique for further 
investigation.
Methods
Definition of anatomic landmarks based on 3D echo
In order to identify anatomic landmarks, seen in views that demonstrate specific 
RV walls, and to determine how to steer a 2D imaging plane (iRotate, Philips Medi-
cal systems, Best, the Netherlands) using a matrix-array transducer in order to 
acquire these views, we first examined several three-dimensional (3D) echocar-
diographic data sets. A total of 15, 3D datasets, acquired from the apical window, 
from normal subjects, and from patients with acquired and congenital (dilated 
RVs) heart disease, were examined with the TomTec 4D cardio-View 3.0 (TomTec-
Arena version 1.2, TomTec, Munich, Germany) using the multiplane reconstruction 
analysis (MPR). The TomTec software features a quad screen display with three 2D 
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cut planes (sagittal, transverse, and coronal) and a 3D volume cube, created from 
a 3D volume dataset. With MPR, three planes (sagittal, transverse, and coronal) 
can be positioned through a region of interest and moved simultaneously. The 
four-chamber (4C) view displayed in the sagittal plane was adjusted to center the 
interventricular septum (IVS)-RV apex along the midline and then transected at 
the base of the right and left ventricle (Figure 1A). The corresponding short-axis 
view, displayed in the transverse plane, shows anterior, lateral, and inferior wall 
of the RV (Figure 1B and 1C). With the MPR, it is possible to rotate around the 
IVS in this transverse plane, thereby anatomic landmarks could be defined in the 
corresponding sagittal plane.
Identified anatomic landmarks
In all examined 3D datasets, the four walls (anterior, lateral, inferior, and right ven-
tricular outflow tract (RVOT) anterior wall) of the RV could be identified according 
to a unique anatomic landmark. The anatomic landmarks that we identified were 
as follows:
• Mitral valve (standard 4C view): showing the lateral wall of the RV
• Coronary sinus: showing the anterior wall of the RV
Figure 1
A. Display of the sagittal plane from the TomTec 4D Cardio-View multiplane reconstruction analysis program 
showing the right side of the interventricular septum (IVS) along the centerline. The white solid line depicts 
the position of the cut plane for the transverse image, B. B. Display of the transverse plane showing the basal 
short-axis view of the right ventricle (RV). The cut plane (white solid line) transverses the lateral wall of the RV, 
IVS and left ventricle (LV). C. Schematic drawing of the transverse plane of the RV as seen in B. The RV walls 
displayed are as follows: Ant = anterior; Lat = lateral; Inf = inferior.
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• Aortic valve: showing the inferior wall of the RV
• RVOT: showing the RVOT anterior and inferior wall of the RV.
The rotation around the IVS and the corresponding anatomic landmark identified 
in the sagittal plane are shown in Figure 2.
Assessment of RV function with iRotate mode
The study was conducted in two phases: First, our proposed model was examined 
in healthy subjects, and then, a pilot study on patients with a diseased RV was 
performed.
Figure 2
Schematic drawings and multiplane reconstruction of echocardiographic images displayed using the TomTec 
4D Cardio-View analysis program. Left: schematic drawing and echocardiographic images of the cut planes A-D 
displaying the right ventricle (RV) in the transverse plane, viewed from the RV aspect. LV=left ventricle. Right: 
schematic drawing and echocardiographic images of the cut planes A-D from the RV and corresponding land-
mark in the sagittal plane. A. Four-chamber view (0°). Landmark mitral valve giving rise to the lateral wall. B. 
Coronary sinus view (+40°). Landmark coronary sinus (CS) giving rise to the anterior wall. C. Aortic view (-40°). 
Landmark aortic valve (AoV) giving rise to the inferior wall. D. Coronal view (-90°). Landmark right ventricular 
outflow tract (RVOT) giving rise to the RVOT anterior wall.
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Healthy population
We prospectively recruited 120 healthy subjects (51% male, age range 21-67 
years) with no medical history or current symptoms that suggested cardiovas-
cular disease. All subjects underwent physical examination, a standard 12-lead 
electrocardiogram and a detailed echocardiogram with the addition of four apical 
views of the RV, according to the unique anatomic landmarks as described above. 
Exclusion criteria were any abnormal findings on the physical examination, elec-
trocardiogram, or echocardiogram. The study was carried out according to the 
principles of the Declaration of Helsinki and approved by the local medical ethics 
committee. Written informed consent was obtained from all subjects.
Pilot study patients
An additional, pilot test population, which is comprised of 20 adult patients (55% 
male, age range 18-70 years) with RV pathology, consequent to congenital heart 
disease, was studied to observe whether this 13-segment model was feasible in 
a diseased state. We did not perform this pilot test to evaluate RV function in 
a quantitative manner. The patients prospectively included were referred to the 
echocardiography department for routine measurements of their cardiac function 
and had a sufficient acoustic window. Ten patients had a volume overloaded RV 
due to atrial septal defect (n=4), tetralogy of Fallot with severe residual pulmonary 
regurgitation (n=6). Ten patients had a pressure overloaded RV (Doppler tricus-
pid regurgitation velocity >3m/sec), pulmonary hypertension (n=3), pulmonary 
homograft stenosis (n=2), systemic RV consequent to an atrial switch operation 
in infancy for D-transposition of the great arteries (n=5). All patients were in New 
York Heart Association (NYHA) class I or II. A complete 2D echocardiogram includ-
ing four additional apical RV views was acquired as for the healthy subjects.
Transthoracic 2D iRotate mode
Two experienced echocardiographers (JMcG, WV) performed the 2D echocar-
diograms including four additional apical views of the RV acquired with iRotate 
mode. In iRotate mode a full electronic rotation of 360° (adjustable by 5° steps) 
can be performed.7 All studies were acquired in harmonic imaging using an iE33 
or EPIQ7 ultrasound system (Philips Medical systems, Best, the Netherlands) 
equipped with a X5-1 matrix-array transthoracic probe. From the apical window, a 
standard apical 4C view was adjusted to acquire a focused nonforeshortened RV 
view with the IVS-RV apex centered along, or as near as possible, to the midline 
of the sector. With the iRotate mode an approximate 130° electronic rotation was 
performed. Using the anatomic landmarks, as defined above, four standard views 
of the RV were acquired during end-expiratory breath-hold (Figure 3).
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• Four chamber view at 0°
• Coronary sinus view at approximately +40°
 (slight posterior angulation of the transducer maybe necessary)
• Aortic view at approximately -40°
 (slight anterior angulation of the transducer maybe necessary)
• Coronal view (RVOT) at approximately -90°
Images of a pressure and volume overloaded RV acquired with 2D iRotate are 
shown in Figure 4.
Learning curve
The impact of a learning curve on the feasibility of endocardial borders delinea-
tion of RV segments in our proposed model was sought by comparing data from 
the first consecutive 20 subjects with the following consecutive 20 subjects.
Right ventricular wall segmentation according to the 
echocardiographic views
We analyzed the walls of the RV in the four views and divided each wall into three 
segments: basal, mid-, and apical segment (segments 1-12). In the coronal view, 
the RVOT anterior wall was defined as the 13th segment (Figure 3). The IVS was 
not included in this model, as it does not exclusively reflect RV function.4, 8 In total, 
the visualization of the RV wall was evaluated for 13 segments. An experienced 
echocardiographer (JMcG) analyzed all the 13 segments in a dynamic format and 
graded each segment: 0 = not visible; 1 = partially visible (part of the segment or 
0% 20% 40% 60% 80% 100%
Optimal
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Figure 3
Schematic drawing of the cut planes (A-D) with their corresponding echocardiographic images:
Left: 2D right ventricle (RV) image. Center: Tricuspid annular plane systolic excursion (TAPSE). Right: Tricuspid 
annular peak systolic velocity (S’) for each cut plane in a healthy subject. Mean value of TAPSE and S’ calculated 
from all views is 33 mm and 13.9 cm/sec, respectively. (A) Four-chamber view with segments 1-3, (B) coronary 
sinus view with segments 4-6, (C) aortic view with segments 7-9, (D) coronal view with segments 10-13.
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the whole segment is visible during only part of the cardiac cycle); 2 = visible (the 
whole segment is visible during the entire cardiac cycle) and 3 = optimal (excellent 
delineation of endocardium during the entire cardiac cycle).
TAPSE and TDI
Tricuspid annular plane systolic excursion (TAPSE) was measured with 2D echo-
cardiography-guided M-mode, and tricuspid annular peak systolic velocity (S’) 
was measured with the pulsed-wave tissue Doppler imaging technique (TDI) in all 
four RV images acquired with iRotate mode at the: (1) lateral tricuspid annulus in 
the four-chamber view, (2) anterior tricuspid annulus in the coronary sinus view, 
(3) inferior annulus in the aortic view, and (4) inferior annulus in the coronal view. 
All measurements, as stated in the guidelines, were obtained with the ultrasound 
beam as parallel as possible to the direction of the tricuspid annular motion of 
that segment.4 With sporadic use, when the ultrasound beam was not parallel to 
the tricuspid annular motion, a TAPSE measurement was taken directly on the 2D 
image at the end-diastolic position of the tricuspid annulus taken at the beginning 
RV
RV LV
RV
LV
C
A B
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Inf
Ant
Figure 4
Left (A-D). 2D iRotate in a patient with severe residual pulmonary regurgitation and impaired right ventricle 
(RV) systolic function. Left: 2D RV image. Center: Tricuspid annular plane systolic excursion (TAPSE). Right: 
Tricuspid annular peak systolic velocity (S’). Mean values of TAPSE and S’ calculated from all views are 17 mm 
and 6.1 cm/sec, respectively. Right (a-d). 2D iRotate in a patient with a systemic RV and impaired systolic func-
tion. Left: 2D RV image. Center: TAPSE. Right: TDI S’. Mean values of TAPSE and TDI S’ calculated from all views 
are 17 mm and 8.2 cm/sec, respectively. Note: both mean values of TAPSE and S’ are lower than in the healthy 
subjects. A(a) = four-chamber view, B(b) = coronary sinus view, C(c) = aortic view, D(d) = coronal view.
13-segment model for assessing right ventricular function 57
3
of the QRS complex and its greatest apical long-axis displacement. All recordings 
were performed during end-expiratory breath-hold.
Statistical analysis
Continuous variables are presented as mean ± standard deviation (SD), and cat-
egorical variables are presented as frequencies and percentages. Intra-observer 
agreement (JMcG) and inter-observer agreement (JMcG and MM) of the TAPSE 
and TDI peak systolic velocity (S’) were assessed by repeated analysis in 30 
datasets at least two months after the initial analysis. The agreement between 
two measurements was determined as the mean of the differences ± 1.96SD.9 Ad-
ditionally, the coefficient of variation (SD of the differences of two measurements 
divided by their mean) was provided. All statistical analyses were performed us-
ing SPSS statistics version 21.0 (IBM Corp., Armonk, NY, USA). A P-value of <0.05 
was considered significant.
results
Healthy population
The normal population comprised of 120 subjects with normal cardiac anatomy 
and function. Baseline characteristics of the normal population are listed in 
Table 1.
The additional acquisition time for our proposed model of four additional RV 
views is approximately 1-2 minutes. The iRotate mode, to assess the RV from the 
standard apical window, was feasible in 118 of the 120 (98%) healthy subjects. Two 
subjects were excluded from the study due to absence of apical window. One or 
more of the RV views could not be acquired with iRotate mode in an additional six 
subjects.
Table 1 Baseline characteristics of healthy subjects
Characteristic n=120
Age, years 43 ± 13
Men, n (%) 61 (51%)
Height, cm 174 ± 9
Weight, kg 74 ± 12
BMI, kg/m² 24 ± 3
Systolic blood pressure, mmHg 125 ± 14
Diastolic blood pressure, mmHg 79 ± 9
QRS duration, ms 96 ± 9
Baseline characteristics are expressed as mean ± SD or n.
58 Chapter 3
Transverse plane Sagittal plane
(0°)
(+40°)
(-40°)
(-90°)
Figure 5 Feasibility of the right ventricular (RV) segments for each view. Left: Healthy subjects 
(n=120). 1344 (86%) of the total 1560 RV segments were visualized. Note: this low percentage is 
mainly due to the poor visibility of the 13th segment. Right: Pilot study (n=20). 248 (95%) of the 
total 260 RV segments were visualized. Basal-mid-apical segment: 1-3 (four-chamber view), 4-6 
(coronary sinus view), 7-9 (aortic view), 10-12 (coronal view), 13 (right ventricular outflow tract 
anterior wall).
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Visualization of 13 segments of the right ventricle
The feasibility of the RV segments is shown in Figure 5. In the first 20 subjects, 
83% (215/260 segments) of the segments could be visualized; when excluding the 
RVOT segment, this was 88% (212/240 segments). In the following 20 subjects, 
86% (224/260 segments) of the segments could be visualized; when excluding the 
RVOT segment, this was 91% (218/240 segments)
In total, 1344 (86%) of 1560 RV segments could be visualized. The RVOT segment 
was only visualized in 27 (23%) subjects. After exclusion of this segment, 1317 
(91%) of the total 1440 RV segments were visualized.
TAPSE and TDI measurements
The feasibility per view and measurement of the TAPSE and the TDI velocity S’ are 
shown in Table 2. The TAPSE and TDI velocity S’ were lower in the coronal view 
than the mitral, aortic, and coronary sinus views.
Intra- and inter-observer variability
The mean differences and coefficients of variation for the intra- and inter-observer 
agreement of the TASPE and TDI velocity S’ are displayed in Table 3.
Table 2 Mean values of TAPSE and TDI (S’) for each RV view (n=120)
TAPSE mm TDI (S’) cm/sec
View N (%) Mean ± SD Range N (%) Mean ± SD Range
Four chamber 117 (98%) 26 ± 4 17 - 37 116 (97%) 12.0 ± 2.0 7.9 - 16.9
Coronary sinus 113 (94%) 27 ± 4 17 - 36 111 (93%) 12.0 ± 2.0 6.7 - 18.1
Aortic view 116 (97%) 25 ± 4 17 -3 3 113 (94%) 11.1 ± 2.1 6.3 - 15.6
Coronal view 111 (93%) 23 ± 3 14 - 33 110 (92%) 9.9 ± 1.9 6.1 - 14.0
Table 3 Intra- and inter-observer variability measurements for TAPSE and TDI (S’) (n=30)
 
 
Intra-observer Inter-observer
Mean 
difference
Coefficient of variation 
(%)
Mean 
difference
Coefficient of variation 
(%)
TAPSE Four chamber 0.0 ± 1.7 7 -0.4 ± 1.5 6
  Coronary sinus -0.4 ± 2.5 10 0.0 ± 2.1 9
  Aortic view -0.2 ± 2.5 10 0.0 ± 1.7 7
  Coronal view -0.5 ± 1.8 8 0.3 ± 1.9 9
TDI (S’) Four chamber 0.3 ± 1.3 12 0.2 ± 0.6 8
  Coronary sinus 0.0 ± 1.4 13 0.3 ± 0.9 5
  Aortic view 0.3 ± 1.2 13 0.1 ± 0.7 7
  Coronal view 0.1 ± 0.8 9 0.0 ± 0.5 5
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Pilot study patients
All patients in the pilot group had at least moderate RV dilatation. The RV systolic 
function varied between the diseased states. The iRotate mode was feasible in all 
study patients; the feasibility of the RV segments is shown in Figure 5. In total, 248 
(95%) of 260 RV segments could be visualized. The RVOT segment was classed 
partially visible in 12 and visible in three patients. TAPSE and TDI velocity S’ were 
feasible in all views in all patients.
disCussion
The current study shows that among unselected healthy subjects, a 13-segment 
standardized model for RV assessment is feasible using 2D iRotate mode, based 
on unique anatomic landmarks and achieved from a single acoustic window. The 
visibility of the RVOT anterior wall remains challenging; however, the visibility 
was higher in the diseased RV.
It is recommended to record multiple 2D images for assessment of RV func-
tion.4, 6, 10 This multiview approach, based on several acoustic windows, is sus-
ceptible to error (oblique views, operator dependency) and is a major limitation 
of RV assessment due to the lack of reproducibility on serial follow-up. Moreover, 
as this approach is not always feasible in the routine setting, often only the apical 
4C view is acquired and an RV analyses consists of dimension, right ventricular 
fractional area change (RVFAC), and TAPSE and TDI (S’) measurements. RV linear 
dimensions and regional function assessment are dependent on probe rotation 
and different views, and it is therefore recommended to state the window from 
which the measurement was performed in order to permit inter-study compari-
son.4, 6 Our study provides a robust and standardized RV segmentation.
With the introduction of transthoracic 3D echocardiography, the assessment 
of RV size and function in adults and children was thought to improve and solve 
some of the problems of 2D echocardiography.11 Theoretically, 3D echocardiog-
raphy could provide all information that could be added using our proposed 
model. Several studies have extensively investigated RV function and found that 
3D echocardiography improved the accuracy and reproducibility of RV assess-
ment and identified RV dysfunction quite accurately.12 However, most published 
data compose of small and rather selective patient populations based on mod-
erate to good image quality.13 In a real-world setting, Renella et al. evaluated 3D 
echocardiography of the RV in pediatric and congenital heart disease patients 
(age 1-20 years), and they found that RV volumes were measurable in only 58% of 
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the patients.13 Moreover, current ASE/EACVI recommendations acknowledge the 
limitations of performing 3D RV assessment in every patient.6
In this study, a comprehensive evaluation of the RV can be achieved, from one 
acoustic window, with 2D iRotate mode based on anatomic landmarks. Compared 
to the standard multiview approach, 2D iRotate evaluation of the RV takes only 
a few minutes making it very attractive and robust for routine use in the echo-
laboratory and at bedside. There is a short learning curve for data acquisition 
based on the fact that there was minimal increase in the feasibility score (83-86%) 
after the first 20 subjects. However, with less experienced echocardiographers, 
the learning curve could possibly be slightly longer. Of note, the 2D iRotate mode 
is limited to the matrix-array transducer. Furthermore, a true nonforeshortened 
RV view with the IVS-RV apex centered along, or as near as possible to, the midline 
of the sector is mandatory.
The feasibility of the RV segments, excluding the RVOT anterior wall, is good, 
with 81% of the segments adequately visible. The feasibility of the apical segments 
is less when compared to the mid- and basal segments, probably due to the sharp 
curvature of the RV apex and also, the known difficulty in obtaining high quality 
2D images in the near field, which could contribute to this finding.14
The feasibility of RVOT anterior wall is poor, visible in only 23% of the subjects 
of which 16% were scored partially visible. Reduced feasibility was also observed 
in the anterior wall in the coronary sinus view when compared to the feasibil-
ity of the lateral wall (mitral view), inferior wall (aortic view), and inferior wall 
(coronal view). This suboptimal visualization of the most anterior segments of the 
RV could be explained by the retrosternal position of the heart in the thorax. Also 
the long axis of the normal sized heart is superior-inferior (vertical), which again 
would contribute to the difficulty in visualizing the most anterior segments, with 
echocardiography.15
RV wall deformation consists of three components: radial, longitudinal, and 
circumferential. Despite their limitations, TAPSE and TDI (S’) are simple and re-
producible measurements used to assess RV longitudinal systolic function.4, 16, 17 
As far as we know, our current study is the first study to assess multiple TAPSE 
and TDI (S¢) measurements from the tricuspid annulus. TAPSE was feasible in 
one view or more in 93% or more and TDI (S¢) 92% or more healthy subjects. 
Both measurements fell into consistent ranges for normal subjects as stated in 
the guidelines for the apical 4C view (reference values: TAPSE 16-30 mm, TDI 10-
19 cm/s).4 Inter- and intra- observer variability were acceptable as coefficients of 
variation were <10% and <14%, respectively. Recently Forsha et al. investigated 
RV strain in an 18-segment model of the RV in 40 healthy subjects. The RV strain 
analysis was feasible, and the global peak strain and peak dyssynchrony measures 
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fell into consistent range for normal subjects. The authors acknowledged that the 
lack of universal standardized RV views is an obvious limitation of the study. In 
our study, we provide standardized RV views and segmentation as the basis for 
future RV analysis.
The pilot study
These patients were included simply to demonstrate whether this model is feasible 
in the diseased RV. The results are encouraging; the feasibility of the segments is 
similar to the normal RV. The feasibility of the apical segment, as in the healthy 
subjects, remains less when compared to the mid- and basal segment. However, 
feasibility of the segments in the coronal and RVOT view appears to be slightly 
better than in the healthy subjects. This could be explained by the fact that in 
the diseased RV (dilated or hypertrophic), the long axis of the heart is often more 
horizontal, and therefore, the sternum will compromise the image quality to a 
lesser degree.15 Also in the dilated RV, the apex is moved automatically more to 
the center of the 2D sector and the rotation around the RV with iRotate mode be 
noted to be easier than in the normal RV.
Clinical implementations
One of the critical limitations of 2D echo recordings is the potential for variabil-
ity in the 2D planes during follow-up. Well-defined anatomic landmarks result in 
robust image orientation, precise echocardiographic follow-up, and less oblique 
plane acquisition, implying that this simple approach could minimize or avoid 
such variability. With this method of scanning, the RV walls are visualized in their 
long axis. This could allow strain and strain rate imaging to be performed on more 
segments of the RV and its complex contraction pattern to be evaluated in more 
detail. Further studies are warranted to investigate these issues.
Limitations
This study provides a novel model of RV assessment of a potential value. There 
are some study limitations. First, we did not perform test-retest repeatability in 
this study. Our study comprised of a relatively small sample of RV pathology. Our 
model might not be feasible in patients with extremely dilated LVs because we will 
be unable to align the IVS-RV apex in the center of the imaging sector. Therefore, 
the clinical utility and the incremental value of our proposed model need to be 
confirmed in a larger population. Moreover, a direct comparative study between 
our 2D iRotate model and 3D echocardiography in a large consecutive series is 
warranted.
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ConClusion
2D transthoracic iRotate mode enables a comprehensive evaluation of the normal 
and diseased RV. Our proposed approach provides a standardized protocol for RV 
acquisition and assessment from a single acoustic window with a fixed transducer 
position, using simple anatomic landmarks. The anterior, lateral, inferior, and 
outflow tract anterior wall of the RV could be assessed; reducing acquisition time 
compared to the multiview approach and enhances the accuracy of RV evaluation. 
Further studies are warranted to discover the full potential of this new technique 
for evaluation of the RV in various diseased states.
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abstraCt
Background
Prospective data on long-term survival and clinical outcome beyond 30 years after 
surgical correction of tetralogy of Fallot are nonexistent.
Methods and Results
This longitudinal cohort study consists of the 144 patients with tetralogy of Fallot 
who underwent surgical repair at <15 years of age between 1968 and 1980 in our 
center. They are investigated every 10 years. Cumulative survival (data available 
for 136 patients) was 72% after 40 years. Late mortality was due to heart failure 
and ventricular fibrillation. Seventy-two of 80 eligible survivors (90%) participated 
in the third in-hospital investigation, consisting of ECG, Holter, echocardiography, 
cardiopulmonary exercise testing, N-terminal pro-brain natriuretic peptide mea-
surement, cardiac magnetic resonance (including dobutamine stress testing), and 
the Short Form-36 questionnaire. Median follow-up was 36 years (range, 31–43 
years). Cumulative event-free survival was 25% after 40 years. Subjective health 
status was comparable to that in the normal Dutch population. Although systolic 
right and left ventricular function declined, peak exercise capacity remained sta-
ble. There was no progression of aortic root dilation. A previous shunt operation, 
low temperature during surgery, and early postoperative arrhythmias were found 
to predict late mortality (hazard ratio, 2.9, 1.1, and 2.5, respectively). An increase 
in QRS duration and a deterioration of exercise tolerance and ventricular dysfunc-
tion did not predict mortality. Insertion of a transannular patch was a predictor for 
late arrhythmias (hazard ratio, 4.0; 95% confidence interval, 1.2–13.4).
Conclusions
Although many patients needed a reoperation or developed arrhythmias, late 
mortality was low, and the clinical condition and subjective health status of most 
patients remained good. Previous shunt, low temperature during surgery, and 
early postoperative arrhythmias were found to predict late mortality.
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introduCtion
Tetralogy of Fallot (ToF) is the most prevalent form of cyanotic congenital heart 
diseases.1 Although mortality was substantial in the earliest era of surgical cor-
rection,2 survival has improved dramatically over the years: 90% of patients are 
currently alive 30 years after successful surgical correction at a young age.3–6 
Despite these satisfactory results, survival up to 30 years is lower than in the 
normal population, and little is known about long-term functional outcome and life 
expectancy beyond 30 years.5,7 Although anatomic correction and physiological 
correction have been achieved, complications such as pulmonary regurgitation 
leading to right ventricular (RV) dysfunction, recurrent obstruction of the RV 
outflow tract, arrhythmias, sudden death, and aortic dilation and regurgitation 
are found in late survivors.1,8,9
Information on outcome after correction beyond 30 years is limited and has 
mostly been collected retrospectively. Most previous studies focused on a selec-
tion of patients regularly seen at the outpatient clinic, which may lead to selection 
bias. Our study is part of a unique ongoing longitudinal follow-up that started 
in 1990. The patients are investigated in hospital every 10 years.10,11 The aim of 
the present study is to provide data on survival and clinical course, including 
late sequelae, in survivors up to 40 years after initial correction and to detect 
predictors for outcome.
Methods
Study patients
All consecutive patients who underwent surgical correction for ToF (excluding 
pulmonary atresia) in our institution between 1968 and 1980 at <15 years of age 
were included in this longitudinal study. The cohort was first studied in 1990, 
and the second follow-up was performed in 2001. For the current third follow-up, 
survival status of the patients was obtained from the Dutch National Population 
Registry. All patients who were alive and had participated in 1 or both of the 
earlier follow-up studies were invited for the third in-hospital investigation in 2011 
to 2012. Detailed information describing the baseline characteristics, surgical 
procedure, and 10- and 20-year follow-up results has been reported previously.10,11 
The study protocol was approved by the institutional Medical Ethics Committee 
(2010-015). Written informed consent was obtained from all study participants.
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Survival and adverse events
Survival was compared with the survival of the reference, age-matched Dutch 
population. Adverse events were defined as all-cause mortality, cardiac reinter-
ventions (both percutaneous and surgical), symptomatic arrhythmias (needing 
medication or an intervention), stroke, heart failure (needing medication or hos-
pital admission), and endocarditis.
Clinical assessment
Medical examination included history, physical examination, subjective health 
status assessment (Short Form-36), standard 12-lead ECG, 24-hour ambulatory 
Holter monitoring, 2-dimensional echocardiography, cardiopulmonary exercise 
testing, N-terminal pro-brain natriuretic peptide (NT-proBNP) measurement, and 
cardiac magnetic resonance (CMR) imaging with dobutamine stress testing unless 
contraindicated. If a patient was unwilling or unable to visit the outpatient clinic, 
a questionnaire was sent to obtain information on morbidity and subjective health 
status and to receive permission for the use of information from medical records.
Subjective health status assessment
The scores on the 36-item short-form healthy survey (Short Form-36) of all study 
participants were compared with results of the normative Dutch population12 and 
with their own results from 2001.
ECG and Holter monitoring
Standard 12-lead surface ECGs were analyzed for rhythm, PR interval, and QRS 
duration. ECGs with pacemaker rhythm were excluded from comparison of con-
duction times. A 24-hour Holter monitoring was performed with a Cardio Perfect 
Holter DR180+ 3-channel recorder (Welch Allyn Cardio Control, NorthEast Moni-
toring, Maynard, MA).
Echocardiography
A complete 2-dimensional transthoracic Doppler echocardiography was per-
formed with the iE33 xMATRIX X5-1 system (Philips Medical Systems, Best, the 
Netherlands). Cardiac dimensions and function were measured according to the 
current guidelines.13,14 RV function was assessed visually to allow comparison with 
the 2 previous studies. Additionally, more objective measures, including fractional 
area change and tricuspid annular plane systolic excursion, were measured to 
quantify RV function.
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Cardiopulmonary exercise testing
Maximal workload and peak oxygen consumption (peak Vo2) were assessed by 
cardiopulmonary exercise testing using a bicycle ergometer with gradual work-
load increments of 20 W/min (ramp protocol) and compared with the values of 
normal individuals corrected for age, sex, height, and weight. The ratio of minute 
ventilation to carbon dioxide production (Ve/Vco2) was assessed at the anaerobic 
threshold and at maximum workload. Performance was considered maximal when 
a respiratory quotient of ≥ 1.1 was reached.
NT-proBNP measurement
Peripheral venous blood samples were collected after 30 minutes of rest. Plasma 
NT-proBNP levels were determined with the use of the commercially available 
electrochemiluminescence immunoassay Elecsys (Roche Diagnostics, Basel, Swit-
zerland). The normal value for NT-proBNP in our hospital is <14 pmol/L.
CMR imaging with dobutamine
CMR imaging was performed with a Signa 1.5-T whole-body scanner (GE Medical 
Systems, Milwaukee, WI) with dedicated phased-array cardiac surface coils. De-
tails of the MR sequence used have been reported previously.15 Images were col-
lected at rest and after low-dose (7.5 μg·kg−1·min−1) and high-dose (20 μg·kg−1·min−1) 
dobutamine administration. Contraindications for the use of dobutamine were 
previous sustained ventricular tachycardia (VT), frequently recurrent supraven-
tricular tachycardia, and inflow or outflow obstruction of the ventricles. For CMR 
analyses, a commercially available Advanced Windows workstation (GE Medical 
Systems) was used, equipped with Q-mass (version 5.2, Medis Medical Imaging 
Systems, Leiden, the Netherlands). The ventricular volumetric data set was quan-
titatively analyzed by a single investigator (J.A.A.E.C.) using manual outlining of 
endocardial borders in end systole and end diastole, excluding large trabeculae 
(visible on 3 subsequent slices) and the papillary muscles from the blood volume. 
Biventricular end-diastolic volume, end-systolic volume, ejection fraction (EF), 
and valvular regurgitation fractions were calculated and compared with reference 
values.16
Statistical analysis
For the descriptive data analyses, we used the Statistical Package for Social 
Sciences (version 20.0, SPSS, IBM Corp., Armonk, NY, USA). Continuous data are 
presented as mean with standard deviation or median with interquartile range. 
Categorical variables are presented as frequencies and percentages. For compari-
son of continuous variables between independent groups, the Student unpaired 
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t-test was used; for repeated measures, the paired t-test or Wilcoxon signed-rank 
test were performed. Frequencies of unpaired data were compared by use of the 
χ2 test or Fisher exact test when applicable, and for paired data, the McNemar 
test was used. To quantify correlations between 2 variables, we used the Pearson 
correlation test or Spearman correlation test. For advanced statistical analyses 
of the longitudinal and survival data, the R software version 3.0.1 package was 
used (www.r-project.org). Univariable and multivariable Cox proportional hazard 
regression analyses were used to identify predictors for the predefined events: 
all-cause mortality, arrhythmias or pacemaker implantation, and pulmonary valve 
replacement (PVR). The following covariates were included in the models: early 
postoperative arrhythmias, temperature during surgery, palliative shunt before 
corrective surgery, insertion of a transannular patch, age at operation, and era of 
operation (before or after 1975). Because of the low frequencies for the aforemen-
tioned events, we used a penalized likelihood approach for estimating the Cox 
model.17 To account for missing covariate data, we used a multiple imputation ap-
proach.18 Wald tests were used to assess which covariates were most associated 
with the risk of each event. Time-dependent Cox regression analysis was used to 
assess the effects of the time-dependent covariates: QRS duration, VT on Holter, 
exercise capacity, and left ventricular (LV) fractional shortening on outcome. For 
description of survival of the total cohort and the Dutch reference population, 
the Kaplan–Meier method was used. Cumulative event incidences were computed 
with the use of a nonparametric estimator of cumulative incidence functions. All 
statistical tests were 2 sided, and the level of significance was at P<0.05.
results
Study patients
The original study cohort consisted of 144 consecutive patients who underwent 
surgical correction of ToF between 1968 and 1980. Baseline characteristics are 
presented in Table 1. Further baseline and surgical details have been reported pre-
viously.10,11 For the present study 36 years (range, 31–43 years) after correction, 80 
patients were eligible. Of them, 72 (90%) were included: 53 (66%) participated in-
hospital and 19 (24%) gave permission to use the hospital records of their regular 
clinical follow-up. There were no differences in baseline characteristics between 
the participating and nonparticipating patients.
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Survival
Survival status was obtained in 136 patients (94%). Eight patients moved abroad 
and were untraceable. Cumulative survival after surgical correction was 83% after 
10 years, 81% after 20 years, 78% after 30 years, and 72% after 40 years (Figure 1). 
In total, 35 of the 144 patients died, 23 within 30 days after surgery. Of the hospital 
survivors, cumulative survival was 98% after 10 years, 96% after 20 years, 92% after 
30 years, and 86% after 40 years. In patients who survived 30 days postoperatively, 
incident mortality rate was 0.29 per 100 patient-years.
In the last 10 years, 6 patients died. Three patients died of end-stage heart failure 
26, 28, and 38 years after surgery at 31, 32, and 51 years of age, respectively. Two of 
them had nonsustained VTs on Holter in 1990 or 2001. In 1 of these patients, death 
was triggered by an infection. Two other patients died of ventricular fibrillation 24 
and 34 years after surgery at 28 and 41 years of age, respectively. One patient died 
after a shooting incident.
Table 1 Baseline characteristics
 
Total 1990 2001 2012
No third 
study* P-value†
(n=144) (n=79) (n=79) (n=72) (n=72)  
Male, n (%) 87 (60) 46 (58) 44 (56) 42 (58) 45 (63) 0.609
Age at study, yrs (IQR) - 18.5 [15.1-23.2] 30.4 [26.3-35.6] 39.8 [36.1-45.5] - -
Age at operation, yrs (IQR) 4.6 [1.7-6.6] 4.3 [1.4-6.5] 4.3 [1.4-6.6] 3.8 [1.4-6.6] 4.9 [1.8-7.2] 0.163
Prior palliation, n (%) 50 (35) 25 (32) 25 (32) 20 (28) 30 (42) 0.080
Transannular patch, n (%) 87 (60) 48 (55) 47 (54) 48 (67) 44 (51) 0.488
Hypothermia, n (%)
Temperature <20°C 43 (30) 25 (32) 27 (34) 24 (33) 19 (26) 0.746
Temperature 20-35°C 89 (62) 52 (66) 50 (63) 47 (65) 42 (58)
Temperature unknown 12 (8) 2 (2) 2 (3) 1 (1) 11 (15)  
IQR indicates interquartile range.
*Including deceased and emigrated patients. †2012 vs no third study.
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Figure 1 Kaplan–Meier plot describing survival in the studied cohort compared with the Dutch 
reference population. ToF indicates tetralogy of Fallot.
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Adverse events
Cumulative event-free survival after 40 years was 25% (Figure 2). In the last 10 
years, 35 patients (49% of the participants) were hospitalized at least once.
Reinterventions
The cumulative incidence of reinterventions after 35 years of follow-up was 44% 
(Figure 3). In the last decade, 32 patients required ≥1 reinterventions: PVR (n=20); 
closure of a ventricular septal defect (n=8); balloon dilation of the pulmonary 
artery or branch (n=6); aorta-related reoperation (n=3), including 1 elective aortic 
arch replacement because of an aneurysm (aortic diameter, 57 mm); and infun-
dibulectomy (n=1).
Pulmonary valve replacement
Despite a rather conservative approach to PVR in our center, 11 the cumulative 
incidence of PVR was 40% at 35 years (Figure 3). Of the participating patients, 35 
underwent PVR at a median of 24 years (interquartile range, 16–29 years) after the 
initial correction. In the last decade, surgical PVR was performed in 19 patients for 
the first time, 2 of whom underwent transcatheter PVR later. One patient under-
went transcatheter PVR after receiving a surgical homograft in 2000.
Arrhythmias
The cumulative incidence of symptomatic arrhythmias was 17% at 35 years (Fig-
ure 4). In the last decade, 5 patients had new symptomatic arrhythmias; 3 patients 
had atrial fibrillation and needed electric cardioversion. One of them underwent 
catheter ablation afterward. One patient had atrial flutter, and 1 patient was 
treated for arrhythmias of unknown origin in another hospital. In the last decade, 
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Figure 2 Cumulative incidence of all events.
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2 patients received a pacemaker and 2 received an implantable cardioverter-
defibrillator (ICD). Both ICDs were implanted for secondary prevention after the 
patients experienced sustained VTs. One other patient had an ICD indication 
because of recurrent VTs but has refused implantation. Thirty-five years after 
surgical correction, the cumulative incidences of pacemaker and ICD implantation 
were 10% and 5% respectively.
Heart failure
The cumulative incidence of heart failure at 35 years of follow-up was 3%.
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Figure 3 Cumulative incidences of pulmonary valve replacement (PVR) and all reinterventions.
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Figure 4 Cumulative incidences of supraventricular tachycardia (SVT), ventricular tachycardia 
(VT), and all arrhythmias, including implantation of pacemakers and cardioverter-defibrillators.
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Stroke
In the last decade, 4 patients had a transient ischemic attack. Two of them had an 
open foramen ovale.
Endocarditis
Two patients were diagnosed with endocarditis: 1 had bacteremia with Streptococ-
cus oralis 5 years after ICD implantation, which resolved on antibiotics only after 
the ICD had been removed. The other had bacteremia with Streptococcus sanguis 
21 years after pulmonary homograft implantation. The patient was treated with 
antibiotics and remained free of recurrent bacteremia afterward.
Subjective health status assessment
Patients scored significantly better on the domains of role limitations resulting 
from physical or emotional problems, bodily pain, and social functioning com-
pared with normative data (Figure 5). In direct comparison with their own previ-
ous results, patients showed a less favorable general health perception (P=0.042) 
than 10 years ago.
ECG and Holter monitoring
The ECG and Holter findings are summarized in Table 2. None of the patients had 
ventricular pauses >3 seconds.
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Figure 5 Results of Short Form-36 for patients with tetralogy of Fallot (ToF) and the normal Dutch 
population. Higher scores indicate more favorable subjective health status. *P<0.001.
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Echocardiography
Echocardiographic findings are summarized in Tables 2 through 4. The systolic 
function of both ventricles diminished in the last 10 years. In 21 patients (40%), 
the estimated RV pressure was >40 mm Hg, but in all but 3 patients, this was com-
pletely attributable to residual pulmonary stenosis. Normal diastolic LV function 
was observed in 35 patients (55%), impaired relaxation in 13 (20%), pseudonormal 
diastolic filling in 2 (3%), and restrictive relaxation pattern in 14 (22%). There was 
no progression of aortic root dilation in the last decade. No correlations were 
found between pulmonary regurgitation or tricuspid regurgitation and right atrial 
dilation, RV dilation, or RV function.
Cardiopulmonary exercise testing
Table 2 shows the results of bicycle ergometry. Forty percent of the patients had 
a reduced exercise capacity (<85% of expected workload). These patients did not 
significantly differ from those with a normal test result with regard to age at the 
time of operation, current age, or findings at echocardiography and CMR (dimen-
sions and ventricular function).
NT-proBNP measurement
Median NT-proBNP level was 16.4 pmol/L (interquartile range, 6.7–32.0 pmol/L). 
An elevated NT-proBNP level (>14.0 pmol/L) was measured in 58% of the patients. 
NT-proBNP (logarithmic) correlated modestly with echocardiography-derived LV 
end-systolic dimension (r=0.31, P=0.03) and CMR-derived LV end-diastolic volume 
(r=0.36, P=0.01). No correlations were found with age at operation, current age, 
exercise capacity, or RV dimensions.
Table 2 Diagnostic measurements
 
 
   P-value*  
1990 2001 2012 2012 vs. 1990 2012 vs. 2001
Electrocardiography n=79 n=79 n=70    
Rhythm, n (%)  
Sinus 66 (84) 69 (87) 58 (83) 0.7 0.3
Atrial 6 (8) 5 (6) 4 (6) 0.7 1.0
Atrial flutter 1 (1) 3 (4) 0 - -
Atrial fibrillation 0 0 1 (1) - -
Nodal 1 (1) 0 0 - -
Pacemaker 5 (6) 2 (3) 7 (10) 1.0 0.1
PR interval (mean ± SD), ms 159 ± 32 162 ± 27 173 ± 41 0.008 0.02
PR >200 ms, n (%) 3 (4) 4 (6) 11 (18) 0.02 0.1
QRS duration (mean ± SD), ms 120 ± 29 135 ± 32 144 ± 32 <0.001 <0.001
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Table 2 Diagnostic measurements (continued)
 
 
   P-value*  
1990 2001 2012 2012 vs. 1990 2012 vs. 2001
QRS duration >120 ms, n (%) 27 (39) 46 (62) 46 (72) <0.001 0.1
QRS duration >180 ms, n (%) 1 (1) 6 (8) 8 (13) 0.1 0.2
24-hour Holter n=70 n=76 n=56   
Supraventricular arrhythmias, n (%) 15 (21) 44 (59) 29 (52) 0.03 1.0
Sinus node disease 12 (17) 20 (27) 14 (25) 0.5 1.0
SVT 7 (10) 27 (36) 19 (34) 0.3 0.8
Paroxysmal atrial fibrillation 1 (1) 1 (1) 1 (2) 1.0 1.0
Paroxysmal atrial flutter 0 1 (1) 0 - -
VT 3-10 complexes, n (%) 7 (10) 9 (12) 10 (18) 1.0 0.4
VT >10 complexes, n (%) 0 1 (1) 1 (2) - 1.0
Bicycle ergometry n=73 n=71 n=52   
Maximal heart rate, (mean ± SD), % 86 ± 11 89 ± 10 86 ± 12 0.7 0.04
Maximal exercise capacity (mean ± SD), % 88 ± 17 83 ± 16 89 ± 18 0.6 0.02
Exercise capacity <85%, n (%) 26 (36) 39 (55) 21 (40) 1.0 0.3
Arrhythmia, n (%) 14 (19) 17 (24) 12 (23) 0.2 0.6
Vo2 max (%) - - 81 ± 17 - -
RERmax - - 1.4 ± 0.2 - -
Ve/Vco2, anaerobic threshold - - 27.0 ± 4.0 - -
Ve/Vco2, max workload - - 29.5 ± 4.1 - -
Echocardiographic parameters n=79 n=79 n=70   
RA dilation, n (%) 35 (44) 65 (82) 59 (86) <0.001 0.7
RV dilation, n (%) 72 (91) 56 (71) 62 (89) 0.7 0.01
LA dilation, n (%) 3 (4) 12 (15) 23 (34) <0.001 0.01
LV dilation, n (%) 1 (1) 7 (9) 7 (10) 0.4 1.0
RV systolic function normal, n (%) - 54 (78) 19 (28) - <0.001
LV systolic function normal, n (%) 76 (96) 70 (90) 34 (50) <0.001 <0.001
FS <20%, n (%) 3 (4) 7 (10) 6 (9) 0.6 0.7
Valve regurgitation (>trace) , n (%)
AR 4 (5) 15 (19) 19 (28) <0.001 0.1
MR 0 6 (8) 13 (19) 0.004 0.004
PR 65 (82) 62 (79) 43 (62) 0.002 0.001
TR 45 (57) 49 (62) 49 (71) 0.1 0.4
Vmax PR, m/s 1.8 1.8 2.0 0.007 0.1
Vmax TR, m/s 2.7 2.8 2.7 0.6 0.7
LA diameter, mm 32 ± 6 37 ± 7 39 ± 6 <0.001 0.001
LV diameter, mm 44 ± 6 49 ± 6 48 ± 7 <0.001 0.7
Aortic diameter, mm 32 ± 6 37 ± 6 36 ± 5 0.002 0.08
AR indicates aortic regurgitation; FS, fractional shortening; LA, left atrial; LV, left ventricular; MR, mitral regur-
gitation; PR, pulmonary regurgitation; RA, right atrial; RERmax, maximum respiratory exchange ratio; RV, right 
ventricular; SVT, supraventricular tachycardia; TR, tricuspid regurgitation; Vmax, maximal velocity found with 
Doppler echocardiography; and VT, ventricular tachycardia.
*P-values are displayed only for measures performed in two or all three studies.
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CMR imaging
CMR was performed in 49 of the 72 patients (68%). Contraindications for CMR were 
either the presence of a pacemaker or ICD or claustrophobia. The results of CMR 
are summarized in Table 5. RV and LV end-diastolic dilation was observed in 15 
patients (31%) and 2 patients (4%), respectively. In 23 patients (47%), RV EF was 
diminished, and in 14 (29%) patients, LV EF was diminished. RV EF correlated with 
LV EF (r=0.54, P<0.001). Thirty patients consented to dobutamine stress. In 5 of 
them, dobutamine administration was terminated before the dose was increased 
because of adverse effects: increase in ventricular extrasystoles, ventricular 
bigeminy, nonsustained VT, symptomatic blood pressure drop, and anxiety. All of 
these effects recovered spontaneously. LV EF and RV EF increased significantly after 
administration of 7.5 μg·kg−1·min−1 dobutamine (P<0.001 for both), but after a dose 
of 20 μg·kg−1·min−1, there was no further increase (P=0.4 and P=0.9, respectively).
Table 3 Diagnostic test results performed only in 2012: Echocardiography
Median IQR Abnormal, n (%)*
PR Vmax, m/s 2.0 [1.7-2.3] 17 (46)
TAPSE, mm 18 [16-22] 10 (16)
RV FAC, % 38 [32-48] 15 (33)
LV EF, % 51 [45-57] 15 (42)
E/A ratio 1.4 [1.0-1.8] 6 (9)
E/E’ ratio 9.4 [8.0-12.6] 6 (10)
DET, ms 190 [160-240] 27 (43)
IVC collapse >50%, n (%) 60 (94)
HV ratio S>D, n (%) 7 (15)
DET indicates deceleration time; FAC, fractional area change; HV S/D ratio, hepatic vein ratio of systolic to 
diastolic wave; IQR, interquartile range; IVC, inferior vena cava; LV EF, left ventricular ejection fraction; PR, 
pulmonary regurgitation; RV, right ventricular; TAPSE, tricuspid annular plane systolic excursion; and Vmax, 
maximal velocity found with Doppler echocardiography.
*According to the reference values in the guidelines for structural heart disease.13,14
Table 4 Diagnostic test results performed only in 2012: MRI
 
At rest
(n=49)
7.5 µg/kg/min 20 µg/kg/min P-value
dobutamine
(n=30)
dobutamine
(n=26)
Rest vs 7.5 
µg/kg/min
7.5 vs 20 µg/
kg/min
LV EDV/BSA, mL/m2 74 [64-86] 70 [62-84] 60 [55-71] 0.071 <0.001
LV ESV/BSA, mL/m2 29 [22-37] 16 [13-22] 12 [10-17] <0.001 <0.001
LV EF, % 61 [54-69] 77 [74-83] 80 [74-84] <0.001 0.247
RV EDV/BSA, mL/m2 96 [81-120] 92 [79-121] 89 [75-109] 0.417 <0.001
RV ESV/BSA, mL/m2 49 [36-63] 36 [28-49] 35 [25-42] <0.001 0.048
RV EF, % 49 [45-59] 63 [53-69] 64 [57-70] <0.001 0.939
BSA indicates body surface area; EDV, end-diastolic volume; EF, ejection fraction ESV, end-systolic volume; FAC, 
fractional area change; LV, left ventricular; and RV, right ventricular.
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Predictor analyses
Results of the baseline parameters Cox regression analysis are presented in 
Table 5. Early postoperative arrhythmias, a palliative shunt before initial correc-
tion, and lower temperature during surgery were predictive of mortality. In the 
time-dependent Cox regression analyses, no predictors for mortality were found. 
Increase in QRS duration and decrease in maximally achieved workload during 
cardiopulmonary exercise testing over time were predictive for PVR (hazard 
ratio, 1.14 per 10-millisecond increase, P=0.023; and hazard ratio, 0.961, P=0.001, 
respectively) but not for mortality. Ventricular dysfunction on echocardiogram 
or arrhythmias on Holter in 1990 or 2001 did not predict adverse outcome. After 
adjustment for changes in QRS duration, exercise capacity, VTs on Holter, and LV 
fractional shortening, patients without a previous palliative shunt still showed 
Table 5 Predictors of the clinical endpoints all-cause mortality, arrhythmias/pacemaker implanta-
tion, and PVR
Endpoint
Univariable model  Multivariable model
HR CI P-value HR CI P-value
All-cause mortality              
Early postoperative arrhythmias 3.33 1.60-6.95 0.001* 2.52 1.18-5.36 0.017*
Temperature during surgery (per 1°C 
decrease)
1.18 1.05-1.30 0.003* 1.14 1.01-1.28 0.029*
Prior shunt 1.64 0.85-3.23 0.144 2.94 1.32-6.25 0.008*
Transannular patch 1.27 0.62-2.61 0.518 0.74 0.36-1.53 0.419
Age at operation 0.90 0.81-1.01 0.071 0.89 0.76-1.03 0.118
Operated after 1975 0.93 0.47-1.84 0.833 0.54 0.24-1.20 0.131
Arrhythmias/PM implantation            
Early postoperative arrhythmias 4.36 1.57-12.10 0.005* 3.68 1.29-10.52 0.015*
Temperature during surgery (per 1°C 
decrease)
1.00 0.90-1.12 0.923 1.01 0.89-1.14 0.906
Prior shunt 2.17 0.91-5.00 0.080 1.96 0.68-5.56 0.213
Transannular patch 5.91 1.37-25.47 0.017* 3.99 1.19-13.41 0.026*
Age at operation 1.00 0.86-1.15 0.947 0.95 0.79-1.15 0.621
Operated after 1975 0.58 0.25-1.38 0.219 0.41 0.16-1.03 0.059
Pulmonary valve replacement            
Early postoperative arrhythmias 1.90 0.79-4.57 0.149 1.33 0.55-3.25 0.525
Temperature during surgery (per 1°C 
decrease)
1.09 1.00-1.16 0.045* 1.02 0.93-1.11 0.650
Prior shunt 1.64 0.86-3.13 0.133 2.50 1.00-6.25 0.049*
Transannular patch 6.40 2.26-18.10 <0.001* 3.50 1.39-8.86 0.008*
Age at operation 0.91 0.82-1.01 0.087 0.92 0.79-1.05 0.215
Operated after 1975 2.72 1.29-5.76 0.009* 1.88 0.84-4.20 0.126
CI indicates confidence interval; HR, hazard ratio; PM, pacemaker; and PVR, pulmonary valve replacement.
*Significant.
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a trend toward lower all-cause mortality (hazard ratio, 0.22; P=0.064). The pres-
ence of a supraventricular arrhythmia on ECG in 1990 or 2001 predicted mortality 
(hazard ratio, 13.9, P=0.016; and hazard ratio, 14.5, P=0.004, respectively).
disCussion
In this unique prospective, longitudinal cohort study of an unselected cohort of 
ToF patients with detailed clinical evaluation and analysis of predictors for out-
come, we found that late mortality up to 40 years was low. Early postoperative ar-
rhythmias were found to be a new predictor for late mortality. Although morbidity 
was substantial, the subjective health status was excellent, and objective exercise 
capacity remained stable.
Mortality and major events
In the total cohort, cumulative survival 40 years after surgical correction was 72%, 
with one fifth of deaths occurring within 30 days after surgery. In the hospital 
survivors, cumulative survival was 86% after 40 years of follow-up. This is only 
slightly lower than survival in the general Dutch population. The causes of late 
death in our cohort were heart failure and arrhythmia, which is in accordance 
with the literature.3,4,19,20 Morbidity was substantial in our population; only one 
quarter of the patients were free from events after 40 years. Reinterventions were 
required in nearly half of the patients, mostly PVR. This is considerably more than 
reported in other studies, probably reflecting the earlier era of initial operation 
and longer duration of follow-up in our study.6,19,21
Health status assessment
Exercise capacity was clearly impaired in our ToF patients but remained stable 
in the last 10 years. The lowest peak Vo2 in our study population was 51% of 
the predicted value. This is still considerably higher than the 36% described by 
Giardini et al.22 as a cutoff value for greater risk of cardiac-related death. Remark-
ably, patients themselves reported favorable physical functioning and even less 
interference from physical problems in their work and daily activities than the 
reference Dutch population. This is in contrast to earlier reports by Knowles et 
al.,23 who reported less favorable results in ToF patients compared with their 
healthy siblings. The better scores in our group may be due to different frames 
of reference, overcompensation, and social desirability.24 Over time, our patients 
showed a decrease in general health perception scores, which can be related to 
age because this effect also is seen in the general population.12
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Arrhythmias
Arrhythmias and sudden death are important late complications.4,8,25 We found 
a lower prevalence of arrhythmias than described by Khairy et al.25 In our study, 
supraventricular arrhythmias were common on Holter, but only 5 patients had 
symptomatic arrhythmias. The prevalence of SVT on Holter did not increase in the 
last decade and did not predict outcome. In addition, an increase in QRS duration 
did not predict arrhythmias or mortality. However, strikingly, 2 of the 3 patients 
with an atrial arrhythmia (atrial flutter) on ECG in 2001 died during the last 10 
years. Their atrial arrhythmia could have been an indicator of worsening hemody-
namics, but none of these patients had more than mild RV dysfunction, and only 
1 had LV dysfunction in 2001. It seems that these supraventricular arrhythmias 
should not be considered insignificant.
Ventricular function
Late deterioration of RV and LV function has been an increasing concern.26,27 Indeed, 
this was found in our study because systolic RV function was impaired in >75% 
and systolic LV function in 50% of the patients. Moreover, diastolic LV dysfunction 
was found often. The deterioration of LV function could be explained by adverse 
ventricular-ventricular interaction associated with RV dilation, which influences 
LV twist.28 We found a significant association between RV and LV dysfunction. In 
addition, we found a modest but significant correlation between LV dimensions 
and NT-proBNP levels. In other studies, NT-proBNP levels correlated with both 
LV and RV dimensions and LV function.29 Whether NT-pro-BNP predicts clinical 
outcome remains to be established. Administration of dobutamine during CMR 
led to an increase in RV EF and LV EF at a low dose, but no further increase was 
observed at a high dose. As described by Parish et al.,30 who found a similar stress 
response, this is caused mainly by the lack in further decrease of RV end-systolic 
volume, indicating diminished contractile reserve. Because this is not apparent at 
rest, dobutamine stress CMR may contribute to the decision making in terms of 
intervention such as timing of PVR in these patients.31
Aortic dilation
Dilation of the ascending aorta is found in 15% to 87% of the ToF patients,32 presum-
ably inherent to volume overload resulting from the original overriding position 
of the aorta. Additionally, intrinsic vascular wall properties could play a role. We 
found aortic root dilation (≥40 mm) in 24% of our patients at the last follow-up. 
The long-term risk of aortic dilation in ToF patients has not been clarified yet. In 
our longitudinal follow-up, the aortic diameter did not increase over time, and 
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until now, no aortic dissection occurred. However, in 1 patient, the aortic arch was 
electively replaced because of an aortic diameter of 57 mm.
Predictors for late events
Patients with a palliative shunt before initial correction, that is, Waterston shunt, 
Blalock-Taussig shunt, or Potts anastomosis, were more at risk of dying or needing 
PVR than patients without them. Because in our cohort the use of a palliative 
shunt was related to the era of surgery rather than to anatomy, selection bias 
regarding more or less favorable anatomy is very unlikely. Therefore, our study 
supports early initial correction without previous shunt if the patient’s condition 
tolerates.
Mortality was higher in patients who experienced early postoperative arrhyth-
mias. In addition, these patients had a higher risk of late arrhythmias or pace-
maker implantation. The occurrence of early arrhythmias and their relation to the 
increased risk of death and permanent pacing have previously been described in 
small series and, on the basis of our results, seem to have clinical relevance.33,34 
More attention for these early postoperative arrhythmias and their underlying 
mechanism is needed and may attribute to risk stratification for preventive inter-
ventions such as ICD implantation.
A QRS duration >180 milliseconds and an increase in QRS duration over time 
have been recognized as predictors for VT and late sudden death.4,35 Our study 
showed a steady increase in QRS duration over time. However, all patients with 
a QRS duration >180 milliseconds in 1990 or 2001 are still alive, and QRS dura-
tion could not be identified as predictor for mortality in our study. Although the 
numbers in our study are small, supraventricular arrhythmias on ECG in 1990 or 
2001 seem to be predictive of mortality. The importance of atrial arrhythmias as a 
predictor for outcome has been suggested before. However, the exact mechanism 
remains to be elucidated.8
The insertion of a transannular patch has received much attention as a possible 
cause of pulmonary regurgitation and long-term morbidity. Our results confirm 
the association of a transannular patch with PVR but not with mortality. These 
results are similar to the results of the study by Lindberg et al.36 Furthermore, we 
found an association between the use of a transannular patch and the occurrence 
of late arrhythmias. Nowadays, surgeons tend to use smaller transannular patches 
to minimize pulmonary regurgitation and its long-term sequelae. Whether this will 
result in better outcome has to be established.
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Study limitations
Although the number of patients in this study is relatively small, we report the 
results of a longitudinal follow-up of consecutive patients without selection bias 
related to disease severity. After a median follow-up of 36 years, we gathered medi-
cal information on 72 of the approached patients (90%). We found no significant 
differences in baseline characteristics between participating and nonparticipating 
patients; therefore, we believe that we have minimized selection bias.
From 1968 to 1980, the era in which our cohort was operated on, the standard 
surgical policy gradually changed from secondary correction after previous 
shunting, use of a large transannular patch, and surgery at very low temperature 
to primary correction at higher temperatures. These factors were accounted for in 
our analyses of predictors for outcome. We believe that there is no bias concern-
ing temperature during surgery, but we cannot completely exclude that the use of 
a previous shunt was related to more complex anatomy.
Diagnostic methods have been changed during the last 36 years. For comparing 
echocardiography data of the present study with the previous studies, we had to 
use the same methods used in the past. Some of these techniques are not seen as 
being up-to-date. However, we also performed and reported innovative diagnostic 
methods available in 2012.
ConClusions
Long-term survival after successful surgical correction of ToF in childhood is 
good. Morbidity, however, is substantial, with almost half of the patients needing 
at least 1 reintervention. There is concern about the deterioration of both RV and 
LV function. Nevertheless, the clinical condition and subjective health status of 
most patients remain good, and aortic dimensions did not increase over time.
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abstraCt
Aims
Many patients with repaired Tetralogy of Fallot (ToF) have right ventricular (RV) 
volume overload due to pulmonary regurgitation (PR).We studied the effect of 
volume overload on global and regional RV and left ventricular (LV) deformation, 
and their relationships with conventional diagnostic parameters.
Methods and Results
In this cross-sectional study, 94 prospectively recruited ToF patients (61% male, 
age 32.8 ± 9.5 years, age at repair 1.9 [0.8–5.7] years, 39% pulmonary homograft) 
and 85 healthy controls of similar age and sex underwent echocardiography and 
electrocardiography. In a subset of patients, cardiac magnetic resonance imaging, 
bicycle ergometry, and NT-proBNP measurement were performed within the same 
day. With speckle-tracking echocardiography, we analysed peak systolic global 
longitudinal strain (GLS), segmental longitudinal strain and strain rate of the RV 
free wall, LV lateral wall, and septum. Patients had a lower RV free wall strain than 
controls (-18.1 ± 4.5 vs. -26.5 ± 4.5%, P<0.001), especially at the apical segment 
(-15.9 ± 7.4 vs. -28.2 ± 7.7%, P<0.001), and lower RV strain rate. LV GLS was also 
lower (-17.4 ± 2.5 vs. -19.6 ± 1.9%, P<0.001), mainly due to the interventricular sep-
tum. Patients with PR >25% had higher LV GLS and RV free wall strain than patients 
with PR ≤25% (P=0.004, P=0.039, respectively). No relationships were found with 
NT-proBNP or exercise capacity.
Conclusion
RV free wall strain and strain rate are decreased in adults late after ToF repair, 
especially at the apical segment suggesting that apical function is most affected 
in these RVs. Regarding the LV, septal strain is decreased indicating that RV dys-
function adversely affects LV function, probably by mechanical coupling of the 
ventricles.
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introduCtion
Tetralogy of Fallot (ToF) is the most prevalent form of cyanotic congenital heart 
disease.1 Early surgical repair has dramatically improved survival of ToF patients. 
However, residual lesions such as pulmonary regurgitation (PR) and right ven-
tricular (RV) dysfunction are common after late repair.2 RV dysfunction also seems 
to affect left ventricular (LV) systolic function.3–6
RV and especially LV dysfunction are important indicators of clinical outcome.3,4,7 
Therefore, early detection of ventricular dysfunction is essential. Echocardio-
graphic evaluation of biventricular function in ToF patients has been challenging 
because of the complex shape of the ventricles. Speckle-tracking echocardiog-
raphy (STE) provides objective measurements to quantify ventricular function, 
independently of angle and ventricular geometry.8 One of the measurements is 
strain imaging, also known as myocardial deformation imaging, which may detect 
ventricular dysfunction in a pre-clinical phase. Although strain imaging is mainly 
developed for LV mechanics, it can also be used to study RV deformation.9
In ToF patients with normal LV ejection fraction (EF), decreased LV longitu-
dinal strain has been reported, suggesting subclinical LV myocardial damage.10 
Decreased RV longitudinal strain has also been described; however, these studies 
are mainly performed in small groups or in children.10 – 12
Our aim was to evaluate LV and RV deformation in adults with ToF late after their 
initial surgical repair and to investigate relationships with ventricular dimensions 
and function, severity of valvular diseases, exercise capacity, and N-terminal pro-
Brain Natriuretic Peptide (NT-proBNP).
Methods
Study population
For this cross-sectional study, we prospectively recruited patients who had un-
dergone surgical ToF repair between 1968 and 1995. The study protocol included 
echocardiography, 12-lead electrocardiography (ECG), bicycle ergometry, cardiac 
magnetic resonance (CMR) imaging, and NT-proBNP measurement, all performed 
on the same day. Exclusion criteria were a pacemaker, atrial fibrillation, and poor 
quality of echocardiographic images, resulting in inadequate speckle-tracking 
analysis of both ventricles. Baseline characteristics were collected as current age, 
sex, and surgical data. Echocardiographic data of the patients were compared 
with data of healthy controls. The healthy controls were voluntarily recruited via 
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an advertisement and had no medical history, medication or current symptoms 
suggesting cardiovascular disease.
The study was carried out according to the principles of the Declaration of 
Helsinki and approved by the local medical ethics committee. Written informed 
consent was obtained from all subjects.
Echocardiography
Two-dimensional greyscale harmonic images were obtained in the left lateral de-
cubitus position using an iE33 ultrasound system (Philips Medical Systems, Best, 
the Netherlands) equipped with a transthoracic broadband S5-1 (1–5 MHz) or X5-1 
matrix transducer (1–5 MHz extended operating frequency range) at a frame rate 
of >60 frames/s. We used the guidelines of the American Society of Echocardiogra-
phy for chamber measurements, including LVEF (Simpson’s method), RV fractional 
area change (FAC), and tricuspid annular plane systolic excursion (TAPSE).8 For 
valvular regurgitation and stenosis, we used recommendations of the European 
Association of Echocardiography.13 – 15
Speckle-tracking analysis
Offline analyses of the data sets were performed using STE by QLAB version 9.0 
(Philips Medical Systems). At the standard apical four-chamber view (A4C), we 
defined the endocardium of the LV lateral wall and septum to analyse LV peak 
systolic global longitudinal strain (GLS), segmental longitudinal strain, and strain 
rate (Figure 1A). The interventricular septal strain was measured along with the 
LV lateral wall, because QLAB has been developed for LV mechanics. LV GLS at 
A4C was considered feasible when at least six of the seven segments were mea-
surable. For LV GLS based on the three apical views, at least 12 segments of the 
17-segment model had to be measurable (Figure 1). For analysis of RV free wall 
strain, segmental strain, and strain rate, we defined the endocardium of the free 
wall at the RV-centred A4C (Figure 2). RV free wall strain was scored feasible when 
all three segments could be measured. The LV algorithm was applied for both ven-
tricles. After positioning tracking points on an end-diastolic frame, the program 
tracked these points on a frame-by-frame basis. When tracking was suboptimal, 
we retraced the endocardial border. Peak systolic longitudinal strain and strain 
rate were defined as the peak negative value on the curve during the ejection 
phase. Data were exported to a spreadsheet program (Excel; Microsoft Corpora-
tion, Redmond, WA, USA). All references to strain changes consider the absolute 
value of the number, so that higher or increase in longitudinal strain means a more 
negative number and lower or decrease means a less negative number.16
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Figure 1 Left ventricular longitudinal strain measurements.
The left ventricle was traced at the apical four- (A), two- (B), and three-chamber view (C). The walls were auto-
matically divided into seven segments at each view. Strain and strain rate curves were plotted for each segment. 
Left ventricular global longitudinal strain was based on the average of 17 segments (D).
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CMR imaging
CMR imaging was performed using a Signa 1.5-T scanner (GE Medical Systems, 
Milwaukee, WI, USA) with dedicated phased-array cardiac surface coils. Details 
of the used CMR sequence have been reported previously.17 For analyses, an 
Advanced Windows workstation (GE Medical Systems) was used, equipped with 
QMass and QFlow version 5.2 (Medis Medical Imaging Systems, Leiden, the Neth-
erlands). The ventricular volumetric data set was quantitatively analysed by one 
investigator (J.C.) using manual outlining of endocardial borders in end-systole 
and end-diastole excluding large trabeculae (visible on three subsequent slices) 
and papillary muscles from the blood volume. Biventricular end-diastolic volume, 
end-systolic volume, stroke volume (SV), and EF were calculated using the disc 
summation method. To define the basal RV, images of the atria were acquired and 
the exact delineation was cross checked on other images. We included the portion 
of the RV outflow tract below the pulmonary valve in the RV volume measure-
Figure 2 Right ventricular longitudinal strain measurements.
The right ventricular free wall was traced from base to apex. Strain and strain rate curves were plotted for each 
segment. Global longitudinal strain of the free wall was based on the three regional values.
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ments. Pulmonary regurgitation fraction was determined from flow measurements 
in phase contrast sequences.
Cardiopulmonary exercise testing
Peak work load, heart rate, oxygen consumption (Vo2), respiratory exchange ratio 
(RER), and CO2-equivalent (Eqco2) were assessed on a bicycle ergometer with 
gradual workload increments of 20 W/min (Ramp protocol) and compared with 
normative data.
NT-proBNP measurement
Peripheral venous blood samples were collected after 30 min of rest. Plasma NT-
proBNP levels were determined with use of the commercially available electroche-
miluminescence immunoassay Elecsys (Roche Diagnostics, Basel, Switzerland). 
The normal value in our hospital is <14 pmol/L.
Statistical analysis
Continuous data are presented as mean ± standard deviation (SD) or as median 
with interquartile range (IQR). Categorical data are presented as frequencies and 
percentages. For comparison of normally distributed data in one group, we used 
the paired t-test, between two groups the Student’s t-test, and between more than 
two groups the one-way ANOVA test. NT-proBNP values were log transformed to 
create a normal distribution. In case of skewed distribution, the Mann–Whitney U 
test was applied. For comparison of frequencies, the χ2 test or Fisher’s exact test 
was used and for quantifying correlations the Pearson or Spearman correlation 
test. Multivariable regression analysis was performed for associations between 
strain and baseline characteristics.
Intra-observer and inter-observer agreement of LV GLS at A4C and RV free wall 
strain were assessed by repeated analysis (M.M., J.M.) in more than half of the 
data sets and of RV segmental strain in a quarter of the data sets at least half a 
year after the initial analysis on the second cardiac cycle at the same images. The 
limits of agreement between two measurements were determined as the mean of 
the differences ± 1.96SD and presented in a Bland–Altman plot. Additionally, the 
coefficient of variation (SD of the differences of two measurements divided by 
their mean) was provided.
All statistical analyses were performed using the Statistical Package for Social 
Sciences version 21 (SPSS, IBM Corp., Armonk, NY, USA). The statistical tests were 
two sided, and P<0.05 was considered statistically significant.
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results
Study population
Figure 3 presents an overview of the patient participation. Table 1 shows the base-
line characteristics of the study population. Twenty patients have had a palliative 
shunt before initial repair with a median duration of 4 years [IQR: 3–6].The patients 
were studied 27 years [IQR: 23–35] after initial surgical repair. Thirty-seven (39%) 
patients underwent primary pulmonary valve replacement (PVR) due to severe PR 
22 years [IQR: 18–26] after surgical repair and 6 years [IQR: 4–9] before the current 
study. None of the patients have had secondary PVR. In the subsets of patients 
with CMR, cardiopulmonary exercise testing, or NT-proBNP measurement, their 
baseline characteristics were also comparable with those of the healthy controls. 
Table 2 presents conventional echocardiographic characteristics. Table 3 shows 
the degree of PR in patients with PVR and patients without PVR.
LV longitudinal strain and strain rate
The mean LV GLS in patients was significantly lower than in controls, mainly due 
to decreased midventricular and apical septal strain (Figure 4). Table 4 presents 
LV strain rate values.
Eligible ToF patients
n=128
 Excluded:
 -  Poor image quality 
 -  Pacemaker                 
 -  Atrial brillation        
 LV GLS (A4C, A2C, A3C)    
  LV GLS (A4C)
 
 -  ECG               
 -  Bicycle ergometry    
 -  CMR                            
 -  NT-proBNP                
 RV free wall strain 
 
 
 -  ECG
 - Bicycle ergometry
 -  CMR
 - NT-proBNP
n=77 (82%)
n=81 (86%)
n=77 (100%)
n=59 (77%)
n=56 (73%)
n=73 (95%)
n=62 (66%)
n=62 (100%)
n=49 (79%)
n=46 (74%)
n=61 (98%)
n=25
n=8
n=1
Included patients 
n=94
Figure 3 Flow chart of the study patients.
An overview of the patient inclusion, feasibility of strain measurements, and number of patients per additional 
diagnostic test. We defined image quality as poor when speckle-tracking analysis was infeasible for both ven-
tricles. Bicycle ergometry was not performed in 24 patients mainly due to refusal or inability; CMR not in 28 due 
to refusal or claustrophobia.
A2C, apical two-chamber view; A3C, apical three-chamber view; A4C, apical four-chamber view; CMR, cardiac 
magnetic resonance imaging; ECG, electrocardiography; GLS, global longitudinal strain.
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RV longitudinal strain and strain rate
The mean RV free wall strain was significantly decreased in patients, as well as the 
strain of the three segments separately (Figure 5). In patients, the RV apical strain 
was lower than the RV basal strain (P<0.001) and midventricular strain (P=0.010). 
In controls, strain values of the three segments were comparable. Table 4 presents 
RV strain rate values.
Relationships with baseline characteristics and clinical parameters
Table 5 presents the results of a sub-analysis for age groups, sex, and surgical 
characteristics.
Age at repair correlated weakly with RV free wall strain (r=-0.31, P=0.013) and LV 
GLS (r=-0.24, P=0.033). After multivariable regression analysis adjusting sex, cur-
rent age, and body surface area, associations were no longer significant between 
age at repair and RV free wall strain (β=-0.27, P=0.130), or LV GLS (β=-0.28, P=0.053). 
No other correlations with surgical characteristics were found. The QRS duration 
Table 1 Characteristics of the ToF patients and healthy controls
Clinical characteristics
Patients Controls
P-value(n=94) (n=85)
Age at time of study (years) 32.8 ± 9.5 34.4 ± 11.6 0.308
Male 57 (61%) 48 (56%) 0.572
BMI (kg/m2) 23.9 ± 4.3 23.7 ± 3.1 0.717
Systolic blood pressure (mmHg) 124 ± 16 125 ± 13 0.993
Diastolic blood pressure (mmHg) 76 ± 13 76 ± 9 0.770
NYHA functional classification
Class I 92 (98%) 85 (100%) 0.498
Class II 2 (2%) -
Rhythm
Sinus rhythm 90 (96%) 85 (100%) 0.123
Atrial rhythm 4 (4%) -
QRS duration (ms) 141 ± 28 99 ± 9 <0.001
RBBB 75 (80%) -
QRS duration >180 ms 7 (7%) -
Age at operation (years) 1.9 [0.8-5.7] -
Type of repair
Transannular patch 63 (67%) -
Infundibulectomy 28 (30%) -
Unknown 3 (3%) -
Prior palliative shunt 20 (21%) -  
Pulmonary valve replacement 37 (39%) -
Categorical data are presented as n (%), and continuous data as mean + SD or median [IQR]. Bold font style rep-
resents statistically significant differences. BMI, body mass index; NYHA, New York Heart Association; RBBB, 
right bundle branch block.
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correlated with RV free wall strain (r=0.31, P=0.015) which means that patients 
with a longer QRS duration had lower RV strain. QRS duration did not correlate 
with LV GLS.
With cardiopulmonary exercise testing, the mean peak workload was 88 ± 17% of 
normal; peak heart rate 87 ± 9%; peak Vo2 81 ± 17%; peak RER 1.36 ± 0.19 and peak 
Eqco2 29.1 ± 4.7. No significant correlations were found between RV free wall strain 
and LV GLS with these parameters.
The median NT-proBNP level was 13.1 [IQR: 5.5–23.4] pmol/L. NT-proBNP was 
elevated in 42 (47%) patients. Log-transformed NT-proBNP tended to correlate 
with LV GLS (r=-0.23, P=0.052), but not with RV free wall strain.
Table 2 Conventional echocardiographic characteristics of the ToF patients and healthy controls
Characteristic Patients  Controls  P-value
LV end-diastolic dimension (mm) 48 ± 6 48 ± 4 0.694
LV end-systolic dimension (mm) 32 ± 7 29 ± 4 0.001
LV fractional shortening (%) 33 ± 10 40 ± 7 <0.001
LV EF Simpson’s (%) 51 ± 7 58 ± 5 <0.001
RV longitudinal dimension (mm) 88 ± 9 79 ± 7 <0.001
RV basal dimension (mm) 44 ± 8 37 ± 6 <0.001
RV FAC (%) 40 ± 9 45 ± 8 0.011
TAPSE (mm) 19 ± 4 28 ± 4 <0.001
Valvular disease in patients Mild Moderate Severe
Aortic regurgitation 23 (24%) 1 (1%) -
Aortic stenosis 2 (2%) - -
Mitral regurgitation 15 (16%) 1 (1%) -
Pulmonary regurgitation 32 (34%) 15 (16%) 27 (29%)
Pulmonary stenosis 40 (43%) 15 (16%) 2 (2%)
Tricuspid regurgitation 55 (59%) 7 (7%) -
Continuous data are presented as mean + SD; categorical data as n (%). Bold font style represents statistically 
significant differences. EF, ejection fraction; FAC, fractional area change; TAPSE, tricuspid annular plane systolic 
excursion.
Table 3 Degree of pulmonary regurgitation in patients with and without pulmonary valve replace-
ment
Degree of PR None,
n (%)
Mild,
n (%)
Moderate,
n (%)
Severe,
n (%)
PVR 11 (55) 19 (59) 6 (40) 1 (4)
No PVR 9 (45) 13 (41) 9 (60) 26 (96)
PR, pulmonary regurgitation; PVR, pulmonary valve replacement.
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Relationships with echocardiographic parameters
A positive correlation between RV free wall strain and LV GLS was found in all 
subjects (r=0.46, P<0.001) and in the patient group itself (r=0.37, P=0.010). Figure 6 
shows a strong correlation between RV free wall strain with TAPSE and moder-
ate correlation with RV longitudinal dimension. The RV segments separately 
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Figure 4 Mean LV global and segmental longitudinal strain of ToF patients (n=81) and healthy 
controls (n=85).
Peak systolic LV GLS was based on measurements at the apical two-, three-, and four-chamber view. Strain val-
ues of the six segments were measured at the apical four-chamber view. The error bars show 95% confidence 
interval. Only significant P-values are depicted. GLS, global longitudinal strain.
Table 4 The peak systolic strain rate of the LV septal wall, LV lateral wall, and RV free wall of ToF 
patients and healthy controls
 Patients Controls P-value
LV strain rate (s-1)
Septum, base -1.10 ± 0.34 -1.01 ± 0.27 0.047
Septum, mid -1.14 ± 0.38 -1.18 ± 0.27 0.465
Septum, apex -1.10 ± 0.32 -1.21 ± 0.18 0.007
Lateral, apex -1.20 ± 0.39 -1.18 ± 0.40 0.721
Lateral, mid -1.49 ± 0.60 -1.25 ± 0.38 0.003
Lateral, base -1.51 ± 0.53 -1.47 ± 0.48 0.620
RV strain rate (s-1)
Free wall, base -1.43 ± 0.46 -1.67 ± 0.57 0.017
Free wall, mid -1.43 ± 0.47 -1.68 ± 0.61 0.014
Free wall, apex -1.17 ± 0.46 -1.66 ± 0.55 <0.001
Strain rate values are presented as mean ± SD.
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correlated also significantly with TAPSE and RV longitudinal dimension. Table 6 
summarizes correlations between biventricular GLS and other echocardiographic 
parameters.
Patients with an LVEF <50% had a lower LV GLS (-16.3 ± 2.7%) than patients 
with an LVEF ≥50% (-18.4 ± 2.1%, P=0.001). RV free wall strain in patients with RV 
FAC <35% tended to be lower (-16.9 ± 4.0%) than in patients with normal RV FAC 
(-19.2 ± 4.6%, P=0.094). Table 5 shows a sub-analysis for the severity of pulmonary 
valve disease. No significant differences in LV GLS and RV free wall strain were 
found between patients with none, mild, or moderate tricuspid regurgitation.
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Figure 5 Mean RV free wall and segmental longitudinal strain of ToF patients (n=62) and healthy 
controls (n=54). Peak systolic RV free wall strain was measured at the apical four-chamber view. The error 
bars show 95% confidence interval. GLS, global longitudinal strain.
A
Healthy controls
ToF patients
A
B
Healthy controls
ToF patients
Figure 6 Correlations between RV free wall strain with conventional parameters.
Significant correlations were observed between RV free wall strain and TAPSE (A), and RV end-diastolic longitu-
dinal dimension (B).TAPSE, tricuspid annular plane systolic excursion.
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Relationships with CMR parameters
The median PR fraction was 20% [IQR: 0–43]. Patients with PR >25% had a sig-
nificantly higher strain than patients with PR ≤25% (Table 5). In the group with 
PR >25%, none of the patients had a PVR vs. 16 (52%) PVR patients in the group 
with PR ≤25% (P<0.001). Table 7 presents CMR-derived ventricular volumes and 
EFs, and their correlations with GLS.
Table 5 Sub-analysis for age groups, sex, surgical characteristics, and pulmonary valve disease 
in ToF patients
  
n LV GLS 
(%)
P-value n RV free wall
strain (%)
P-value
Age (years) <30 35 -17.1±2.3 0.243 32 -17.6±4.0 0.381
 ≥30 42 -17.7±2.6   30 -18.6±5.0  
Sex Male 44 -16.8±2.4 0.011 40 -16.7±3.9 0.001
Female 33 -18.3±2.4 22 -20.6±4.5
Age at repair (years) <2 41 -16.8±2.1 0.011 33 -17.0±3.9 0.037
 ≥2 36 -18.2±2.6   29 -19.3±4.9  
Surgical era ≤1980 31 -17.5±2.6 0.894 23 -18.0±5.2 0.924
>1980 46 -17.4±2.4 39 -18.1±4.2
Transannular patch Yes 49 -17.4±2.5 0.896 45 -18.2±4.3 0.759
 No 25 -17.5±2.4   15 -17.8±5.3  
Preoperative palliative shunt Yes 17 -17.7±3.1 0.606 16 -19.5±5.3 0.144
No 59 -17.3±2.3 46 -17.6±4.2
RBBB Yes 62 -17.6±2.6 0.389 50 -17.9±4.5 0.587
 No 15 -16.9±2.0   12 -18.7±4.7  
PS grade, echocardiography None (<2 m/s) 30 -17.6±2.5 0.660a 24 -18.9±4.8 0.308a
Mild-moderate (2-4 m/s) 45 -17.3±2.5 36 -17.6±4.4
Severe (≥4 m/s) 2 -18.9±2.0 2 -16.9±2.1
PR grade, echocardiography None 19 -17.1±2.8 0.516 12 -18.9±5.0 0.049
 Mild-moderate 37 -17.3±2.5   30 -16.7±3.9  
 Severe 21 -17.9±2.0   20 -19.7±4.6  
PR fraction, CMR (%) ≤2518 29 -16.7±2.3 0.003b 21 -17.2±3.8 0.044
>25 20 -18.6±1.6 20 -19.9±4.5
Pulmonary homograft Yes 32 -17.0±2.7 0.194 24 -16.8±3.9 0.087
 No 45 -17.8±2.3   38 -18.9±4.7  
Strain values are presented as mean+SD. Bold font style represents statistically significant differences.
CMR, cardiac magnetic resonance; PR, pulmonary regurgitation; PS, pulmonary stenosis; RBBB, right bundle 
branch block.
aBecause of the small number of patients with severe pulmonary stenosis, they were excluded from statistical 
analysis. bDifference in statistical outcome between PR grade assessed with echocardiography and with CMR 
could be caused by the smaller number of patients with CMR.
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Intra-observer and inter-observer agreement
The mean difference of the intra-observer measurements was -0.13 ± 1.40% for the 
LV GLS at A4C and -0.02 ± 2.00% for the RV free wall strain. The mean difference of 
the inter-observer measurements was -0.06 ± 1.49% for the LV GLS at A4C and 0.18 
± 2.68% for the RV free wall strain (Figure 7). The intra-observer agreement for RV 
segmental strain (3 segments) was -0.67 ± 4.53% and the inter-observer agreement 
was 0.33 ± 7.28%.
Table 6 Correlations and differences between global longitudinal strain and echocardiographic 
parameters of ToF patients
  LV GLS  
Pearson’s r P-value
LV end-diastolic dimension 0.04 0.713
LV end-systolic dimension 0.34 0.002
LV fractional shortening -0.44 <0.001
LV EF Simpson’s -0.45 <0.001
  RV free wall strain
Pearson’s r P-value
RV longitudinal dimension 0.37 0.003
RV basal dimension -0.16 0.221
RV FAC -0.22 0.108
TAPSE -0.48 <0.001
Bold font style represents statistically significant correlations.
EF, ejection fraction; FAC, fractional area change; GLS, global longitudinal strain; TAPSE, tricuspid annular plane 
systolic excursion.
Table 7 CMR parameters and correlations with global longitudinal strain in ToF patients.
  LV GLS  
Median [IQR] Spearman’s ρ P-value
LV SV/BSA 44 [40-51] -0.16 0.228
LV ESV/BSA 30 [25-37] 0.41 0.002
LV EDV/BSA 75 [68-87] 0.16 0.253
LV EF (%) 59 [52-65] -0.49 <0.001
PR fraction (%) 20 [0-43] -0.42 0.003
    RV free wall strain
Median [IQR] Spearman’s ρ P-value
RV SV/BSA 55 [47-67] -0.32 0.030
RV ESV/BSA 53 [40-70] -0.12 0.436
RV EDV/BSA 106 [91-140] -0.19 0.201
RV EF (%) 52 [45-56] -0.11 0.485
PR fraction (%) 20 [0-43] -0.28 0.075
Bold font style represents statistically significant correlations.
BSA, body surface area (m2); EDV, end-diastolic volume (mL); ESV, end-systolic volume (mL); GLS, global longi-
tudinal strain; IQR, inter-quartile range; PR, pulmonary regurgitation; SV, stroke volume (mL).
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disCussion
In this prospective cross-sectional study, RV as well as LV peak systolic longitudi-
nal strain are decreased in ToF patients. Of the RV free wall, especially the apical 
deformation is impaired, suggesting that apical function is affected most in these 
volume overloaded RVs. Of the LV, the septal strain is decreased, which indicates 
potential ventricular–ventricular interaction.
RV longitudinal strain
In normal RV anatomy, longitudinal contraction is the major contributor to the 
overall RV performance.19 The longitudinal strain of all three RV free wall seg-
ments was decreased in the patients, presumably as a result of chronic volume 
overload. Decreased free wall strain was also described by others; however, they 
A B
C D
Intra-observer agreement
Inter-observer agreement
COV = 8.8%
COV = 7.6%
COV = 13.2%
COV = 9.1%
Figure 7 Bland–Altman plots demonstrating intra-observer and inter-observer agreement.
Left ventricular strain and right ventricular free wall strain for intra-observer (A and B) and inter-observer 
agreement (C and D) were measured at the apical four-chamber view. The solid lines depict the mean difference 
of two measurements, and the dashed lines depict the limits of agreement.
A4C, apical four-chamber view; COV, coefficient of variation.
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included only a small group of patients.10,12 The apical strain was more decreased 
than the strain of the other RV segments, which was also observed in children,11 
confirming that RV basal and midventricular function are better preserved than 
apical function. The reason why the apical segment is most sensitive to volume 
overload is not exactly clear. It has been suggested that the RV apical part is more 
affected by wall stress, because it is thinner and more trabeculated than the inlet 
and outlet parts.19,20 The higher regional wall stress results in a dilated and more 
rounded apical shape.20 This remodelling could lead to greater reduction in apical 
contractile function resulting in more decreased strain. Another explanation could 
be that in some RVs a hypertrophied moderator band and trabeculations lead to 
a smaller regional volume and therefore might decrease the apical deformation.21
Remarkably, patients with severe PR had less decreased RV free wall strain than 
patients with none–moderate PR. Possibly, the higher strain values in patients 
with severe PR are a result of a compensatory mechanism. Moreover, the lower RV 
strain in patients with none–moderate PR could possibly be explained by the fact 
that some of them received a PVR after long-term suffering from severe PR. The 
exposure to severe PR and the reinterventions could lead to decreased RV strain. 
However, these hypotheses remain speculative. The exact underlying mechanism 
is unclear and follow-up is necessary to evaluate RV deformation over time.
Timing of PVR is controversial and the optimal indications are not completely 
clear yet. After PVR, RV EF does often not improve,22 suggesting that irreversible 
myocardial damage has already been occurred when using a more conservative 
approach. Decreased strain may be present before changes in EF become visible 
and might be of additional value in identifying patients in need of PVR. However, to 
conclude that decreased strain is an early sign of ventricular dysfunction in these 
patients and could be an additional criterion for reinterventions, a prospective 
longitudinal study is required.
Ventricular–ventricular interaction
LV dysfunction is a strong determinant of clinical outcome in ToF patients,3,6,7 
making early detection important. RV dysfunction may lead to LV dysfunction in 
ToF patients.3 – 5,10,23 RV free wall strain of our adult patients was related with LV 
GLS, suggesting ventricular–ventricular interaction. Decreased LV GLS was mainly 
caused by decreased strain of the midventricular and apical septum, both inter-
ventricular segments. Also in children the assessment of ventricular–ventricular 
interaction revealed that RV free wall strain and LV GLS were closely related and 
that LV strain was significantly decreased at the mid and apical levels.24 Moreover, 
decreased RV function in ToF patients results in smaller or impaired LV twist.23,24
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RV pressure and volume loading are likely to affect the LV through several po-
tential interventricular mechanisms, e.g. changes in septal curvature, shared myo-
cardial fibres and electromechanical dyssynchrony. Additionally, in ToF patients, 
mechanical interventricular interaction is observed by the interventricular septal 
patch that leads to dysfunction of at least a part of the septum.25 A prospective 
follow-up is needed to conclude whether decreased septal strain is a pre-clinical 
sign of LV dysfunction.
Relationships with clinical parameters
RV free wall strain correlated moderately with TAPSE and modestly with CMR-
derived indexed RV SV, but not with RV EF. Mercer-Rosa et al.26 described in ToF 
patients an association of TAPSE with RV SV, but not with RV EF which is cor-
responding with our results. An explanation for lack of correlation between RV 
free wall strain and RV EF could be that in case of changed loading conditions, 
the RV compensates decreased longitudinal strain with an increase in radial or 
circumferential strain to preserve its EF. During a 4-year follow-up in adults with 
ToF, the RV EF remained unchanged, whereas the RV GLS decreased significantly.12 
Hayabuchi et al.27 described in children with repaired ToF a decreased RV longitu-
dinal septal strain, but a normal circumferential and increased radial strain. These 
deformation characteristics may be the same or even more pronounced in adults. 
The lack of correlation could also be caused by the CMR-derived volumes that are 
observer dependent and sensitive to the used method.
Another explanation could be that RV free wall strain reflects deformation of 
the RV inflow and apical part, but not of the RV outflow tract. Many ToF patients 
have an outflow patch which could influence the regional function. Wald et al.28 
demonstrated with CMR that regional RV outflow tract abnormalities adversely 
affect global RV EF. Whether it is feasible and reliable to measure RV longitudinal 
strain at different views with echocardiography to get a better estimation of RV 
function is unknown and has to be investigated.
RV free wall strain appears to have discriminative ability for quality of life in 
ToF patients;29 however, whether decreased strain is a predictor of clinical out-
come is unknown. Our study showed no correlation between RV free wall strain 
and exercise performance, which is in contrast with the observed correlation in 
children by Alghamdi et al.30 Reasons for this discrepancy could be the differences 
in surgical era, patient age or, as described by Wald et al.,28 that the RV outflow 
tract function is a more important determinant of exercise performance. We did 
not find significant relationships between NT-proBNP levels and strain values. 
However, single NT-proBNP measurements rarely allow meaningful correlations 
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with imaging parameters, and therefore, sequential measurements are needed to 
draw further conclusions.
RV strain values have not been adjusted to RV size to possibly reveal further 
correlations as was done in children,11 because it is not recommended in the cur-
rent guidelines.8
Intra-observer and inter-observer agreement
We found a higher variation in strain values of the RV than the LV. This could 
probably be explained by the fact that the RV free wall is more difficult to im-
age than the LV, the RV consisted of fewer segments and that the algorithm has 
been developed for the LV shape. Although the variation is higher for RV free 
wall strain, the reproducibility is still good. The intra-observer and inter-observer 
variation of RV segmental strain was considerable, but the mean difference of the 
two measurements was small meaning that the observed decrease in strain was 
well reproducible.
Limitations
We measured peak systolic longitudinal deformation. Analysis of radial and cir-
cumferential deformation may have provided additional information, but shorten-
ing of the RV is larger longitudinally than radially and, therefore, contributes more 
to RV contraction.19 We assumed that the same applies to RVs of ToF patients. In 
addition, RV radial and circumferential strain measurements are not available on 
QLAB software. Rotational movements play a significant role for LV function, but 
we decided to measure strain in longitudinal direction making comparisons with 
RV strain clearer.
Cardiopulmonary exercise tests and CMR exams were not performed in about 
one quarter of the patients. Therefore, correlation analysis results should be 
interpreted with caution.
ConClusions
The RV free wall longitudinal strain and strain rate are decreased in ToF patients, 
most pronounced at the apical segment. This suggests that apical function is most 
affected in these volume overloaded RVs. With regard to the LV, the strain of the 
septum is decreased indicating that RV dysfunction negatively affects LV function, 
probably due to mechanical ventricular coupling. Whether decreased strain is an 
early and subclinical sign of ventricular dysfunction in ToF patients, and whether 
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decreased strain could be an objective criterion for reinterventions, is unclear 
and requires a prospective longitudinal study.
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abstraCt
Aims
Left ventricular (LV) dysfunction is a major determinant of late adverse clinical 
outcome in adult patients with tetralogy of Fallot (ToF). Therefore, early detection 
is important. Speckle-tracking echocardiography (STE) has emerged as a quan-
titative technique to assess LV function. The aim of this study was to evaluate 
LV rotation and twist with STE in adult ToF patients and their association with 
right ventricular (RV) and LV dimensions and function, exercise capacity, and NT-
proBNP level.
Methods
Eighty-two ToF patients and 56 healthy controls matched for age and gender 
underwent echocardiography, electrocardiography, cardiac magnetic resonance 
imaging (CMR), bicycle ergometry, and NT-proBNP measurement. For STE, short-
axis parasternal views were obtained at the LV base and apex. We analysed LV 
apical and basal rotation curves and calculated LV twist.
Results
Of the 82 ToF patients (55% male, age 33 ± 10 years, 98% NYHA I), 58 (71%) had nor-
mal twist, but lower than the controls [12.5 (IQR: 6.6) vs. 16.9 (IQR: 8.2) degrees, 
P=0.002] mainly due to decreased apical rotation. Twenty-one (26%) patients had 
abnormal apical rotation which was associated with larger LV dimensions and de-
creased systolic biventricular function. Multivariable regression analyses showed 
positive relations of LV twist with biventricular systolic function measured with 
echocardiography as well as CMR.
Conclusion
The majority of adults with corrected ToF show a reduced LV twist. Strikingly, one-
quarter of these patients have an abnormal apical rotation which is associated 
with decreased systolic LV and RV function. These findings suggest that abnormal 
apical rotation is a new objective diagnostic criterion for detection of ventricular 
dysfunction.
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introduCtion
Nowadays, a growing number of adult patients require regular follow-up after 
surgical correction of tetralogy of Fallot (ToF) in early childhood. These patients 
often present with pulmonary regurgitation (PR), right ventricular (RV) dysfunc-
tion, and arrhythmias. After the third post-operative decade their risk of death 
increases.1–3 RV dysfunction has been studied extensively in ToF patients and its 
progression may also affect left ventricular (LV) function.2,4,5 Therefore, the LV has 
recently gained more attention. Several studies found a close relationship between 
RV and LV function in patients with corrected ToF, indicating the potential patho-
physiological role of ventricular interaction that may lead to clinical deterioration 
at long-term follow-up.6–8 Although ventricular interactions and the influence of RV 
dilatation on LV shape and function have not been studied in detail, and although 
the mechanisms have not been completely elucidated,9,10 LV dysfunction is a 
strong independent determinant of clinical outcome2,11–13 making early detection 
of LV dysfunction important.
In the assessment of LV function, speckle-tracking echocardiography (STE) has 
extended the possibilities from evaluating linear to rotational deformation and 
allows angle-independent quantification of complex LV motion patterns, e.g. rota-
tion and twist.4,10,12,14 Many studies have demonstrated that LV rotation and twist 
are feasible in clinical settings, and that they may provide a useful clinical measure 
for early detection of a subclinical state that is likely to progress into heart failure. 
Whether this is also true for patients with ToF is unknown. Our hypothesis is that 
LV dysfunction develops in most adult patients a long time after initial correction 
of ToF. Therefore, we used STE in adult patients with corrected ToF to investigate 
LV rotation patterns and twist and its association with RV and LV dimensions and 
function, the severity of PR, and N-terminal pro-Brain Natriuretic Peptide (NT-
proBNP) level, a commonly used biomarker for heart failure.
Methods
We approached consecutive patients who had undergone surgical repair for 
ToF between 1968 and 1995 and who were seen at our adult congenital cardiol-
ogy outpatient clinic. The exclusion criteria were the presence of left bundle 
branch block, atrial fibrillation, pacemaker, or echocardiographic images with 
insufficient quality for adequate speckle tracking. Baseline characteristics were 
collected as age, gender, type of reparative surgery, and duration of follow-up 
since operation. The study protocol included 12-lead electrocardiography (ECG), 
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echocardiography, cardiac magnetic resonance imaging (CMR), bicycle ergome-
try, and NT-proBNP measurement. Echocardiographic data were compared with 
those of healthy controls. The healthy controls were employees of the university 
or the hospital who had no medical histories or current symptoms suggesting 
cardiovascular disease. We aimed to compose a control group with the same age 
and sex distribution as in the patient group. Because we could not find for every 
single patient a matched control, we decided to match the whole patient group to 
a control group. The medical ethics committee approved the study, and informed 
consent was obtained from all patients and healthy controls.
Echocardiography
Two-dimensional greyscale harmonic images were obtained in the left lateral de-
cubitus position using a commercially available ultrasound system (iE33; Philips 
Medical Systems, Best, the Netherlands) equipped with a broadband (1 to 5-MHz) 
S5–1 or X5-1transducer (frequency transmitted 1.7 MHz; frequency received 3.4 
MHz).We used the guidelines of the American Society of Echocardiography for our 
chamber measurements, including LV and RV dimensions, volumes, LV ejection 
fraction (EF), and RV fractional area change (FAC).15,16 For the assessment of val-
vular regurgitation and stenosis, we used the recommendations of the European 
Association of Echocardiography.17 – 19 To optimize STE, images were obtained at 
a frame rate of >60 frames/s. Parasternal short-axis images at the LV basal level 
(showing the tips of the mitral valve leaflets) with the cross-section as optimal as 
possible were obtained from the standard parasternal position. To obtain a short-
axis image at the LV apical level, the transducer was positioned one or two inter-
costal spaces more caudally, as we have previously described.20 All images were 
transferred to a QLAB workstation (Philips Medical Systems) for offline analysis.
Speckle-tracking analysis
Analysis of the data sets was performed using STE by QLAB version 9.0. To assess 
LV rotation, we defined the endocardium and epicardium at each of the two levels. 
Subsequently a speckle-tracking region of interest was automatically generated to 
include the myocardium on an end-diastolic frame. After positioning the tracking 
points, the programme tracked these points on a frame-by-frame basis using a 
least squares global affine transformation. The rotational component of this affine 
transformation was then used to generate rotational profiles. Data were exported 
to a spreadsheet program (Excel; Microsoft Corporation, Redmond, WA, USA).
Counterclockwise rotation, as viewed from the apex, was expressed as a positive 
value, and clockwise rotation as a negative value. The peak apical rotation (AR) 
and peak basal rotation (BR) were analysed during the ejection phase. We defined 
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peak AR >4 degrees as normal (mean AR of the healthy controls - two standard 
deviations). BR was defined abnormal when the rotation was absent, reversed, or 
prolonged. The twist was defined as the maximal value of simultaneous systolic 
AR - BR. In the present study, various LV rotation patterns were recognized. A nor-
mal twist pattern was characterized by end-systolic clockwise BR and end-systolic 
counterclockwise AR.21 All other patterns were defined as abnormal. Because of 
the presence of abnormal twist patterns, we could not perform analysis on LV 
torsion (i.e. LV twist normalized for LV length).
The QLAB software showed good intra-observer and inter-observer reproduc-
ibility of LV twist measurements22 and we found excellent agreement of the first 10 
patients analysed by two independent observers. Therefore, we did not perform 
reproducibility analysis.
CMR imaging
CMR results were only obtained in patients undergoing CMR for routine clinical 
follow-up. CMR imaging was performed using a Signa 1.5-Tesla whole-body scanner 
(General Electric Medical Systems, Milwaukee, WI, USA) with dedicated phased-
array cardiac surface coils. Details of the used MR sequence have been reported 
previously.23 For CMR analyses, a commercially available Advanced Windows 
workstation (GE Medical Systems) was used, equipped with Q-mass (version 5.2, 
Medis Medical Imaging Systems, Leiden, the Netherlands). The ventricular volu-
metric data set was quantitatively analysed using manual outlining of endocardial 
borders in end-systole and end-diastole. Biventricular end-diastolic volume, end-
systolic volume (ESV), EF, and valvular regurgitation fractions were calculated.
Exercise capacity
Maximal exercise capacity and peak oxygen consumption (peak Vo2) were as-
sessed by bicycle ergometry. Exercise test results were only obtained in patients 
undergoing bicycle ergometry for routine clinical follow-up on the same day as 
the echocardiography. Workload was increased stepwise with 10–20 W/min. The 
results were compared with the results of healthy subjects adjusted for age, sex, 
and body height.
NT-proBNP levels
Peripheral venous blood samples were collected after 30 min rest. Plasma 
NT-proBNP levels were determined with the use of a commercially available 
electrochemiluminescence immunoassay kit (Elecsys, Roche Diagnostics, Basel, 
Switzerland). NT-proBNP ≤14 pmol/L is defined as normal in our laboratory.
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Statistical analysis
Continuous variables are presented as means ± standard deviation (SD) or as 
median with interquartile range (IQR). Categorical variables are presented as 
frequencies and percentages. For comparison of normally distributed, continuous 
variables between patients and controls Student’s t-tests were used; in case of 
skewed distribution Mann–Whitney U tests. For comparison of frequencies, the 
χ2 test or Fisher’s exact test was used. For quantifying correlations between two 
variables, the Pearson or Spearman correlation test was applied. Multivariable re-
gression analyses were performed for associations between rotational parameters 
and systolic function, adjusted for gender, BMI, age of repair, the use of a transan-
nular patch, and pulmonary valve replacement (PVR). All statistical analyses were 
performed using SPSS version 20 (IBM Corp., Armonk, NY, USA). P-values < 0.05 
were considered statistically significant.
results
Characteristics of the study population
A total of 123 ToF patients underwent echocardiography with focus on the LV 
rotation and twist. Forty-one (33%) of these patients were excluded: in 15 the 
visualization of the apex was inadequate and in 10 the visualization of the base; 8 
had poor quality in both views; 4 had a pacemaker; 2 were in atrial fibrillation, 1 
had a left bundle branch block; and 1 was pregnant. In the remaining 82 patients, 
adequate tracking was possible in the apical short-axis view and basal short-axis 
view, so they formed the study population. The control group consisted of 56 in-
dividuals matched for gender and age (50% male, age 31 ± 7 years). Table 1 shows 
the clinical and echocardiographic characteristics of the study population. The 
patients were studied 29.2 ± 7.4 years after initial corrective surgery; at the time of 
the study 98% of them were in NYHA class I. Thirty-seven (45%) patients received 
a pulmonary homograft because of severe PR 20.1 ± 7.9 years after the initial 
operation. Five of whom, underwent recent PVR <1 year before echocardiography. 
Seventy-five (91%) patients were in sinus rhythm and 7 (9%) in atrial rhythm. 
All these patients had a regular rhythm. The mean QRS complex duration of the 
patients with ToF was 140 ± 31 ms. A complete right bundle branch block was 
present in 57 (70%) of the patients, an incomplete right bundle branch block in 6 
(7%), and unspecified delayed conduction in 5 (6%). RV systolic function assessed 
with eyeballing was graded in four groups: normal (n=23), mildly impaired (n=45), 
moderately impaired (n=13), and severely impaired (n=1). LV systolic function was 
also graded in normal (n=44), mildly impaired (n=37), and severely impaired (n=1).
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Apical rotation and basal rotation
Figure 1 represents the LV rotational parameters of the healthy controls and the 
patients with corrected ToF. The AR was normal in all healthy controls [10.1 (IQR: 
4.4) degrees]. The median AR in the patients with corrected ToF was 8.1 (IQR: 7.7) 
degrees. Sixty-one (74%) of these ToF patients had a normal AR [9.4 (IQR: 6.2), 
P=0.349 compared with the controls) and 21 (26%) ToF patients had an abnormal 
AR. This abnormal AR was due to reversed rotation in 11 patients, reduced rota-
tion (<4 degrees) in 8, and absent rotation in 2.
The median BR of the healthy controls was -7.0 (IQR: 5.8) degrees; of the ToF 
patients it was -5.2 (IQR: 3.6) degrees. Of these patients, 66 (80%) had a normal BR. 
Table 1 Clinical and echocardiographic characteristics of the study population
Clinical characteristics Patients (n=82)
Age at time of study (years) 32.6 ± 9.7
Male, n (%) 45 (55)
Type of repair , n (%)
Transannular patch 60 (73)
Infundibulectomy 22 (27)
Pulmonary homograft 37 (45)
Echocardiography, n (%) 82 (100)
TAPSE (mm) 18 ± 5
Pulmonary regurgitation, n (%)
Mild 30 (37)
Moderate 8 (10)
Severe 24 (29)
Pulmonary stenosis, n (%)
Mild 33 (40)
Moderate (≥ 3.0 m/s) 12 (15)
Severe (≥ 4.0 m/s) 2 (2)
Tricuspid regurgitation, n (%)
Mild 49 (60)
Moderate 7 (9)
Severe -
Aortic regurgitation, n (%)
Mild 21 (28)
Moderate 1 (1)
Severe -
Aortic stenosis, n (%)
Mild 1 (1)
Moderate-severe -
TAPSE, tricuspid annular plane systolic excursion.
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Of the 16 (20%) patients with abnormal BR, 9 patients had reversed BR, 6 absent 
BR, and 1 prolonged BR.
Table 2 presents the comparison of demographic and echocardiographic vari-
ables between the groups of corrected ToF patients with normal AR and those with 
abnormal AR. The patients with abnormal AR had larger LV dimensions than the 
patients with normal AR, and more had a decreased systolic LV and RV function. 
There were no differences in the severity of pulmonary stenosis or regurgitation 
between the two groups.
Left ventricular twist
All healthy controls and 58 (71%) patients with corrected ToF showed a normal 
twist pattern. However, these patients had a significantly lower LV twist than 
controls [12.5 (IQR: 6.6) vs. 16.9 (IQR: 8.2) degrees, P=0.002] (Figure 1).Twenty-
four (29%) patients had an abnormal twist pattern. Figure 2 shows the various 
rotation patterns we observed. In 11 patients, the abnormal twist pattern was due 
to abnormal BR, in 8 patients it was due to abnormal AR (Figure 2B), and in 5 to 
abnormal rotation at both levels (Figure 2C).
Pulmonary valve replacement, interventricular septum, rhythm, and 
NT-proBNP
The median BR, AR, and twist were similar between the patients without PVR, 
recent PVR, and PVR >1 year before echocardiography.
Healthy controls
ToF patients with normal twist
ToF patients with abnormal twist
Median twistMedian BR Median AR
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Figure 1 Rotational parameters of the left ventricle in patients with tetralogy of Fallot and in 
healthy controls.
BR, basal rotation; AR, apical rotation. The error bars show inter-quartile ranges.
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Table 2 Comparison of structural parameters in patients with normal and abnormal AR
 Normal AR Abnormal AR P value
 (n=61) (n=21)  
Surgery Age at repair (years) 3.5 ± 6.3 2.7 ± 2.8 0.557
  Type of repair, n (%)      
  Transannular patch 42 (69) 18 (86) 0.133
  Infundibulectomy 19 (31) 3 (14)  
  Pulmonary homograft 27 (44) 10 (48) 0.790
Physical examination Body mass index (kg/m2) 23 ± 4 26 ± 4 0.037
ECG QRS duration (ms) 140 ± 30 140 ± 33 0.981
Echocardiography Right atrial dilatation, n (%)      
  None 26 (43) 7 (33) 0.581
  Mild-moderate 24 (39) 11 (52)  
  Severe 11 (18) 3 (14)  
  Right ventricle      
  End-diastolic annulus (mm) 42 ± 8 43 ± 7 0.772
  End-diastolic apex-base (mm) 88 ± 10 86 ± 8 0.416
  TAPSE (mm) 18 ± 5 19 ± 5 0.780
RV FAC (%) 41 ± 9 36 ± 8 0.126
  Left ventricle      
  End-syst dim/BSA 17 ± 3 19 ± 4 0.011
  End-dias dim/BSA 25 ± 3 27 ± 3 0.038
  E/A ratio 1.69 ± 0.61 1.82 ± 1.12 0.612
  E/E’ ratio 10.4 ± 4.2 9.4 ± 3.3 0.356
  Deceleration time (ms) 199 ± 58 186 ± 44 0.334
LV ejection fraction (%) 53 ± 6 48 ± 6 0.008
  Systolic LVF, n (%)      
  Normal 38 (62) 6 (29) 0.008
  Impaired 23 (38) 15 (71)  
  Systolic RVF, n (%)      
  Normal 21 (34) 2 (9) 0.028
  Impaired 40 (66) 19 (91)  
  IVS, n (%)      
  Normal 28 (46) 10 (48) 0.253
  Flattening 26 (43) 11 (52)  
  Paradoxal 7 (11) 0 (0)  
  Pulmonary stenosis, n (%)      
  None-mild 50 (82) 18 (86) 1.000
  Moderate-severe 11(18) 3 (14)  
  Pulmonary regurgitation, n (%)      
  None-mild 35 (57) 15 (71) 0.255
  Moderate-severe 26 (43) 6 (29)  
  Tricuspid regurgitation, n (%)  
  None-mild 58 (95) 17 (81) 0.067
  Moderate-severe 3 (5) 4 (19)  
Laboratory NT-proBNP >14, n (%) 25 (44) 11 (55) 0.390
TAPSE, tricuspid annular plane systolic excursion; FAC, fractional area change; BSA, body surface area; E/A 
ratio, ratio of early filling to late filling velocity on transmitral Doppler; E/E′ ratio, ratio of early filling velocity 
on transmitral Doppler to early relaxation velocity on tissue Doppler; LVF, left ventricular function; RVF, right 
ventricular function; IVS, interventricular septum.
122 Chapter 6
The interventricular septal motion differed significantly between the groups 
of ToF patients with normal LV twist pattern and those with abnormal twist pat-
tern. In the patient group with normal twist pattern, 45% had septal flattening or 
paradoxal wall motion against 75% in the group with abnormal twist (P=0.013). 
Between the normal and abnormal BR groups was a trend towards significance in 
interventricular septal motion (48 vs. 75%, P=0.056), but no difference was found 
between the normal and abnormal AR groups.
No significant difference was observed with regard to the rhythm: 55 (95%) of 
the patients with normal twist pattern were in sinus rhythm, and 20 (83%) of the 
patients with abnormal twist pattern (P=0.186).
NT-proBNP levels were collected in 77 (94%) patients. The median NT-proBNP 
level was 13.1(IQR:18.1) pmol/L. The NT-proBNP levels were similar in patients of 
the abnormal twist group and those of the normal twist group.
Analyses with systolic function measured with echocardiography
LV EF was assessed using the biplane Simpson’s method. In 54 (66%) patients, im-
age quality of the two- and four-chamber views was sufficient for adequate tracing 
  
  







 



 





  
   










 



 





  
  







 



 





    
   







 



 





 

     
     
     
     
     
     
Figure 2 Various rotation types in patients with corrected ToF.
Fifty-eight patients had a normal twist pattern (A); of the patients with abnormal twist pattern, 11 had an ab-
normal BR and 8 an abnormal AR (B); 5 had both abnormal basal and abnormal AR (C). Note that 8 patients 
with normal twist pattern have reduced AR (,4 degrees). LV EF, left ventricular ejection fraction, RV FAC, right 
ventricular fractional area change.
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of the LV. The measurement of RV FAC was possible in 58 (71%) patients. Table 3 
presents the comparison of rotational parameters between patients with normal 
vs. abnormal RV FAC, and in patients with normal vs. abnormal LV EF. The median 
twist was significantly lower in patients with abnormal RV FAC and in patients with 
abnormal LV EF.
Multivariable regression analysis adjusted for gender, BMI, age of repair, the 
use of a transannular patch, and PVR showed a significant association between 
twist and LV EF (β=0.47, P=0.001) and between twist and RV FAC (β=0.35, P=0.010) 
measured with echocardiography. Figure 3 shows the correlations between LV EF 
and RV FAC with the LV rotational parameters. LV EF was stronger correlated with 
AR than BR, whereas RV FAC was stronger correlated with BR.
CMR imaging
Fifty-three (65%) patients underwent CMR, in 50 of whom ventricular volumes and 
EF could be measured and in 47 PR fraction. The median time interval between 
echocardiography and CMR was 0.0 (IQR: 0.52) years. None of the patients un-
derwent reinterventions during this time interval. After adjustment for gender, 
BMI, age of repair, the use of transannular patch, and PVR, significant associations 
were found between BR and RV end-diastolic volume normalized to BSA (β=0.337, 
P=0.009), and RV ESV normalized to BSA (β=0.425, P=0.002), but not between AR 
and RV volumes. Additionally, RV EF was significantly associated with BR (β=-0.43, 
P=0.003) and twist (β=0.30, P=0.034). LV EF was significantly associated with AR 
(β=0.61, P < 0.001) and twist (β=0.60, P < 0.001). No correlations were found be-
tween rotational parameters and PR grades.
Exercise capacity
In 55 (67%) patients an exercise study was performed, 26 of whom underwent 
peak Vo2 measurement. The median workload capacity was 86% (IQR: 22) and the 
Table 3 Comparison of rotational parameters in patients with normal and abnormal systolic func-
tion
 RV FAC <35% RV FAC ≥35% P-value
Basal rotation (degrees) -3.8 [3.1] -6.1 [3.1] 0.003
Apical rotation 5.7 [6.3] 9.2 [7.3] 0.074
Twist 10.5 [6.5] 13.2 [6.4] 0.016
  LVEF <50% LVEF ≥50%  
Basal rotation -4.9 [2.7] -6.1 [3.7] 0.033
Apical rotation 5.2 [6.1] 9.1 [6.6] 0.021
Twist 9.1 [6.4] 13.2 [5.5] 0.006
The results are presented as median [IQR]. LV EF was measured with Simpson’s method.
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median peak Vo2 was 83% (IQR: 28).We compared the median maximal work load, 
maximal heart rate, peak Vo2 and peak RER (all in % of expected) between the nor-
mal and abnormal twist group, between the normal and abnormal AR group, and 
between the normal and abnormal BR group. Only maximal heart rate between 
the normal and abnormal twist group differed signifi cantly (89 vs. 84%, P=0.044). 
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Figure 3 Correlations between LV rotational parameters and LV ejection fraction and RV frac-
tional area change.
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The maximal work load correlated significantly with BR and with twist (r=-0.276, 
P=0.041; r=0.306, P=0.023, respectively).
disCussion
This study demonstrates that LV twist is reduced in adults with corrected ToF, 
mainly as a result of decreased AR. Over a quarter of patients had an abnormal 
AR that was associated with larger LV dimensions and decreased biventricular 
systolic function.
Reduced left ventricular twist
In normal left ventricles, the dynamic interaction between subendocardial and 
subepicardial fibre helices leads to a twisting deformation. This twisting deforma-
tion has an important role in optimizing LV ejection. The understanding of LV twist 
in congenital heart disease is extremely limited. Reduced LV twist was reported in 
a few studies performed in children with corrected ToF.24,25 In this study, 71% of the 
ToF patients had a normal twist pattern, but the twist was reduced in degrees. The 
study by Takayasu et al. described that the torsion in ToF patients was reduced 
due to decreased AR and/or reversed BR. Forty-one per cent had a positive BR 
at the time of peak torsion.24 We found a reversed basal pattern in 11% of the 
patients, 7% had no BR, and 1% a prolonged rotation. These last two patterns were 
not described by Takayasu et al.
A relationship between RV and LV systolic functions has been previously de-
scribed in ToF patients. Broberg et al.11 described that moderate-to-severe RV 
systolic dysfunction is more prevalent in patients with LV dysfunction. RV pres-
sure and volume loading are likely to predispose the LV to the adverse effects 
through several potential interventricular coupling mechanisms. In patients with 
ToF, mechanical interventricular interaction is observed by the obligatory inter-
ventricular septal defect patch that results in dysfunction of at least a portion of 
the ventricular septum26,27 and may contribute to the abnormal BR.
In the study of Puwanant et al.,28 the pulmonary artery pressure was inversely 
correlated with LV twist in patients with pulmonary hypertension due to septal 
flattening. In patients with ToF, it has been hypothesized that the ventricular 
septal shift due to RV pressure overload during the systolic phase and/or RV 
volume overload during the diastolic phase may be a mechanism that underlies 
suboptimal ventricular interactions. Our study also demonstrates a significant 
difference in septal motions between the groups with and without normal twist 
pattern. Between abnormal septal motions and abnormal BR a trend towards 
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significance was found, but not between abnormal septal motions and abnormal 
AR. This finding suggests that abnormal septal motion influences BR, rather than 
AR, and therefore influences the twist.
Neurohormonal interventricular interaction probably also plays a role, because 
ventricular loading conditions activate the renin–angiotensin–aldosterone system, 
which in turn instigates myocardial fibrogenesis.29 The suggestion that abnormal 
twist is a sign of cardiac dysfunction is supported by the finding of Mornos et al.30 
that log-transformed NT-proBNP levels correlated inversely with LV twist. In our 
study, we did not find a correlation.
In addition to these findings in the literature, multivariable regression analyses 
showed significant associations between systolic function and rotational param-
eters, these were strongest between LV systolic function and AR, and between RV 
systolic function and BR. To assess if subclinical reduced twist really progresses 
to LV dysfunction represented as decreased LV EF, follow-up of patients is needed.
The value of apical rotation in ToF
In models of LV mechanics, it has been shown that the LV myocardial fibre archi-
tecture is important for LV function. Van Dalen et al.31 demonstrated that espe-
cially LV AR is influenced by LV configuration and highlights the vital influence of 
cardiac shape on LV systolic function. In this study, abnormal AR was observed 
in more than one-quarter of all ToF patients. This group showed a significantly 
higher incidence of biventricular systolic dysfunction and larger LV dimensions.
Sheehan et al. reconstructed the RV of ToF patients and normal subjects in three 
dimensions. Patients with ToF had only at the apical level a significantly enlarged 
RV cross-sectional area. Second, the cross-sectional apical shape was rounder in 
patients with ToF. This RV apical dilatation may lead to distortion of LV apical 
geometry and altered fibre orientation of the apex of the heart, which can result 
in abnormal or decreased AR.32 Our study demonstrates that impaired systolic 
RV function, assessed with eyeballing and with RV FAC, is related with reduced 
or abnormal LV AR in adult patients with corrected ToF, likely by alteration of 
LV configuration. However, we did not observe a relationship between the echo-
cardiographic RV dimensions, i.e. annulus and apex–base, and AR. To investigate 
the predictive value of abnormal AR in patients with ToF, a prospective study is 
essential.
Limitations
Adequate STE could not be performed in all patients because of the insufficient 
image quality. Also RV dilatation may hamper imaging because of the replacement 
of the LV apex as the acoustic window. Therefore, in this study all the images were 
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obtained with great caution to reassure the acquisition of the true apex. If there 
was any doubt of image quality, the patient was excluded.
Imaging of the apical and basal levels was performed sequentially instead of 
simultaneously, thus introducing a potential error in the twist calculation. To 
minimize this error, we have matched the RR intervals of the two segments before 
generation of the twist.
We realized that the use of LV EF measured with the biplane Simpson’s method 
is questionable in patients with ToF, because of the altered LV shape due to RV 
volume overload. However, it is the most suitable echocardiographic method for 
LV EF at this moment. In one-third of the patients image quality was insufficient for 
this measurement, due mainly to the LV shift. With regard to the various rotation 
patterns we observed, LV EF was more often missing in the abnormal rotation 
groups. Therefore, the median LV EF could be overestimated in these groups.
ConClusion
The majority of adults with corrected ToF has a reduced LV twist as assessed with 
speckle-tracking echocardiography. Strikingly, in more than one-quarter of the ToF 
patients an abnormal AR is observed, which is associated with larger LV dimen-
sions and decreased systolic biventricular function. These findings suggest that 
abnormal AR is a new and additional objective diagnostic criterion for detection 
of ventricular dysfunction.
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abstraCt
Background
Amino-terminal B-type natriuretic peptide (NT-proBNP) may detect early cardiac 
dysfunction in adults with tetralogy of Fallot (ToF) late after corrective surgery. 
We aimed to determine the value of NT-proBNP in adults with ToF, and establish 
its relationship with echocardiography and exercise capacity.
Methods and Results
NT-proBNP measurement, electrocardiography and detailed 2D-echocardiography 
were performed on the same day in 177 consecutive adults with ToF (mean age 
34.6 ± 11.8 years, 58% male, 89% NYHA I, 29.3 ± 8.5 years after surgical correction). 
Thirty-eight percent of the patients also underwent a cardiopulmonary-exercise 
test. Median NT-proBNP was 16 [IQR 6.7-33.6] pmol/L, and was elevated in 55%. 
NT-proBNP correlated with right ventricular (RV) dilatation (r=0.271, P<0.001) and 
RV systolic dysfunction (r=-0.195, P=0.022), but more strongly with LV systolic 
dysfunction (r=-0.367, P<0.001), which was present in 69 patients (39%). Moderate 
or severe pulmonary regurgitation was not associated with higher NT-proBNP. 
Tricuspid and pulmonary regurgitation peak velocities correlated with NT-proBNP 
(r=0.305, P<0.001 and r=0.186, P=0.045, respectively). LV twist was measured with 
speckle-tracking echocardiography in 71 patients. An abnormal LV twist (20 pa-
tients, 28%) was associated with elevated NT-proBNP (P=0.030). No relationship 
between NT-proBNP and exercise capacity was found.
Conclusions
NT-proBNP levels are elevated in more than 50% of adults with corrected ToF, 
while they are in stable clinical condition. Higher NT-proBNP is most strongly 
associated with elevated pulmonary pressures, and with LV dysfunction rather 
than RV dysfunction. NT-proBNP has the potential to become routine examination 
in patients with ToF to monitor ventricular function and may be used for timely 
detection of clinical deterioration.
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introduCtion
Tetralogy of Fallot (ToF) is the most common form of cyanotic congenital heart 
disease (ConHD), with a birth prevalence of approximately 3-4 per 10,000 live 
births.1 The survival of patients with ToF has improved considerably since Lille-
hei reported the first successful corrective surgery in 1954.2 Despite satisfactory 
survival results of over 90%, 30 years after corrective surgery,3,4 an increasing 
number of late complications are encountered such as pulmonary regurgitation 
with the need for reintervention, right and left ventricular dysfunction, aortic root 
dilatation and arrhythmias. Although no clear data on very long-term outcome are 
available yet, life expectancy is presumed to be diminished.3
Nearly all adults with ToF have some degree of residual pulmonary regurgitation 
(PR) due to repair of the right ventricular (RV) outflow tract during corrective 
surgery. Pulmonary regurgitation causes volume overload of the RV, which can 
lead to RV dilatation and dysfunction.5 The progression of RV dysfunction may 
also affect the left ventricle (LV), whereas both ventricles are known to interact.6,7 
Up to 20% of all adults with ToF develop LV dysfunction.8 Early detection of de-
terioration in ventricular function is crucial, as both RV and LV dysfunction can 
lead to heart failure and life-threatening ventricular arrhythmias, which are both 
associated with increased morbidity and mortality.9
Exercise capacity in adults with ToF is often diminished,10 and a worse cardio-
pulmonary-exercise test is known to be predictive for adverse outcome in these 
patients.11
Another diagnostic tool that may be used to detect early changes in ventricular 
function and exercise capacity is the well-established heart failure biomarker N-
terminal probrain natriuretic peptide (NT-proBNP). NT-proBNP is released from 
the cardiac myocytes in response to pressure and volume overload, and is a 
marker of increased myocardial-wall stress. While natriuretic peptides have been 
proven to be of adjuvant diagnostic and prognostic value in patients with acquired 
heart failure,12 less is known about the usefulness of NT-proBNP in ToF. A recent 
article demonstrated that even though the vast majority of adults with ToF are 
asymptomatic, they have elevated NT-proBNP levels.13 The significance of this 
observation is unknown, and therefore the potential diagnostic and prognostic 
value of NT-proBNP remains to be determined. We established NT-proBNP levels in 
adult patients with ToF and assessed the echocardiographic and exercise-related 
determinants of elevated NT-proBNP.
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Methods
Patient inclusion
Patients diagnosed with ToF were recruited consecutively at the adult ConHD 
outpatient clinic at Erasmus Medical Center between May 2010 and March 2013. 
All patients had to be 18 years of age or older.
Clinical assessment
All patients underwent an extensive 2D-transthoracic echocardiogram with speck-
le-tracking echocardiography, electrocardiogram, laboratory testing and were 
seen by a cardiologist on the same day. A subgroup of patients also underwent a 
cardiopulmonary-exercise test with peak oxygen uptake (peak Vo2). Exercise tests 
were not performed in all patients due to logistical reasons, and exercise results 
were only included in this study when the test was performed in the same week. 
The following patient characteristics were obtained: age, gender, surgical history, 
New York Heart Association (NYHA) functional class, body mass index (BMI), 
blood pressure, heart rate, and oxygen saturation.
Echocardiography
Two-dimensional echocardiography was performed by experienced sonographers 
with use of the commercially available system iE33 (Philips, Best, the Nether-
lands). Measured dimensions included the left ventricle (LV) end-diastolic and 
end-systolic endocardial diameter; right ventricle (RV) end-diastolic annulus and 
apex-base diameter; left atrium (LA) four chamber longitudinal diameter and area 
at the end of the ventricular systole. As quantitative measurement of the right 
atrium (RA) was not possible in all patients, we assessed RA size visually, which 
was then graded as no, mild or severe dilation.14,15 Chamber dimensions were 
indexed for body surface area (BSA). Left ventricular systolic function was as-
sessed on the basis of LV ejection fraction (LVEF) with use of the biplane modified 
Simpson’s rule.14 Right ventricular systolic function was assessed using tricuspid 
annulus plane systolic excursion (TAPSE), right ventricular fractional area change 
(RV FAC) and systolic excursion of the lateral tricuspid annulus (S′) using tissue 
Doppler imaging (TDI). Diastolic LV function was assessed using pulsed wave Dop-
pler of the mitral valve inflow (E, A, E/A-ratio and deceleration time) and septal 
TDI (E′). For the assessment of valvular regurgitation and stenosis, we used the 
recommendations of the European Association of Echocardiography.16-18
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Speckle-tracking echocardiography
Speckle-tracking echocardiography (STE) was used to evaluate LV twist. For opti-
mal STE, images of the apical and basal short-axis were obtained with a frame rate 
of ≥60 frames/second. Images were transferred to a QLAB workstation to perform 
offline analysis (Philips Medical Systems). The images were analysed with QLAB 
software version 9.0. LV twist was defined as the maximal value of simultaneous 
systolic apical rotation minus basal rotation. Twist patterns of ToF patients were 
compared with twist patterns of healthy individuals, who were defined as normal. 
A normal twist pattern is characterized by an end-systolic clockwise basal rotation 
and end-systolic counter-clockwise apical rotation.19 Other twist patterns were 
defined as abnormal. Excellent intra-observer and inter-observer reproducibility 
for LV twist measurements using QLAB software has been described for our lab.20
Cardiopulmonary-exercise test
Maximal exercise capacity (workloadmax) and peak oxygen uptake during exercise 
(peak Vo2) were assessed using bicycle ergometry. Workload was increased 
gradually by 10-20 watts per minute. Exercise capacity results were compared 
with reference values that were adjusted for age, gender, body height and weight. 
Performance was considered maximal when a respiratory exchange ratio (RER) 
of >1.0 was reached.
Laboratory testing
Peripheral venous blood samples were obtained from all patients after at least 15 
minutes of rest. Creatinine levels were assessed since renal dysfunction is known 
to influence NT-proBNP levels. Renal dysfunction was defined as a creatinine 
level of ≥200 μmol/l. Plasma NT-proBNP levels were measured using an enzyme 
immunoassay (Elecsys, Roche Diagnostics, Basel, Switzerland). The cut-off value 
of normal in our laboratory is ≤14 pmol/l.
Statistical analysis
Continuous variables were reported as mean ± standard deviation when normally 
distributed, or median and interquartile ranges (IQR) were reported when not 
normally distributed. Categorical variables were presented as frequencies and 
percentages. Differences in continuous variables between two groups were com-
pared using the Student’s unpaired t-test when normally distributed or Wilcoxon 
rank sum test when data distribution was skewed. Differences in continuous vari-
ables with normal distribution between more than two groups were investigated 
with one-way ANOVA, or when not normally distributed investigated with Kruskal 
Wallis test. Baseline characteristics were compared between patients with normal 
136 Chapter 7
and elevated NT-proBNP levels. To compare categorical data, the χ2 test or when 
applicable, the Fisher’s exact test were used. Correlation analyses between NT-
proBNP and patient characteristics were performed using the Pearson correlation 
test or the Spearman correlation test when data was skewed. Linear regression 
modelling was performed to evaluate the relationship between NT-proBNP and 
echocardiographic and bicycle ergometry parameters. We adjusted for baseline 
characteristics that were significantly associated with NT-proBNP, including age, 
gender and NYHA class which are known factors that influence NT-proBNP lev-
els.21 As NT-proBNP is non-parametric, the variable was log-transformed which 
created a normal distribution for further statistical analyses. All statistical tests 
were two-sided and a P-value of <0.05 was considered statistically significant. The 
Statistical Package for Social Sciences, version 21.0 (SPSS, IBM Corp., Armonk, NY, 
USA) was used for all statistical analyses.
Medical ethics and data quality
The study was carried out according to the principles of the Declaration of Helsinki 
and approved by the local medical ethics committee. Written informed consent 
was obtained from all patients. Several measures were taken to ensure optimal 
data quality. Before the statistical analyses, manual edit checks were performed 
by the investigators to search for missing data, contradictory data entries and for 
values that were out of the specified normal range. Data of a random sample of 
15 participants (8%) was checked by an independent investigator; no discrepan-
cies were observed between data in medical records and in the database used for 
statistical analyses.
results
A total of 177 ToF patients were included in the study, 28 of whom had a diagnosis 
of ToF with pulmonary valve atresia (ToF/PA). Baseline characteristics of all study 
participants are summarized in Table 1. Median NT-proBNP level was 15.6 [IQR 6.7-
33.6] pmol/L. In 55% of the patients the NT-proBNP level was above the reference 
value of normal (>14 pmol/L). None of the patients had renal dysfunction (median 
creatinine level 75 [IQR 65 – 83.5] μmol/L). In Table 1 the baseline characteristics 
are presented for all patients together, and specified for patients with normal or 
elevated NT-proBNP levels. NT-proBNP levels were significantly higher in women 
than in men (23.9 [IQR 13.8-41.3] pmol/L versus 9.6 [IQR 4.8-21.4] pmol/L, P<0.001). 
Median NT-proBNP levels increased with NYHA class (NYHA I 14.5 [IQR 6.3-29.4] 
pmol/L, NYHA II 29.7 [IQR 16.7-135.3] pmol/L, NYHA III (n=1) 169.6 pmol/L, P<0.001. 
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Patients with elevated NT-proBNP had undergone corrective surgery at older age, 
and more often had a prior palliative shunt. In patients with normal NT-proBNP 
levels a transannular or RVOT patch was used more often during corrective 
surgery. NT-proBNP levels did not differ between patients with or without prior 
pulmonary valve replacement.
Electrocardiography
The majority of patients were in sinus rhythm (n=146, 83%), and had a right bundle 
branch block (n=118, 91%) (Table 2). In 22 patients (12%) QRS duration was ≥180 
milliseconds. Mean QRS duration was longer in patients with an elevated NT-proB-
NP level. NT-proBNP levels were significantly higher in patients in atrial fibrillation 
(101.3 [IQR 40.5-661] pmol/L) than in patients in sinus rhythm (13.9 [IQR 6.3-26.9] 
pmol/L) or pacemaker rhythm (24.6 [IQR 14.3-43.8] pmol/L), P<0.001.
Table 1 Baseline patient characteristics
 All patients
NT-proBNP
≤14 pmol/l
NT-proBNP
>14 pmol/l P-value
Number of patients 177 80 (45%) 97 (55%)
Age (years) 33 [26-43] 31 [24-35] 39 [29-47] <0.001
Male patients 103 (58%) 62 (78%) 41 (42%) <0.001
Body Mass Index (kg/m2) 24.1 ± 4.2 24.0 ± 4.5 24.3 ± 4.0 0.696
NYHA class (I/II) (%) 89/11a 95/5 84/16a 0.033
Pulmonary valve atresia 27 (16%) 11 (14%) 16 (17%) 0.613
Associated lesions  
Atrial septal defect 10 (6%) 6 (6%) 4 (4%) -
Muscular ventricular septal defect 1 (1%) 0 1 (1%) -
Patent ductus arteriosus 7 (4%) 5 (6%) 2 (2%) -
Aortic coarctation 1 (1%) 0 1 (1%) -
Surgerical characteristics  
Age at time of corrective surgery (years) 2.8 [1.1-6.9] 1.7 [0.8-4.6] 4.8 [1.6-8.7] <0.001
Time since corrective surgery (years) 29.7 [22.9-36.0] 27.0 [21.6-32.6] 33.5 [24.2-38.1] 0.001
Prior shunt 64 (37%) 21 (26%) 43 (44%) 0.013
- Blalock-Taussig shunt 46 (26%) 17 (21%) 29 (30%) 0.192
- Waterston shunt 18 (10%) 4 (5%) 14 (14%) 0.039
Patch used to broaden RVOT 111 (63%) 57 (71%) 54 (56%) 0.011
Pulmonary valve replacement 97 (55%) 46 (58%) 51 (53%) 0.513
Time corrective surgery - PVR (years) 20.3 [13.6-26.5] 19.1 [14.1-25.0] 20.3 [13.3-29.0] 0.520
Categorical variables are presented as number (percentage).
Continuous variables are presented as mean ± standard deviation or median [interquartile range]
P-values are given for the comparison of variables between patients with normal and elevated NT-proBNP.
NYHA = New York Heart Association; RVOT = right ventricular outflow tract; PVR = pulmonary valve replace-
ment. a one patient was in NYHA functional class III
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Echocardiography
Based on annulus and apex-base diameter, more than 50% of the patients had a di-
lated RV (Table 3). RV function (i.e. RV fractional area change<35%, TAPSE<16 and/
or S’<10) was diminished in one-third of the patients. Right ventricular fractional 
area change was similar in patients with and without elevated NT-proBNP (39 ± 
10 versus 41 ± 10%, P=0.255). Thirty-nine percent of the patients had a diminished 
LV function (LV ejection fraction <50%). Left ventricular EF was significantly lower 
in patients with elevated NT-proBNP than in patients with normal NT-proBNP (49 
± 9% versus 54 ± 6%, P=0.010). Correlations between NT-proBNP and echocardio-
graphic parameters of cardiac function, dimensions, and valvular function are 
presented in Figure 1 and 2.
Sixty-five patients (31%) had moderate or severe pulmonary regurgitation. The 
severity of pulmonary regurgitation was not related to NT-proBNP in the total 
study population or in a subgroup of patients without prior pulmonary valve 
Table 2 Electrocardiogram and bicycle ergometry
 All patients
NT-proBNP
≤14 pmol/l
NT-proBNP
>14 pmol/l P-value
Electrocardiogram  
Rhythm:  
- Sinus rhythm 146 (83%) 74 (92%) 72 (74%) 0.001
- Atrial fibrillation 4 (2%) 0 4 (4%) -
- Pacemaker rhythm 18 (10%) 4 (5%) 14 (14%) 0.039
- Ectopic atrial / junctional rhythm 9 (5%) 2 (3%) 7 (7%) -
Heart rate (beats per minute) 75 ± 13 76 ± 13 74 ± 13 0.266
QRS duration (ms) 144 ± 32 137 ± 29 150 ± 33 0.010
If QRS duration >120 ms: 127 (72%) 58 (76%) 69 (71%) 0.699
- Right bundle branch block 117 (91%) 53 (91%) 64 (93%) 0.970
- Left bundle branch block 2 (1%) 0 2 (3%) -
- Non-specific IVCD 8 (5%) 5 (9%) 3 (4%) -
QRS duration ≥ 180 ms 22 (12%) 7 (9%) 15 (16%) 0.099
Bicycle ergometry  
Number of patients 68 (38%) 31 (39%) 37 (38%)
Maximal workload (% of predicted) 86 [74-98] 85 [80-92] 87 [67-103] 0.475
Maximal heart rate (% of predicted) 87 [78-95] 85 [77-96] 87 [79-94] 0.726
Peak oxygen uptake measurement (n=42)  
Peak Vo2 max (% of predicted) 77 [70-88] 76 [71-81] 79 [66-96] 0.687
RERmax 1.37 [1.25-1.47] 1.45 [1.45-1.49] 1.26 [1.15-1.39] 0.010
Categorical variables are presented as number (percentage).
Continuous variables are presented as mean ± standard deviation or median [interquartile range].
P-values are given for the comparison of variables between patients with normal and elevated NT-proBNP.
IVCD = intraventricular conduction delay, RERmax = maximal respiratory exchange ratio.
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replacement (PVR). NT-proBNP was significantly higher in patients with more 
severe tricuspid regurgitation (Figure 2). The peak velocity of pulmonary regur-
gitation (PRvmax) correlated with NT-proBNP levels (r=0.186, P=0.045). NT-proBNP 
levels also correlated with tricuspid regurgitation peak velocity (TRvmax) (r=0.305, 
Table 3 Echocardiographic findings and associations with logNT-proBNP
 
 
  
Correlation 
analysis  
Multivariable 
analysisa  
  (r) P-value (β) P-value
LA longitudinal diameter (mm) 56 ± 9 0.47 <0.001 0.048 <0.001
LA area (cm2) 21 ± 5 0.53 <0.001 0.102 <0.001
LV end-diastolic diameter (mm) 48 ± 6 0.284 <0.001 0.059 0.014
LV end-systolic diameter (mm) 33 ± 6 0.342 <0.001 0.080 <0.001
RA size  
normal/mild/severe (n.a.) 48/61/51(17)   <0.001 0.462 <0.001
RV apex-base diameter (mm) 87 ± 8 0.177 0.031 0.035 0.028
RV annulus diameter (mm) 45 ± 8 0.271 0.001 0.063 0.002
LV ejection fraction (%) 51.4 ± 8.3 -0.367 <0.001 -0.049 <0.001
RV FAC (%) 40.1 ± 9.8 -0.195 0.022 -0.026 0.001
TAPSE (mm) 18 ± 5 -0.132 0.104 — —
TDI RV free wall (S’) (cm/s) 9.5 ± 2.4 -0.124 0.150 — —
Mitral valve inflow  
E-wave (m/s) 0.81 ± 0.22 0.073 0.349 — —
A-wave (m/s) 0.52 ± 0.16 0.069 0.379 — —
E/A - ratio 1.7 ± 0.74 0.017 0.824 — —
Deceleration time (ms) 196 ± 54 -0.150 0.057 -0.003 0.053
E/E’ - ratio 11.1 ± 4.2 0.296 <0.001 0.030 0.125
Aortic stenosis vmax (m/s) 1.11 ± 0.32 0.080 0.340 — —
Aortic regurgitation:   0.002 0.328 0.024
none/mild/moderate/severe (n.a.) 113/56/4/0 (4)   0.002 0.328 0.024
Pulmonary stenosis:  
mild/moderate/severe (n.a.) 142/31/2 (2)   0.252
Pulmonary stenosis vmax (m/s) 2.20 ± 0.76 -0.198 0.220 — —
Pulmonary regurgitation:  
none/mild/moderate/severe (n.a.) 42/65/28/37(5)   0.692 — —
Pulmonary regurgitation vmax (m/s) 1.97 ± 0.39 0.186 0.045 0.512 0.027
Tricuspid regurgitation:  
none/mild/moderate/severe (n.a.) 50/107/16/2(2)   0.001 0.259 0.034
Tricuspid regurgitation vmax (m/s) 2.86 ± 0.57 0.305 <0.001 0.680 <0.001
Mitral regurgitation:  
none/mild/moderate/severe (n.a.)   134/40/1/0 (2)   0.350 — —
Values are presented as mean ± standard deviation or frequencies
ms = milliseconds; m/s = meter per second; n.a. = not available; vmax = peak flow velocity
aadjusted for baseline characteristics age, gender, NYHA class, rhythm and age at corrective surgery
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P<0.001). In 32 patients moderate or severe pulmonary stenosis was present which 
did not correlate with NT-proBNP levels. Aortic and mitral valve measurements 
were not correlated with NT-proBNP levels either.
The results of the multivariate analyses are summarized in Table 3. NT-proBNP 
was most strongly associated with TRvmax and PRvmax. The association between 
NT-proBNP and TRvmax remained significant after adjustment for the presence of 
pulmonary stenosis (β=0.488, P=0.032). The correlation with diastolic function 
parameter E/E’-ratio was no longer significant.
Speckle-tracking echocardiography – left ventricular twist
Left ventricular twist was assessed in 73 patients (41%), who had sufficient-quality 
images of the basal and apical short-axis view. Twenty of these patients (27%) had 
an abnormal LV twist pattern. In the patients with an abnormal LV twist pattern, 
NT-proBNP levels were more often elevated than in patients with a normal LV twist 
pattern (70% versus 42%, P=0.030).
Cardiopulmonary-exercise test
An exercise-stress test was performed in 68 patients (38%). There was no difference 
in baseline characteristics of patients who underwent an exercise stress test and 
A B C
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Figure 1 Correlations between NT-proBNP and cardiac function and dimensions.
The correlations are presented for NT-proBNP and LV end-diastolic dimension indexed for BSA (A), E/E’-ratio 
(B), LV ejection fraction (C), RV annulus diameter indexed for BSA (D), LA area (E) and RV fractional area 
change (F). Correlation lines with 95% confidence interval are shown.
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patients who did not. The median achieved percentage of predicted target work-
load was 86 [IQR 74 – 98]% (Table 2). Thirty-seven patients (54%) achieved <85% 
of the predicted target workload. Forty patients (58%) reached ≥85% of the target 
heart rate. Patients with normal exercise capacity had median NT-proBNP levels 
similar to those in patients with decreased exercise capacity. Additional peak 
oxygen uptake measurements were obtained in 42 patients. Median peak Vo2 was 
76.5 [IQR 69.8 – 88.0] % of predicted. All patients reached an RER quotient of >1.0 
(median 1.37 [IQR 1.25 – 1.47]). No significant association between NT-proBNP 
levels and peak Vo2 was observed. RER quotient was significantly lower in patients 
with elevated NT-proBNP (Table 2).
A B
C D
Figure 2 Correlations between NT-proBNP and parameters of valvular function.
The correlations between NT-proBNP and TR peak velocity (A) and PR peak velocity (B) are presented. Associa-
tions between NT-proBNP and TR severity (C) and PR severity (D) are presented. Correlation lines with 95% 
confidence interval are shown.
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disCussion
In adults with tetralogy of Fallot late after corrective surgery NT-proBNP levels 
were elevated in over 50% of patients, although 89% of these patients were asymp-
tomatic. Since higher NT-proBNP was associated with ventricular dysfunction, the 
biomarker could be of additive value for the detection of deteriorating cardiac 
function. NT-proBNP correlated with systolic RV function, but more strongly with 
systolic LV function and dimensions. This may indicate the importance of LV 
dysfunction in patients with ToF, or possibly NT-proBNP release of the RV is in 
general less than the LV. Also a clear relationship with elevated pulmonary pres-
sures was found, while no clear relation with severity of pulmonary regurgitation 
was observed. The higher NT-proBNP levels in women confirm the previously 
described sex-differences for NT-proBNP in the general population by Luchner 
et al.22 The higher NT-proBNP levels in women and older patients underscore the 
need for sex and age-specific reference values for diagnostic purposes. The finding 
that half of the patients with ToF had elevated NT-proBNP possibly indicates the 
need for ToF-specific cut off-points to predict adverse outcome, or may indicate 
the presence of sub-clinical pathology, where NT-proBNP can be an early marker 
of further deterioration in ventricular function. This remains to be investigated 
with follow-up data.
NT-proBNP and echocardiographic parameters
The finding that higher NT-proBNP levels were associated with lower LV ejection 
fraction, is in line with similar findings in patients with acquired LV systolic dys-
function23 and emphasizes the use of NT-proBNP as an additional tool for monitor-
ing of LV dysfunction in ToF patients. Recent studies show that one out of five 
adult patients with corrected ToF develops LV dysfunction.8 LV dysfunction 
could be caused by direct influences of longstanding cyanosis before corrective 
surgery, consistent with our finding of higher NT-proBNP levels in patients that 
underwent corrective surgery at older age. Also deterioration of RV function 
due to pressure and volume overload of the RV could be a cause of diminished 
LV function, because of adverse ventricular-ventricular interaction.7 In children 
with corrected ToF, the relationship between NT-proBNP and LV function is not 
observed, presumably because LV function in these children is generally still 
normal.24 Nevertheless, in adults with corrected ToF it seems that NT-proBNP is of 
additional value to detect deterioration in LV function. Perhaps NT-proBNP levels 
rise before echocardiographic signs of LV dysfunction become apparent, which 
provides the possibility for early detection and treatment, but this remains to be 
established in a prospective study.
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NT-proBNP was also strongly related to peak velocities of tricuspid and pulmo-
nary valve regurgitation, also after adjustment for the presence of pulmonary valve 
stenosis. These results are in line with the findings by Norozi et al25 and confirm 
that higher natriuretic peptide levels are associated with higher pulmonary pres-
sures in patients with corrected ToF. Elevated pulmonary pressures are associ-
ated with adverse outcome, and therefore the association between NT-proBNP 
and pulmonary pressures may indicate a possible prognostic role of NT-proBNP. 
Higher pulmonary pressures may have been a result of left-sided cardiac prob-
lems, or possibly an oversized prior palliative shunt at young age may have led to 
increased pulmonary arterial wall resistance. Since pulmonary wedge pressures 
were not available in our study, the exact mechanism behind these findings needs 
further investigation.
In our patients, the relationship between NT-proBNP and RV dilatation was 
stronger than the relationship between NT-proBNP and RV systolic function, 
which is confirmed by several other reports that describe NT-proBNP in patients 
with ToF.26,27 The modest association between NT-proBNP and RV systolic function 
may be underestimated due to difficulties in RV function assessment. Although 
we have used all available new diagnostic methods, the currently used imag-
ing techniques remain to have limitations regarding adequate quantification of 
systolic function due to the complex RV morphology. The relationship between 
NT-proBNP and RV dilatation is in line with the relationship between NT-proBNP 
and severity of TR, since a dilated RV annulus will be accompanied by more severe 
TR. RV dilatation is caused primarily by volume overload due to longstanding 
pulmonary regurgitation. Interestingly, NT-proBNP levels were elevated regardless 
of PR severity and independent of prior PVR. Although further enlargement of 
the RV can be prevented by PVR,28 the optimal timing of surgical PVR remains 
challenging. Because NT-proBNP is positively correlated with RV dimension and 
function, NT-proBNP may be helpful as an additional tool in decision-making on 
PVR in individual patients. Possibly, the level of NT-proBNP and its changes over 
time are early signs of RV dysfunction and can differentiate between well-tolerated 
PR and PR needing reintervention. Whether higher NT-proBNP levels can mark the 
need for pulmonary valve intervention in ToF patients with a dilated RV needs to 
be determined.
NT-proBNP levels were higher in patients with more severe TR and larger atria. 
This supports the idea that NT-proBNP is secreted not only from the ventricles, 
but also from atrial cardiomyocytes and atrial granules in which NT-proBNP is 
stored.29 Elevated intra-atrial pressure and stretching of the atrial wall due to vol-
ume overload will stimulate NT-proBNP release. This could also explain why AF 
is associated with higher NT-proBNP, since patients with enlarged atria are more 
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prone to develop AF and AF itself can lead to further enlargement of the atria.30 As 
only a few patients in our study were in AF it was not possible to evaluate the 
direct influence of AF on NT-proBNP adjusted for presence of atrial dilatation.
NT-proBNP and speckle-tracking echocardiography
NT-proBNP levels were highest in patients with an abnormal LV twist. This find-
ing was also seen in a study by Mornos et al, which investigated patients with 
reduced LVEF.31 The correlation between this new echocardiographic technique 
and NT-proBNP is promising because both techniques might be able to detect 
changes in cardiac function earlier than currently used tests, such as conventional 
echocardiography or cardiac magnetic resonance imaging (CMR). As knowledge 
of speckle-tracking echocardiography in adult congenital heart disease including 
tetralogy of Fallot is still limited,32,33 further research in this field is clearly war-
ranted. Also newer modalities in CMR imaging, using gadolinium or CMR-feature 
tracking could contribute to establishing early markers for deterioration.
NT-proBNP and exercise capacity
Among the 68 patients that underwent bicycle ergometry, we observed no cor-
relation between NT-proBNP and exercise capacity and peak Vo2. Although higher 
NT-proBNP is associated with decreased exercise capacity and peak Vo2 in adult 
ConHD in general,13 results for Fallot patients in previous studies are contradict-
ing. Possibly our patient population was too small to demonstrate a relationship, 
whereas Norozi et al did find a significant correlation between NT-proBNP and 
peak Vo225 in adults with corrected ToF. However, since the results of Koch and 
colleagues are comparable to our results, the exact relationship between exercise 
capacity and NT-proBNP in these patients is still unclear. As decreased exercise 
capacity is a known determinant of less favourable prognosis in patients with 
ConHD,34 the relationship with NT-proBNP has to be studied in a larger cohort of 
ToF patients.
Study limitations and future perspectives
Magnetic resonance imaging is the gold standard for precise determination of 
ejection fraction and ventricular volumes. Nevertheless, echocardiography is a 
well-established and the most widely used imaging tool, thus the observed signifi-
cant correlations between echo measurements and NT-proBNP are of great value.
This study was a single-centre study and its cross-sectional design did not make 
it possible to determine the prognostic value of NT-proBNP. The higher NT-proBNP 
levels in female patients and increase of NT-proBNP with age do indicate the need 
for gender and age-specific reference values.
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ConClusion
NT-proBNP levels are elevated in more than 50% of the adults with corrected ToF, 
while they are in a stable clinical condition. Higher NT-proBNP levels are most 
strongly associated with elevated pulmonary pressures, and left ventricular 
dysfunction rather than with right ventricular dysfunction. NT-proBNP has the 
potential to become a routine investigation in patients with ToF to monitor ven-
tricular function and may be used for timely detection of clinical deterioration. 
The positive correlations between NT-proBNP and RV dilation and dysfunction 
indicate that there may be a possible future role for NT-proBNP in the difficult 
decision of reintervention in patients with corrected ToF.
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abstraCt
Background
Few prospective data are available regarding long-term outcomes after surgical 
ventricular septal defect (VSD) closure.
Objectives
Our objective was to investigate clinical outcomes > 30 years after surgical VSD 
closure.
Methods
Patients who underwent childhood surgical VSD closure between 1968-1980 
were reexamined every 10 years. In 2012, we invited eligible patients to undergo 
another examination, including electrocardiography, Holter-monitoring, echocar-
diography, bicycle ergometry, NT-proBNP measurement and subjective health 
assessment.
Results
Cumulative survival was 86% at 40 years. Causes of mortality were arrhythmia, 
heart failure, endocarditis, post valvular surgery, pulmonary hypertension, non-
cardiac, and unknown. Cumulative event-free survival after surgery was 72% at 40 
years. Symptomatic arrhythmias occurred in 13% and surgical or catheter-based 
reinterventions in 12%. Prevalence of impaired right ventricular systolic function 
increased from 1% in 2001 to 17% in 2012 (P=0.001). Left ventricular systolic func-
tion was impaired but stable in 21%. Aortic regurgitation occurred more often in 
the last 20 years (P=0.039) and mean exercise capacity decreased (P=0.003). NT-
proBNP (median 11.6 pmol/L [IQR:7.0-19.8]) was elevated (> 14 pmol/L) in 38%. A 
concomitant cardiac lesion, e.g. patent ductus arteriosus, and aortic cross-clamp 
time were determinants of late events (HR = 2.84 [95%CI:1.23-6.53]; HR = 1.47 per 
10 minutes [95%CI:1.22-1.99], respectively). Patients rated their subjective health 
status significantly better than a reference population.
Conclusions
Survival up to 40 years after successful surgical VSD closure is slightly lower than 
in the general Dutch population. Morbidity is not negligible, especially in patients 
with a concomitant cardiac lesion.
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introduCtion
Ventricular septal defect (VSD) is by far the most common congenital heart de-
fect, with a birth prevalence of 2.62 per 1,000 live births.1,2 Small defects may not 
have hemodynamic consequences, but the presence of a significant left-to-right 
shunt can cause left ventricular (LV) overload, pulmonary arterial hypertension, 
ventricular dysfunction, arrhythmias, and aortic regurgitation.3,4 Surgical closure 
at a young age is still the treatment of choice, and mid- to long-term results are 
good with regard to survival, morbidity, and quality of life.5-7 Therefore, most 
such patients have been discharged from routine cardiological follow-up. For 
both patients and their treating physicians, it is essential to know whether the 
pre-operative left-to-right shunt and the VSD patch affect biventricular function 
or the conduction system in the long term. However, information on mortality 
and morbidity beyond 30 years after surgical VSD closure is scarce, and almost 
all such data were collected retrospectively, which introduces the possible bias 
of including only patients with residual morbidity who are still seen at outpatient 
clinics.
Our study is part of a unique, ongoing longitudinal follow-up of patients with 
congenital heart defects who underwent surgery at a young age at our institu-
tion between 1968 and 1980. The current study had 3 objectives: first, to evaluate 
survival 30 to 40 years after surgical VSD closure in an unselected cohort; second, 
to investigate the current clinical condition of survivors by extensive in-hospital 
examination and to detect determinants of outcome; and third, to evaluate the 
present subjective health status of survivors.
Methods
Study patients
All consecutive patients who underwent surgical VSD closure at our institution 
between 1968 and 1980 at <15 years of age formed the original study cohort. This 
cohort was first studied in 1990, with a second follow-up performed in 2001.5,6 
In 2010 to 2012, survival status was obtained from the Dutch National Popula-
tion Registry, and all surviving patients who had participated in 1 or both of the 
previous studies were actively invited to participate in a third study for clinical 
examination at the outpatient clinic of Erasmus Medical Center. The study proto-
col was approved by the institutional Medical Ethics Committee. Written informed 
consent was obtained from all participants.
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Adverse events
Survival rates were compared with the expected survival rates of an age-matched 
Dutch population. Adverse events included all-cause mortality, surgical or 
catheter-based cardiac reinterventions, symptomatic arrhythmias (requiring 
medication, cardioversion, ablation, or insertion of a pacemaker/implantable 
cardioverter-defibrillator [ICD]), endocarditis, and heart failure (requiring medi-
cation or hospital admission). Mortality and events were defined as “early” when 
they occurred within 30 days post-operatively, and “late” when they occurred 
beyond 30 days. All events were assessed by 2 independent investigators (M.E.M., 
J.A.A.E.C.).
Clinical assessment
Examinations included history, physical examination, standard 12-lead electro-
cardiography (ECG), 24-h Holter monitoring, echocardiography, cardiopulmonary 
exercise testing, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) 
measurement. If a patient was unwilling or unable to visit the outpatient clinic, 
questionnaires were sent to obtain information on morbidity and subjective health 
status, and to receive permission to use the patient’s medical records.
Electrocardiography and 24-h Holter monitoring
Standard 12-lead surface ECGs were analyzed for rhythm, PR interval, and QRS 
duration. A 24-h Holter monitoring was performed with a CardioPerfect Holter 
DR180+ 3-channel recorder (Welch Allyn Cardio Control, NorthEast Monitoring, 
Maynard, Massachusetts). Sinus node disease (SND) was defined according to the 
Kugler criteria: nodal escape rhythm, sinus arrest >3 s, or severe sinus bradycar-
dia (<30 beats/min at night or <40 beats/min during daytime).8
Cardiopulmonary exercise testing
Maximal workload, heart rate, and peak oxygen consumption (peak Vo2) were 
assessed by bicycle ergometry with a gradual workload increment of 20 W/min 
(ramp protocol) and compared with normative values corrected for age, sex, 
height, and weight. Performance was considered maximal when a respiratory 
exchange ratio >1 was reached.
Echocardiography
A complete 2-dimensional transthoracic echocardiogram was performed with 
the commercially available IE33 system (Philips Medical Systems, Best, the 
Netherlands). Cardiac dimensions, ventricular function, and valvular function 
were measured according to published guidelines.9-12 LV and right ventricular (RV) 
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systolic function were assessed visually to enable comparison with the 2 previous 
studies. Systolic function was graded as normal or mildly, moderately, or severely 
impaired. Additionally, more objective measurements, including LV ejection frac-
tion (Simpson’s method), RV fractional area change, and tricuspid annulus plane 
systolic excursion, were used to quantify systolic ventricular function. Measure-
ments were obtained by 2 independent observers (M.E.M.,J.A.A.E.C.).
NT-proBNP measurement
Peripheral venous blood samples were collected after 30 min of rest. Plasma NT-
proBNP levels were determined with use of the commercially available electroche-
miluminescence immunoassay Elecsys (Roche Diagnostics, Basel, Switzerland). 
The normal value in our hospital is <14 pmol/l.
Subjective health assessment
The 36-item short-form health survey (SF-36) was completed to assess subjective 
health status. Results for the patients were compared with their results from 10 
years earlier and with normative data from the general Dutch population.13
Statistical analysis
Continuous data are presented as mean ± SD or median with interquartile range 
(IQR) depending on the data distribution. Categorical data are presented as fre-
quencies and percentages. Changes in patient characteristics since the follow-up 
study in 1990 and 2001 were evaluated by estimating a trend by use of mixed mod-
els, which take missing values into account. Changes in characteristics between 
2001 and 2012 were analyzed by paired Student t-tests. Differences between inde-
pendent subgroups were evaluated by unpaired Student t tests or Mann-Whitney 
U tests (continuous data) and by χ2 test or Fisher exact test (categorical data). 
To quantify correlations between 2 variables, the Spearman correlation test was 
used.
Cumulative survival and event-free survival for all patients and for patients 
with successful VSD surgery (i.e., excluding early post-operative mortality) were 
determined by the Kaplan-Meier method. We compared the cumulative survival of 
isolated and nonisolated VSD patients by the log-rank test. Cumulative event inci-
dences were computed with the use of a nonparametric estimator of cumulative 
incidence functions, with death as a competing risk. Univariable and multivariable 
Cox regression analyses were used to identify determinants of pre-defined adverse 
events: all-cause mortality, arrhythmias, reinterventions, heart failure, and endo-
carditis.
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The mixed models were estimated by use of SAS software (version 9.3, SAS 
Institute, Inc., Cary, North Carolina). The cumulative incidence functions were 
estimated with R (version 3.1.1, R Foundation for Statistical Computing, Wien, 
Austria). All other statistical analyses were performed with the Statistical Package 
for Social Sciences (version 21, SPSS, IBM Corp., Armonk, NY, USA). The statistical 
tests were 2-sided, and P<0.05 was considered statistically significant. Further 
information on statistical analysis can be found in the Online Appendix.
results
Study patients
The original study cohort consisted of 174 consecutive patients who underwent 
surgical VSD closure between 1968 and 1980. Figure 1 presents an overview of 
patient participation for the current study. Baseline characteristics, including 
surgical details and follow-up duration, are presented in Table 1. Further baseline 
and surgical details have been reported previously.5,6
Median follow-up duration of the actively included patients was 35.8 years (IQR: 
34.0 to 37.3 years; range 30.4 to 40.3 years). Of 91 patients, 70 participated in-
hospital, and 21 completed the questionnaires and gave permission to use their 
hospital records. Twenty-seven of the 91 patients (30%) had 1 or more concomi-
  Original surgical cohort             n=174
 
  Approached for current study*  n=108
 
  Included in current study       n=91
 
 Excluded:
  - Died postoperatively <30 days       n=17
  - Died between 30 days postoperatively 
    and 1990       n=3
  - Died between 1990 and 2001       n=3
  - Died between 2001 and current study n=7
  - Emigrated/lost       n=18
  - Refused all prior participations       n=18
 - No response       n=9
 - Refused participation       n=8
 Included:
  - Study 1990          n=107
  - Study 2001      n=95
Figure 1 Flow chart of the study patients
One patient died shortly after participation in the study. We used the in-hospital examination results for this 
study and scored him as deceased in the survival analysis. *Patients who were alive, traceable, and partici-
pated in the studies of 1990, 2001, or both.
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tant cardiac lesions (nonisolated VSD), including patent foramen ovale (n=11), 
pulmonary stenosis (n=10), patent arterial duct (n=6), aortic coarctation (n=5), 
atrial septal defect (n= 4, of whom 2 had partial abnormal pulmonary venous re-
turn), mitral stenosis (n=2), and aortic stenosis (n=1). A patent foramen ovale was 
included as a concomitant lesion when an intervention was performed to close it. 
There were no discrepancies between assessments of the 2 evaluators regarding 
post-surgical events.
Survival
Information on survival was available for 156 patients (90%). Cumulative survival 
after surgical closure, including early post-operative mortality, was 89% at 10 years, 
87% at 20 years, 85% at 30 years, and 78% at 40 years, which was significantly 
lower than in the general Dutch population of comparable age (Figure 2A). Thirty-
one patients died, with 17 deaths occurring within 30 days of surgery. Cumulative 
survival after successful surgery, excluding early post-operative mortality, was 
99% at 10 years, 96% at 20 years, 95% at 30 years, and 86% at 40 years, which was 
Table 1 Baseline and follow-up characteristics of the study patients
 
Total 1990 2001 2012
No third 
study* P-value†
(n=174) (n=107) (n=95) (n=91) (n=83)  
Male 96 (55) 64 (60) 57 (60) 56 (62) 40 (48) 0.077
Age at study (years) - 19.2 [14.2-23.7] 29.2 [24.5-33.5] 39.6 [35.2-43.8] - -
Age at operation (years) 2.3 [0.5-6.9] 3.4 [0.6-7.1] 2.1 [0.6-6.5] 2.9 [0.5-6.5] 1.9 [0.5-7.1] 0.664
Age at operation <1 year 60 (34) 34 (32) 33 (35) 30 (33) 30 (36) 0.660
Pre-operative RV systolic pressure (mmHg) 70 [47-83] 69 [42-85] 68 [42-82] 68 [42-82] 70 [54-85] 0.371
Pre-operative Qp/Qs ratio 2.0 [1.7-2.8] 2.0 [1.7-2.8] 2.0 [1.7-2.9] 2.0 [1.7-2.8] 2.1 [1.6-2.8] 0.916
Type of VSD
Perimembranous 134 (77) 91 (85) 78 (82) 74 (81) 60 (72) 0.157
Muscular 8 (5) 1 (1) 2 (2) 2 (2) 6 (7) 0.154
Nonisolated VSD 56 (32) 32 (30) 29 (31) 27 (30) 30 (36) 0.363
Previous PA banding 15 (9) 6 (6) 4 (4) 6 (7) 9 (11) 0.318
Hypothermia during surgery
Temperature <20°C 70 (40) 38 (35) 37 (39) 33 (36) 37 (45) 0.285
Temperature 20-35°C 101 (58) 67 (63) 56 (59) 56 (62) 45 (54)
Temperature unknown 3 (2) 2 (2) 2 (2) 2 (2) 1 (1)
RV incision 82 (47) 56 (52) 46 (48) 46 (51) 36 (43) 0.344
VSD closure with patch 155 (89) 95 (89) 86 (91) 80 (88) 75 (90) 0.605
Postoperative arrhythmia < 30 days
Tachyarrhythmia 10 (6) 5 (5) 4 (4) 4 (4) 6 (7) 0.522
Heart block 9 (5) 2 (2) 3 (3) 3 (3) 6 (7) 0.313
Cardiac arrest 3 (2) - - - 3 (4) -
Values are n (%) or median [interquartile range]. *Including deceased and emigrated patients. †2012 vs. no third 
study. PA = pulmonary artery; RV = right ventricular; VSD = ventricular septal defect.
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slightly lower than the general Dutch population (Figure 2B). Successful surgery 
was defined as the group without early post-operative mortality.
In the last 10 years, 8 patients died. One patient died of ventricular fibrillation 
34 years after surgery at 34 years of age. He had received a pacemaker for SND 
20 years earlier. One patient who had developed moderate aortic stenosis had 
sudden death, presumably due to an arrhythmia, 39 years after surgery at the 
age of 49 years. One patient died of heart failure as a result of severely dilated 
cardiomyopathy, 28 years after surgery, at the age of 28. There were 3 noncardiac 
deaths, attributable to breast cancer, lung cancer, and alcohol abuse 29, 33, and 31 
years after surgery, respectively. The cause of death was unknown for 2 patients, 
who died 34 and 42 years after surgery, respectively.
Cumulative survival rates of isolated versus nonisolated VSD patients up to 39 
years after surgery were comparable (93% vs. 88%) (Figure 3A).
Adverse events
Cumulative survival free of adverse events was 63% at 40 years (Figure 2A). 
When early post-operative mortality was excluded, event-free survival was 72% 
(Figure 2B). The event-free survival at 40 years was significantly better in isolated 
versus nonisolated VSD patients (79% vs. 57%, respectively) (Figure 3B).
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Figure 2 Cumulative survival and event-free survival of VSD patients with and without early post-
operative mortality and events
Kaplan-Meier curves for survival and event-free survival of patients after surgical closure of ventricular septal 
defect (VSD), including early mortality and events within 30 days after surgery (A), and after exclusion of early 
mortality and events (B). Seventeen patients died within 30 days after surgery and 14 died during follow-up of 
the following causes: arrhythmia (n=4), heart failure (n=1), endocarditis (n=1), valvular surgery (n=1), pulmo-
nary hypertension (n=1), noncardiac cause (n=4), and unknown (n=2). The dashed lines depict 95% confidence 
intervals. Survival curve of Dutch population represents survival from age 3 to 43 years. *Number of patients at 
risk for survival. †Number of patients at risk for event-free survival.
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Reinterventions
Cumulative incidence of late reinterventions at 40 years of follow-up was 12% 
(Figure 4B). An overview of the reinterventions is summarized in Table 2.
Arrhythmias
Cumulative incidence of late symptomatic arrhythmias including pacemaker im-
plantation at 40 years was 13% (Figure 4C). In the last decade studied, 7 patients 
developed new symptomatic arrhythmias: 1 patient had recurrent atrial flutter 
and fibrillation, treated with electrical cardioversion and catheter ablation; 1 
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Figure 3 Cumulative survival and event-free survival of isolated and nonisolated VSD patients
Kaplan-Meier curves for survival (A) and event-free survival (B) of patients with isolated and nonisolated ven-
tricular septal defect (VSD) (mortality, n=7/7; cardiac reintervention, n=2/12; arrhythmia, n=9/3; endocarditis, 
n=2/2; heart failure, n=3/1, respectively). Patients who died <30 days after surgery are excluded from this figure. 
*Number of isolated VSD patients at risk. †Number of nonisolated VSD patients at risk.
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Figure 4 Cumulative incidence functions of events after exclusion of early post-operative mortal-
ity and events
Cumulative incidence function of all adverse events (A), surgical or catheter-based cardiac reinterventions 
(B), and symptomatic arrhythmias that required medication, cardioversion, ablation, or pacemaker/implant-
able cardioverter-defibrillator (C). Patients who died <30 days after surgery are excluded from this figure. The 
dashed lines depict 95% confidence intervals.
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patient who had a pacemaker for 19 years had recurrent atrial fibrillation treated 
with electrical cardioversion; 1 patient had atrial fibrillation treated with vera-
pamil; and 1 patient had paroxysmal atrioventricular reentrant tachycardia. The 
cumulative incidence of late pacemaker implantation, including ICD in 2 patients, 
was 7% at 40 years. In the last decade studied, 3 pacemakers were implanted: 1 
for SND, 1 for severe bradycardia, and 1 for complete heart block. The last patient 
received a biventricular ICD because of ventricular tachycardias and diminished 
ejection fraction due to dilated cardiomyopathy. During total follow-up, 3 patients 
developed complete heart block.
Endocarditis
Cumulative incidence of late endocarditis at 40 years was 4%. During the last 10 
years, 1 patient was diagnosed with pacemaker endocarditis caused by Staphylo-
coccus aureus, which required treatment with antibiotic drugs and replacement of 
the pacemaker system.
Heart failure
Cumulative incidence of late heart failure at 40 years was 4%. During the last 
decade studied, 3 patients developed heart failure. One of them died during hos-
pitalization, 1 was admitted to the hospital several times, and 1 was hospitalized 
for heart failure triggered by a pneumonia. One of these patients developed heart 
failure 9 years after epicardial pacemaker implantation, and 1 had diminished LV 
function before pacemaker implantation.
Table 2 Types of late cardiac reinterventions
First decade Second decade
Residual VSD 2 Resection aortic (re)coarctation 3
Resection pulmonary stenosis 2 Balloon dilation aortic (re)coarctation 2
Resection aortic coarctation 1 Residual VSD 1
Resection subvalvular aortic stenosis 1 Surgery for restenosis aortic valve 1
Closure patent ductus arteriosus 1 Aortic root replacement 1
False aneurysm ascending aorta 1 Aortic valve replacement 1
Closure sternal dehiscence 1 Pulmonary valve replacement 1
Balloon dilation pulmonary stenosis 1
Third decade  Fourth decade  
Bentall procedure 1 Stenting aortic recoarctation 1
Aortic valve replacement 1
    Mitral valve replacement 1
Information on late cardiac reinterventions (beyond 30 days after surgery) was available for 118 patients. Four-
teen patients underwent one or more reinterventions. VSD = ventricular septal defect.
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Electrocardiography and Holter monitoring
The ECG and Holter findings are summarized in Table 3. None of the patients had 
ventricular pauses longer than 3 s.
Cardiopulmonary exercise testing
Table 3 shows the results of bicycle ergometry. Of the 33 patients with a dimin-
ished exercise capacity (i.e., workload <85% of expected), 6 (18%) had 1 or more 
reinterventions compared with 1 (3%) in the group with normal exercise capacity 
(P=0.049). No differences were found with regard to current age, surgical charac-
teristics, isolated versus nonisolated VSD, QRS duration, or ventricular function.
Table 3 Standard 12-lead and 24-h Holter electrocardiogram, bicycle ergometry and echocardiog-
raphy
1990 2001 2012 P-value
Electrocardiography n=107 n=95 n=79
Rhythm
Sinus 104 (97) 86 (91) 72 (91) <0.001
Atrial 1 (1) 2 (2) 2 (3) 0.430
Nodal 1 (1) 3 (3) 1 (1) 0.816
Pacemaker 1 (1) 4 (4) 4 (5) 0.102
Atrial flutter 0 0 0 -
PR interval (ms)* 148 ± 29 151 ± 28 159 ± 30 <0.001
PR ≥200 ms 5 (5) 7 (8) 6 (8) 0.287
QRS duration (ms)† 101 ± 21 113 ± 27 117 ± 27 <0.001
QRS duration ≥120 ms 26 (25) 29 (32) 25 (33) 0.306
QRS duration ≥180 ms 0 2 (2) 1 (1) 0.405
24-hour Holter n=103 n=92 n=68  
Supraventricular arrhythmias 21 (20) 25 (27) 25 (37) 0.024
Sinus node disease 21 (20) 8 (9) 4 (6) 0.003
SVT 0 19 (21) 22 (32) <0.001
Paroxysmal atrial fibrillation 0 0 1 (1) -
Paroxysmal atrial flutter 0 0 0 -
VT 3-10 complexes 6 (6) 2 (2) 3 (4) 0.492
VT >10 complexes 0 0 0 -
Bicycle ergometry n=103 n=93 n=69  
Maximal heart rate (%) 89 ± 9 88 ± 10 88 ± 12 0.013
Maximal workload (%) 94 ± 19 91 ± 24 87 ± 19 0.003
Workload <85% 30 (29) 37 (40) 33 (48) 0.009
Arrhythmias 5 (5) 10 (11) 5 (7) 0.464
Peak Vo2 (%) - - 87 ± 20 -
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Echocardiography
Echocardiographic findings are summarized in Tables 3 and 4. Systolic LV func-
tion was mildly impaired in 11 patients (14%), moderately impaired in 3 (4%), and 
severely impaired in 2 (3%). The percentage of patients with impaired systolic LV 
function was 14% in 2001 and 21% in 2012 (P=0.180). Normal diastolic LV function 
was observed in 63 patients (89%), pseudonormal diastolic function in 6 (8%), and 
restrictive relaxation pattern in 2 (3%). Systolic RV function was mildly impaired in 
10 patients (13%) and moderately impaired in 3 (4%). The percentage of patients 
with impaired systolic RV function increased significantly over the last decade of 
study from 1% to 17% (P=0.001). Patients with impaired systolic RV function more 
often had an elevated estimated RV systolic pressure than patients with normal 
Table 3 Standard 12-lead and 24-h Holter electrocardiogram, bicycle ergometry and echocardiog-
raphy (continued)
1990 2001 2012 P-value
Echocardiographic parameters n=107 n=95 n=76  
LA end-systolic dimension (mm) 32 ± 5 37 ± 6 38 ± 6 0.003
LV end-systolic dimension (mm) 32 ± 5 34 ± 5 33 ± 6 0.464
LV end-diastolic dimension (mm) 49 ± 6 52 ± 5 50 ± 6 0.255
LV fractional shortening (%) 34 ± 6 34 ± 7 35 ± 8 0.647
Fractional shortening <30% 19 (18) 24 (25) 19 (25) 0.256
LV posterior wall dimension (mm) 9 ± 2 10 ± 2 8 ± 2 0.594‡
Aorta end-diastolic dimension (mm) 30 ± 5 33 ± 5 33 ± 5 <0.001
Aortic valve regurgitation
None-trace 95 (89) 79 (83) 59 (79) 0.039§
Mild-moderate 12 (11) 16 (17) 16 (21)
Severe 0 0 0
Mitral valve regurgitation
None-trace 91 (87) 84 (88) 69 (92) 0.249§
Mild-moderate 14 (13) 11 (12) 6 (8)
Severe 0 0 0
Pulmonary valve regurgitation
None-trace 81 (78) 68 (72) 66 (89) 0.108§
Mild-moderate 23 (22) 27 (28) 7 (10)
Severe 0 0 1 (1)
Tricuspid valve regurgitation
None-trace 63 (62) 41 (43) 40 (53) 0.151§
Mild-moderate 38 (38) 54 (57) 34 (46)
Severe 0 0 1 (1)  
Values are n (%), or mean ± SD. *Atrial, nodal, and pacemaker rhythm were excluded from analysis. †Pacemaker 
rhythm was excluded from analysis. ‡Significance test was based on log-transformed values. §Significance test 
was based on binary variables (none–trace vs. mild–severe).
LA = left atrium; LV = left ventricular; SVT = supraventricular tachycardia; VT = ventricular tachycardia.
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systolic RV function (42% vs. 12%, P=0.036), more often had a pacemaker (23% 
vs. 3%, P=0.033), and more often had impaired systolic LV function (69% vs. 11%, 
P<0.001). Diastolic LV function did not differ significantly between patients with 
impaired or normal systolic RV function. There were no significant differences 
in systolic biventricular function between patients with isolated and nonisolated 
VSD, with and without RV incision, or with and without VSD patch.
The percentage of patients with mild or moderate aortic regurgitation increased 
significantly over the last 20 years from 11% in 1990 to 21% in 2012 (P=0.039).
NT-proBNP measurement
NT-proBNP was measured in 68 patients. The median level was 11.6 pmol/l (IQR: 
7.0 to 19.8 pmol/l), with an elevated level (>14.0 pmol/l) measured in 26 patients 
(38%). The highest value was 56.5 pmol/l, measured in a woman with an isolated 
VSD, in sinus rhythm, and without clinical signs of heart failure. Median NT-proBNP 
was comparable between patients with an isolated VSD (n=50) and those with a 
nonisolated VSD (n=18; 11.2 pmol/l [IQR: 6.9 to 18.4 pmol/l] vs. 14.3 pmol/l [IQR: 6.8 
to 28.1 pmol/l], P=0.436). Patients with impaired systolic RV function (n=8) tended 
to have a higher NT-proBNP than patients with normal RV function (n=59; 16.2 
pmol/l [IQR: 12.9 to 26.6 pmol/l] vs. 11.1 pmol/l [IQR: 6.4 to 19.5 pmol/l], P=0.063). 
No relationships were found with systolic LV function, ventricular dimensions, age 
at operation, current age, or exercise capacity.
Subjective health status assessment
Seventy-four patients completed the SF-36 health survey. The results are depicted 
in Figure 5. Patients obtained significantly better scores than the reference popula-
Table 4 Results of additional diagnostic tests performed only in 2012
Parameter n Median IQR Abnormal, n (%)*
LVEF (%) 38 54 [49-61] 9 (24)
E/A ratio 72 1.3 [1.1-1.7] 2 (3)
E/E’ ratio 71 8.5 [6.3-10.0] 5 (7)
Deceleration time (ms) 72 185 [158-218] 20 (28)
RV basal dimension (mm) 65 40 [34-46] 26 (40)
RV longitudinal dimension (mm) 64 77 [69-84] 12 (19)
TAPSE (mm) 61 19 [18-22] 3 (5)
RV fractional area change (%) 49 40 [37-43] 7 (14)
Estimated RV systolic pressure (mmHg) 53 28 [24-35] 10 (19)
*According to the reference values in the guidelines.9,10 Right ventricular dimensions were measured during 
end-diastolic phase. IQR = interquartile range; LVEF = left ventricular ejection fraction; RV = right ventricular; 
TAPSE = tricuspid annular plane systolic excursion.
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tion on all scales except for general health perceptions, which were comparable 
(P=0.089). The patients’ results were comparable with their own results 10 years 
earlier, except for mental health, which they now rated better (85 ± 13% vs. 80 ± 
11%, P=0.030).
Determinants of clinical outcome
Higher pre-operative systolic RV pressure tended to be a determinant of mortality 
(hazard ratio [HR]: 1.02; 95% confidence interval [CI]: 1.00 to 1.04). Univariable 
regression analyses identified nonisolated VSD, early post-operative arrhythmias, 
and aortic cross-clamp time as determinants of late events, including mortality. 
In multivariable regression analysis with these determinants, patients with non-
isolated VSD or patients with longer aortic cross-clamp time had higher risk for 
events (HR: 2.84 [95% CI: 1.23 to 6.53]; HR: 1.47 per 10 min [95% CI: 1.22 to 1.99 per 
10 min], respectively). Early postoperative arrhythmias showed a trend toward 
predicting later events (HR: 2.59 [95% CI: 0.92 to 7.29]). Patients with a complete 
heart block in the early post-operative period more often developed symptomatic 
arrhythmias during follow-up (HR: 9.7 [95% CI: 2.1 to 44.6]). No other baseline 
characteristics were significant determinants of outcome.
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Figure 5 Results of SF-36 for VSD patients and the reference Dutch population
Higher scores represent more favorable subjective health status. A high score on the bodily pain scale indicates 
subject was free from pain. Error bars show 95% confidence interval. *P <0.01. SF-36 = 36-item short-form health 
survey; VSD = ventricular septal defect.
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disCussion
In this unique longitudinal cohort study of VSD patients who underwent surgical 
repair at a young age, survival up to 40 years was relatively good but lower than 
in the general Dutch population. Although morbidity was substantial, especially 
among patients with nonisolated VSD, the reported subjective health status was 
even better than normative data.
Mortality and adverse events
Cumulative survival 40 years after surgical VSD closure was 78% in our cohort. 
One-half of these deaths occurred within 30 days after surgery. Currently, pul-
monary artery banding is performed only rarely, and advances in surgical and 
anesthesiology techniques and improvements in peri-operative care have greatly 
reduced peri-operative mortality.14 In addition, the care during follow-up is better 
organized today. Therefore, these early results are not applicable to patients who 
have undergone surgery in more recent years. With the exclusion of in-hospital 
operative mortality, however, cumulative survival in our cohort was 86% at 40 
years, which was still slightly lower than in the general population. In more than 
one-half of the cases, late mortality was cardiac related: cardiac arrest/sudden 
death, reoperation, and heart failure (Central Illustration).
Cumulative survival was similar between patients with isolated and nonisolated 
VSD. Morbidity was higher in patients with nonisolated VSD and was dominated 
by reinterventions for concomitant lesions, for example, aorta-related problems 
or pulmonary stenosis.
Health status and ventricular function
Most of our patients rated their physical functioning better than the reference 
population; however, their maximal workload at exercise testing was clearly lower 
than the reference population, with almost one-half of the patients having a dimin-
ished maximal workload. Furthermore, the maximal workload decreased over the 
last decades studied. The median peak Vo2 of 87% in our study population was a 
bit higher than the 73% in the study by Kempny et al.15 This difference could prob-
ably be explained by the fact that they included patients who underwent exercise 
testing as part of their ongoing outpatient care, whereas our study included many 
patients who had been discharged from routine clinical follow-up.
The occurrence of aortic regurgitation appears to be an important issue after 
VSD surgery. In our cohort, 1 patient developed severe aortic regurgitation that 
necessitated aortic valve replacement, and in the other patients, the prevalence 
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of aortic regurgitation nearly doubled over the last 20 years of the study, from 11% 
in 1990 to 21% in 2012.
Systolic LV function remained stable over the last decade of study, but impaired 
systolic RV function increased. In our cohort, systolic RV dysfunction was not 
related to VSD patch or RV incision, but the vast majority of patients with sys-
tolic RV dysfunction had systolic LV dysfunction and more often had elevated 
RV systolic pressure. This relationship between RV and LV dysfunction could be 
explained in part by the presence of a pacemaker in a quarter of patients with 
RV dysfunction or by systolic ventricular interaction. In the case of systolic LV 
dysfunction, pulmonary pressure increases, which results in reduction of RV 
contractility. Moreover, ventricular interaction is mediated by forces at the inter-
ventricular septum and mechanical coupling through shared myocardial fibers: 
When the LV becomes more spherical, the fibers of the interventricular septum 
become less oblique, which reduces and impairs RV contractile function.16,17 Sys-
tolic ventricular interaction is also observed in other congenital heart defects.18,19 
Another explanation for the higher prevalence of RV dysfunction over time may 
be the use of a more sophisticated echocardiographic assessment to facilitate 
the detection of dysfunction. Using tissue Doppler imaging, Klitsie et al.20 found 
a systolic RV impairment up to 20 months after surgical VSD closure in children. 
Although subclinical RV impairment may not be of direct clinical relevance, it 
could be a first sign of systolic RV dysfunction and does stress the importance of 
detailed evaluation of RV function after VSD surgery.
NT-proBNP levels were elevated in more than one-third of the patients. This 
is striking, because the majority of patients were asymptomatic and had normal 
systolic biventricular function. No studies were found in the published data on 
BNP levels in adults after surgical VSD closure, and only a few in children,21 which 
reported mildly increased levels. Prospective studies are necessary to elucidate 
the prognostic value of BNP in these patients.
Arrhythmias
In the last 10 years of the study, 4 patients developed supraventricular arrhyth-
mias, and 3 required pacemaker implantation. Cumulative incidence of late symp-
tomatic arrhythmias at 40 years was 13%. This was much lower than the incidence 
after surgical VSD closure at adult age22 but higher than in patients who underwent 
surgery after 1980.14,23 The incidence of arrhythmias after surgical closure of an 
atrial septal defect at young ages is higher.24
Recently, interest has been generated in development of percutaneous tech-
niques to close VSDs; however, this technique is not implemented in routine 
clinical practice and has even ceased in most clinics because of the high rate of 
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post-procedural heart block (up to 8%).4,25 This is higher than the incidence in our 
cohort after surgical closure at a young age (3%), as well as at an adult age.22,23
Subjective health status assessment
A remarkable finding of the SF-36 results was that patients reported a more favor-
able functioning than the reference Dutch population on 7 of the 8 scales and 
comparable functioning on 1 scale (general health perceptions). These propitious 
results for VSD patients may be attributable to different frames of reference than 
the normal population, more adequate coping with the disadvantageous conse-
quences of the congenital heart defect at advanced age, overcompensation, or 
social desirability.26
Determinants of clinical outcome
Although numbers in our study were relatively small, patients with early post-
operative arrhythmia tended to develop more late events. In another cohort of 
patients with surgically repaired VSD, transient and complete heart blocks were a 
risk factor for latemortality.27 In that study, a substantial percentage of deceased 
patients had not received a pacemaker because either pacemakers had not been 
developed at that time or they were only newly available. The relation between 
early post-operative arrhythmias and arrhythmias during follow-up was also 
described after surgery at young age for other congenital heart defects.24,28 The 
relation may be explained by surgical damage to the conduction system or by 
post-operative scar tissue and fibrosis. Early arrhythmias might therefore reveal 
patients at risk for late complications.
A simple concomitant cardiac lesion and longer aortic cross-clamp time during 
surgery were determinants of late events. The fact that patients with a concomi-
tant cardiac lesion have a greater risk of events appears directly related to the 
relatively higher number of reinterventions in this group.
Study limitations
Although the number of patients was relatively small, we report results of a longi-
tudinal follow-up of consecutive patients without selection bias related to disease 
severity. After a median follow-up of 36 years, we gathered medical information 
on 84% of the eligible patients. We found no significant differences in baseline 
characteristics between participating and nonparticipating patients. Therefore, 
we believe that we have minimized selection bias.
Diagnostic methods have changed over time. For comparisons of echocardio-
graphic data with previous studies, we had to use the same methods as were used 
in the past, which may not be considered current state of the art. However, we also 
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performed and reported innovative diagnostic methods available in the current 
era.
ConClusions
Survival up to 40 years after successful surgical VSD closure is good but slightly 
lower than in the general Dutch population. Although many patients have been 
discharged from routine follow-up at outpatient clinics, morbidity is substantial, 
especially in patients with nonisolated VSD. There is concern about systolic LV and 
RV dysfunction, which were observed in 21% and 17% of patients, respectively, and 
about occurrence of aortic regurgitation, which almost doubled over the last 20 
years of the study. Early postoperative arrhythmia is a borderline determinant and 
aortic cross-clamp time a significant determinant of late events. Therefore, clinical 
follow-up with long intervals seems advisable. Despite the reported morbidity, the 
subjective health status is excellent.
Central illustration. Outcome up to 40 years after surgical VSD closure
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Additional information on statistical analysis
Changes in patient characteristics since the follow-up study in 1990 and 2001 were 
evaluated by estimating a trend using mixed models which take missing values 
into account. For the continuous variables, a trend was estimated using linear 
mixed models. When the distribution of the variables deviated from normality, 
log-transformations were applied. For the binary variables, generalized linear 
mixed models were estimated with a logit-link function. The variables with three 
categories (aortic, mitral, pulmonary and tricuspid regurgitation) were recoded as 
binary variables (none-trace vs. mild-severe).
Univariable and multivariable Cox regression analyses were used to identify 
determinants of the predefined adverse events: all-cause mortality, arrhythmias, 
reinterventions, heart failure and endocarditis. The following baseline charac-
teristics were included as determinants in the analyses: non-isolated VSD, age 
at repair, era of repair, preoperative systolic RV pressure, pulmonary-systemic 
flow ratio, preoperative palliation, temperature during surgery, RV incision, early 
postoperative arrhythmias, and aortic cross-clamp time. Baseline characteristics 
that turned out to be significant in the univariable Cox regression analysis, were 
implanted in the multivariable Cox regression model. For every ten events, one 
characteristic could be implemented in the multivariable Cox regression model.
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abstraCt
Objective
To describe the very long-term outcome after surgical closure of an atrial septal 
defect (ASD).
Design
Longitudinal cohort study of 135 consecutive patients who underwent surgical 
ASD repair at age <15 years between 1968 and 1980. The study protocol included 
ECG, echocardiography, exercise testing, N-terminal prohormone of brain natri-
uretic hormone, Holter monitoring and cardiac MRI.
Main outcome measures
Survival, major events (cardiac reinterventions, stroke, symptomatic arrhythmia 
or heart failure) and ventricular function.
Results
After 35 years (range 30–41), survival status was obtained in 131 of 135 patients 
(97%): five died (4%), including two sudden deaths in the last decade. Fourteen 
patients (16%) had symptomatic supraventricular tachyarrhythmias and six 
(6%) had a pacemaker implanted which was predicted by early postoperative 
arrhythmias. Two reoperations were performed. One ischaemic stroke occurred. 
Left ventricular (LV) and right ventricular (RV) ejection fractions (EF) were 58 ± 
7% and 51 ± 6%, respectively. RVEF was diminished in 17 patients (31%) and in 11 
(20%) the RV was dilated. Exercise capacity and quality of life were comparable to 
the normal population. No clear differences were found between ASD-II or sinus 
venosus type ASD.
Conclusions
Very long-term outcome after surgical ASD closure in childhood shows good sur-
vival and low morbidity. Early surgical closure prevents pulmonary hypertension 
and reduces the occurrence of supraventricular arrhythmias. Early postoperative 
arrhythmias are predictive for the need for pacemaker implantation during early 
follow-up, but the rate of late pacemaker implantation remains low. Although RVEF 
was unexpectedly found to be decreased in one-third of patients, the functional 
status remains excellent.
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introduCtion
While transcatheter closure with a device is the current method of choice for 
correction in patients with a suitable atrial septal defect (ASD), surgical closure 
was first choice treatment until the 1990s and is still the only treatment for large 
and non-centrally located defects. After successful operation at a young age, the 
natural history of patients with ASD improved dramatically with life expectancy 
similar to that of the general population.1-3
The retrospective study of Murphy et al.1 was the first to demonstrate the ben-
efits of early surgical closure. The incidence of postoperative atrial arrhythmias 
appeared to be related to the age of the patient at the time of repair. Benefits 
of closure in childhood have been confirmed by others,3-7 although persistent 
ventricular dilation has been reported in some but not all studies.
Early and mid-term follow-up of transcatheter ASD closure shows excellent 
results.8 For a comparison of both closure techniques, information on outcome 
beyond 30 years is crucial.
The aim of the present study was to provide data on mortality, morbidity and 
ventricular function up to 40 years after surgery. The investigation is based on a 
unique longitudinal cohort of consecutively operated patients who we examine in 
hospital every 10 years using the same protocol.
Methods
Study population
All patients who underwent surgical closure of secundum (ASD-II) or sinus veno-
sus type ASD in our institution between 1968 and 1980 at an age <15 years were 
included in this study. The first follow-up study was performed in 1990, the second 
in 2000–2001 and the current third study in 2010–2011. Detailed information on 
the surgical procedure and earlier results have been published previously.3,5 
Current patient survival status was obtained from the Dutch National Population 
Registry. All living patients who participated in one or both of the earlier studies 
were approached for participation in the current study. The in-hospital cardiac 
examination included medical history, physical examination, standard 12-lead 
ECG, 24-h ambulatory ECG (Holter), echocardiography, bicycle ergometry with 
oxygen consumption measurement, N-terminal prohormone of brain natriuretic 
hormone (NT-proBNP), cardiac MRI (CMR) and the 36-item Short Form Health 
Survey (SF-36) questionnaire. If the patient was unwilling or unable to visit the 
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clinic, a written questionnaire was sent to obtain information on morbidity and 
permission to use available information from their medical records.
Major events
Survival was compared with that of the normal age-matched Dutch population. 
Major events were defined as cardiac reinterventions, stroke, symptomatic ar-
rhythmia, heart failure or endocarditis. Arrhythmias were defined as symptomatic 
if antiarrhythmic medication was prescribed, cardioversion or catheter-based or 
surgical ablation had been applied, or pacemaker implantation was performed.
ECG and Holter monitoring
Standard 12-lead surface ECGs and Holter recordings were analysed as described 
previously.3 ECGs with pacemaker rhythm were excluded for comparison of con-
duction times. Heart rate variability (HRV) was compared with that of 10 years 
earlier using the SD of all normal RR intervals (SDNN).
Echocardiography
Complete two-dimensional (2D) and colour flow Doppler imaging as well as 
pulsed-wave and continuous-wave Doppler echocardiography was performed 
using an iE33 xMATRIX X5-1 echocardiograph (Philips Medical Systems, Best, The 
Netherlands). All up-to-date techniques and definitions were used following the 
current guidelines.9-15 For right ventricular (RV) function the following parameters 
were used: fractional area change (FAC) (normal if ≥35%), S′ of the tricuspid an-
nulus (normal if ≥10 cm/s) and tricuspid annular plane systolic excursion (TAPSE) 
(normal if ≥16 mm). For left ventricular (LV) function, 2D ejection fraction (EF) 
according to the Simpson rule was obtained. For comparison with the two previ-
ous studies, ventricular function was also assessed visually. Dilation was defined 
as left atrial (LA) dimension >45 mm and LV end-diastolic dimension >58 mm.3,5
Bicycle ergometry
Maximal exercise capacity and peak oxygen consumption (peak Vo2) were as-
sessed by bicycle ergometry with gradual increments of workload of 20 Watts/
min. Exercise capacity and peak Vo2 were compared with that of normal individu-
als corrected for age, gender, body height and weight. Exercise capacity and peak 
Vo2 <85% of the predicted value were considered to be decreased. Performance 
was considered maximal when a respiratory quotient (RER) of ≥1.1 was reached.
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NT-proBNP
After a 30 min rest, venous blood samples were collected for determination of 
NT-proBNP. Standard kits to determine NT-proBNP levels were used (Roche Diag-
nostics, Basel, Switzerland) with a cut-off value for elevation of 14 pmol/L.16
CMR imaging
CMR imaging was performed using a Signa 1.5 Tesla whole body scanner (General 
Electric Medical Systems, Milwaukee, Wisconsin, USA) using dedicated phased-
array cardiac surface coils. Details of the MR sequence used have been reported 
previously.17 For CMR analysis, a commercially available Advanced Windows 
workstation (GE Medical Systems) was used, equipped with Q-mass (V.5.2, Medis 
Medical Imaging Systems, Leiden, The Netherlands). The ventricular volumetric 
data set was quantitatively analysed using manual outlining of endocardial bor-
ders in end-systole and end-diastole. Biventricular end-diastolic volume (EDV), 
end-systolic volume (ESV), SV, EF and the regurgitation fractions of the valves were 
calculated. The results were compared with reported normal values: RVEF ≤49% 
and LVEF ≤54% were considered decreased and RV EDV >107.5 mL/m2, RV ESV >47.2 
mL/m2, LV EDV >102.5 mL/m2 and LV ESV >38.7 mL/m2 were considered enlarged.18
Health status assessment and family history
The results of the SF-36 questionnaire were compared with those in the normal 
Dutch population.19 Patients were also asked for the presence of a congenital heart 
defect in one of their first- or second-degree relatives.
Statistical analysis
Continuous data are presented as mean ± SD unless indicated otherwise. Cat-
egorical variables are represented by frequencies and percentages. Comparison 
of continuous variables between independent groups was made by Student t-tests. 
In the case of a skewed distribution in paired groups, the Wilcoxon signed rank 
test was performed. When comparing frequencies, the χ2 test or Fisher exact test 
was used where applicable, and for paired categorical data the McNemar test. For 
quantifying associations between two variables the Pearson correlation test was 
applied. Univariate and multivariate analysis of predictors of survival and major 
events was performed with the Cox proportional hazards model. A priori the fol-
lowing variables were selected: age at operation, ASD subtype, preoperative shunt 
size, cardiopulmonary bypass time and postoperative arrhythmia. HRV in 2001 
was tested as a predictor for arrhythmias thereafter. The probability of survival 
and event-free survival over time was displayed as a Kaplan–Meier plot. The level 
of significance was chosen at P<0.05 (two-sided).
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results
Survival
Information on survival status was obtained in 131 of the 135 patients. Four patients 
were lost to follow-up before 2001. During the total follow-up period, five patients 
died (4%). Two patients (both ASD-II) were found dead in bed 28 and 36 years 
after surgery. In neither of the patients was an autopsy performed. One of them 
had complained of palpitations 2 weeks before he died but he had not consulted 
a physician. The other was known to have diminished LV function attributed to 
longstanding RV pacing. Both patients had no risk factors for coronary disease. 
The other three patients died from non-cardiac causes (cancer in two, suicide in 
one). Cumulative survival after ASD surgery was 100% after 10 and 20 years, 98% 
after 30 years and 91% after 40 years (Figure 1). This is comparable to the normal 
Dutch population.20 Survival in the ASD-II and sinus venosus subgroups was not 
significantly different.
Study population
The original study cohort consisted of 135 patients (105 ASD-II and 30 sinus veno-
sus type). Table 1 demonstrates their characteristics. Age at operation was 7.5±3.5 
years (range 0–14). There was no in-hospital or early mortality. Of the 105 eligible 
patients (alive and participating in the earlier studies), 85 (81%) agreed to partici-
pate in the third follow-up study after a mean follow-up of 35 years (range 30–41). 
Of the 21 patients with sinus venosus defect, 19 had an anomalous pulmonary 
venous drainage; one patient had a persistent left superior caval vein.
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Figure 1 Survival and survival free of major events (defined as reoperation, arrhythmia, heart 
failure, endocarditis, pacemaker implantation, hospitalisation and death).
All-cause mortality, n=5; cardiac surgery, n=2; stroke, n=1; symptomatic arrhythmia, n=16. Survival of the normal 
population is shown from the age of 7.5 years, the mean age at operation of the cohort. ASD, atrial septal defect.
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Major events
Event-free survival is plotted in Figure 1.
Reinterventions
Before 2001 one additional operation was performed for closure of a patent ar-
terial duct. Between 2001 and 2011, one cardiac reoperation was necessary for 
symptomatic mitral valve regurgitation. Both operations were in patients with 
ASD-II.
Arrhythmia
Until 2001, 10 patients had symptomatic arrhythmias and, in the last 10 years, six 
additional patients developed symptomatic arrhythmias. One showed frequent 
symptomatic sinus arrests necessitating permanent pacemaker implantation. 
Three were treated medically for atrial flutter (n=1) or atrial fibrillation (n=2), 
one needed electrical cardioversion for atrial flutter and afterwards underwent 
catheter ablation and one patient was treated medically for supraventricular 
tachycardia (SVT). During the total follow-up period 16% of the patients developed 
symptomatic arrhythmias.
Heart failure
None of the patients developed heart failure.
Table 1 Patient characteristics
Total 1990 2001 2011
Number of patients 135 104 94 85
Men, n (%) 59 (44) 44 (42) 39 (41) 33 (39)
Cardiac catheterization at diagnosis
QP-QS ratio 2.3:1 2.3:1 2.3:1 2.3 ± 0.7
Peak systolic PA pressure, mmHg 26 26 26 26 ± 7
Surgical data
Age at operation, years 7.5 ± 3.5 7.3 7.5 7.4 ± 3.5
Mode of closure
Direct closure 76% 75% 75% 72%
Closure with patch 24% 25% 25% 28%
Sinus venosus type 22% 22% 23% 25%
Follow-up since surgery, years 15 (10-22) 26 (21-33) 35 ± 2.7(range 30-41)
Age at the time of study, years 22 33 43 ± 4.8 (range 32-54)
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Stroke
An ischaemic stroke occurred in one patient with sinus venosus type ASD. No 
evidence of residual shunt or arrhythmia was found.
ECG and Holter monitoring
Twelve-lead ECG data are presented in Table 2. Atrial flutter was found in two 
patients, of whom one was new. The QRS duration increased significantly during 
the last 10 years, but only one new case of right bundle branch block was found.
On the 24-h Holter no sustained ventricular tachycardia (VT) was found in 1990, 
2001 or 2011 (Table 2). There was a trend towards more supraventricular arrhyth-
mias over time. Atrioventricular (AV) conduction disturbances were observed in 
nine patients.
Heart rate variability
The mean SD of all normal RR intervals (SDNN) was 166.7 ± 57.9 ms in 2001 and 
143.4 ± 42.0 ms in 2011 (P=0.2). There was no difference in HRV between patients 
with ASD-II and sinus venosus types.
Echocardiography
Echocardiographic findings are summarised in Tables 2 and 3. No residual shunts 
were found. A normal diastolic LV function was observed in 88% of patients, mild 
abnormal relaxation in 9% and pseudonormal diastolic filling in 3%. TAPSE was 
decreased in 22% of the patients, FAC was reduced in 10% and S′ was diminished 
in 43%. Comparing patients with ASD-II and sinus venosus defects, there were no 
significant differences except that S′ and TAPSE were significantly lower in patients 
with sinus venosus type whereas RV FAC was higher.
Table 2 Standard 12-lead electrocardiogram, 24-h Holter, bicycle ergometry and echocardiograph-
ic parameters in 1990, 2001 and 2011
P-value*
1990 2001 2011 2011 vs 1990 2011 vs 2001
ECG
Rhythm
Sinus 93 (89%) 82 (89%) 63 (89%) 0.6 1.0
Atrial 6 (6%) 5 (5%) 3 (4%) - 1.0
Nodal 1 (1%) 1 (1%) 0 - -
Atrial flutter 0 1 (1%) 2 (3%) - 1.0
Pacemaker 4 (4%) 3 (3%) 3 (4%) 0.5 1.0
PR interval 154 153 161 0.002 <0.001
PR >200 ms 3% 5% 9% - 0.06
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Table 2 Standard 12-lead electrocardiogram, 24-h Holter, bicycle ergometry and echocardiograph-
ic parameters in 1990, 2001 and 2011 (continued)
P-value*
1990 2001 2011 2011 vs 1990 2011 vs 2001
QRS duration, ms 88.3 96.1 100.4 <0.001 0.001
QTc segment, ms 388 388 400 <0.001 <0.001
LVH or RVH 4.1% 4.6% 1.4% 1.0 1.0
24-hour Holter
Supraventricular arrhythmias 44 (45%) 36 (41%) 39 (57%) 0.2 0.6
Sinus node disease 38 (39%) 27 (31%) 16 (24%) 0.3 0.5
SVT 6 (6%) 18 (21%) 30 (44%) <0.001 0.06
Paroxysmal A fibrillation 0 0 0 - -
Paroxysmal A flutter 0 1 (1%) 0 - -
Continuous A flutter 0 1 (1%) 1 (2%) - 1.0
VT 3-10 complex 3 (3%) 4 (5%) 4 (6%) 1.0 1.0
VT >10 complex 0 0 0 - -
Conduction disturbances 17 (17%) 8 (9%) 10 (15%) 1.0 0.2
First degree AV block 14 (14%) 8 (9%) 7 (10%) 0.8 0.7
Second AV block 2 (2%) 0 2 (3%) 1.0 -
Third AV block 0 0 0 - -
Bicycle ergometry
Maximum heart rate (% of expected) 92% 92% 90% 0.6 0.5
Maximum exercise capacity (% of expected) 104% 95% 96% -
Significant arrhythmia 0 0 0 -
Peak Vo2 (% of expected) - - 96% -
RER max - - 1.3 -
Echocardiography
RA dilation 5.8% 18.7% 23.5% 0.007 0.8
RV dilation 26.0% 23.5% 34.3% 0.2 0.5
LA dilation 1.0% 12.2% 15.7% 0.008 0.7
LV dilation 4.0% 8.8% 2.9% 1.0 0.1
LV systolic function normal 97.1% 95.5% 95.5% 0.6 1.0
RV systolic function normal 100% 100% 67.2% - <0.001
Valve insufficiency (>trace)
AoI 0% 1.1% 2.9% - -
MI 11.5% 13.5% 20.0% 0.8 0.1
PI 44.2% 45.0% 55.7% <0.02 <0.02
TI 42.3% 48.3% 57.1% 1.0 0.7
Vmax PI, m/s 1.6 1.5 1.7 0.7 0.8
Vmax TI, m/s 2.1 2.2 2.3 0.03 0.03
*Because of incomplete follow-up (paired) data, not all P-values are displayed.
AoI, aortic insufficiency; AV, atrioventricular; LA, left atrium; LV, left ventricle; LVH, left ventricular hypertrophy; 
MI, mitral insufficiency; PI, pulmonary insufficiency; RA, right atrium; RER, respiratory exchange ratio; RV, right 
ventricle; RVH, right ventricular hypertrophy; SVT, supraventricular tachycardia; TI, tricuspid insufficiency; 
Vmax, maximal velocity found with Doppler echocardiography; peak Vo2, peak consumption (not performed in 
1990/2001); VT, ventricular tachycardia.
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Bicycle ergometry
The results of exercise testing in 1990, 2001 and 2011 are listed in Table 2. Eighteen 
patients (27%) had a diminished exercise capacity at last follow-up. Mean peak Vo2 
was 96 ± 25% (range 60–194%). One-third had a mean peak Vo2 of <85%, one-third 
85–100% and one-third performed >100%. The threshold RER of 1.1 was reached in 
97%. Patients with reduced exercise capacity or peak Vo2 did not differ significantly 
from those with a normal test result with regard to preoperative shunt size, age at 
the time of operation or findings by echocardiography or CMR (dimensions and 
ventricular function). There were no significant differences between patients with 
ASD-II and sinus venosus defects but there was a trend towards a better workload 
in the patients with sinus venosus type ASD (P=0.07).
NT-proBNP
An increased NT-proBNP level (>14.0 pmol/L) was present in 53% of the patients. 
Values varied from 1.5 to 116 pmol/L with a mean of 15.0 pmol/L. No correlation 
between NT-proBNP and age, age at surgery, ASD type or LV and RV dimensions 
or function was found.
CMR imaging
CMR was performed in 57 patients. Reasons for not having a CMR investigation 
were patients’ refusal, prematurely ended because of claustrophobia and two 
patients had a pacemaker. One study could not be analysed due to technical prob-
lems. The results of CMR are summarised in Table 4. There were no differences in 
Table 3 Echocardiographic parameters 2011
ASD-II Sinus venosus defect P-value
Left ventricle
E/A ratio 1.3 ± 0.4 1.3 ± 0.4 0.99
E/E’ ratio 8.4 ± 5.0 8.5 ± 3.4 0.95
DET (ms) 226 ± 46 224 ± 49 0.94
LVEF Simpson (%) 56 ± 5 57 ± 9 0.56
Right ventricle
TAPSE (mm) 19 ± 4 16 ± 2 <0.01
RV pressure (mmHg) 27 ± 5 26 ± 4 0.60
FAC (%) 43 ± 9 53 ± 7 <0.01
S’ (mm) 11 ± 2 9 ± 2 <0.01
ASD, atrial septal defect; DET, deceleration time; E/A ratio, ratio early filling velocity on transmitral Doppler/
late filling; E/E0 ratio, ratio early filling velocity on transmitral Doppler/early relaxation velocity on tissue Dop-
pler; FAC, fractional area change of right ventricle; LVEF Simpson, left ventricular ejection fraction according 
to modified Simpson rule; RV, right ventricle; S′, tricuspid annulus maximal systolic tissue Doppler velocity; 
TAPSE, tricuspid annular plane systolic excursion.
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mean ventricular volumes or EFs between patients with ASD-II and sinus venosus 
type defects. However, there was a trend towards more dilated RV volumes in the 
sinus venosus group (dilated ESV in 57% vs 27%, P=0.054).
Health status assessment and family history
The mean scores on the SF-36 survey for the patients and the normal population 
are shown in Figure 2. Having had an event did not adversely affect SF-36 scores.
A self-reported family history of congenital heart disease was found in 23% of 
patients (n=16); of these, 56% were in first-degree relatives. The majority of family 
members also had an ASD (n=8). Other defects were a ventricular septal defect 
(n=3), patent ductus arteriosus (n=2), univentricular heart (n=1) and valvular 
heart disease (n=2). Some had more than one defect. Information on genetic test-
ing was not recorded.
Predictors for late events
Univariate analysis identified only the occurrence of arrhythmias in the early post-
operative period as a predictor for the need for permanent pacing during follow-
up (HR=16 (95% CI 3 to 70); P<0.001). Multivariate analysis was not performed 
because the number of events was too low.
Table 4 Cardiac MRI
ASD-II Sinus venosus defect P-value
LV EDV/BSA, mean ± SD (mL/m2) 80 ± 15 83 ± 16 0.6
LV EDV dilation 5% 14% 0.3
LV ESV/BSA 33 ± 10 36 ± 11 0.4
LV ESV dilation 24% 43% 0.2
LV EF (%) 59 ± 7 57 ± 8 0.4
LV EF decreased 17% 29% 0.4
RV EDV/BSA 92 ± 15 96 ± 16 0.4
RV EDV dilation 17% 29% 0.4
RV ESV/BSA 44 ± 10 48 ± 11 0.2
RV ESV dilation 27% 57% 0.05
RV EF (%) 52 ± 6 50 ± 7 0.2
RV EF decreased 24% 50% 0.1
RV EF ≤49% and LV EF ≤54% were considered decreased and RV EDV >107.5 mL/m2, RV ESV >47.2 mL/m2, LV 
EDV >102.5 mL/m2 and LV ESV >38.7 mL/m2 were considered enlarged. BSA, body surface area; EDV, end-diastol-
ic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; RV, right ventricle.
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disCussion
In this cohort of patients who underwent surgical closure of a haemodynamically 
significant ASD 30–41 years ago we found very good survival, no pulmonary hy-
pertension, good exercise performance and a low incidence of supraventricular 
arrhythmias.
Total survival was comparable to the normal Dutch population. However, two 
patients in the ASD-II group suffered from sudden death in the last decade at the 
age of 36 and 40 years. In these patients arrhythmia as the cause of death cannot 
be excluded and is even very likely in one.
Signs of pulmonary hypertension, a major problem that may occur in patients 
without closure of the ASD,1,21 were not found. In addition, the clinical condition 
of the patients appeared excellent with normal exercise capacity in most patients. 
Neither heart failure nor residual shunts were observed. One patient developed 
an ischaemic stroke but a clear relation to the heart defect could not be found. 
However, 6% of patients required pacemaker implantation during total follow-up.
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Figure 2 Results of the Short Form Health Survey questionnaire for patients with both types of 
atrial septal defect (ASD) and the normal Dutch population.
a=significant difference between patients with ASD-II and sinus venosus type ASD; b=significant difference be-
tween patients with ASD-II and the normal Dutch population; c=significant difference between patients with 
sinus venosus type ASD and the normal Dutch population. Higher scores reflect higher levels of functioning or 
well-being.
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Arrhythmias
Of the 41% (n=36) of patients with some form of asymptomatic atrial arrhythmia 
on Holter recording 10 years ago,3 8% had developed new symptomatic arrhyth-
mias in the past 10 years. This was comparable to the incidence in patients with a 
negative Holter recording in 2001. Thus, the predictive value of the asymptomatic 
arrhythmias seen on Holter monitoring seems limited. The prevalence of atrial 
fibrillation in our patients (12%) is higher than in the general population (<0.5%)22 
but substantially lower than that reported in natural history studies of patients 
with ASD (up to 50%) and after surgical closure at adult age.1,4,6,7,21,23 This indicates 
that early closure is beneficial in the very long term. Surgical scars do not seem 
to induce atrial flutters on a large scale. The lower incidence of atrial fibrillation 
appears to be related to earlier termination of the left-to-right shunt, thereby 
preventing right-sided pressure overload and further right atrium dilation which 
would have increased the vulnerability to atrial arrhythmias.7,24 Whether device 
ASD closure will also prevent the occurrence of SVTs in the long term or will make 
patients prone to arrhythmias by direct stretching of the atrial septum or circular 
scar formation around the device remains to be established.
Ventricular dimensions, function and pressure
On echocardiography we found a mildly impaired RV function in one-third of our 
patients. This is somewhat unexpected as RV function was normal in all patients 
10 years ago. This finding may be due to advances in the assessment of RV func-
tion as nowadays we use more sophisticated parameters than the mere visual 
assessment which was the only available method used in our earlier studies. We 
found no association between RV function and changes in QRS duration. The find-
ings of FAC and S′ wave as well as the CMR results confirm abnormal RV function 
in a quarter of our patients. CMR was not performed in our earlier studies but 
RV dilation has also been described by others after shorter follow-up. De Koning 
et al.25 described this in younger patients who had their surgical correction in a 
more recent era. In contrast to others and our results, no RV dilation on CMR was 
reported by Bolz et al. even though the same normal values were applied and the 
mean age at operation is comparable (6.5 vs 7.6 years).26-28 However, their follow-
up period was shorter.
Mild LV function impairment was found in one-fifth of our patients on CMR. 
This might be a result of the preoperative volume overload due to ventricular 
interaction. Literature on LV function after surgical ASD repair is lacking, but there 
are some reports of improvements of LV systolic function after transcatheter ASD 
closure.29,30
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ASD-II versus sinus venosus type ASD
We did not find any significant difference in survival, occurrence of events, inci-
dence of arrhythmias, ECG (QRS duration) and Holter-ECG or exercise capacity be-
tween patients undergoing surgery for ASD-II and sinus venosus defects. However, 
TAPSE and S′ were slightly reduced on echocardiography in patients with sinus ve-
nosus defects. On the other hand, RV FAC was higher in this group. Integrating all 
these results, patients with a sinus venosus defect may have a worse longitudinal 
RV function with probably a compensatory preserved circumferential function. 
New studies with larger patient groups are needed to confirm these findings.
Predictors for late events
The occurrence of arrhythmias in the early postoperative period showed a strong 
relation with the need for permanent pacing during early follow-up. Most pacemak-
ers had been implanted in the early years after surgery, most are probably related 
to surgical damage to the conduction system for two of the three patients (66%) 
requiring pacemaker implantation within 4 years after surgery had a bradycardia 
as their postoperative arrhythmia. However, two patients needed a pacemaker for 
AV block very late after surgery. This is an unexpected finding for which we do not 
have a clear explanation.
We were not able to identify any other predictors for mortality, late events or 
ventricular dysfunction.
Study limitations
As in most studies in this field, the numbers are relatively low and therefore all re-
sults should be interpreted with caution. The number of patients lost to follow-up 
was limited with regard to information on survival status, but is larger considering 
study participation: only 65% of the survivors of the total cohort participated in 
the last follow-up. The patients considered ineligible for participation were either 
lost to follow-up, had moved far abroad or did not participate in the previous stud-
ies. We believe, however, that after a follow-up of almost 40 years, participation of 
80% of eligible patients is very acceptable and can be regarded as a representative 
sample.
ConClusions
Very long-term (30–41 years) outcome after surgical ASD closure in childhood 
shows excellent survival and low morbidity, although two sudden unexplained 
deaths occurred at 28 and 36 years after surgery. No pulmonary hypertension and 
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a low incidence of supraventricular arrhythmias were found. The general health 
and exercise capacity of the patients are excellent and comparable with the nor-
mal Dutch population. Persistent RV dilation, which was observed in our earlier 
follow-up studies in this cohort of patients, was confirmed by CMR. Although EFs 
of both RV and LV are unexpectedly decreased and RV volumes remain enlarged 
in some of the patients, their clinical condition remains sound.
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abstraCt
Aims
It is unknown whether right-ventricular (RV) volume overload caused by an atrial 
septal defect (ASD) still has its effect on RV deformation long after repair. We 
evaluated RV and left-ventricular (LV) deformation beyond 30 years after surgical 
ASD repair in childhood, and studied relationships with conventional diagnostic 
parameters.
Methods and results
In this prospective study, we included 102 subjects: 51 patients with repaired 
ASD(39% male, age 43.3 ± 4.9 years, age at repair 7.9 ± 3.6 years) and 51 healthy 
controls of similar age and sex. All subjects underwent echocardiography and 
electrocardiography. Additionally, ASD patients underwent cardiac magnetic 
resonance imaging (CMR), bicycle ergometry, and NT-proBNP measurement. 
With speckle-tracking echocardiography, we analysed peak systolic longitudinal 
strain of the RV lateral wall, LV lateral wall, and septum. RV lateral wall global 
longitudinal strain (GLS) was lower in patients (-20.4 ± 2.7%) than controls (-26.8 
± 4.2%, P<0.001), due mainly to decreased apical strain (-19.3 ± 6.2 vs. -28.8 ± 8.3%, 
P<0.001). RV lateral wall GLS correlated with CMR-derived RV and LV end-diastolic 
volumes (ρ=0.49, P=0.014; ρ=0.53, P=0.005), and with RV and LV end-systolic 
volumes (ρ=0.43, P=0.034; ρ=0.46, P=0.019). LV GLS was similar between patients 
and controls (P=0.144). No significant correlations were found with NT-proBNP or 
exercise capacity.
Conclusion
Although ASD repair was already performed in childhood, RV longitudinal strain, 
especially of the apical segment, is decreased in patients 35 years after surgery. 
This suggests that RV function has still been affected in the long run, probably due 
to the early RV volume overload, but possibly also as sequel of surgery.
Myocardial deformation long after repair of asd 193
10
introduCtion
Atrial septal defect (ASD) is one of the most common congenital heart defects 
with an estimated birth prevalence of 1.6 per 1000 live births.1 When repaired at 
young age, ASD patients have a life expectancy similar to the general population.2-4 
Before closure, patients with an ASD have right heart volume overload caused 
by left-to-right shunting. Some patients also have anomalous pulmonary venous 
return which will result in right heart overload. The right ventricular (RV) volume 
overload and increased end-diastolic dimensions are well tolerated for many 
years,5 but eventually diminished RV function, hypokinesia, and heart failure tend 
to occur, resulting in an increased morbidity, e.g. arrhythmia, and also higher 
mortality.6,7 Even when ASD repair is performed in childhood, some studies report 
RV dilation or impaired RV function in a substantial part of the patients.4,8,9 The 
effect of the preoperative chronic volume loading on RV function in later life is still 
not completely elucidated.
The recent introduction of speckle-tracking echocardiography (STE) provides 
objective measurements to quantify segmental and global ventricular function, 
independently of angle and ventricular geometry.10 One of the measurements is 
strain imaging, also known as myocardial deformation imaging, and may detect 
subtle ventricular dysfunction. Although strain imaging is mainly developed for 
left-ventricular (LV) mechanics, it can also be used to study the RV myocardial 
deformation.11 Earlier studies, mainly performed in small patient samples with 
transcatheter ASD closure, have shown that RV peak systolic longitudinal strain 
values are increased before closure, and decreased after closure.12-14 However, no 
data are available about strain in adult patients late after surgical ASD closure in 
childhood.
The aim of this study was to evaluate LV and RV myocardial deformation in adult 
patients at least 30 years after successful surgical ASD closure, and to investigate 
relationships with ventricular dimensions and function, exercise capacity, N-
terminal pro-Brain Natriuretic Peptide (NT-proBNP), and surgical characteristics.
Methods
Study population
We approached all patients who had undergone surgical repair for ASD between 
1968 and 1980 in our institution. The protocol of this prospective study included 
echocardiography, 12-lead electrocardiogram (ECG), bicycle ergometry, cardiac 
magnetic resonance (CMR) imaging, and NT-proBNP measurement, all performed 
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on the same day. Exclusion criteria were the presence of a pacemaker, atrial fibril-
lation or flutter, and poor quality of echocardiographic images. Baseline charac-
teristics were collected as age, sex, and surgical data. Echocardiographic data of 
the patients were compared with data of healthy controls. The healthy controls 
were voluntarily recruited by an advertisement. They had no medical history or 
current symptoms suggesting cardiovascular disease and did not take chronic 
medication.
The study was carried out according to the principles of the Declaration of 
Helsinki and approved by the local medical Ethics Committee. Written informed 
consent was obtained from all patients.
Echocardiography
Two-dimensional greyscale harmonic images were obtained in the left lateral 
decubitus position using an iE33 ultrasound system (Philips Medical Systems, 
Best, the Netherlands) equipped with a transthoracic broadband S5–1 (1–5 MHz) 
or X5-1 matrix transducer (composed of 3040 elements, with 1–5 MHz extended 
operating frequency range). We used the guidelines of the American Society of 
Echocardiography for chamber measurements, including LV ejection fraction 
(EF), RV fractional area change (FAC), and tricuspid annular plane systolic excur-
sion (TAPSE).15,16 These measurements were used in combination with visual 
assessment to grade systolic LV and RV function. For the assessment of valvular 
regurgitation, we used recommendations of the European Association of Echo-
cardiography.17,18 For estimating the presence of pulmonary hypertension by 
echocardiography, we used the guidelines of the European Society of Cardiology.19 
To optimize STE, images were obtained at a frame rate of >60 frames/s.
Speckle-tracking analysis
Offline analyses of the data sets were performed using STE by QLAB version 9.0 
(Philips Medical Systems, Best, the Netherlands). Peak systolic longitudinal strain 
and strain rate of six LV segments were measured at the standard apical four-cham-
ber view. LV global longitudinal strain (GLS) was based on strain measurements 
of 17 segments at the apical four-, two-, and three-chamber views (Figure 1A). For 
the analysis of RV lateral wall GLS, RV segmental strain and RV segmental strain 
rate, we defined the endocardium at the RV-centred apical four-chamber view 
(Figure 1B). The LV algorithm was applied for both the LV and RV. After positioning 
the tracking points on an end-diastolic frame, the program tracked these points 
on a frame-by-frame basis. If tracking was suboptimal, we retraced the endocardial 
border. LV and RV longitudinal strain and strain rate were defined as the peak 
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Figure 1 Left-ventricular (A) and right-ventricular (B) longitudinal strain measurements.
The left ventricle was traced at the apical four-, two-, and three-chamber views at end diastole. The walls were 
automatically divided into seven segments at each view. The segmental strain measurements were plotted in a 
bull’s eye and the left-ventricular global longitudinal strain was calculated. The right-ventricular lateral wallwas 
traced from base to apex at end diastole. The lateral wall was automatically divided into three segments. The 
global longitudinal strain of the lateral wall was calculated from these three segments. AP4, apical four-chamber 
view; AP2, apical two-chamber view; AP3, apical three-chamber view; GL, global longitudinal.
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negative value on the curve during the ejection phase. Data were exported to a 
spreadsheet program (Excel; Microsoft Corporation, Redmond, WA, USA).
Cardiac magnetic resonance imaging
CMR imaging was performed using a Signa 1.5-Tesla whole-body scanner (GE Medi-
cal Systems, Milwaukee,WI, USA) with dedicated phased-array cardiac surface 
coils. Details of the used CMR sequence have been reported previously.20 For CMR 
analyses, a commercially available Advanced Windows workstation (GE Medical 
Systems) was used, equipped with Q-mass version 5.2 (Medis Medical Imaging 
Systems, Leiden, the Netherlands). The ventricular volumetric data set was quan-
titatively analysed using manual outlining of endocardial borders in end-systole 
and end-diastole. Biventricular end-diastolic volume (EDV), end-systolic volume 
(ESV), stroke volume (SV), and EF were calculated and compared with reference 
values.21
Cardiopulmonary exercise testing
Maximal work load, maximal heart rate and peak oxygen consumption (peak 
Vo2) were assessed by a bicycle ergometer with gradual workload increments of 
20 Watts per minute (Ramp protocol), and compared with the values of normal 
individuals corrected for age, sex, height, and weight.
NT-proBNP measurement
Peripheral venous blood samples were collected after 30 min of rest. Plasma NT-
proBNP levels were determined with use of a commercially available electroche-
miluminescence immunoassay Elecsys (Roche Diagnostics, Basel, Switzerland). 
The normal value for NT-proBNP in our hospital is <14 pmol/L.
Statistical analysis
Continuous variables are presented as mean ± standard deviation (SD) or as 
median with interquartile range (IQR). Categorical variables are presented as 
frequencies and percentages. For comparison of normally distributed continuous 
variables between two groups the Student’s t-tests was used. In case of skewed 
distribution of continuous variables, the Mann–Whitney-U test was applied. For 
comparison of frequencies, the χ2-test or Fisher’s exact test was used. For quan-
tifying correlations between two variables, the Pearson or Spearman correlation 
test was applied. Because NT-proBNP values were not normally distributed, the 
values were log-transformed to create a normal distribution for further statistical 
analyses. Adjustment for multiple comparisons was performed by the Bonferroni 
correction. All statistical analyses were performed using the Statistical Package 
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for Social Sciences version 21 (SPSS, IBM Corp., Armonk, NY, USA). The statistical 
tests were two-sided and a P<0.05 was considered statistically significant.
Intraobserver variability was assessed by repeated analysis of the data sets at 
least half a year after the initial analysis and blinded to the initial results. Assess-
ment of interobserver variability was performed by a second observer in half of 
the data sets. The agreement between two measurements was expressed with 
Bland–Altman’s limits of agreement (mean of the differences ± 1.96 SD).22
results
Study population
An overview of the patient participation and feasibility of the strain measurements 
is presented in Figure 2. Bicycle ergometry was not performed in two patients due 
to inability and CMR was not performed in five due to refusal or claustrophobia. In 
all healthy controls, LV strain measurements were feasible. RV lateral wall strain 
could be measured in 18 of the first (60%) 30 controls and, due to the steep learn-
ing curve, in 20 of the last (95%) 21 controls. Table 1 shows the baseline charac-
Included patients 
n=51
Feasibility LV strain 
n=49 
Feasibility RV strain 
n=29
Eligible patients
n=61
Excluded:
Poor image quality, n=7
Atrial ­utter, n=2
Pacemaker, n=1
  ECG 
  Bicycle ergometry    
  CMR                 
  NT-proBNP 
n=49  (100%)
n=47  (96%)
n=44  (90%)
n=48  (98%)
  ECG 
  Bicycle ergometry
  CMR
  NT-proBNP    
n=29  (100%)
n=28  (97%)
n=26  (90%)
n=28  (97%)
Figure 2 Flow chart of the study patients.
An overview of the patient inclusion, feasibility of left- and right-ventricular strain measurements, and the num-
ber of patients per additional diagnostic test. Left-ventricular strain was feasible in 38 patients with secundum 
type ASD and 11 with sinus venosus type; right-ventricular strain was feasible in 24 with secundum type ASD 
and five with sinus venosus type. CMR, cardiac magnetic resonance imaging; ECG, electrocardiography; LV, left 
ventricular; NT-proBNP, N-terminal pro-Brain Natriuretic Peptide; RV, right ventricular.
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teristics of all patients and controls. In a subanalysis of patients with feasible RV 
strain, the characteristics were comparable with those of the controls.
The included patients were studied 35.4 ± 2.9 years after surgical closure. Five 
patients used cardiac medication: metoprolol (n=2), sotalol (n=1), flecainide (n=1), 
and ACE-inhibitor (n=1). Three of these also used statins and oral anticoagulants.
In all patients with a sinus venosus type defect, a patch was used for closure; 
of the patients with a secundum type defect, a patch was used in only two (5%) 
patients. All patients with sinus venosus type defect had a partial abnormal 
pulmonary venous return before repair. Patients with secundum type ASD and 
patients with sinus venosus type had a comparable preoperative Qp/Qs ratio [2.2 
(IQR 1.7–2.7) vs. 2.1 (IQR 1.8–2.9), P=0.707] and preoperative mean pulmonary 
artery pressure [14 mmHg (IQR 12–16 mmHg) vs. 15 mmHg (IQR 11–17 mmHg), 
P=0.931, respectively].
Conventional echocardiographic characteristics of the patients and controls are 
presented in Table 2. Of these characteristics, only TAPSE differed significantly 
between patients with secundum type defect [20 mm (IQR 16–22 mm)] and sinus 
venosus defect [17 mm (IQR 13–18 mm), P=0.006]. In a subanalysis of patients with 
Table 1 Characteristics of the study population
Clinical characteristics
ASD patients Controls
P-value(n=51) (n=51)
Age at time of study (years) 43.3 ± 4.9 41.4 ± 10.8 0.249
Male 20 (39) 20 (39) 1.000
BMI (kg/m2) 24.8 ± 3.9 23.9 ± 3.4 0.211
Systolic blood pressure (mmHg) 129 ± 19 122 ± 11 0.039
Diastolic blood pressure (mmHg) 81 ± 11 76 ± 10 0.061
NYHA functional classification
Class I 48 (94) 51 (100) 0.243
Class II 3 (6) -
QRS duration (ms) 100 ± 11 98 ± 10 0.316
Incomplete RBBB 12 (24) - -
QRS duration >120 ms 2 (4) - -
Age at operation (years) 7.9 ± 3.6 - -
Type of ASD
Secundum type 39 (76) - -
Sinus venosus 12 (24) - -
Qp/Qs ratio 2.3 ± 0.7 - -
Type of repair
Direct closure 37 (73) - -
Patch 14 (27) - -
Categorical data are presented as n (%) and continuous data as mean ± standard deviation.
BMI, body mass index; NYHA, New York Heart Association; RBBB, right bundle branch block.
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feasible RV strain, no significant differences were found in LV and RV dimensions 
compared with those of controls.
One patient possibly had a minimal residual shunt. Pulmonary regurgitation was 
absent in 48 (94%) patients, mild in 2 (4%), and moderate in 1 (2%). Tricuspid 
regurgitation was absent in 20 (39%) patients, mild in 29 (57%) and moderate in 
2 (4%). None of the patients had severe pulmonary or tricuspid regurgitation. 
Echocardiographic signs suggestive of pulmonary hypertension were not found.
Table 2 Conventional echocardiographic characteristics of the patients and healthy controls and 
CMR imaging characteristics of the patients
 Patients Controls P-value
Echocardiography n=51 n=51
LV end-diastolic dimension (mm) 48 ± 5 48 ± 4 0.619
LV end-systolic dimension (mm) 30 ± 5 29 ± 4 0.233
LV fractional shortening (%) 38 ± 7 40 ± 7 0.071
LV ejection fraction Simpson’s (%) 56 ± 5 58 ± 5 0.131
Systolic LV function, n (%)
Normal 49 (96) 51 (100) 0.495
Mildly impaired 2 (4) -
Moderately impaired - -
RV longitudinal dimension (mm) 75 ± 7 76 ± 6 0.682
RV basal dimension (mm) 40 ± 7 37 ± 6 0.035
RV FAC (%) 43 ± 8 46 ± 6 0.053
TAPSE (mm) 19 ± 4 29 ± 4 <0.001
Systolic RV function, n (%)
Normal 34 (67) 51 (100) <0.001
Mildly impaired 16 (31) -
Moderately impaired 1 (2) -  
Cardiac magnetic resonance imaging n=46
LV end-diastolic volume (mL) 156 ± 32 -
LV end-systolic volume (mL) 67 ± 22 -
LV stroke volume (mL) 89 ± 17 -
LV ejection fraction (%) 58 ± 7 -
RV end-diastolic volume (mL) 179 ± 36 -
RV end-systolic volume (mL) 88 ± 23 -
RV stroke volume (mL) 91 ± 21 -
RV ejection fraction (%) 51 ± 6 -
FAC, fractional area change; LV, left ventricular; RV, right ventricular; TAPSE, tricuspid annular plane systolic 
excursion.
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Left-ventricular longitudinal strain
Figure 3 shows the peak systolic LV GLS and the peak systolic longitudinal strain 
of six different segments. The mean LV GLS was similar between patients and 
controls. When focused on the different segments of the LV, only the apical septal 
strain was significantly lower (less negative) in patients than in controls. The mid-
septal strain tended to be lower in patients (P=0.059).
Right-ventricular longitudinal strain and strain rate
Figure 4 shows the peak systolic RV lateral wall GLS and segmental longitudinal 
strain. The mean RV lateral wall GLS was significantly lower in patients than in 
controls. In 15 (52%) patients, the RV lateral wall GLS was lower than the strain 
value of the 95th percentile (-20.7%) of the controls. Of the three RV lateral wall 
segments, particularly the apical longitudinal strain was significantly lower in 
patients. In 13 (45%) patients, the RV apical strain was lower than the strain value 
of the 95th percentile (-18.5%) of the controls. A positive correlation was found 
between RV lateral wall GLS and LV GLS in the patient group (r=0.47, P=0.023).
With regard to the strain rate of the RV lateral wall, only the apical strain rate 
was significantly lower in patients (-1.35 ± 0.43s-1) than controls (-1.69 ± 0.63s-1, 
P=0.010).
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Figure 3 Left-ventricular global and segmental longitudinal strain in ASD patients (n=49) and 
healthy controls (n=51).
The peak systolic segmental longitudinal strain at the apical four-chamber view was feasible in 49 patients. 
Left-ventricular global longitudinal strain was based on the measurements at the apical two-, three-, and four-
chamber views which was feasible in 39 of these 49 patients. In the healthy controls, all measurements were 
feasible. The error bars show 95% confidence interval. GLS, global longitudinal strain; LV, left ventricular.
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Surgical characteristics, ECG, NT-proBNP levels, and exercise testing
Patients with a secundum type defect had higher LV GLS and RV lateral wall GLS 
than patients with a sinus venosus defect [LV GLS: -19.5% (IQR -18.5; -21.6%) vs. 
-18.2% (IQR -17.2; -19.6%), P=0.024 and RV GLS: -21.2% (IQR -19.1; -23.1%) vs. -17.7% 
(IQR -16.8; -18.5%), P=0.009]. Qp/Qs-ratio before repair did not correlate with LV 
GLS nor with RV lateral wall GLS, but when focused on the segmental strain a 
significant correlation was found between Qp/Qs-ratio and the RV mid-segment 
(r=-0.46, P=0.016). Two patients had a preoperative mean pulmonary artery pres-
sure ≥25 mmHg, namely 26 and 29 mmHg. One of these patients had a RV lateral 
wall GLS of -23.7% which is significantly higher than the mean RV lateral wall GLS 
in the patient group (P<0.001); in the other patient RV strain was not feasible. No 
correlations were found between strain and preoperative mean pulmonary artery 
pressure, age at repair, aortic cross-clamp time, or current age.
None of the patients had a complete right bundle branch block and 12 (24%) 
had an incomplete right bundle branch block. RV lateral wall GLS and LV GLS were 
comparable between patients with an incomplete right bundle branch block and 
patients without (P=0.407, P=0.210, respectively).
The median NT-proBNP level was 13.7 pmol/L [IQR 8.7– 23.4 pmol/L]. NT-proBNP 
was elevated in 25 (50%) patients. Log-transformed NT-proBNP did not correlate 
with LV GLS or RV lateral wall GLS.
With bicycle ergometry, all patients reached a respiratory exchange ratio >1.0 
considering a maximal exercise performance. The mean peak heart rate was 91 ± 
   
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Figure 4 Right-ventricular lateral wall global and segmental longitudinal strain in ASD patients 
(n=29) and in healthy controls (n=38).
This figure presents the mean peak systolic right-ventricular lateral wall global longitudinal strain measured at 
the apical four-chamber view, and the mean peak systolic strain of the three segments of the right-ventricular 
lateral wall. The error bars show 95% confidence interval. *After adjustment for multiple comparisons by the 
Bonferroni correction, P<0.017 was considered statistically significant. GLS, global longitudinal strain; RV, right 
ventricular.
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12% of the expected value; peak workload 97 ± 19%; and peak Vo2 96 ± 27%. The 
peak workload tended to correlate with RV lateral wall GLS (r=0.34, P=0.076). No 
further evident relationships were found between these variables and LV GLS or 
RV lateral wall GLS.
Echocardiographic and CMR-derived parameters
CMR-derived characteristics are presented in Table 2. LV dilation was measured in 
3 (7%) patients and RV dilation in 7 (16%). Twelve (26%) patients had a diminished 
LV EF and 16 (34%) a diminished RV EF. Of the CMR-derived dimensions and func-
tion, only the RV EF differed significantly between patients with ASD secundum 
type defect [51% (IQR 47–56%)] and with sinus venosus defect [48% (IQR 44–51%), 
P=0.044]. Correlations of strain measurements with echocardiographic-derived 
dimensions and with CMR-derived volumes are summarized in Table 3. After 
exclusion of the patients with a dilated RV, the mean RV lateral wall GLS remained 
significantly lower in patients (-20.6±2.9%, P<0.001) than controls.
Table 3 Correlations between left-ventricular global longitudinal strain and right-ventricular lat-
eral wall global longitudinal strain with echocardiographic and CMR-derived parameters in ASD 
patients
 
LV GLS RV lateral wall GLS
Spearman’s ρ P-value Spearman’s ρ P-value
Echocardiography n=39 n=29
LV end-diastolic dimension -0.06 0.736 0.38 0.041
LV end-systolic dimension -0.04 0.788 0.04 0.835
LV fractional shortening 0.07 0.682 0.40 0.041
LA parasternal long-axis dimension -0.07 0.684 0.41 0.027
RV longitudinal dimension 0.04 0.823 0.38 0.043
RV basal dimension 0.26 0.115 0.13 0.512
CMR imaging n=37 n=26
LV end-diastolic volume 0.05 0.788 0.53 0.005
LV end-systolic volume 0.10 0.548 0.46 0.019
LV stroke volume -0.10 0.539 0.41 0.036
LV ejection fraction -0.11 0.513 -0.25 0.223
RV end-diastolic volume 0.19 0.267 0.49 0.014
RV end-systolic volume 0.42 0.012 0.43 0.034
RV stroke volume -0.10 0.583 0.32 0.125
RV ejection fraction -0.37 0.028 -0.19 0.358
Bold-face values represent statistically significant correlations. CMR, cardiac magnetic resonance; GLS, global 
longitudinal strain; LA, left atrium; LV, left ventricular; RV, right ventricular.
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Inter- and intraobserver variability
The interobserver variability was -0.29 ± 1.64% for the LV GLS at the apical four-
chamber view, and 0.39 ± 2.89% for the RV lateral wall GLS. The intraobserver 
variability was -0.21 ± 1.40% for the LV GLS at the apical four-chamber view, and 
0.04 ± 1.99% for the RV lateral wall GLS (Figure 5).
disCussion
A remarkable observation in this prospective study is the decreased RV global 
and segmental longitudinal strain in ASD patients more than 30 years after surgical 
repair at young age. To the best of our knowledge, this is the first study to assess 
A  Inter-observer variability of LV global longitudinal strain
C    Intra-observer variability of LV global longitudinal strain
B   Inter-observer variability of RV global longitudinal strain
D   Intra-observer variability of RV global longitudinal strain
Figure 5 Bland–Altman plots of inter- and intraobserver variability for left-ventricular global lon-
gitudinal strain (A, C) and right-ventricular lateral wall global longitudinal strain (B, D).
The longitudinal strain measurements were assessed at the apical four-chamber view. The solid lines depict the 
mean difference of two measurements, and the dashed lines depict the limits of agreement (mean difference of 
the two measurements ± 1.96 SD).
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myocardial deformation with STE in adult ASD patients long after their initial 
repair.
Left-ventricular longitudinal strain
The mean LV GLS of our patients was comparable with that of controls. A study 
performed in adult ASD patients who underwent percutaneous closure also de-
scribed a normal LV GLS before, as well as after the closure.12 When focused on the 
different segments, the strain of the apical septum was decreased, possibly due 
to the diminished RV function which interacts with the septum. We did not see re-
lationships of LV strain with LV echocardiographic and CMR-derived parameters, 
probably because of the small ranges and normal values in almost all patients in 
our group.
Right-ventricular longitudinal strain
Even though the patients were already operated in childhood, we still observed a 
decreased peak systolic RV lateral wall GLS. This reduction is presumably a result 
of preoperative chronic volume overload or is related to the closure technique. 
In children and adults with an open ASD, RV GLS is increased in comparison with 
healthy controls. This increase is caused by volume overload,12-14,23 and induces 
RV remodelling which possibly also took place in our patient group before closure. 
In patients undergoing closure at adult age, RV dilation is a relatively common 
finding,13,24 but even when closure is performed at young age, some studies report 
impaired RV function or dilation in a substantial part of the patients.4,8,9 These 
findings in combination with our results suggest that even when ASD patients are 
operated at young age, RV remodelling already took place leading to decreased 
strain of the RV lateral wall.
In addition, the surgery itself, including factors such as closure technique, use of 
cardiopulmonary bypass or hypothermia, might also contribute to decreased RV 
deformation. To confirm that surgery is a possible cause, a longitudinal study is 
required comparing strain values of patients with a surgically closed ASD with val-
ues of patients with a percutaneously closed ASD after the same follow-up period.
The strain was most decreased in the apical segment, which is in line with stud-
ies by Van de Bruaene and Jategaonkar,13,14 though almost all of these ASDs were 
closed percutaneously and at adult age. The more profound impairment of the 
apical deformation, could be explained by several possible causes.25-27 The first 
explanation could be the RV geometry and anatomy: the apical portion of the RV is 
thinner and more trabeculated than the basal portion. When the wall is thinner, the 
passive wall stress is higher, which is inversely related with strain and therefore 
results in smaller longitudinal deformation. A second possible explanation is that 
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in remodelled RVs of ASD patients, the apical segment seems to be more straight 
than in healthy subjects. The wall stress is higher in structures with straight 
walls. Thirdly, it could be possible that in some RVs a hypertrophied moderator 
band and trabeculations lead to a smaller regional volume and therefore might 
decrease the apical deformation.28 Lastly, it could be explained by alterations of 
β-adrenergic receptor signalling. RV volume overload leads to β-adrenergic sig-
nalling abnormalities, e.g. increased levels of β-adrenergic receptor kinase 1, and 
redistribution which result in a significant reduction in chamber contractility.
It is important to mention that myocardial deformation does not directly reflect 
contractility, but is influenced by preload, afterload, and ventricular volume.29,30 
However, these studies involved only the LV. In our study, lower RV lateral wall 
GLS was moderately associated with greater RV volumes. In a subanalysis of 
patients with RV volumes in the normal range, the RV lateral wall GLS remained 
significantly lower in patients than in controls. Thus, even when the possible 
confounding influence of ventricular volume is excluded, the mean RV lateral wall 
GLS of the patients remains decreased.
Surgical characteristics, ECG, NT-proBNP levels, and exercise testing
Patients with sinus venosus defect had lower RV and LV GLS than patients with 
secundum type defect. The TAPSE and CMR-derived RV EF were also lower in this 
group. These differences may be explained by the partial abnormal pulmonary 
venous return in patients with sinus venosus defect or by the surgical technique 
that has been used: all patients with sinus venosus type defect received a septal 
patch, whereas only a few of the patients with secundum type. The preoperative 
mean pulmonary artery pressure and Qp/Qs ratio were comparable between the 
two groups. These findings suggest that the type of defect itself or type of surgi-
cal repair play a more important role on RV GLS than the degree of RV volume 
overload. This is in accordance with the finding by Kowalik et al.31 who concluded 
that RV deformation of the base and apex did not differ significantly in patients 
with various degrees of left-to-right shunts. However, a relationship was observed 
between RV deformation of the mid-segment and Qp/Qs ratio. Patients with mod-
erate left-to-right shunts had the highest strain values.31We found that higher pre-
operative Qp/Qs ratio was associated with higher strain of the RV mid-segment.
The presence of an incomplete right bundle branch block does not seem to af-
fect the RV lateral wall GLS in our cohort. We did not find a relationship between 
NT-proBNP levels and RV or LV GLS. The clinical relevance of NT-proBNP in this 
group of patients remains unknown.
Regarding the cardiopulmonary exercise testing in our study, RV lateral wall 
GLS tended to correlate with peak workload, which points out the potential clini-
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cal significance of decreased RV lateral wall GLS. However, no relationship was 
found with peak Vo2, which is in contrast with the relationship of RV apical strain 
with peak Vo2 found by Van De Bruaene et al.14 This disagreement may be due 
to the smaller number of patients in our study with feasible RV strain as well as 
performed peak Vo2. We could not draw conclusions with regard to arrhythmias, 
because patients with arrhythmias were excluded. Therefore, clinical relevance of 
decreased RV lateral wall GLS seems limited. To find out whether decreased strain 
is an early marker for detecting right heart failure in a preclinical phase which 
could lead to manifest and clinical relevant heart failure in later life, a longer 
follow-up of these patients needs to be established. Routine clinical follow-up with 
long intervals might be advisable for these patients.
Echocardiographic and CMR-derived parameters
A positive relationship was observed between RV lateral wall GLS and LV GLS. 
Furthermore, RV lateral wall GLS correlated not only significantly with RV param-
eters, such as longitudinal dimension and end-diastolic and end-systolic volumes, 
but also with LV parameters, such as fractional shortening and end-diastolic and 
end-systolic volumes. These findings are possibly a result of the mechanical in-
teraction between the ventricles due to the continuity of the muscle fibres which 
binds the ventricles together.27
Limitations
We only measured peak systolic longitudinal deformation. Analysis of radial and 
circumferential deformation may have provided additional information, but short-
ening of the RV is larger longitudinally than radially, and therefore contributes 
more to RV contraction.27 We assumed that the same applies to the RVs in ASD 
patients. In addition, the RV radial and circumferential strain measurements are 
not available on our QLAB software. Rotational movements play a significant role 
for LV function, but we decided to measure strain in longitudinal direction making 
comparisons with RV strain clearer.
In case of RV disease, the interventricular septum could be affected. We consid-
ered the interventricular septum as an LV structure because the QLAB software 
has been developed for the LV shape.
Although we approached all eligible patients who were operated between 1968 
and 1980 in our clinic, we must state that there could be a selection bias in par-
ticipation of patients regarding disease severity. RV strain was feasible in 29 (57%) 
patients which could induce selection bias. However, baseline characteristics of 
patients with feasible RV strain, as well as without feasible RV strain, were com-
parable with the baseline characteristics of controls, apart from the higher BMI in 
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patients without feasible RV strain. The small number of patients with feasible RV 
strain (n=29) limits the statistical analyses and power of the study.
ConClusions
Even though surgical ASD repair was already performed in childhood, RV lateral 
wall GLS is significantly decreased 35 years after closure. This reduction in strain 
is presumably a result of chronic volume overload before repair, but also the sur-
gery itself could have affected the RV. LV GLS is comparable between the patients 
and controls. A prospective longitudinal study is required to determine whether 
decreased strain is an early marker for detecting heart failure in a preclinical 
phase which could lead to manifest right heart failure. A routine clinical follow-up 
with long intervals might be advisable for these patients.
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abstraCt
Aims
Late systolic dysfunction of the systemic right ventricle (RV) in patients with 
transposition of the great arteries (TGA) is of major concern. Right ventricular 
global longitudinal strain (GLS) might be able to identify early dysfunction.
Methods and Results
Adults with TGA after Mustard operation (TGA-Mustard) or congenitally corrected-
TGA (ccTGA) underwent echocardiography, electrocardiography, and NT-proBNP 
measurement. Using speckle-tracking echocardiography, we analysed longitudinal 
strain and strain rate, and compared findings in both patients groups, to healthy 
controls and with clinical parameters. We included 42 patients (mean age 37 ± 7 
years, 69% male) with a systemic RV [32 TGA-Mustard (34 ± 4 years after correc-
tive surgery) and 10 ccTGA], and 32 healthy controls (mean age 36 ± 11 years). 
Global longitudinal strain of the systemic RV was lower in patients than GLS of 
the systemic LV in controls (-14.2 ± 3.5 vs. -20.0 ± 3.0%, P<0.001). Average LS of the 
RV lateral wall was lower in patients with TGA-Mustard (-15.5 ± 3.4%) than ccTGA 
(-18.3 ± 3.6%, P=0.047). Right ventricular GLS tended to be lower in patients in 
NYHA class II than I, and correlated with NT-proBNP (r=0.49, P<0.001), RV frac-
tional area change (r=-0.39, P=0.019), RV apex-base-diameter (r=0.37, P=0.021), and 
QRS duration (r=0.41, P=0.014).
Conclusions
Global longitudinal strain of the systemic RV in patients is lower than GLS of the 
systemic LV in healthy controls, especially in the apical segment, and tended to 
be lower in TGA-Mustard than ccTGA patients. Since RV GLS correlates with RV 
function, myocardial deformation is useful as a more quantitative tool to measure 
systemic RV function. Decreased GLS was associated with elevated NT-proBNP 
and tended to correlate with worsening NYHA class, which strengthens the poten-
tial prognostic value of GLS in patients with a systemic RV.
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introduCtion
In patients with transposition of the great arteries corrected by Mustard operation 
(TGA-Mustard) and congenitally corrected TGA (ccTGA) the morphologic right 
ventricle (RV) supports the systemic circulation.1 Right ventricular geometry is not 
made to encounter this chronic pressure overload.2 Therefore, the main concern 
regarding the long-term outcome of these patients is the function of the systemic 
RV. Although the RV can tolerate systemic pressures during childhood, after the 
third decade of life progressive deterioration of RV function is documented.3,4
Right ventricular dysfunction and failure are important determinants of adverse 
outcome,5 hence adequate monitoring and early detection of deterioration in RV 
function is crucial. Nonetheless, assessment of RV function is difficult, given its 
complex geometry. Increasing data suggest that measures of myocardial defor-
mation during systole, e.g. systolic strain and strain rate are strong indices of 
ventricular function.6 With myocardial deformation assessed by speckle-tracking 
echocardiography (STE), regional myocardial function is quantified,7 and ven-
tricular dysfunction may be detected in an earlier phase than with conventional 
echocardiography. Myocardial fibres of the RV are mostly longitudinally orien-
tated2 and therefore global RV function is thought to be best reflected by longitu-
dinal myocardial deformation.8 In patients with a systemic RV, strain imaging to 
evaluate RV function is feasible,9-11 but information on additional diagnostic and 
prognostic value for clinical practice is still limited.12 Furthermore, differences 
between patients with TGA-Mustard and ccTGA have not been assessed yet.
We hypothesized that myocardial deformation is reduced in adults with a sys-
temic RV compared with healthy controls, and that it is related to clinical and 
echocardiographic parameters of cardiac function. In this study, we aimed to 
assess RV function with myocardial deformation in patients with TGA-Mustard 
and patients with ccTGA, and compare both patients groups. Furthermore, the 
relationship between RV myocardial deformation and clinical parameters includ-
ing conventional echocardiography, electrocardiography, and NT-proBNP was 
assessed to determine the clinical value of RV myocardial deformation.
Methods
Patient inclusion
Consecutive patients with Mustard-TGA or ccTGA seen at the adult congenital 
cardiology outpatient clinic of Erasmus MC between April 2011 and December 
2013 were approached to participate in this prospective study. Patients had to 
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be ≥18 years of age. Exclusion criteria were insufficient image quality for adequate 
speckle tracking and irregular heart rhythm. To compare echocardiographic data, 
a control group of healthy volunteers of similar age was used. All healthy volun-
teers had no medical history or current symptoms of cardiovascular disease. The 
study was carried out according to the principles of the Declaration of Helsinki 
and the local medical ethics committee approved the study protocol. Written 
informed consent was gathered from all patients and healthy controls.
Data collection
Baseline characteristics were collected, including age, sex, age at time of correc-
tive surgery, time since corrective surgery, cardiac medical history, and New York 
Heart Association (NYHA) functional class. In all patients physical examination, 
a standard 12-lead electrocardiogram, a detailed echocardiogram, and venous 
blood samples were performed.
Echocardiography
Two-dimensional greyscale harmonic images were obtained in the left lateral de-
cubitus position using a commercially available iE33 ultrasound system (Philips 
Medical Systems, Best, the Netherlands) equipped with a transthoracic broadband 
S5-1 (1-5 MHz) or X5-1 matrix transducer (composed of 3040 elements, with 1-5 
MHz extended operating frequency range). The guidelines of the American Society 
of Echocardiography were used for chamber quantification.13,14 Right ventricular 
dimensions (annulus and apex-base diameter) were measured from the apical 
four-chamber view. Left ventricular and RV function was assessed visually using 
the so-called ‘eyeballing’ and graded as normal, mildly, moderately, or severely 
impaired. Additionally, RV function was assessed using tricuspid annular plane 
systolic excursion (TAPSE), RV fractional area change (FAC), RV dP/dT from the 
tricuspid regurgitation (TR) continuous wave signal, and systolic excursion of the 
lateral tricuspid annulus (S’) using the tissue Doppler imaging (TDI). The recom-
mendations of the European Association of Echocardiography were used for the 
assessment of valvular stenosis and regurgitation.15 In addition to the standard 
echo protocol, greyscale images were obtained for STE at a frame rate of >60 Hz. 
All images were transferred to a dedicated workstation (QLAB, Philips Medical 
Systems) for further offline analysis.
Speckle-tracking analyses
All speckle-tracking analyses were performed using QLAB STE package, version 
9.0 (Philips Medical Systems). In patients with a systemic RV, the apical four-
chamber view was used to assess global longitudinal strain (GLS) of the systemic 
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RV, average longitudinal strain (LS) of the RV lateral wall, average LS of the septal 
wall, and segmental strain and segmental strain rate of the six ventricular wall 
segments (Figure 1). Similar measurements were performed in healthy controls 
using the apical four-chamber view: GLS of the systemic LV, average LS of the RV 
lateral wall, average LS of the septal wall and average LS of the LV lateral wall. 
Average LS of the RV lateral wall in patients was compared with average LS of the 
subpulmonary RV lateral wall as well as average LS of the systemic LV lateral wall 
in healthy controls. Longitudinal strain was defined as the maximal negative value 
of the strain curve during systole. Strain rate was defined as the most negative 
value on the strain rate curve during systole. The QLAB LV algorithm was used for 
measurements of the LV and RV.
Laboratory testing
Peripheral venous blood samples were obtained in all participants after they had 
rested for 30 minutes. Renal function was assessed by creatinin levels. Severe re-
nal dysfunction was defined as a creatinin level of >200 μmol/L. Plasma NT-proBNP 
levels were determined with the use of a commercially available electrochemilu-
minesence immunoassay kit (Elecsys, Roche Diagnostics, Basel Switzerland). The 
reference value for normal in our laboratory is <14 pmol/L.
Statistical analysis
Continuous variables with a normal distribution are presented as mean ± stan-
dard deviation (SD) or, when data was skewed, as median and interquartile range 
(IQR). Categorical variables are presented as frequencies and percentages. The 
Student’s t-test was used to compare normally distributed, continuous variables 
between patients and controls, or between ccTGA and TGA-Mustard patients; 
the Mann-Whitney-U test was performed in case of a skewed distribution. When 
GLS of the systemic RV was compared between more than two groups, i.e. for the 
A B C
Figure 1 Two-dimensional longitudinal strain analysis of the RV in a TGA-Mustard patient.
(A) GLS of the systemic ventricle composed of seven segments. (B) Average LS of the RV lateral wall composed 
of three segments. (C) Average LS of the septal wall composed of three segments.
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various degrees of systemic ventricular dysfunction, one-way ANOVA was used. 
Frequencies between patients and controls were compared using the χ2-test or 
Fisher’s exact test. Correlations between echocardiographic parameters and NT-
proBNP were tested with the use of the Pearson’s correlation test or Spearman’s 
Rho correlation test. Multivariable linear regression analyses were used to assess 
associations between GLS of the systemic RV and NT-proBNP, adjusted for age, 
sex and NYHA functional class. Since the distribution of NT-proBNP was skewed, 
NT-proBNP values were log-transformed which created a normal distribution that 
was used for further analysis.
Intraobserver variability of GLS was assessed by repeated analysis of the Qlab 
data sets at least one month after the initial analysis and blinded to the initial 
results by one investigator (J.A.E.). To assess interobserver variability, a second 
investigator (M.E.M) performed GLS analysis. The agreement between two mea-
surements was expressed using the 95% confidence interval and determined as 
the mean of the differences ±1.96SD, as described by Bland-Altman.16
A P-value of <0.05 was considered statistically significant. All statistical tests 
were performed using SPSS Statistics, version 21.0 (SPSS, IBM Corp., Armonk, NY, 
USA).
results
Baseline patient characteristics
Fifty-seven patients with a systemic RV were eligible. Fifteen patients were ex-
cluded because of restricted visualization and/or inadequate image quality of the 
RV images needed for STE. In total, 42 patients were included in this study (mean 
age 36.9 ± 7.4 years, 69% male); 32 patients with TGA-Mustard and 10 patients with 
ccTGA. The control group consisted of 32 healthy volunteers with a mean age of 
36.3 ± 11.5 years (60% male). Baseline characteristics of the patients are listed in 
Table 1. Time since operation of patients with TGA-Mustard was 33.9 ± 4.3 years. 
In 12 patients (29%), TGA was associated with ventricular septal defect. In two 
patients, mild baffle obstruction was observed and one patient had mild baffle 
leakage, but these residual lesions were well tolerated and haemodynamically 
insignificant.
All patients were in NYHA functional class I or II. None of the patients had severe 
renal dysfunction. Eighty-one percent of the patients was in sinus rhythm. Of these 
patients, QRS duration was 121 ± 20 ms, and 60% had QRS duration of ≥120 ms.
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Table 1 Baseline patient characteristics
 
All patients 
(n=42)
TGA-Mustard
(n=32)
ccTGA
(n=10) P-value*
Age (years) 36.9 ± 7.4 35.6 ± 5.6 40.8 ± 10.8 0.141
Male 29 (69) 22 (69) 7 (70) 0.687
Age at operation (years) - 1.3 ± 1.4 -
Time since operation (years) - 33.9 ± 4.3 -
Concomitant cardiac lesions
Ventricular septal defect (corrected) 12 (29) 10 (32) 2 (20) 0.696
Pulmonary stenosis >mild 6 (14) 5 (16) 1 (10) 1.000
Baffle stenosis or leakage - 3 (9) -
NYHA class (I/II) 34/8 26/6 8/2 1.000
Heart rate (bpm) 72 ± 19 73 ± 16 67 ± 27 0.443
Systolic blood pressure (mmHg) 125 ± 14 125 ± 15 123 ± 13 0.676
Diastolic blood pressure (mmHg) 80 ± 13 80 ± 14 82 ± 7 0.606
Height (m) 1.75 ± 0.1 1.75 ± 0.1 1.72 ± 0.1 0.339
Weight (kg) 78 ± 16 79 ± 17 74 ± 13 0.398
Body Mass Index (kg/m2) 25.5 ± 4.6 25.7 ± 5.0 24.9 ± 3.0 0.624
Peripheral oxygen saturation (%) 98 [96-100] 97 [96-99] 99 [97-100] 0.069
Pacemaker implantation 8 (19) 4 (13) 4 (40) 0.012
ICD implantation 3 (7) 2 (6) 1 (10) 1.000
Combined PM/ICD implantation 2 (5) 1 (3) 1 (10) 0.424
Electrocardiography
Sinus rhythm 34 (81) 30 (94) 4 (40) 0.001
Pacemaker rhythm 6 (14) 1 (3) 5 (50) 0.002
Atrial rhythm 2 (5) 1 (3) 1 (10) 0.424
QRS duration (ms) 120 ± 19 121 ± 20 111 ± 15 0.297
QRS >120 ms 17 (40) 16 (50) 1 (10) 0.342
Cardiac medication
Beta-blocker 9 (21) 4 (13) 5 (50) 0.023
ACE inhibitor 14 (33) 9 (28) 5 (50) 0.259
Diuretics 8 (19) 6 (19) 2 (20) 0.930
Anti-arrhythmic drug 5 (12) 3 (9) 2 (20) 0.577
Laboratory results
Creatinine (µmol/L) 78 [68-83] 74 [68-83] 81 [74-88] 0.119
NT-proBNP (pmol/L) 27.4 [17.6-55.2] 29.9 [21.7-53.9] 19.1 [10.3-66.6] 0.259
Categorical variables are presented as frequencies (percentage).
Continuous variables are presents as mean ± SD or median [interquartile range].
ACE, angiotensin converting enzyme; AV, atrioventricular; ICD, implantable cardioverter defibrillator; NT-proB-
NP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; PM, pacemaker; SR, sinus 
rhythm; TGA, transposition of the great arteries. *TGA-Mustard vs. ccTGA. Significant P-values <0.05 are indi-
cated in bold.
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Echocardiography
The echocardiographic findings are presented in Table 2. Right ventricular func-
tion was at least mildly impaired in all, and moderately or severely impaired in 
62% of the patients. Median RV FAC was 24 (IQR 5–39)%. Left ventricular function 
was normal or mildly impaired in all but one patient. Moderate to severe TR was 
Table 2
All patients
(n=42)
TGA-Mustard
(n=32)
ccTGA
(n=10) P-value
RV dimensions
RV annulus diameter (mm) 49 ± 7 50 ± 6 49 ± 11 0.795
RV apex-base diameter (mm) 84 ± 9 86 ± 9 78 ± 10 0.038
RV systolic function
Good 0 0 0 0.607
Mildly impaired 16 (38) 12 (38) 4 (40)
Moderately impaired 21 (50) 17 (53) 4 (40)
Severely impaired 5 (12) 3 (9) 2 (20)
Fractional area change (%) 24 ± 7 24 ± 8 23 ± 7 0.538
RV TDI S’ lateral wall - 8.4 ± 1.4 NM -
TAPSE (mm) - 12 ± 3 NM -
dP/dT RV (mmHg/s) - 833 ±277 NM -
Strain parameters
GLS of the systemic RV (%) -14.2 ± 3.5 -13.9 ± 3.2 -15.1 ± 4.4 0.334
LS of the RV lateral wall (%) -16.1 ± 3.6 -15.5 ± 3.4 -18.3 ± 3.6 0.047
LS of the septal wall (%) -12.5 ± 4.0 -12.3 ± 3.7 -13.1 ± 5.3 0.658
LV systolic function
Good 31 (74) 24 (75) 7 (70) 0.760
Mildly impaired 10 (24) 7 (22) 3 (30)
Moderately impaired 1 (2) 1 (3) 0
Severely impaired 0 0 0
Valvular function
Tricuspid regurgitation grade
None 5 (12) 2 (6) 3 (30) 0.006
Mild 20 (48) 19 (59) 1 (10)
Moderate 13 (30) 7 (22) 6 (60)
Severe 4 (10) 4 (13) 0
Mitral regurgitation Vmax (m/s) (n=11) 2.8 ± 0.8 3.0 ± 0.8 2.3 ± 0.4 0.076
ulmonary regurgitation, early diastolic, Vmax (m/s) (n=20) 2.0 ± 0.7 2.1 ± 0.7 1.4 ± 0.3 0.070
Pulmonary regurgitation, late diastolic, Vmax (m/s) (n=17) 0.9 ± 0.6 0.9 ± 0.7 0.6 ± 0.2 0.396
Tricuspid regurgitation Vmax (m/s) (n=25) 4.8 ± 0.4 4.8 ± 0.4 4.9 ± 0.4 0.627
Values are presented as frequencies (percentage) or mean ± SD.
LV, left ventricle; RV, right ventricle; NM, not measured; TDI, tissue Doppler imaging; TAPSE, tricuspid annular 
plane systolic excursion; Vmax, peak flow velocity.
Significant P-values <0.05 are indicated in bold.
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observed in 40% of the patients. None of the patients had more than mild pulmo-
nary regurgitation or aortic regurgitation. Right ventricular apex-base diameter 
was smaller in ccTGA patients than TGA-Mustard patients, and ccTGA patients 
more often had more than mild TR than TGA-Mustard patients; all other echocar-
diographic findings did not differ significantly.
GLS of the systemic ventricle
Global longitudinal strain of the systemic RV in patients was significantly lower 
than GSL of the systemic LV in healthy controls (-14.2 ± 3.5% vs. -20.1 ± 3.0%, 
P<0.001) (Figure 2). Global longitudinal strain of the systemic RV did not signifi-
cantly differ between patients with TGA-Mustard and ccTGA (-13.9 ± 3.2% versus 
-15.1 ± 4.4%, P=0.334) (Figure 3).
Average LS of the ventricular walls
Average LS of the RV lateral wall was -16.1 ± 3.6% for patients with a systemic RV, 
which was significantly reduced compared to average LS of the RV lateral wall 
(-26.6 ± 4.4%, P<0.001) and average LS of the LV lateral wall (-20.5 ± 3.9%, P<0.001) 
in healthy controls. Also, average LS of the septal wall was significantly lower in 
patients than in healthy controls (-12.5 ± 4.0% versus -20.8 ± 3.1%, P<0.001).
Average LS of the RV lateral wall was significantly decreased in patients with 
TGA-Mustard compared with ccTGA (-15.5 ± 3.4% vs. -18.3 ± 3.6%, P=0.047), while no 
significant difference in average LS of the septal wall was seen (Figure 3, Table 2).
Figure 2 GLS of the systemic ventricle in 
patients and healthy controls.
Strain values are presented as mean and stan-
dard deviation.
Figure 3 GLS of the systemic RV and average LS 
of the ventricular walls in both patient groups.
Strain values are presented as mean and standard de-
viation.
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Segmental strain and strain rate
The results for segmental strain are shown in Table 3 and Figure 4. The significant 
reduction in strain of patients compared with controls was seen in all segments, 
but most prominent in the apical segments. Additionally, segmental strain rates 
of all three segments of the RV lateral wall were significantly lower in patients 
compared with controls (Table 3). Segmental strain and strain rate between TGA-
Mustard and ccTGA patients was not significantly different.
GLS of the systemic RV and baseline patient characteristics
Global longitudinal strain of the systemic RV tended to be lower in men than in 
women (-13.5 ± 3.3% vs. -15.7 ± 3.6%, P=0.067). These sex differences were not seen 
among the healthy controls. Global longitudinal strain of the systemic RV tended 
to be lower in patients in NYHA functional class II than class I (-12.2 ± 3.6% vs. 
-14.6 ± 3.4%, P=0.083). Global longitudinal strain of the systemic RV correlated with 
QRS duration (r=0.412, P=0.014). There were no associations between GLS and 
age, blood pressure, heart rate or time since Mustard surgery. Global longitudinal 
strain of the systemic RV in the six patients with a pacemaker rhythm did not differ 
from patients without a pacemaker rhythm (-15.0 ± 3.7% vs. -14.0 ± 3.5%, P=0.503).
Table 3 Segmental strain and strain rate
All patients Healthy controls
 
TGA-Mustard ccTGA P-value
Number of patients 42 32 32 10  
Lateral wall  
Longitudinal strain (%) Systemic RV Subpulmonary RV Systemic LV  Systemic RV Systemic RV
Lateral wall; basal -19.5 ± 7.7 -28.6 ± 7.9‡ -24.4 ± 7.0†  -20.8 ± 7.9 -15.6 ± 5.9 0.064
Lateral wall; midwall -14.7 ± 6.8 -26.5 ± 5.5‡ -19.4 ± 6.0†  -13.8 ± 6.7 -18.0 ± 6.6 0.108
Lateral wall; apical -14.2 ± 6.7 -28.7 ± 7.6‡ -17.3 ± 5.3*  -13.3 ± 6.7 -16.7 ± 6.3 0.164
Strain rate (s-1) Systemic RV Subpulmonary RV Systemic LV  Systemic RV Systemic RV
Lateral wall; basal -1.25 ± 0.54 -1.69 ± 0.45‡ -1.45 ± 0.34  -1.32 ± 0.58 -1.01 ± 0.33 0.109
Lateral wall; midwall -1.06 ± 0.32 -1.73 ± 0.67‡ -1.17 ± 0.34  -1.04 ± 0.33 -1.10 ± 0.30 0.653
Lateral wall; apical -0.98 ± 0.48 -1.66 ± 0.57‡ -1.19 ± 0.35*  -0.93 ± 0.44 -1.16 ± 0.59 0.199
Septal wall  
Longitudinal strain (%) Systemic RV Systemic LV  Systemic RV Systemic RV
Septal wall; basal -10.5 ± 5.2 - -18.2 ± 4.5‡  -9.6 ± 4.7 -12.7 ± 6.0 0.117
Septal wall; midwall -12.2 ± 5.5 - -21.4 ± 4.5‡  -11.6 ± 5.1 -14.1 ± 6.8 0.245
Septal wall; apical -13.8 ± 5.6 - -22.9 ± 5.6‡  -14.1 ± 4.9 -12.8 ± 8.0 0.653
Values are presented as mean ± SD.RV, right ventricle; LV, left ventricle. Levels of significance for comparison 
with systemic RV parameters in patients: *P<0.05, †P<0.01 ‡P<0.001.
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GLS of the systemic RV and echocardiographic parameters
Global longitudinal strain of the systemic RV correlated with RV apex-base diameter 
(r=0.374, P=0.021). Global longitudinal strain of the systemic RV was significantly 
lower in patients with RV function graded as moderately to severely impaired 
(-12.7 ± 3.3%) compared with patients with normal or mildly impaired RV function 
(-16.8 ± 2.1%, P<0.001). Global longitudinal strain of the systemic RV correlated 
with RV FAC (r=-0.391, P=0.019). No correlation with TAPSE was observed. Global 
longitudinal strain of the systemic RV was measured for the various degrees of 
TR: no TR (-9.9 ± 3.0%), mild TR (-14.2 ± 3.1%), moderate TR (15.8 ± 3.2%), and 
severe TR (-14.4 ± 3.4%). There were no significant differences between GLS of the 
systemic RV in patients with no compared to mild pulmonary regurgitation.
GLS of the systemic RV and NT-proBNP
The median NT-proBNP level was 27.4 (IQR 17.7 – 55.2) pmol/L. NT-proBNP was 
elevated in 88% of the patients, i.e. above 14 pmol/L, the cut-off point used in our 
hospital. Global longitudinal strain of the systemic RV correlated negatively with 
NT-proBNP (Figure 5). After adjustment for age, sex, and NYHA class in a multivari-
able regression model, GLS of the systemic RV remained significantly associated 
with NT-proBNP (β=0.117, P=0.006).
Figure 4 Segmental strain of the lateral wall.
Levels of significance are presented for comparison of: (A) systemic RV lateral wall in patients vs. systemic 
LV lateral wall in healthy controls, (B) systemic RV lateral wall in patients vs. subpulmonary RV lateral wall in 
healthy controls, (C) systemic RV lateral wall in TGA-Mustard patients vs. ccTGA patients.
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Interobserver and intraobserver variability
The interobserver variability was -0.26 ± 1.71% for the GLS of the systemic RV at 
the apical four-chamber view, and intraobserver variability was -0.01 ± 1.32% for 
GLS of the systemic RV (Figure 6).
disCussion
This prospective study demonstrates that patients with a systemic RV have 
decreased GLS of the systemic ventricle when compared with healthy controls, 
which is most pronounced in the apical segments, suggesting that apical function 
has suffered most from chronic pressure overload. Moreover, decreased GLS of 
Figure 5 Correlation between GLS of the systemic RV and NT-proBNP.
Intra-observer variability for RV GLSA BInter-observer variability for RV GLS
Figure 6 Bland–Altman plots for intra- and interobserver variability for measurement of GLS of 
the systemic RV.
(A) Interobserver variability; (B) intraobserver variability.
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the systemic RV is associated with increased NT-proBNP release and possibly with 
worsening NYHA functional class as well, indicating the potential prognostic value 
of GLS. Although GLS did not differ between patient groups, average LS of the 
lateral wall was lower in patients with TGA-Mustard than in patients with ccTGA.
Quantitative assessment of systemic RV function
Right ventricular function in patients with a systemic RV is known to deteriorate 
progressively at adult age.3,17 Although echocardiography is a well-established 
diagnostic tool to quantitatively assess LV function, its use to quantify RV function 
is questioned because an adequate geometry model for RV volumes is lacking, 
especially in the context of congenital heart disease.18 Therefore, novel quantita-
tive echocardiographic techniques to assess RV function that are less angle- and 
ventricular geometry dependent, including tissue Doppler and STE, recently 
gained more interest in patients with a systemic RV.10,19,20
When compared with healthy controls, the decrease in LS was significant in all 
RV segments, but most pronounced in the apical segments. Although RV basal 
function is diminished, it is presumably better preserved than RV apical function. 
A systemic RV has to encounter much higher (systemic) pressures than a subpul-
monary RV. The different geometry of a systemic RV, a rounder-shaped ventricle, 
could cause a shift in myocardial wall stress. This could explain the observed 
differences in segmental strain. That chronic pressure overload seems to be the 
main cause of diminished GLS is underlined by similar results for decreased GLS 
in pressure-overloaded RVs due to pulmonary hypertension. 21,22
Decreased GLS of the systemic RV correlated with RV dysfunction assessed 
by RV FAC; however, no relationship was observed between GLS and TAPSE. A 
previous study by De Caro et al.23 demonstrated that TAPSE is not a useful mea-
sure in patients with a systemic RV. Deteriorating RV function is also reflected by 
prolonged QRS duration and RV annulus dilation, which both have been described 
to be associated with worse prognosis.24
Right ventricular dysfunction often results in dilation of the RV annulus, which 
frequently leads to progressive TR in patients with a systemic RV. Prevention of TR 
progression is of great importance. Whether tricuspid valve surgery in these pa-
tients is helpful or not, needs to be confirmed in a large cohort study.25 Significant 
TR is associated with unfavourable clinical outcome. Reduced GLS of the systemic 
RV was not only associated with worse RV function, but also with prolonged QRS 
duration. This demonstrates the potential value of STE for quantitative monitoring 
of cardiac function, which may also lead to more adequate treatment of RV dys-
function, which could eventually avoid TR progression in these patients. Since our 
GLS values were comparable with the findings of other studies,8,12,26 the feasibility 
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of STE for RV function assessment in patients with a systemic RV is strengthened. 
Nevertheless, more follow-up data are needed to determine whether GLS is indeed 
predictive for clinical endpoints, including TR progression, in patients with a 
systemic RV.
GLS of the systemic RV and NT-proBNP and NYHA classification
This is the first study that investigated the relationship between RV myocardial 
deformation and NT-proBNP release in patients with a systemic RV. NT-proBNP, 
a marker of increased myocardial wall stress,27 is elevated in the majority of 
patients with a systemic RV.28 NT-proBNP correlated with GLS of the systemic 
RV. The correlation between NT-proBNP and GLS is scattered, although stronger 
than previous reported modest correlations between NT-proBNP and other RV 
systolic function measurements such as RV FAC.28 Hence, this correlation is not 
strong, both markers may provide complementary information. A recent study by 
Westhoff-Bleck et al.29 demonstrated the potential prognostic value of NT-proBNP 
to predict the risk of heart failure, heart transplantation and mortality in patients 
with a systemic RV. Together with the possible association between RV GLS and 
clinical events demonstrated by Kalogeropoulos et al.,26 the relationship between 
RV GLS and NT-proBNP could indicate a possible future role for both diagnostic 
tools in the evaluation of the patients’ prognosis. This will have to be confirmed 
in a longitudinal study.
Global longitudinal strain of the systemic RV tended to be lower in patients in 
NYHA class II than patients in NYHA class I. Similar to NT-proBNP, NYHA functional 
class has shown to be an independent predictor for worse clinical outcome, i.e. 
heart failure, heart transplantation, and death, in patients with a systemic RV.29 
Since GLS of the systemic RV was reduced in patients in NYHA II as well as in 
patients in NYHA I, one could criticize the additional value of reduced strain on 
outcome. On the other hand, GLS tended to be more reduced in patients in NYHA 
II, which could indicate subclinical deterioration and underline the potential 
prognostic value of GLS in these patients. Because our study population was small 
and included only patients in NYHA functional class I or II, we cannot draw firm 
conclusions on the relationship between GLS and NYHA classification.
Differences between Mustard surgery and congenitally corrected TGA
Average LS of the lateral wall was lower in patients with TGA-Mustard than in 
patients with ccTGA, while with conventional echocardiographic clear differences 
between the two groups have not been described previously. There were no sig-
nificant differences in baseline characteristics besides the prior cardiac surgery 
in TGA-Mustard patients. Possibly, the lower LS was caused by the prior surgical 
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intervention. Loss in RV longitudinal contractile function with compensatory gain 
in transversal contraction is seen in patients after other cardiac surgery, i.e. coro-
nary artery bypass surgery.30 Pettersen et al.19 described a similar phenomenon in 
young adolescents after Senning surgery, where circumferential strain exceeded 
LS in the systemic RV lateral wall.
Another reason for better preserved LS in patients with ccTGA could be that 
their RV is more resistant to chronic pressure overload because the RV of ccTGA 
patients encounters systemic pressure from birth, whereas patients with TGA-
Mustard go through a period without pressure overload of the RV. Furthermore, 
the difference could be explained by the absence of additional atrial function to 
contribute to RV function in patients with TGA-Mustard. Although we know that 
both patients with TGA-Mustard and ccTGA will develop RV dysfunction and heart 
failure,3,33 this difference in average LS of the lateral wall may indicate that dete-
rioration in RV function is less progressive in patients with ccTGA than in patients 
with Mustard-TGA. However, the difference in RV GLS between the patients groups 
did not reach significance and therefore this difference warrants further investiga-
tion in a larger study.
Limitations
The assessment of RV function with echocardiography remains difficult, partly 
due to its complex geometry. Technical difficulties in visualizing the RV lateral 
wall, which is situated behind the sternum must be taken into account. Our study 
described myocardial deformation in a longitudinal direction only, whereas cir-
cumferential strain may be important as well, as is stated by Pettersen et al.19 
However, our study population was older, and in our experience, the suboptimal 
acoustic window for short-axis images (i.e. imaged in the near field because of 
anterior displacement of the enlarged RV) made it impossible to have reliable 
circumferential and radial strain measurements in these older patients. Therefore, 
these measurements were not performed. The large RVs in our relatively old 
patient cohort may also explain why one-fourth of the patients in our study had 
to be excluded because of inadequate image quality for STE. This is substantially 
more than previous studies reporting exclusion rates of 10-15%.8,12 However, since 
LS from speckle-tracking analysis has a good intra- and interobserver variability 
and is a predictor for all-cause mortality in patients with left-side heart failure, this 
strain parameter holds promise as a risk predictor for patients with a systemic RV. 
Furthermore, our study population was relatively small, and therefore our results 
will have to be confirmed by a larger study.
Comparing a systemic RV of patients with healthy controls is difficult. To make 
the comparison as complete as possible, we compared the patients’ systemic RV 
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to the lateral wall of the morphologic RV as well as the systemic LV in healthy 
controls. The QLAB LV algorithm was used to assess RV function, which is debat-
able because of the difference in ventricular contraction pattern.19
ConClusion
Global longitudinal strain of the systemic RV is lower in patients than GLS of the 
systemic LV in healthy controls, which is most pronounced in the apical segments, 
suggesting that apical function has suffered most from the chronic pressure over-
load. Since RV GLS correlates with RV function and dimensions, future use of GLS 
as a more quantitative tool to measure RV function may be well possible. The 
associations between reduced RV GLS and increased NT-proBNP levels as well as 
the tendency to worsening NYHA class indicate the potential prognostic value of 
strain measurement in patients with a systemic RV.
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abstraCt 
Purpose
Despite successful aortic coarctation (CoA) repair, systemic hypertension often 
recurs which may influence left ventricular (LV) function. We aimed to detect early 
LV dysfunction using LV global longitudinal strain (GLS) in adults with repaired 
CoA, and to identify associations with patient and echocardiographic character-
istics.
Methods 
In this cross-sectional study, patients with repaired CoA and healthy controls were 
recruited prospectively. All subjects underwent echocardiography, ECG and blood 
sampling within one day. With speckle-tracking echocardiography, we assessed LV 
GLS on the apical four-, three- and two-chamber views.
Results
We included 150 subjects: 75 patients (57% male, age 33.4±12.8 years, age at repair 
2.5 [IQR:0.1-11.1] years) and 75 healthy controls of similar sex and age. LV GLS 
was lower in patients than in controls (-17.1±2.3% vs. -20.2±1.6%, P<0.001). Eighty 
percent of the patients had a normal LV ejection fraction, but GLS was still lower 
than in controls (P<0.001). In patients, GLS correlated with systolic and diastolic 
blood pressure (r=0.32, P=0.009; r=0.31, P=0.009), QRS duration (r=0.34, P=0.005), 
left atrial dimension (r=0.27, P=0.029), LV mass (r=0.30, P=0.014) and LV ejection 
fraction (r=-0.48, P<0.001). Patients with either associated cardiac lesions, multiple 
cardiac interventions or aortic valve replacement had lower GLS than patients 
without. 
Conclusion 
Although the majority of adults with repaired CoA seem to have a normal systolic 
LV function, LV GLS was decreased. Higher blood pressure, associated cardiac 
lesions, and larger left atrial dimension are related with lower GLS. Therefore, LV 
GLS may be used as objective criterion for early detection of ventricular dysfunc-
tion. 
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introduCtion
Coarctation of the aorta (CoA) is common (5–8 % of all congenital heart defects) 
and is considered to be part of a generalized arteriopathy with a reduced compli-
ance of arterial vascular walls, instead of only a circumscript narrowing of the 
aorta.1-3 Patients can have associated lesions, such as a bicuspid aortic valve, sub-
valvular, valvular, or supravalvular aortic stenosis, and mitral valve stenosis.3 CoA 
causes left ventricular (LV) pressure overload, which can lead to increased myo-
cardial wall stress, LV systolic and diastolic dysfunction, and the development of 
arterial collaterals.3 In order to relieve the obstruction, a surgical or transcatheter 
intervention is needed. Despite successful repair, late cardiovascular problems 
occur including systemic hypertension in 30–75 % of the cases,4-6 compensatory 
LV hypertrophy, heart failure, coronary heart disease, stroke and sudden cardiac 
death.6, 7 Early detection of LV dysfunction could be important for risk stratification 
or early initiation of treatment. Speckle-tracking echocardiography (STE) is a 
sophisticated technique that provides a quantitative assessment of the motion of 
myocardial tissue, independently of angle and ventricular geometry, which could 
detect subclinical myocardial dysfunction.8,9 One of the measurements is strain 
imaging which is defined as deformation of the myocardial wall normalized to its 
original size. Because strain in longitudinal direction is the most widely used type 
of strain and is a robust index for clinical studies,10 we have chosen to focus on 
longitudinal strain. One study recently described a significant lower LV global lon-
gitudinal strain (GLS) after CoA repair in a small cohort of heterogeneous patients 
including children and adults.11 Our group of CoA subjects, age- and sex-matched, 
is the largest and oldest in which LV GLS has been studied to date. 
The aim was to evaluate LV GLS in adults after CoA repair and healthy controls 
of similar age and sex, and to study relationships between GLS and patient charac-
teristics such as smoking, interventions, hypertension, aortic valve morphology, 
other associated congenital cardiac lesions, and prior cardiovascular events, but 
also with conventional echocardiographic measurements and cholesterol and 
N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) levels.
Methods
Study population
Consecutive patients who were ≥18 years of age and had undergone CoA repair 
were recruited at the adult outpatient cardiology clinic at Erasmus MC between 
September 2011 and June 2014. Exclusion criteria were a pacemaker, irregular 
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heart rhythm, and poor quality of the echocardiographic images at all apical views 
for adequate STE. This prospective study’s protocol included medical history, 
physical examination, echocardiography, 12-lead electrocardiography, and cho-
lesterol and NT-proBNP measurements all on the same day. Patient characteristics 
included age, sex, medication, clinical parameters, type of initial repair, number 
of interventions (surgical or transcatheter), aortic valve replacement, aortic valve 
morphology, other associated congenital cardiac lesions and prior cardiovascular 
events (coronary artery disease, heart failure, stroke). Hypertension was defined 
as the requirement of antihypertensive drugs or when ≥3 times an elevated blood 
pressure was measured (systolic >140 mmHg or diastolic >90 mmHg). Healthy con-
trols of similar age and sex were voluntarily recruited via an advertisement. They 
had no medical history or current symptoms suggesting cardiovascular disease 
and did not take any chronic medication.
All procedures were in accordance with the ethical standards of the institutional 
research committee and with the 1964 Helsinki declaration and its later amend-
ments. Informed consent was obtained from all participants.
Echocardiographic image acquisition 
Two-dimensional greyscale harmonic images were obtained in the left lateral decu-
bitus position using an iE33 ultrasound system (Philips Medical Systems, Best, the 
Netherlands) equipped with a transthoracic X5-1 matrix transducer (composed of 
3040 elements, with 1-5 MHz extended operating frequency range). Images were 
acquired at frame rates of >55 frames/sec. The echocardiographic studies were 
stored in Digital Imaging and Communications in Medicine (DICOM) format.
Conventional echocardiographic measurements
For chamber measurements and LV mass calculation, we used the current recom-
mendations for cardiac chamber quantification.12 For normal systolic LV ejection 
fraction (EF) assessed with the Simpson’s method, we used the reference values of 
≥52 % for males and ≥54 % for females.12 In addition, LV systolic function was visu-
ally graded as normal or mildly, moderately or severely impaired. From the apical 
four-chamber view (A4C), pulsed-wave Doppler examination was performed to 
obtain peak mitral inflow velocities at early (E) and late (A) diastole and E decel-
eration time. Tissue Doppler imaging was performed to obtain myocardial tissue 
velocity at the mitral annulus at early diastole (E’). For left atrial (LA) size, we 
measured the anteroposterior diameter in the parasternal long-axis view and the 
LA area in the A4C at end-systole.12 For the assessment and grading of valvular 
stenosis and regurgitation, we used the recommendations of the European As-
sociation of Echocardiography.13–15
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Speckle-tracking analysis
Offline analysis of the data sets was performed using STE by QLAB version 9.0 
(Philips Medical Systems, Best, the Netherlands). Analysis was performed accord-
ing to the vendor’s instructions. Cardiac cycles were defined by the positioning of 
R-waves. 
To assess peak systolic LV GLS, the endocardial and epicardial borders were 
traced in the apical four-, three- and two-chamber views (A3C, A2C) on an end-
diastolic frame (Figure 1a-c). The software automatically divided the walls in 
several segments (LV algorithm based on 17-segment model) and tracked these 
points on a frame-by-frame basis. When tracking was suboptimal, we readjusted 
Figure 1 Example of left ventricular longitudinal strain measurements in a patient with repaired 
aortic coarctation.
The LV was traced in the apical four-, two-, and three-chamber views at end-diastole. The walls were automati-
cally divided into seven segments at each view and the global longitudinal strain at each view was calculated (A-
C). The segmental strain measurements were plotted in a bull’s eye and the left ventricular global longitudinal 
strain based on all three apical views was calculated (D).
AP2 = apical two-chamber view; AP3 = apical three-chamber view; AP4 = apical four-chamber view; GL = global 
longitudinal.
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the borders. Segments with persistently inadequate tracking were excluded from 
further analysis. Peak systolic strain values were defined as the peak values on 
the curves during the ejection phase. We reported the peak systolic LV GLS based 
on measurements of all three apical views (Figure 1d). Data were exported to a 
spreadsheet program (Excel; Microsoft Corporation, Redmond, WA, USA). All 
references to strain changes consider the absolute value of the number, so that 
higher or increase in longitudinal strain means a more negative number and lower 
or decrease means a less negative number.8
NT-proBNP measurement
Peripheral venous blood samples were collected and plasma NT-proBNP levels 
were determined with use of the commercially available electrochemilumines-
cence immunoassay Elecsys (Roche Diagnostics, Basel, Switzerland). The normal 
value in our hospital is <14 pmol/L.
Statistical analysis
Continuous variables are presented as mean ± standard deviation (SD) or as 
median with interquartile range [Q1-Q3]. Categorical variables are presented as 
frequencies and percentages. For comparison of normally distributed continuous 
variables between two groups the Student’s t-test was used and in case of skewed 
distribution, the Mann-Whitney-U test. For comparison between three groups the 
Kruskal-Wallis sum test was applied. For comparison of frequencies, the χ2-test or 
Fisher’s exact test was used. For quantifying correlations between two variables, 
the Pearson or Spearman correlation test was applied. Multivariable regression 
analysis was performed for patient characteristics which were significant associ-
ated with LV GLS. In case of collinearity of these variables, we implemented the 
variable with the strongest correlation into multivariable analysis. Because NT-
proBNP values were not normally distributed, the values were log transformed for 
further statistical analyses. 
Intra-observer and inter-observer agreement between two investigators (MM, 
RvG) were assessed by repeated analysis in two third of the data sets at least two 
months after the initial analysis on the second cardiac cycle at the same images 
and blinded to the initial results. The limits of agreement between two measure-
ments were determined as the mean of the differences ±1.96 SD and presented 
in a Bland-Altman plot.16 Additionally, the coefficient of variation (COV; SD of the 
differences of two measurements divided by their mean) was provided.
All statistical analyses were performed using SPSS statistics version 21 (IBM 
Corp., Armonk, NY, USA). The statistical tests were two-sided and a P<0.05 was 
considered statistically significant.
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results
Study population
We included 75 adult patients (57% male, age 33.4±12.8 years) and 75 healthy 
controls of similar sex and age. Figure 2 presents an overview of the patient par-
ticipation and feasibility of the measurements. Table 1 shows the characteristics 
of the study population. The median age at the initial CoA repair, surgical or 
transcatheter, was 2.5 years [0.1-11.0; range: 0-51] and the median follow-up after 
repair was 24.7 years [20.4-31.7]. Sixteen patients underwent aortic valve replace-
ment 11.6 years [5.4-18.0] prior to this study. Six patients (8%) had a history of 
at least one cardiovascular event: transient ischemic attack (n=3), postoperative 
cerebrovascular accident after aortic valve replacement (n=1), subarachnoidal 
bleeding (n=1), and percutaneous coronary intervention because of progressive 
angina (n=1). Of the 20 patients with QRS duration >120 ms, 8 had a right bundle 
branch block, 6 a left, and 6 unspecified. Only one patient (1%) had an elevated 
cholesterol level of 7.7 mmol/L.
Conventional echocardiographic measurements of all subjects are presented in 
Table 2. All diastolic measurements in the CoA patients, except for deceleration 
time, were significantly different from normal controls. Visually assessed systolic 
Patients with repaired CoA
n=86 
Included in study  
n=75 
Feasibility longitudinal strain
       A4C    n=73  (97%) 
       A2C    n=66  (88%)
       A3C    n=65  (87%) 
       GLS    n=68  (91%) 
 Excluded:
 Poor quality n=9 
 Pacemaker   n=1 
 Atrial brillation   n=1 
Figure 2 Flow chart of the study patients.
An overview of the patient inclusion and feasibility of the left ventricular longitudinal strain measurements at 
the different apical views.
A2C = apical two-chamber view; A3C = apical three-chamber view; A4C = apical four-chamber view; GLS = global 
longitudinal strain.
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Table 1 Characteristics of the study population
Clinical characteristics
CoA patients Healthy controls P-value
n=75 n=75  
Age at time of study (yrs) 33.4 ± 12.8 33.9 ± 10.6 0.793
Female 32 (43%) 32 (43%) 1.000
BMI (kg/m2) 25.0 ± 4.1 23.4 ± 3.2 0.015
BSA (m2) 1.90 ± 0.22 1.88 ± 0.16 0.675
Systolic blood pressure (mmHg) 132 ± 17 125 ± 13 0.007
Diastolic blood pressure (mmHg) 79 ± 12 76 ± 9 0.194
Smoker (current or former) 6 (8%) 2 (3%) 1.0
Hypertension* 38 (51%) 0 (0%) <0.001
Any antihypertensive drugs 33 (44%) 0 (0%) <0.001
Betablocker 15 (20%) - -
ACE inhibitor 13 (17%) - -
Angiotensin II antagonist 10 (13%) - -
Diuretics 7 (9%) - -
Aldosteron antagonist 2 (3%) - -
NYHA functional Class I / Class II 74 (99%) / 1 (1%) 75 (100%) / 0 -
Heart rate (bpm) 63 ± 11 64 ± 11 0.701
QRS duration (ms) 113 ± 19 97 ± 10 <0.001
QRS duration >120 ms 20 (27%) 0 -
Age at initial repair (yrs) 2.5 [0.1-11.0] - -
Type of initial repair
End-to-end anastomosis 53 (70%) - -
Teflon patch aortoplasty 9 (12%) - -
Subclavian flap aortoplasty 8 (11%) - -
Bypass 3 (4%) - -
Stent 2 (3%) - -
Total number of cardiac interventions
One 35 (47%) - -
Two 21 (28%) - -
Three or more 19 (25%) - -
Repeated coarctation repair 25 (33%) - -
Aortic valve replacement 16 (21%) - -
Native aortic valve morphology
Bicuspid 52 (70%) - -
Tricuspid 21 (28%) - -
Unknown 2 (2%) - -
Other congenital cardiac lesions† 33 (44%) - -
Ventricular septal defect 20 (27%) - -
Patent ductus arteriosus 11 (15%) - -
PAPVR 3 (4%) - -
Other 9 (12%) - -
Cholesterol level (mmol/L) 4.9 [4.0-5.5] - -
NT-proBNP (mmol/L) 7.2 [3.6-16.7]
*Requiring antihypertensive drugs or ≥3 times measured elevated blood pressure (systolic >140 mmHg or dia-
stolic >90 mmHg). †Apart from bicuspid aortic valve.
Categorical data are presented as n (%) and continuous data as mean ± standard deviation or median [in-
terquartile range]. ACE = angiotensin converting enzyme; BMI = body mass index; BSA = body surface area; 
NYHA = New York Heart Association; PAPVR = partial anomalous pulmonary venous return.
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LV function was graded normal in 63 (84%) patients, mildly impaired in 11 (15%), 
and severely impaired in 1 (1%). The diastolic function was graded as a normal 
pattern in 54 (72%) patients, abnormal relaxation pattern in 3 (4%), pseudonormal 
filling pattern in 9 (12%), restrictive pattern in 5 (7%), and in 4 (5%) patients the 
diastolic function was not analyzable. Aortic stenosis (>2.5 m/s) was observed in 
13 (17%) patients. Aortic regurgitation was graded mild in 32 (43%), moderate in 
3 (4%) and severe in none of the patients. Mitral regurgitation was graded mild in 
20 (27%), moderate in 3 (4%) and severe in none. Tricuspid  regurgitation could be 
measured in 51 patients, of whom 3 (6%) had a peak velocity of >2.8 m/s. 
Left ventricular global longitudinal strain
Patients had a significantly lower mean GLS based on all three apical views 
(-17.1±2.3%), GLS on A4C (-16.9±2.7%), GLS on A2C (-17.9±3.0%), and GLS on A3C 
(-16.9±2.4%) than the healthy controls (all P<0.001). A sub analysis in the 63 pa-
tients (84%) with a visually graded normal systolic LV function revealed that GLS 
was still significantly lower than in controls (Figure 3). LV EF was measurable in 
49 patients of whom 39 (80%) had a normal EF. A sub analysis in these 39 patients, 
also showed that GLS in all three apical views separately was significantly lower 
than in controls (all P<0.001). 
Table 2 Conventional echocardiographic measurements of the study patients.
Echocardiographic measurements Patients (n=75) Controls (n=75)  P-value
LA dimension (mm) 35 ± 6 33 ± 4 0.124
LV end-diastolic dimension (mm) 50 ± 5 48 ± 4 0.034
LV end-systolic dimension (mm) 31 ± 5 29 ± 3 0.010
LV interventricular septum (mm) 9.7 ± 2.7 8.3 ± 1.5 <0.001
LV posterior wall (mm) 9.0 ± 1.5 8.6 ± 1.2 0.052
LV mass (g) 169 ± 56 136 ± 30 <0.001
LV EF Simpson’s (%) 57 ± 7 64 ± 4 <0.001
LV E wave (m/sec) 1.02 ± 0.25 0.76 ± 0.14 <0.001
LV A wave (m/sec) 0.69 ± 0.23 0.43 ± 0.11 <0.001
LV E/A ratio 1.58 ± 0.54 1.90 ± 0.57 0.001
LV deceleration time (ms) 207 ± 62 193 ± 32 0.098
LV E’ (cm/sec) 9.0 ± 2.5 11.2 ± 2.8 <0.001
LV E/E’ ratio 12.4 ± 5.9 7.1 ± 1.8 <0.001
Data are presented as mean ± standard deviation.
A = peak mitral inflow velocity at late diastole; E = peak mitral inflow velocity at early diastole; E’ = early dia-
stolic annular myocardial velocity; EF = ejection fraction; LA = left atrium; LV = left ventricle.
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Relationships with patient characteristics
Table 3 present the relationships between LV GLS and patient characteristics. 
Patients with higher BMI, higher blood pressure or longer QRS duration had a 
lower GLS in all three apical views (Figure 4a and 4b). Patients who had one or 
more associated congenital cardiac lesions, who had undergone multiple cardiac 
interventions or who had undergone aortic valve replacement had a significantly 
lower GLS than patients without these interventions (Figure 5). No significant as-
sociations were found between GLS and current age, age at repair or repeated CoA 
repair. 
Multivariable regression analysis with the variables ‘systolic blood pressure’, 
‘associated cardiac lesions’ and ‘aortic valve replacement’ revealed that the sys-
tolic blood pressure and the presence of associated cardiac lesions were indepen-
dently associated with LV GLS (β=0.290, P=0.009; β=0.353, P=0.002, respectively), 
and that a trend was seen regarding an aortic valve replacement (β=0.188, P=0.087). 
Other significant variables were not implemented in the multivariable analysis 
because of collinearity between the variables. Patients without comorbidity such 
as associated cardiac lesions, aortic valve replacement, cardiac reinterventions 
or hypertension (n=13) still had a lower GLS than the healthy controls (P=0.001). 
In patients with elevated NT-proBNP, GLS on A4C was significantly lower 
(P=0.010) and GLS based on all three apical views tended to be significantly lower 
(P=0.057).
Relationships with conventional echocardiographic measurements
Table 3 summarises the relationships between LV GLS and echocardiographic 
measurements. Patients with a higher LV mass, lower LV EF or larger LA dimen-
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Figure 3 Left ventricular global longitudinal strain in CoA patients with visually graded impaired 
and normal left ventricular systolic function and in healthy controls.
This figure presents the mean peak systolic LV GLS based on the measurements in the apical four-, two- and 
three-chamber view, and the mean peak systolic longitudinal strain at these three views separately. Strain val-
ues of the patients with visually graded normal left ventricular systolic function and of patients with impaired 
left ventricular systolic function are both compared with those of healthy controls.
A2C = apical two-chamber view; A3C = apical three-chamber view; A4C= apical four-chamber view; GLS = global 
longitudinal strain; LV = left ventricular.
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12sion had a lower GLS based on all three apical views (Figure 4c and 4d). LA area 
did not correlate with GLS. A higher E wave was associated with a higher GLS on 
A4C (r=-0.25, P=0.035) and a trend was found towards higher GLS based on all 
three apical views. Online Resource 1 presents the clinical and echocardiographic 
characteristics stratified by tertiles of GLS values.
Intra-observer and inter-observer agreement
The intra-observer agreement for the GLS on A4C was 0.71±1.42% with a COV of 
7.2%. The inter-observer agreement was -0.48±1.53% with a COV of 8.0%. Figure 6 
depicts the Bland-Altman plots.  
Table 3 Correlations with left ventricular global longitudinal strain.
 Correlation coefficient P-value
Patient characteristics
Age* 0.18 0.132
Age at repair* 0.04 0.759
BMI* 0.29 0.018
Systolic blood pressure 0.32 0.009
Diastolic blood pressure 0.31 0.009
QRS duration 0.34 0.005
Cholesterol level 0.11 0.396
Ln NT-proBNP 0.11 0.393
Echocardiographic measurements
LA dimension 0.27 0.029
LV end-diastolic dimension 0.08 0.509
LV end-systolic dimension -0.02 0.889
LV interventricular septum* 0.33 0.008
LV posterior wall* 0.38 0.002
LV mass* 0.30 0.014
LV EF Simpson’s -0.48 <0.001
LV E wave -0.23 0.058
LV A wave* -0.03 0.815
LV E/A ratio* -0.20 0.117
LV deceleration time* -0.05 0.673
LV E’ -0.19 0.149
LV E/E’ ratio* -0.13 0.341
*Spearman’s correlation coefficient
A = peak mitral inflow velocity at late diastole; BMI = body mass index; E = peak mitral inflow velocity at early 
diastole; E’ = early diastolic annular myocardial velocity; EF = ejection fraction; LA = left atrium; Ln = natural 
logarithm; LV = left ventricle; NT-proBNP = N-terminal pro-Brain Natriuretic Peptide.
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disCussion
This prospective study shows that LV GLS is reduced in patients late after CoA 
repair, providing evidence of subclinical LV dysfunction, which is not detectable 
with conventional 2D-echocardiography. Although survival of CoA patients have 
been improved since the introduction of cardiac surgery and percutaneous inter-
ventions, morbidity after repair is still substantial. More than one third of these 
patients encounter late cardiovascular complications after CoA repair. However, 
these results are from the early years of cardiac surgery.7 In order to reduce mor-
bidity, detection of early ventricular dysfunction may identify patients at risk of 
developing ventricular failure or adverse cardiac events. LV GLS could probably 
be a useful prognostic follow-up tool in these patients. 
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Figure 4 Scatter plots showing correlations with left ventricular global longitudinal strain.
Signifi cant correlations were observed between LV GLS and systolic blood pressure (A), QRS-duration (B), left 
atrial dimension at parasternal long axis view (C), and left ventricular ejection fraction measured with Simp-
son’s biplane method (D).
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Decreased left ventricular global longitudinal strain
The feasibility of GLS was higher than the feasibility of EF by Simpson’s method. 
This could be explained by the fact that with STE speckles are followed instead 
of tracing the endocardial border by Simpson’s. The last method requires higher 
quality images. Another important finding is that adult patients after CoA repair 
have decreased LV GLS while their EF is measured as normal. This was also ob-
served in a recent study with CMR feature tracking.17 Older age at repair has been 
shown as a predictor for LV long-axis dysfunction 18, however, even in children with 
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Figure 5 Comparisons of left ventricular global longitudinal strain in CoA patients sorted in vari-
ous groups
Symbols present median and whiskers present interquartile range. The dashed grey line depicts the mean LV 
global longitudinal strain of the healthy controls. *P<0.05 PLAX = parasternal long axis view.
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CoA repair, a decreased GLS was already observed whereas the EF was normal.19 In 
our cohort, patients more often had impaired LV diastolic function than controls, 
which is in line with the observed abnormal LV diastolic function in children with 
CoA.20 Lombardi et al. found a strong correlation between proximal ascending 
aortic elasticity and diastolic function in all children and suggested that, although 
CoA repair was successfully performed, persistently elevated aortic stiffness may 
lead to diastolic impairment. Arterial stiffness is a risk factor for cardiovascular 
events and mortality, and is associated with aging, hypertension and systemic dis-
orders.21 The relationship between arterial stiffness and intima media thickness 
with LV systolic and diastolic deformation has also been described in adults after 
CoA repair 11 and corresponds with our fi nding that blood pressure correlates 
with LV deformation. A meta-analysis of possible demographic and hemodynamic 
variables that contribute to LV GLS in healthy subjects showed that only blood 
pressure was independently associated with strain values.22 However, even in the 
patient group without hypertension, we still observed a decreased GLS compared 
with controls suggesting that other factors apart from blood pressure have impact 
on LV GLS. Besides the arterial stiffness, GLS could also be affected by myocardial 
fi brosis or by infl ammation.23,24 The observed chronic infl ammatory and possibly 
apoptotic reaction in adults with repaired CoA refl ects a functional problem in 
all vessels, regardless of the initial lesion. This could be implied by the increased 
levels of circulated cytokines specifi cally related to vascular endothelial dysfunc-
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Figure 6 Bland-Altman plots demonstrating intra-observer and inter-observer agreement.
Left ventricular global longitudinal strain measurements on apical four-chamber view for intra-observer (A) and 
inter-observer agreement (B). The solid lines depict the mean difference of two measurements, and the dashed 
lines depict the limits of agreement. COV = coeffi cient of variation.
assessment of left ventricular function in Coa patients 245
12
tion.24 All these factors may explain why CoA patients have an increased risk of 
developing late cardiovascular complications despite early repair and improved 
surgical procedures. To state whether decreased strain really enables the detec-
tion of preclinical LV dysfunction, follow-up studies are warranted in both children 
and adults. In addition, studies are needed to determine whether it is possible 
with the use of strain to distinguish between patients who will and who will not 
benefit from early treatment to reduce morbidity.
Relationships with patient characteristics
Univariable regression analysis showed that patients who had associated con-
genital cardiac lesions, who underwent multiple cardiac interventions or who 
underwent aortic valve replacement had a more decreased GLS. This adverse in-
teraction could partly be explained by the interventions themselves and probably 
by the long-time exposure to volume or pressure overload. In contrast, we did not 
find a significant difference in strain between patients with one CoA repair versus 
repeated CoA repair. Higher current blood pressure is related to lower GLS in our 
patient group. However, there is no significant difference in GLS between patients 
who met the criteria for hypertension and those who did not. This could possibly 
be explained by the antihypertensive drugs used by these patients resulting in a 
normal blood pressure nowadays.  These findings stress the importance of tight 
blood pressure regulation in this patient population even after successful CoA 
repair. The effect of tight blood-pressure control on GLS in these patients may be 
of interest and deserves further study.
Patients with CoA more often have hypertension and hypercholesterolemia 
which predispose to coronary artery disease.6 However, only 6 (former) smokers 
were included in our study and only one patient had an elevated cholesterol level. 
Therefore, no conclusions can be drawn regarding these risk factors and GLS.
Relationships with conventional echocardiographic measurements
Although the anteroposterior LA diameter did not differ significantly from that of 
healthy controls, we observed that the LA diameter correlated with the GLS. This 
suggests LV-LA interaction which is in line with the arterial-LV-LA interaction ob-
served in CoA patients 11, as well as in preclinical patients with cardiovascular risk 
factors.25 An enlarged LA, even when measured only in anteroposterior direction, 
is associated with adverse cardiovascular outcomes.26 In contrast, LA area did not 
correlate with GLS, possibly due to the poor image quality of the LA at the A4C. 
Furthermore, LV mass is an important risk factor for cardiovascular events.27 In 
our study, a higher LV mass, but also thicker LV posterior wall and interventricular 
septum, both important parameters for LV mass, were associated with lower GLS. 
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The patients of our study cohort were relatively young with a mean age of 33 
years, and therefore surveillance of GLS might be regarded as an important treat-
ment target in reducing the risk for events.
Intra-observer and inter-observer agreement
The coefficients of variation for the intra-observer and inter-observer measure-
ments were acceptable and comparable to other STE studies.28,29 
Limitations
A limitation is the relatively heterogeneous group of patients restricting the abil-
ity to perform some subgroup analyses. Significant differences we found between 
subgroups should be interpreted with caution. 
ConClusions
Despite a well-repaired CoA, the majority of adult patients have decreased LV 
GLS at late follow-up, while conventional 2D-echocardiography showed normal 
systolic LV function. Patients with higher blood pressure, associated congenital 
cardiac anomalies, higher LV mass or larger LA dimension have more decreased 
LV GLS. Whether decreased LV GLS will eventually lead to clinical heart failure and 
can identify patients in subclinical heart failure, and whether early detection can 
reduce morbidity, needs to be investigated in follow-up studies.
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online suPPleMent
Online Resource 1. Clinical and echocardiographic characteristics stratified by global longitudinal strain val-
ues in tertiles
Tertiles (GLS, %): 10.6-16.1% 16.2-17.9% 18.0-22.3% P-value
n=23 n=22 n=23
Kruskal 
wallis
Age (years) 37.1 [21.6-48.4] 27.8 [22.6-35.4] 30.2 [20.7-37.7] 0.394
Body mass index (kg/m2) 26.3 [23.5-28.7] 24.4 [21.9-28.4] 22.8 [21.3-26.3] 0.097
Systolic blood pressure (mmHg) 131 [127-155] 131 [127-140] 135 [119-140] 0.583
Diastolic blood pressure (mmHg) 81 [75-90] 80 [74-85] 74 [67-79] 0.047
QRS duration (ms) 113 [103-138] 106 [97-118] 112 [104-119] 0.32
LA dimension (PLAX) (mm) 36 [32-41] 36 [30-42] 33 [30-35] 0.052
LV end-diastolic dimension (mm)  51 [46-55] 49 [47-53] 49 [45-53] 0.702
LV end-systolic dimension (mm) 31 [28-33] 31 [28-35] 31 [27-33] 0.812
Interventricular septum (mm) 10 [9-11] 9 [8-11] 9 [8-10] 0.018
LV posterior wall (mm) 10 [9-10] 9 [8-10] 8 [7-9] 0.023
LV mass calculated (g) 181.1 [146.9-214.2] 160.0 [138.3-210.7] 149.45 [120.2-175.0] 0.127
LV EF Simpson’s (%) 54 [52-57] 56 [54-61] 61 [53-66] 0.032
LV deceleration time (ms) 185 [160-218] 191 [159-251] 201 [175-241] 0.784
LV E-top (m/sec) 0.87 [0.73-1.17] 1.00 [0.86-1.20] 1.10 [0.90-1.16] 0.092
LV E/A-ratio  1.33 [1.09-1.66] 1.49 [1.27-1.99] 1.58 [1.26-2.25] 0.161
LV E’ (cm/sec) 8.11 [6.68-9.49] 9.80 [8.34-12.60] 8.89 [7.68-11.43] 0.035
NT-proBNP 9.4 [2.7-21.1] 7.2 [5.2-13.9] 5.5 [2.6-10.3] 0.475
Data are presented as median [1st quartile-3rd quartile]. 
E = peak mitral inflow velocity at early diastole; E’ = early diastolic annular myocardial velocity; EF = ejection 
fraction; GLS = global longitudinal strain; LA = left atrium; LV = left ventricle; NT-proBNP = N-terminal pro-Brain 
Natriuretic Peptide; PLAX = parasternal long-axis view
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suMMary and general disCussion
This thesis investigated the long-term outcome in adult patients with congenital 
heart disease (CHD) and evaluated novel, non-invasive echocardiographic tech-
niques in both a healthy population and in adult patients with CHD. These novel 
echocardiographic techniques could contribute to a more accurate quantitative 
assessment of left ventricular (LV) and right ventricular (RV) function. Especially 
in the field of CHD, focus on the right heart is of eminent importance. Due to the fact 
that most acquired cardiovascular diseases affect primarily the LV, the emphasis in 
cardiology has predominantly been on imaging of the left heart. This has resulted 
in less clinical experience in how to study the RV. As a result of the retrosternal 
position and the complex shape of the RV, imaging and functional assessment with 
ultrasound can be difficult. With novel echocardiographic techniques as speckle-
tracking echocardiography (STE) subtle changes in myocardial deformation can 
be detected, which may be a sign of early ventricular dysfunction.1, 2 With the 
early detection of ventricular dysfunction, we aim for a better outcome for CHD 
patients. In this general discussion, we will address our research questions and 
discuss the outcomes against the background of published literature. We will end 
this chapter with a brief discussion on future perspectives.
Novel echocardiographic techniques in a healthy population
During the last decade, two-dimensional (2D) STE has become available which of-
fers objective measurements to quantify regional and global ventricular function, 
independent of angle and ventricular geometry.3 With the use of STE, ventricular 
dysfunction may be detected in a pre-clinical phase. However, information on nor-
mal ranges of STE-derived measures and the prognostic value of deviant measures 
is limited, especially in patients with repaired or unrepaired CHD.1, 2, 4, 5
The first part of this thesis focuses on novel echocardiographic techniques in 
the healthy population. We initiated an echocardiographic study with 155 healthy 
individuals, the Navigator study, to obtain normal values for STE-derived param-
eters. These subjects were recruited in a stratified fashion to provide at least four-
teen participants of each sex, representing each age decade from 20 to 72 years. 
In addition, we evaluated possible associations between longitudinal strain and 
anthropometric factors, such as age, sex, body mass index, body surface area and 
blood pressure. Chapter 2 demonstrated that LV peak systolic global longitudinal 
strain (GLS) was higher in female than male subjects. The higher LV GLS in women 
described by us corresponds to the study of Taylor et al.6 who measured GLS with 
feature-tracking cardiovascular magnetic resonance (CMR). We could not provide 
a clear explanation for these higher values. This however is not an incidental find-
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ing, as indicated by the decision of the European Society of Cardiology writing 
group on the current guidelines that the clinical cut-off values for normal LV ejec-
tion fraction are higher for women than men.3 In recent years, increasing attention 
has been paid to sex differences regarding cardiovascular diseases. Differences 
in LV and RV structure and function have been described, including larger vol-
umes and greater mass in healthy men than in healthy women.7-9 In contrast, in 
a meta-analysis including 2,597 healthy normal subjects, no difference in LV GLS 
was found related to sex.10 The different vendors that have been included in this 
study might have had an influence. Nevertheless, our findings of sex-dependent 
variations in longitudinal strain, and the earlier reported variations in cardiac 
mass and volume, advocate the use of sex-specific normal values for myocardial 
deformation in clinical practice.
Besides the finding that sex affects LV GLS, body surface area and blood pres-
sure were also associated with LV GLS. Indexation of LV GLS for body surface area 
resulted in even stronger correlations regarding blood pressure and sex. There-
fore, we advise to correct strain not only for sex, but also for body surface area, as 
only appropriate reference values can be used in the determination of normality 
or abnormality of ventricular function. In the light of this popular topic regarding 
more tailored reference values, it would be interesting to examine the possible 
differences in myocardial deformation with regard to races and ethnicities in large 
studies. These factors could also be crucial to take into account when interpreting 
strain results.
In clinical situations, the majority of ultrasound laboratories use several 
ultrasound machines from different vendors for routine echocardiographic ex-
aminations. One of the main disadvantages of STE is the intervendor variability. 
Published studies aiming to clarify differences in strain values between specific 
disease states and normal conditions often used different ultrasound vendors 
with different analytical software and cutoff values.11 Intervendor peak strain 
values measured by vendor-specific software in the same subjects are frequently 
different and seem incomparable.12 This limitation has raised concerns whether 
STE can become an acceptable mainstream methodology in daily clinical applica-
tion, especially in laboratories with echocardiographic machines from multiple 
vendors.13 In response to these intervendor discrepancies, a task force has been 
established consisting of members of the European Association of Cardiovascular 
Imaging, members of the American Society of Echocardiography and technical 
representatives from interested vendors to reduce the intervendor variability of 
strain measurement.14, 15 They developed a consensus statement to communicate 
standard physical and mathematical definitions of various parameters commonly 
reported in myocardial-deformation imaging. Subsequent to the standardisation 
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created by this task force, the concordance in LV GLS between two leading ultra-
sound manufactures (Philips and GE Medical Systems) has been improved.13 Our 
LV longitudinal strain measurements in healthy controls were assessed with QLAB 
10 (Philips Medical Systems, Best, the Netherlands), a software package released 
after the work of the joint standardisation task force. To our best knowledge, our 
study was the first study reporting normal LV longitudinal strain values for QLAB 
software after the strain standardisation. Even though the task force worked 
toward harmonising GLS measurements resulting in acceptable intervendor vari-
ability, a certain variability still exists.11 Until now, not all vendor systems and 
versions have been evaluated for improved intervendor concordance making 
it unjustified to extrapolate the results to all systems used in clinical work and 
research. Therefore, it remains of paramount importance to continue this task 
force and to bring vendors, cardiologists and scientists together to openly dis-
cuss the technical as well as the clinical issues they encounter. Exchange of their 
expertise and experiences will give vendors opportunities to tune their software, 
to provide more uniformity in results, and to make it more user friendly and less 
time-consuming. Only then can STE become a diagnostic tool in routine clinical 
care and patient follow-up. Although we strive for improvement and wider use of 
strain for diagnostic purposes, we may have to accept that complete concordance 
between strain measurements remains elusory as variability issues also occur in 
other cardiovascular-imaging modalities and measurements.
Assessment of RV function is of utmost importance in patients with CHD. Echo-
cardiographic evaluation of RV is challenging because of the complex shape and 
its retrosternal position. Unlike the LV that can be completely visualised from one 
apical window, a multi-view approach is necessary for a comprehensive evalua-
tion of RV size and function.3, 16 Current echocardiographic methodologies do not 
provide a robust assessment of RV function. Due to the lack of fixed anatomic land-
marks, serial follow-up of RV measurements results in significant inaccuracies.16 
In Chapter 3, our study showed that among the healthy subjects of the Navigator 
study, a 13-segment standardised model for RV assessment is feasible using 2D-
iRotate mode. The iRotate mode is a new visualisation tool developed by Philips,17 
which consists of a matrix transducer that can electronically steer the ultrasound 
beam through 360° to obtain different views within the acoustical window, rather 
than manually rotating the transducer. The 13-segment model created by us was 
based on unique anatomic landmarks and achieved from a single acoustic window. 
As far as we know our study is the first to assess tricuspid annular plane systolic 
excursion (TAPSE) and tissue Doppler imaging (S′) measurements from the tri-
cuspid annulus on the multiple views. Although many segments of the RV walls 
could be visualised, the visibility of the RV outflow tract anterior wall remained 
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challenging. On the other hand, in the pilot study with the diseased RVs (dilatated 
or hypertrophic), the long axis of the heart was more horizontal and therefore 
the sternum distorted the image quality to a lesser degree. We would therefore 
expect that the rotation with iRotate mode around diseased RVs to be easier than 
around normal-sized RVs resulting in better image quality. Whether these multiple 
RV views are suitable for adequate STE and applicable for daily clinical use has to 
be investigated.
Clinical outcome and early detection of ventricular dysfunction in 
repaired tetralogy of Fallot
The second part of this thesis encompasses the evaluation of long-term outcome 
and complications in adult patients after tetralogy of Fallot (ToF) repair and the 
usefulness of STE in these patients to detect ventricular dysfunction at an early 
stage.
In Chapter 4, we described the clinical outcome of a unique prospectively fol-
lowed cohort of unselected ToF patients.18 After excluding postoperative mortality 
within 30 days, the 40-year survival after surgery was 86%. This is slightly lower 
than the survival of the general Dutch population. The causes of late mortality 
in our cohort were heart failure and arrhythmia which are in line with the litera-
ture.19-22 However, those studies had a retrospective design and most of them had 
a shorter follow-up duration. In the fourth decade after surgery, the morbidity 
continued to worsen with an incidence up to 75%. The most frequent events were 
reoperations and arrhythmias. The systolic RV function was impaired in more 
than 75% of the patients and systolic LV function in half of the patients. Nonethe-
less, the self-perceived health status was excellent and objective exercise capacity 
remained stable over the last ten years. This generally good self-perceived health 
status among ToF patients, despite declining cardiac function, was also reported 
by others.23 Self-assessment may be a misleading portrait of the disease state and 
may delay the presentation for treatment.24 Heart failure is one of the main causes 
of death in adult ToF patients. To identify the patients who are at risk for heart fail-
ure, it is essential that their ventricular function could be adequately monitored 
and declining function to be detected earlier. Better risk stratification at an early 
stage would probably result in a more suitable medical treatment regimen or more 
precise timing for reinterventions. However, it must be stated that adequate medi-
cal therapy is not easy to achieve. Most of the commonly used and effective drugs 
which are prescribed in left-sided heart disease, have not been proven beneficial 
in patients with right-sided lesions such as ToF patients.
Amongst ToF patients, the RV has been the ventricle of interest for years. Pro-
gressive RV dilatation and dysfunction, as a result of pulmonary regurgitation, are 
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common and are well-established risk factors for adverse clinical outcomes.25, 26 
Nowadays, some studies report that LV dysfunction is also a strong independent 
determinant of clinical outcome. Therefore, late deterioration of both RV and LV 
function has been an increasing concern.27-30 In our cohort, as described in Chapter 
5, we indeed found a significant relationship between the dysfunction of RV and LV 
measured with conventional echocardiography and cardiac magnetic resonance 
imaging (CMR). Nonetheless, only limited data exist relating the early detection of 
LV dysfunction and the utility and prognostic importance of STE-derived values 
among patients with repaired ToF. In patients with acquired heart disease or 
chronic kidney disease, LV GLS assessed by STE is a predictor of cardiovascular 
events such as heart failure.31 LV GLS is even a predictor superior to LV ejection 
fraction of all-cause and cardiovascular mortality.32, 33 STE can not only be used for 
quantitative assessment of ventricular function by strain measurement, but also 
for better understanding of ventricular-ventricular interaction.
In Chapter 5 and Chapter 6, we gained more insight into ventricular-ventricular 
interaction by evaluating STE-derived strain and rotational parameters in a cohort 
of adult patients with repaired ToF. In Chapter 5 we described the results of peak 
systolic longitudinal strain of the LV and the RV free wall measured with STE in a 
cohort of 94 ToF patients and 85 healthy controls.34 In this cross-sectional study, 
RV as well as LV peak systolic longitudinal strain were lower in the patients than 
in the healthy controls. Of the RV free wall, especially the apical deformation was 
impaired suggesting that apical function is most affected in volume overloaded 
RVs. The RV free wall strain of our adult patients was related with their LV GLS. 
Of the LV, the septal strain was mainly decreased. Both findings indicate potential 
ventricular-ventricular interaction. The assessment of ventricular-ventricular 
interaction in children also revealed that RV free wall strain and LV GLS were 
closely related and that LV strain was significantly decreased at the mid and api-
cal levels.35 Ventricular-ventricular interaction could probably be explained by 
the shared myocardial fibers, changes in septal curvature and electromechanical 
dyssynchrony. Additionally, in this chapter we reported a trend towards a signifi-
cant relationship between LV GLS and N-terminal pro-B-type natriuretic peptide 
(NT-proBNP), a well-established biomarker in acute and chronic heart failure 
due to acquired heart disease. Besides alterations in longitudinal strain, we also 
investigated rotational movements of the LV in 82 adult patients after ToF repair, 
as described in Chapter 6. The majority of ToF patients had a reduced LV twist 
compared with controls, mainly as a result of decreased apical rotation. Patients 
with a decreased or abnormal apical rotation had larger LV dimensions and worse 
systolic biventricular function.36 These findings strengthen the hypothesis that 
RV dysfunction adversely affects LV function. Already in childhood, a reduced 
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LV twist could be observed.35, 37 This reduced LV twist could be caused by RV 
dilatation. RV dilatation, which is most pronounced in the apical part, may lead 
to distortion of LV apical geometry and altered fiber orientation of the apex of the 
heart.38 Subsequently, these alterations could result in abnormal or decreased LV 
apical rotation and eventually LV dysfunction. Adverse ventricular-ventricular in-
teraction may also be affected by abnormal motion of the interventricular septum, 
because abnormal septal motion was more often seen in patients with abnormal 
twist. Another explanation for the ventricular-ventricular interaction could be the 
obligatory interventricular septal defect patch which had been used during repair. 
This patch results in dysfunction of at least a portion of the ventricular septum39, 40 
and may contribute to abnormal basal rotation. In Chapter 7 we focused more in 
depth on the association between NT-proBNP and cardiac function in 177 adults 
with repaired ToF.41 NT-proBNP levels were (slightly) elevated in more than 50% 
of the patients, while they were in stable clinical condition. Higher NT-proBNP 
levels were associated with LV dysfunction rather than RV dysfunction, and with 
larger LV and RV dimensions. Furthermore, patients with an abnormal LV twist 
pattern more often had elevated NT-proBNP levels than patients with a normal LV 
twist pattern. In children with repaired ToF, NT-proBNP was not related to systolic 
LV function, presumably because LV function in these children is generally still 
normal.42
These associations discussed above of STE-derived parameters and NT-proBNP 
in adults with repaired ToF are promising. Because STE may enable the detection 
of changes in cardiac function earlier than currently used tests, such as conven-
tional echocardiography or CMR, this technique could actually play an important 
role in clinical decision making. Therefore, abnormal apical rotation, decreased 
longitudinal strain and elevated NT-proBNP levels are new and important objec-
tive diagnostic criterions for detection of early and subclinical ventricular dys-
function in ToF patients. Whether these measures really have the potential to be 
included in patients’ routine examination to monitor ventricular function and to 
detect clinical deterioration before ventricular dysfunction becomes apparent, is 
unclear and remains to be established in a prospective study. Moreover, further 
research in this field is clearly warranted to determine whether the use of these 
measures as objective diagnostic tools really provide the possibility for more ac-
curate timing of medical treatment or reinterventions. An important requirement 
for reliable follow-up measurements and cut-off values for treatment is that the 
intra-observer and inter-observer agreements of RV strain have to be improved. 
The variability of current RV measurements is too large to determine accurate 
and applicable reference values. The software packages we used had an algorithm 
developed for the LV. Hence, dedicated software packages should be developed 
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for the RV. Furthermore, the image quality of the RV walls has to be improved to 
result in greater feasibility and more adequate tracking. Advances in technology 
are promising and will probably result in better image quality in the future. On the 
other hand the Dutch population, including those with CHD, are becoming more 
adipose which makes the acquirement of good-quality images more troublesome. 
Therefore, we postulate that satisfying image quality of the RV will remain an issue 
in the forthcoming years.
Clinical outcome and early detection of ventricular dysfunction in 
other congenital heart anomalies
The third part of this thesis delineates the long-term outcome and ventricular 
function in patients with a repaired ventricular septal defect (VSD), repaired atrial 
septal defect (ASD), repaired coarctation of the aorta (CoA) or a systemic RV.
A VSD is by far the most common CHD in children.43 The presence of a signifi-
cant left-to-right shunt can cause LV overload, pulmonary arterial hypertension, 
ventricular dysfunction, arrhythmias, and aortic regurgitation.44, 45 Surgical closure 
at young age is the treatment of choice. With a greater number of adults surviv-
ing decades after successful surgery, the urgency is growing for better charac-
terisation of CHD-related morbidities and mortality that occur late after surgical 
intervention.46 Because most such patients have been discharged from routine 
cardiological follow-up, limited data regarding outcomes in late survivors of VSD 
closure were available.47-50 In addition, most studies that have been published 
included only patients who are still seen at the adult outpatient clinic, creating a 
publication bias. In Chapter 8, we provided additional information by describing 
the long-term outcome in a unique longitudinally followed cohort of VSD patients 
who underwent surgical repair at a young age.51 After exclusion of early postopera-
tive mortality, 40-year survival after surgical closure was 86%. This is slightly lower 
than of the general Dutch population, and comparable with the survival of our 
cohort with ToF patients.18 In more than one-half of the cases, late mortality was 
cardiac related. An important issue after VSD surgery is the occurrence of aortic 
regurgitation. In our cohort, the prevalence of aortic regurgitation nearly doubled 
over the last twenty years of the study, from 11% in 1990 to 21% in 2012. Systolic 
LV function was impaired in 21% of the patients but remained stable over the last 
decade. Meanwhile, systolic RV dysfunction increased over the last ten years to 
17%. The vast majority of patients with systolic RV dysfunction had systolic LV 
dysfunction and more often had elevated RV systolic pressure. This biventricular 
dysfunction could be explained either by the presence of a pacemaker in a quarter 
of patients with RV dysfunction or by ventricular-ventricular interaction. In the 
case of LV dysfunction, pulmonary pressure increases, which results in reduction 
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of RV contractility. Moreover, ventricular-ventricular interaction is mediated by 
forces at the interventricular septum and mechanical coupling through shared 
myocardial fibers: when the LV becomes more spherical, the fibers of the interven-
tricular septum become less oblique, which reduces and impairs RV contractile 
function.52, 53 Among children up to 20 months after surgical VSD closure, a systolic 
RV impairment was already found with tissue Doppler imaging.54 Although this 
subclinical RV impairment may not be of direct clinical relevance, it could be a first 
sign of systolic RV dysfunction and stresses the importance of detailed evaluation 
of RV function after VSD surgery. The progressive decline in ventricular function 
at adult age raises concerns that a significant proportion of these patients are at 
risk for developing heart failure in the future.
The next two chapters shed further light on long-term outcome and ventricu-
lar function in patients after surgical ASD repair. In Chapter 9 we described the 
results of a longitudinal follow-up of a cohort of patients who underwent surgical 
closure of a hemodynamically significant ASD at young age.55 The 40-year survival 
was comparable with the normal Dutch population. Despite the morbidity of 30%, 
no heart failure was observed and the exercise performance was normal. On 
both conventional echocardiography and CMR, the RV function was abnormal 
in one-third of the patients. This was somewhat unexpected as RV function was 
normal in all patients ten years ago. Signs of pulmonary hypertension, a major 
problem that may occur in patients without closure of the ASD,56 were not found. 
One-fifth of the ASD patients had mild LV dysfunction on CMR, which could be 
driven by ventricular-ventricular interaction. Literature on LV and RV deformation 
in adult patients late after surgical ASD repair was lacking. Therefore we used STE 
to assess longitudinal strain among 51 ASD patients at least 30 years after surgi-
cal repair as described in Chapter 10.57 Even though these patients were already 
operated in childhood, peak systolic RV free wall GLS was lower than in healthy 
controls. Presumably, this reduction is either a result of the preoperative chronic 
volume overload or related to the closure technique. Both children and adults 
without ASD closure have higher RV GLS than healthy controls due to volume 
overload.58-60 The RV volume overload induces ventricular remodelling which pos-
sibly also took place in our patient group before closure. Besides preoperative 
volume overload, the surgery itself, including factors such as closure technique 
and the use of cardiopulmonary bypass or hypothermia, might also contribute 
to decreased RV deformation. To confirm that surgery is a possible cause, a lon-
gitudinal study is recommended comparing strain of patients with a surgically 
closed ASD with strain of patients with a percutaneously closed ASD after the 
same follow-up length.
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A remarkable finding is that the RV strain was most decreased in the apical seg-
ment, like we also observed in ToF patients. The more profound impairment of the 
apical deformation in both patient groups is a debatable subject. A first possible 
explanation may be the thinner and more trabeculated apical portion compared 
to the basal portion. When the wall is thinner, the passive wall stress is higher, 
which is inversely related with strain and therefore results in smaller longitudinal 
deformation. Secondly, remodelled volume overloaded RVs seem to have a more 
straight apical segment. Structures with straight walls have to deal with higher 
wall stress. Thirdly, it could be possible that in some RVs a hypertrophied mod-
erator band and trabeculations lead to a smaller regional volume and therefore 
might decrease the apical deformation. Lastly, it could be explained by alterations 
of β-adrenergic receptor signaling. RV volume overload leads to β-adrenergic sig-
naling abnormalities, e.g. increased levels of β-adrenergic receptor kinase 1, and 
redistribution which result in a significant reduction in chamber contractility.61-64
The mean LV GLS of the ASD patients was comparable with that of controls 
which is in line with adults who underwent percutaneous closure.58 When focused 
on regional LV deformation, the strain of the apical septum was decreased. A simi-
lar but more pronounced finding was observed in our ToF cohort. Furthermore, 
LV GLS was positively correlated with RV free wall GLS in both patient groups. 
Thus, also findings in ASD patients support the principle of ventricular-ventricular 
interaction, i.a. due to the diminished RV function that interacts with the septum. 
However, the exact impact of the preoperative chronic volume loading on RV and 
LV function in later life is still not completely elucidated. We recommend following 
these patients to determine whether they will develop heart failure in the coming 
decades.
In Chapter 11, we examined a more challenging group of patients with STE: 
patients with a systemic RV.65 A morphologic RV supports the systemic circula-
tion in patients with transposition of the great arteries repaired by an atrial 
switch procedure (TGA-Mustard) and in patients with congenitally corrected TGA 
(ccTGA). RV geometry is not made to encounter this chronic pressure overload.62 
Therefore, patients with TGA-Mustard and ccTGA are afflicted by RV dysfunction 
leading to heart failure. This complication adds to morbidity and induces excess 
mortality in this population.66-68 Hence adequate monitoring and early detection 
of deterioration in RV function is a key point in the follow-up of these patients. 
Our study demonstrated that patients with a systemic RV have lower GLS of the 
systemic ventricle than healthy controls. The lower strain is most pronounced 
in the apical segments, suggesting that apical function has suffered most from 
chronic pressure overload. Thus, besides volume overload as in ToF and ASD 
patients, also pressure overload affects the apical part particularly. GLS of the 
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systemic RV among patients in NYHA class II tended to be lower than among 
patients in NYHA class I. NYHA functional class has shown to be an independent 
predictor of worse clinical outcome, i.e. heart failure, heart transplantation, and 
death, in patients with a systemic RV.69 The tendency of worsening NYHA class 
indicates the potential prognostic value of strain measurement in patients with 
a systemic RV. Average GLS of the RV free wall was lower in patients with TGA-
Mustard than in patients with ccTGA. This is an interesting finding, while with 
conventional echocardiography clear differences between the two groups have 
not previously been described. Possibly, the lower free wall GLS was caused by the 
surgical intervention. Loss in RV longitudinal contractile function with compensa-
tory gain in transversal contraction is seen in patients after other cardiac surgery, 
i.e. coronary artery bypass surgery,70 or gain in circumferential strain in young 
adolescents after Senning surgery.71 Another reason for better preserved GLS in 
patients with ccTGA could be that their RV is more resistant to chronic pressure 
overload. The RV of ccTGA patients encounters systemic pressure from birth, 
whereas the RV of patients with TGA-Mustard did not. Furthermore, the difference 
could be explained by the absence of additional atrial function in patients with 
TGA-Mustard. Although we know that both patients with TGA-Mustard and ccTGA 
will develop RV dysfunction and heart failure,66, 72 this difference may indicate that 
decline in RV function is less progressive in patients with ccTGA than in those with 
Mustard-TGA.
In Chapter 12 we evaluated LV GLS in 75 adult patients after CoA repair and 
in 75 healthy controls. This patient group had been exposed to chronic LV 
pressure overload. Although survival among these patients has improved since 
the introduction of repair, the morbidity is still considerable.73, 74 To improve 
cardiovascular outcome, early detection of LV dysfunction could be helpful. In 
a cross-sectional manner, we showed that LV GLS was reduced in many patients, 
which was not detectable with conventional 2D-echocardiography providing 
evidence of subclinical LV dysfunction. A comparable finding was also observed 
with feature-tracking CMR.75 In addition, we found lower LV GLS when patients 
had higher blood pressure, associated cardiac lesions, aortic valve replacement 
or a larger left atrium. The association of LV GLS with blood pressure in CoA pa-
tients deserves additional attention because it corresponds with the association 
found in the healthy subjects described in Chapter 2. A recently published paper 
reported that higher cumulative exposure to blood pressure over 25 years from 
young adulthood to middle age was associated with lower LV longitudinal strain, 
but not with LV ejection fraction.76 These findings reflect that a relatively small 
increase in afterload will result in lower LV GLS rather than lower LV ejection frac-
tion. This may make strain a sensitive marker for incipient LV dysfunction caused 
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by higher blood pressure. To improve patients’ cardiovascular outcome after CoA 
repair, earlier and/or stricter blood-pressure control might be essential. LV GLS 
may carry diagnostic and prognostic value in such strategy and may be more op-
timal than LV ejection fraction. The clinical utility of LV GLS in these patients and 
the precise effect of strict blood-pressure control on LV GLS deserve further study.
ConClusions and future PersPeCtiVes
This thesis sheds further light on the long-term outcome and ventricular function 
in adult patients with various types of CHDs. We also studied newly introduced 
echocardiographic techniques in both healthy controls and CHD patients. STE is 
a relatively inexpensive and safe imaging modality that provides a more accurate 
method in quantitative analysis of ventricular function than the currently used 
standard 2D-echocardiography. STE also enables detection of subtle changes in 
myocardial wall deformation. We hope that these advances will reduce morbidity 
in the future.
Nowadays, the survival of patients after surgical repair of various CHD types is 
good. Notwithstanding, the morbidity and the occurrence of ventricular dysfunc-
tion are substantial. The most frequent events are reinterventions and arrhyth-
mias. Improvement of risk stratification to identify patients who are at high risk for 
developing complications is important. These high-risk patients would probably 
benefit from more frequent and intensified checks, adjustments in medical treat-
ment or undergoing interventions, whereas in low-risk patients fewer checks are 
required. Such risk stratification may also improve the cost effectiveness in health 
care. Newer echocardiographic techniques described in this thesis seems to 
provide a robust tool for detection of subclinical functional and structural cardiac 
changes, and also for evaluating the natural history and the efficacy of therapeutic 
interventions over time. Based on the current results, however, we can only specu-
late that the early detection of abnormal RV and LV deformation may ultimately 
lead to a successful attempt to slow disease progression. For example, the benefit 
of earlier surgical or percutaneous reinterventions or neurohormonal blockade to 
reverse the ventricular remodelling and prevent clinical heart failure is unknown 
in this population. Our studies concerning the assessment of STE in patients, were 
conducted in a cross-sectional design. Prospective follow-up studies providing 
information about adverse events are warranted to determine the clinical and 
predictive value of STE and the effectiveness of a treatment.
Better understanding of the pathophysiology of CHD will probably enable us 
to modify the disease process resulting in regression of subclinical ventricular 
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changes. However, we must acknowledge that the precise nature of LV dysfunction 
after surgical ToF repair and the underlying mechanisms driving adverse ventricu-
lar-ventricular interactions in this condition remain incompletely understood. The 
role of surgical modifications at time of repair, pulmonary or aortic regurgitation, 
residual RV outflow obstruction, pulmonary stenosis, aortic recoarctation, aortic 
root dilatation, septal mechanics, electro-mechanical dyssynchrony, residual 
shunts and timing of interventions are all factors that could affect biventricular 
function in patients with CHD. Therefore, large prospective studies are required to 
define cause and effect.
The reproducibility of STE-derived LV longitudinal strain in healthy controls is 
good. We recommend the use of sex-specific and body-surface-area-dependent 
reference values. The reproducibility of LV longitudinal strain in CHD patients 
was acceptable. However, it should be emphasised that this imaging technique 
has its limitations. Although the complex-shaped RV could be visualised with 
conventional 2D-echocardiography and iRotate mode, the reproducibility of STE-
derived strain from the RV was considerably lower than from the LV and thus 
worrying. The variability of RV strain was acceptable for research purposes, e.g. 
the assessment of regional dysfunction or analysing ventricular interaction. How-
ever, the variability was too large to establish accurate and applicable reference 
values for diagnostic purposes and for individual patient follow-up. The lower 
reproducibility of RV measurements may be caused by the lack of software pack-
ages specifically for the RV. At the moment we have to use an LV-based algorithm, 
hence, it is necessary for dedicated software packages to be developed for the 
RV. Reproducibility could be further increased by improving image quality of the 
RV walls. Advances in technology are promising and will probably result in bet-
ter image quality in the future. On the other hand, patients are becoming more 
adipose which makes the acquirement of good-quality images more challenging. 
Therefore, we postulate that satisfying image quality of the RV will remain an issue 
the forthcoming years. Another limitation of STE we encountered, was the time-
consuming offline-analysis. It would be a step forward to the widespread clinical 
use and routine day-to-day imaging when the analysis can be performed at bed-
side whereby the results of the measurements could immediately be seen on the 
screen. These observations underline the importance for innovations regarding a 
reliable, inexpensive and minimal time-consuming quantitative assessment of the 
RV. Subsequently, studies are required which critically validate newly introduced 
techniques in healthy volunteers and in patients afterwards.
Overall, this thesis provides an overview of long-term clinical outcome and 
cardiac function in adult patients with CHD. As a result of the observed morbidity, 
we advise a lifelong clinical follow-up for all CHD patients. The clinical use of STE 
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is promising in this field, although some limitations have to be overcome. We hope 
our results motivate new study fields that may eventually lead to an improvement 
in the prognosis of this patient group.
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Een aangeboren hartafwijking (AHA) is de meest voorkomende aangeboren afwij-
king bij pasgeborenen. De acht meest voorkomende hartafwijkingen bij geboorte 
zijn een ventrikelseptumdefect (gaatje in het tussenschot van de hartkamers 
[34%]), atriumseptumdefect (gaatje in het tussenschot van de boezems [13%]), 
open ductus Botalli (open verbinding tussen de aorta en de longslagader [10%]), 
pulmonalisstenose (een vernauwing van de longslagaderklep [8%]), tetralogie 
van Fallot (een combinatie van vier hartafwijkingen [5%]), coarctatio aortae (een 
vernauwing van de aorta [5%]), transpositie van de grote vaten (een verkeerde 
aansluiting van de slagaders uit het hart [5%]) en een aortastenose (vernauwing 
van de aortaklep [4%]). Door zowel de verbeteringen in diagnostiek, hartchirurgie, 
anesthesie en intensive care als de huidige gespecialiseerde cardiologische zorg, 
is de levensverwachting van patiënten met een AHA enorm toegenomen. Tegen-
woordig bereikt ongeveer 90% van de kinderen met een AHA de volwassen leeftijd 
waardoor het aantal groeiende is. Hoewel de operaties op kinderleeftijd hebben 
gezorgd voor een betere levensverwachting, hebben veel patiënten nog wel te ma-
ken met restafwijkingen. Deze restafwijkingen zorgen voor een verhoogd risico op 
complicaties zoals ritmestoornissen en hartfalen, die kunnen leiden tot overlijden. 
Recent is een nieuwe echotechniek geïntroduceerd die in het bijzonder in staat 
is om vroege tekenen van een verminderde hartfunctie weer te geven: speckle-
tracking echocardiografie (STE). Het Engelse woord ‘speckle’ betekent spikkel 
en deze techniek is in staat een microstukje van de hartspier in zijn beweging 
te volgen. Hierdoor is veel nauwkeuriger dan bij voorgaande technieken te zien 
hoe het hart werkt. Met de mogelijkheid om subtiele veranderingen in de functie 
van zowel de linker als de rechter hartkamer te meten, hopen wij hartfalen in 
een vroeger stadium te kunnen detecteren en daardoor mogelijkheden te creëren 
voor vroegere behandeling. Het is namelijk belangrijk om vroegtijdig in te grijpen 
om te proberen te voorkomen dat het hart onherstelbaar beschadigd raakt. Het 
vroeg opsporen van kamerdisfunctie bij volwassen patiënten met een AHA zou 
dus kunnen leiden tot een betere timing van een behandeling, medicamenteus dan 
wel een interventie, wat kan leiden tot een betere overleving en kwaliteit van leven 
bij deze patiënten.
Het doel van dit proefschrift is het in kaart brengen van de langetermijnuit-
komsten bij volwassen patiënten met een AHA en het bestuderen van nieuwe, 
non-invasieve echocardiografische technieken in zowel een gezonde volwassen 
populatie als in volwassen AHA patiënten om de hartfunctie nauwkeurig te kunnen 
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beoordelen. Hoofdstuk 1 is de algemene inleiding van dit proefschrift waarin het 
doel en de indeling van het proefschrift worden beschreven.
Nieuwe echocardiografische technieken in een gezonde populatie
Om normaalwaarden op te stellen voor verschillende parameters gemeten met 
STE, hebben wij een echocardiografische studie opgezet bestaande uit 155 gezon-
de vrijwilligers: de Navigator studie. De deelnemers zijn tussen de 20 en 72 jaar, 
met in iedere leeftijdscategorie van tien jaar minstens veertien deelnemers per ge-
slacht. Een voorbeeld van een meting met STE is de “piek systolische longitudinale 
strain”: de procentuele verkorting van de hartspier in lengterichting tijdens de 
contractiefase. Dit is een kwantitatieve en accurate maat voor hartkamerfunctie. 
In Hoofdstuk 2 presenteren we de normaalwaarden voor linkerkamer piek systoli-
sche longitudinale strain per leeftijdscategorie en per geslacht. De strainwaarden 
van vrouwen zijn hoger dan die van mannen. Verder resulteert het hebben van 
een hogere bloeddruk of een groter lichaamsoppervlak in lagere strainwaarden. 
Daarentegen beïnvloedt leeftijd niet de hoogte van de strain. Naar aanleiding van 
deze bevindingen adviseren wij voor interpretatie van strainwaarden in de klini-
sche praktijk normaalwaarden te hanteren die rekening houden met het geslacht 
en lichaamsoppervlak van de patiënt.
Patiënten met een AHA hebben vooral problemen met de rechter hartkamer. 
Vanwege het feit dat de meeste verworven hartziekten met name de linker 
hartkamer beïnvloeden, is tot nu toe vrijwel alle ervaring met echocardiografie 
links opgedaan. Daarnaast is er minder ervaring in het bestuderen van de rechter 
hartkamer, omdat deze kamer een complexere vorm heeft en achter het borstbeen 
ligt. Met de bestaande echotechnieken kan deze complexe vorm nauwelijks in 
kaart worden gebracht. Philips heeft een nieuwe visualisatiefunctie ontwikkeld, 
“iRotate”, waarbij de matrixtransducer de geluidsgolven 360° elektronisch kan 
draaien met als voordeel dat de transducer met de hand stil kan worden gehouden 
op de borstkas. In Hoofdstuk 3 wordt beschreven hoe met behulp van de iRotate 
functie de volledige rechter hartkamer in beeld kan worden gebracht vanuit één 
standaard echocardiografische view. Verschillende unieke anatomische kenmer-
ken van de rechter hartkamer worden gebruikt als referentiepunten, zodat deze 
opnames makkelijk reproduceerbaar zijn. Alhoewel één wand lastig in beeld te 
krijgen is, de voorwand van de rechterkamer uitstroombaan, kunnen we stellen dat 
deze techniek bruikbaar is in een gezonde populatie, aangezien de overige rech-
terkamer wanden goed te visualiseren zijn in de gezonde vrijwilligers. We hebben 
deze techniek ook toegepast in een cohort van twintig patiënten met een vergrote 
rechter hartkamer door volume- of drukoverbelasting. Een opvallende bevinding 
is dat bij de patiënten de voorwand van de uitstroombaan beter te visualiseren is 
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dan in de gezonde populatie. De visualisatie van de overige rechterkamerwanden 
is vergelijkbaar met die van de gezonde vrijwilligers. Deze positieve bevindingen 
maken de techniek hoopgevend om toegepast te kunnen worden in de klinische 
praktijk. Om te bepalen of het ook mogelijk en betrouwbaar is om met STE strain 
te meten bij deze verschillende rechterkamerwanden verkregen met behulp van 
de iRotate functie, is vervolgonderzoek nodig.
Klinische uitkomsten en vroege opsporing van verminderde 
kamerfunctie bij gerepareerde tetralogie van Fallot
Het tweede deel van dit proefschrift richt zich op de klinische uitkomsten en 
de vroege opsporing van een verminderde hartfunctie bij patiënten met een 
gerepareerde tetralogie van Fallot. Tetralogie van Fallot is een aangeboren hart-
aandoening waarbij vier verschillende afwijkingen voorkomen: een gaatje in het 
kamertussenschot, een vernauwing bij of rondom de longslagaderklep, een over-
rijdende aorta en een dikkere rechterkamerspier. De langetermijnuitkomsten bij 
patiënten na chirurgische reparatie van een tetralogie van Fallot in de huidige 
literatuur zijn beperkt. In Hoofstuk 4 presenteren we de overleving en klinische 
uitkomsten van patiënten met tetralogie van Fallot die op kinderleeftijd tussen 
1968 en 1980 in Rotterdam een operatie hebben ondergaan. In het kader van de 
unieke “Rotterdam Quality of Life” studie worden deze patiënten elke tien jaar 
uitvoerig onderzocht in het ziekenhuis. Na een geslaagde operatie is nu, na 40 
jaar, nog 86% van de mensen in leven, hetgeen net iets lager is dan in de algemene 
Nederlandse bevolking. De oorzaken van overlijden op de lange termijn zijn hart-
falen en ritmestoornissen. Gedurende een follow-up van 35 jaar heeft ongeveer 
75% van de patiënten te maken gehad met één of meer complicaties, waarvan het 
grootste deel bestaat uit re-interventies en ritmestoornissen. Hoewel het aantal 
complicaties lijkt te blijven toenemen met de leeftijd in deze groep patiënten, sco-
ren ze hun kwaliteit van leven vergelijkbaar en op sommige schalen zelfs gunstiger 
dan de algemene Nederlandse bevolking van dezelfde leeftijd. Echter, meer dan de 
helft van de patiënten heeft een verminderde pompfunctie van het hart en daarom 
blijven zowel rechter- als linkerkamerdisfunctie een grote zorg bij deze patiënten.
In Hoofdstuk 5 wordt verder ingegaan op de rechter- en linkerkamerfunctie van 
volwassen patiënten met tetralogie van Fallot waarvoor ze op kinderleeftijd zijn 
geopereerd. Aan deze operatie houden patiënten vaak lekkage van de longslag-
aderklep over wat leidt tot volumeoverbelasting en rechterkamervergroting. Het 
effect van deze volumeoverbelasting op de hartfunctie hebben we gemeten met 
behulp van linkerkamer en rechterkamer piek systolische longitudinale strain in 
94 patiënten en in 85 gezonde controlepersonen van dezelfde leeftijd en hetzelfde 
geslacht. De longitudinale strain van de rechterkamer is lager in de patiënten dan 
276 nederlandse samenvatting
in de gezonde controlepersonen. Vervolgens hebben we in detail gekeken naar drie 
verschillende segmenten van de rechterkamerwand: het deel bij de punt (apex), 
het midden (mid) en het deel bij de klep (basis). Vooral het apicale deel toont 
een verminderde functie wat suggereert dat de apex het meest is aangedaan in 
volumeoverbelaste rechter hartkamers. Een afgenomen pompfunctie van de rech-
terkamer lijkt de linkerkamer te beïnvloeden. De verminderde longitudinale strain 
van de linker hartkamer wordt vooral veroorzaakt door een afgenomen functie 
van het kamertussenschot. Het mechanisme dat de ene hartkamer de andere 
hartkamer beïnvloedt, wordt ventriculaire interactie genoemd. Omdat een slechte 
linkerkamerfunctie gepaard gaat met meer klachten en een slechtere overleving, 
is het noodzakelijk op tijd in te grijpen bij achteruitgang van de rechter hartkamer 
om achteruitgang van de linker hartkamer te voorkomen.
Hoofdstuk 6 beschrijft de draaiende beweging van de linker hartkamer in 82 
patiënten met geopereerde tetralogie van Fallot en 56 gezonde controlepersonen 
om meer inzicht te krijgen in de ventriculaire interactie. In een gezonde situatie 
draait tijdens de contractie het basale deel van de linkerkamer met de klok mee, 
terwijl de punt van het hart tegen de klok in draait. Het hart maakt daardoor een 
wringende beweging, ook wel twist genoemd. Deze twist kan met STE gemeten 
worden en wordt uitgedrukt in graden. De meerderheid van de patiënten heeft een 
verminderde of afwezige linkerkamer twist in vergelijking met de gezonde contro-
les, voornamelijk vanwege een verminderde of abnormale draaiing van de punt 
van het hart. Patiënten met deze abnormale draaiing hebben een grotere linker 
hartkamer en slechtere linker- én rechterkamerfunctie. Aangezien beide kamers 
beïnvloed worden, sterkt deze bevinding het idee van ventriculaire interactie. 
Abnormale twist is mogelijk een nieuw, objectief diagnostisch criterium voor het 
opsporen van een verminderde hartfunctie in patiënten met gerepareerde tetralo-
gie van Fallot.
Hoofdstuk 7 richt zich op de toepassing van N-terminal pro-B-type natriuretic 
peptide (NT-proBNP), een laboratoriummarker die gemeten kan worden in het 
bloed en wordt afgegeven door hartcellen als reactie op volumeoverbelasting 
en rek op de hartwand. Wij hebben de NT-proBNP gemeten in 177 patiënten met 
tetralogie van Fallot. De NT-proBNP waarden zijn verhoogd in meer dan 50% van 
de patiënten terwijl bij de meesten de klinische conditie goed en stabiel is. Hogere 
NT-proBNP waarden hebben een relatie met een verminderde rechterkamerfunc-
tie, maar nog sterker met een verminderde linkerkamerfunctie. NT-proBNP zou 
daarom gebruikt kunnen worden bij de routinematige klinische controles van 
patiënten om de hartfunctie in de tijd te vervolgen en mogelijk ook voor het vroeg-
tijdig opsporen van verslechtering van deze hartfunctie.
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Klinische uitkomsten en vroege opsporing van verminderde 
kamerfunctie bij andere aangeboren hartafwijkingen
Het derde deel van dit proefschrift bevat informatie over de klinische uitkomsten 
en vroege opsporing van een verminderde kamerfunctie bij patiënten met andere 
typen AHA. In Hoofdstuk 8 worden de langetermijnuitkomsten beschreven van 
een longitudinaal gevolgd patiënten cohort 40 jaar na chirurgische sluiting van 
een gaatje in het kamertussenschot (ventrikelseptumdefect, VSD). Dit onderzoek 
is een onderdeel van de “Rotterdam Quality of Life” studie. In het geval van een 
geslaagde operatie op kinderleeftijd, is na 40 jaar nog 86% van de patiënten in 
leven. Dit percentage is iets lager dan die van de algemene Nederlandse bevolking 
en is vergelijkbaar met die van de geopereerde tetralogie van Fallot patiënten. Een 
belangrijk probleem bij VSD patiënten is het ontstaan van lekkage van de aortaklep. 
De laatste twintig jaar is het aantal patiënten met deze kleplekkage bijna verdub-
beld: van 11% in 1990 naar 21% in 2012. Een andere opvallende bevinding is dat 
een substantieel deel van de patiënten naast een verminderde linkerkamerfunctie, 
ook een verminderde rechterkamerfunctie heeft zonder dat ze klachten lijken te 
hebben. Deze kamerfunctie zou in de toekomst meer kunnen verslechteren wat 
uiteindelijk kan leiden tot klinisch hartfalen met klachten en een kortere levens-
verwachting. De VSD patiënten hebben naast een verminderde kamerfunctie in 
de laatste twintig jaar ook een toenemend aantal ritmestoornissen, terwijl het 
aantal chirurgische of percutane re-interventies redelijk stabiel blijft. De patiënten 
scoorden hun eigen kwaliteit van leven beduidend beter dan de algemene Neder-
landse bevolking. Een aanzienlijk deel van deze patiënten is tegenwoordig niet 
meer onder controle bij een cardioloog. Aan de hand van ons onderzoek raden 
wij echter aan om patiënten na chirurgische sluiting van een VSD, ook al is dit een 
relatief eenvoudige AHA, levenslang poliklinisch te blijven vervolgen.
Hoofdstuk 9 bevat informatie over de langetermijnuitkomsten bij volwassen 
patiënten na het sluiten van een gaatje in het boezemtussenschot (atriumseptum-
defect, ASD) op kinderleeftijd, ook een studie die onder de “Rotterdam Quality 
of Life” valt. Na 40 jaar is 91% van deze patiënten in leven, wat vergelijkbaar is 
met de algemene Nederlandse bevolking. Ondanks een redelijke morbiditeit van 
30%, met name vanwege ritmestoornissen, hebben deze patiënten een goede 
inspanningscapaciteit. Net als de andere patiënten die aan een AHA zijn geope-
reerd, scoren ook de patiënten met een chirurgisch gesloten ASD hun kwaliteit 
van leven beter dan de algemene Nederlandse bevolking. Op zowel de standaard 
echocardiografie als op MRI is in een derde van de patiënten een verminderde 
rechterkamerfunctie te zien. Dit is een opmerkelijke bevinding, omdat tien jaar 
geleden de rechterkamer nog normaal was. Eén vijfde van de ASD patiënten heeft 
een milde verslechtering van de linkerhartkamerfunctie op MRI. Ondanks deze 
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verminderde hartkamerfunctie, hebben de patiënten (nog) geen klachten passend 
bij hartfalen. Het is dus belangrijk deze patiënten goed te vervolgen zodat we kun-
nen bepalen of deze verminderde pompfunctie verder achteruitgaat en of er een 
behandeling gestart moet worden.
Hoofdstuk 10 gaat verder in op de kamerfunctie van patiënten met een chirur-
gisch gesloten ASD. De piek systolische longitudinale strain van de linker- en de 
rechterkamer is gemeten in 51 patiënten en 51 gezonde controlepersonen gematcht 
in leeftijd en geslacht. Ook al zijn de patiënten reeds op kinderleeftijd geopereerd, 
de rechterkamer strain is lager dan bij de gezonde controles. Vooral het apicale 
deel van de rechterkamer is aangedaan, net zoals bij de patiënten geopereerd aan 
een tetralogie van Fallot. Deze verminderde kamerfunctie is mogelijk het gevolg 
van de volumeoverbelasting op de rechterkamer voor de sluiting van het ASD. 
Tevens kan ook de operatie zelf, inclusief het gebruik van de hartlongmachine of 
de hypothermie, bijdragen aan de verminderde rechterkamerfunctie. De linker-
kamer strain is in de ASD patiënten 35 jaar na operatie vergelijkbaar met die van 
de gezonde controles. Ook al hebben we een licht verminderde pompfunctie van 
de rechterkamer gevonden bij patiënten met een op kinderleeftijd gesloten ASD, 
ze hebben er momenteel geen klachten van. Om te bepalen of deze verminderde 
kamerfunctie zich in de toekomst zal ontwikkelen tot hartfalen met klachten, zijn 
grote en langdurige onderzoeken nodig.
In Hoofdstuk 11 wordt de longitudinale strain gemeten bij patiënten die een 
systeem rechter hartkamer hebben. Een systeem rechter hartkamer is een hart-
kamer die de morfologie heeft van een rechterkamer maar de functie heeft van 
een linkerkamer. Deze rechterkamer ondersteunt dus de systeemcirculatie in 
plaats van de longcirculatie. Het patiënten cohort bestaat uit 32 patiënten met 
een transpositie van de grote vaten geopereerd volgens de Mustard methode 
en tien patiënten met een congenitaal gecorrigeerde transpositie van de grote 
vaten. Bij de congenitaal gecorrigeerde transpositie van de grote vaten zijn door 
een afwijking in de ontwikkeling van het hart de rechter- en linkerkamer van 
positie verwisseld. Patiënten hebben een verminderde longitudinale strain van 
de systeem rechterkamer vergeleken met de systeem linkerkamer van gezonde 
controlepersonen. De afname in functie komt het meest tot uiting in het apicale 
deel van de rechterkamer. Dit suggereert dat de punt van het hart het meest be-
invloed wordt door de drukoverbelasting. Deze bevinding komt overeen met de 
hierboven beschreven verminderde apicale functie bij patiënten met (voormalige) 
volumeoverbelasting. De verminderde longitudinale piek strain is gerelateerd aan 
verminderde hartfunctie, hogere NT-proBNP waarden en lijkt gerelateerd te zijn 
aan het hebben van klachten passend bij hartfalen. De longitudinale piek strain 
van de rechterkamer is lager in de patiënten die een Mustard operatie hebben 
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ondergaan dan in patiënten met een congenitaal gecorrigeerde transpositie van de 
grote vaten. Dit is een interessante bevinding, aangezien dit verschil niet eerder 
beschreven is met behulp van de standaard echocardiografie. Mogelijk wordt dit 
verschil veroorzaakt door de operatie die de patiënten hebben ondergaan, maar 
meer onderzoek is nodig om dit aan te kunnen tonen dan wel uit te kunnen sluiten.
In Hoofdstuk 12 ligt de focus op de linkerkamerfunctie van patiënten met een 
gerepareerde coarctatio aortae, een vernauwing van de aorta, waardoor deze 
patiënten gedurende lange tijd een drukoverbelasting hebben gehad van de linker 
hartkamer. In dit prospectief cross-sectionele onderzoek is de linkerkamer piek 
systolische longitudinale strain gemeten in 75 patiënten en 75 gezonde controle-
personen gematcht in leeftijd en geslacht. Bij de meerderheid van de patiënten lijkt 
op het standaard echocardiogram dat ze een normale linkerkamerfunctie hebben, 
terwijl gemeten met STE toch een groot deel een verminderde longitudinale strain 
heeft. Deze verminderde strain is geassocieerd met hogere bloeddruk, het hebben 
van nog een andere AHA, een aortaklepvervanging en een grotere linkerboezem. 
Het verband tussen een hogere bloeddruk en een lagere strain is ook gezien bij 
de gezonde controles in Hoofdstuk 2 en geeft aan dat een minimale bloeddrukver-
hoging al snel subtiele veranderingen geeft aan de strain van de linkerkamer. Dit 
maakt piek systolische linkerkamer strain een sensitieve marker voor beginnende 
kamerdisfunctie veroorzaakt door hoge bloeddruk. Of de linkerkamer strain in de 
kliniek echt bruikbaar zal zijn, verdient verder onderzoek.
Concluderend blijkt dat het belangrijk is om alle mensen met een AHA levens-
lang te vervolgen, waarbij de nieuwste echotechnieken betere informatie lijken te 
verschaffen dan de standaard echocardiografie voor het vroegtijdig opsporen van 
problemen, zoals hartfalen.
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danKwoord
Drie jaar geleden begon ik met dit promotieonderzoek en de tijd is voorbij gevlo-
gen. Wie had gedacht dat het zo’n mooie en onvergetelijke tijd zou worden? Hoe-
wel er op dit proefschrift maar één naam staat, zou dit niet tot stand zijn gekomen 
zonder de hulp en steun van vele anderen. Een aantal van hen wil ik graag in het 
bijzonder noemen. 
Allereerst mijn eerste promotor, prof.dr. Roos – Hesselink, beste Jolien, ik ben je 
enorm dankbaar dat je mij de kans hebt gegeven om dit promotietraject te starten. 
Je betrokkenheid en enthousiasme hebben mij continu gemotiveerd bij het opstar-
ten, uitvoeren en voltooien van mijn projecten. Zelfs tijdens de marathon wist je 
me energie te geven door je krachtige high-five. Ik durf te zeggen dat je mij beter 
kende dan ik dacht: zo had jij als enige door dat ik ‘de mol’ was! Dit uitje is één van 
de vele voorbeelden van de gezelligheid in de congenitale groep. Ontzettend be-
dankt voor deze mooie jaren en ik hoop dat wij elkaar nog veel zullen tegenkomen 
in de kliniek en bij congressen.
Mijn tweede promotor, prof.dr. Helbing, beste Wim, jij bent ook een zeer belang-
rijke pijler geweest van dit proefschrift. Met je uitgebreide kennis over aangeboren 
hartziekten en gedrevenheid in de beeldvorming van de rechterkamer, heb je mij 
veel geleerd en vooral uitgedaagd kritischer te kijken en beoordelen. Ik wil je 
bedanken voor de begeleiding en prettige samenwerking. Je gevatte commentaar 
op mijn manuscripten heb ik altijd zeer gewaardeerd. 
Mijn copromotor, dr. van den Bosch, beste Annemien, wat heb ik ontzettend veel 
aan je gehad. Ik was nog maar net begonnen aan mijn promotietraject toen we 
samen naar Leuven gingen voor het myocardial deformation imaging symposium. 
Dat was voor mij de eerste stap in de wereld van de speckle-tracking echocardio-
grafie. Jouw nieuwsgierigheid en enthousiasme hebben mij continu uitgedaagd om 
het maximale uit mijn werk te halen. Daarnaast straal je ook veel sportiviteit en 
gezelligheid uit. Niet voor niets werd jij daarom ‘copromotor of the year’. 
Beste prof.dr. Bogers, dr. Meijboom en prof.dr.ir. de Jong, leden van de kleine com-
missie. Hartelijk dank voor het kritisch lezen en beoordelen van dit proefschrift. 
Prof.dr. van Geuns en dr. Kamp, hartelijk dank voor uw bereidheid om plaats te 
nemen in de grote commissie. 
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Dr. Cuypers, beste Judith, wat hebben wij veel Kaplan-Meiers gebouwd samen! 
Ik kan wel zeggen dat je de afgelopen jaren toch echt mijn promotiemaatje bent 
geworden. Dr. Witsenburg, beste Maarten, dank voor je kritische blik op mijn 
manuscripten en presentaties. Ik heb veel van je jarenlange ervaring kunnen leren. 
Mijn collega’s van Ba-308. Petra, Denise en Titia, ook al was de samenwerking kort, 
dankzij jullie voelde ik me gelijk op mijn plek in de kamer. Jannet, ik heb met nie-
mand zoveel congresreizen gemaakt als met jou. Onze limousinerit in Dallas en ho-
telkamer met kerstballen in Istanboel zal ik zeker niet vergeten! John, wat hebben 
wij samen gelachen om het knallen van jou. Je was een onmisbare kamergenoot 
van wie we de afscheidstekst op het whiteboard niet durfden te wissen. En dan de 
nieuwe lichting: Iris, Vivan en Allard. Alledrie zo verschillend, alledrie geweldige 
collega’s. Iris, jouw gedrevenheid in wielrennen heeft de liefde voor fietsen ook bij 
mij aangewakkerd. Helaas was de keuze voor de Anti-Hero IPA in Chicago minder 
succesvol. Vivan, toen ik je zag dansen bij de dance battle in Barcelona was ik 
direct overtuigd dat jij een ‘keileuke’ collega zou zijn! Jouw aanstekende lach 
maakt het bespreken van moeilijke statistiek zelfs gezellig. Allard, het was iedere 
ochtend weer afwachten hoe geschonden je de kamer binnenkwam. Of het nu gaat 
om jiu jitsu of onderzoek, jij haalt er altijd het maximale uit. Die ‘New England’ gaat 
er vast nog komen! Roderick, ik ben blij dat je het stokje overneemt. Jij gaat zeker 
geen spijt krijgen van het wonen en werken in Rotterdam. Lieve Ba-308’jes, jullie 
hebben er voor mij een onvergetelijke tijd van gemaakt. Ik kom graag nog eens 
langs voor een plensje koffie of om thee te lengelen!
Dan wil ik natuurlijk ook nog onze secretaresses bedanken. Celeste, ik bewonder 
naast je gestructureerde manier van werken, zeker ook jouw heerlijke bakseltjes. 
Tineke, bedankt voor je hulp bij allerlei afspraken en klusjes, maar bovenal je 
persoonlijke betrokkenheid. René, de redder in nood als het om computers en 
alles daaromheen gaat. Ron van Domburg en Eric Boersma, bedankt voor de sta-
tistische hulp. 
De echolaboranten Jackie en Wim, jullie vormen de basis van de Navigator studie 
en zijn daarom onmisbaar geweest bij de totstandkoming van dit proefschrift. Jac-
kie, jouw toewijding in nieuwe echocardiografische ontwikkelingen en je geduld 
om mij de lastige congenitale echo’s uit te leggen, waardeer ik enorm. Succes met 
de vele artikelen die er zeker nog zullen komen! Wim, ontzettend bedankt voor de 
uitgebreide uitleg aan de gezonde vrijwilligers over hun eigen echobeelden. Ik heb 
veel complimenten gekregen hoe duidelijk je dat deed. Natuurlijk wil ik ook graag 
alle andere echolaboranten bedanken: Anja, Beata, Debbie, Ellen, Kwaku, Linda 
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en Lourus. Dames van de polikliniek cardiologie en functieonderzoeken, hartelijk 
dank voor de afspraken, bloedafnames en ECG’s die jullie voor de studie hebben 
gemaakt. 
Uiteraard ben ik de andere collega’s op de gang ‘Ba-3!’ niet vergeten. Hannah, ge-
weldig hoe enthousiast jij over van alles kunt zijn. Ik wil nog steeds graag met jou 
de balletuitdaging aangaan! Lennart, een echte Rotterdamse onderzoekert. Met 
z’n allen naar een wedstrijd in de Kuip kon daarom niet uitblijven, het maakt je 
absoluut een gezellige collega. Een verdieping lager: Marisa, mijn gitaarbuddy. Wat 
hebben wij gelachen met onze gitaar op de rug richting de oude cathkamers. Ons 
optreden gaat er echt een keer van komen. Raluca, een meelevende collega, veel 
geluk met je nieuwe gezinnetje! Renate, tijdens de barbecue heb ik je leren kennen 
en sindsdien is het altijd lachen met jou. Medieval Times was wel één van de hilari-
sche hoogtepunten. Overige arts-onderzoeker en arts-assistenten, dank voor jullie 
hulp tijdens mijn onderzoek en eerste maanden in de kliniek. Ik heb genoten van 
de borrels, congressen, skiweekenden en succesvolle NVVC challenges. Ik hoop 
dat er nog veel mooie momenten zullen komen!
Lieve Linda, Judith, Laura en Rowan, onze vriendschap begon op de middelbare 
school. Linda, wij zijn al lange tijd onafscheidelijk: samen gestart met de studie ge-
neeskunde, mijn huisgenoot geweest en beiden verhuisd naar Tilburg. Wij hebben 
vaak aan een woord, zoals poerd, al genoeg. Ik ben heel blij dat je mijn paranimf 
wilt zijn. Judith, sieraden maken en werken aan de schoolkrant, zo hebben wij sa-
men uren doorgebracht. Tegenwoordig vermaken we ons met uren lachen om niks! 
Laura, een waardevolle vriendin. Onze Gooische Vrouwen avonden zijn geweldig. 
We moeten snel weer een nieuwe serie zoeken. Rowan, ons profielwerkstuk over 
het gezichtsveld was de eerste stap naar medisch wetenschappelijk onderzoek en 
heeft het enthousiasme aangewakkerd. Dat wij nog vele B100-achtige momenten 
gaan meemaken. 
Mijn vriendinnen Anne, Denise, Josien, Anneloes, Lina en Mieke, jullie heb ik 
tijdens mijn studententijd leren kennen. Anne, mijn trouwe stapmaatje, Denise, 
zowel collega als dierbare vriendin, ik geniet van onze uitjes en weekendjes weg. 
Ik ben ervan overtuigd dat wij binnenkort weer iets nieuws gaan ondernemen, 
Krakau opgepast? Josien, samen hebben we onze eerste marathon gelopen. Wat 
een ervaring was dat! Net als onze roadtrip in camper Charly samen met Anneloes, 
zouden we het stappen in Vegas ooit nog overtreffen? Ciao Lina, volgend jaar doe 
ik met je mee aan de triatlon. Mieke, wat een mooie herinneringen heb ik aan ons 
keuzecoschap in Suriname. Laten we snel weer een shopdagje plannen. 
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Alle gezonde vrijwilligers die bereid waren om het uitgebreide echocardiogram 
voor de Navigator studie te ondergaan, ontzettend bedankt!
Lieve Ans, mijn peettante, dankjewel dat je gezonde vrijwilliger was voor mijn 
‘experiment’. Ik kijk met veel plezier terug naar ons uitje in de Markthal. Lieve 
Maria en Hemmo, jullie ook bedankt voor deelname aan het onderzoek en voor het 
meedenken over de lay-out van dit boekje. Jullie liefde en steun zijn onbeschrijflijk. 
De rest van mijn lieve familie, bedankt voor jullie interesse en vertrouwen in de 
totstandkoming van mijn proefschrift.
Lieve schoonouders, Zhi-Gang en Ming, bedankt voor jullie interesse in en deel-
name aan mijn onderzoek. Ik stel jullie gastvrijheid zeer op prijs en hoop nog vaak 
bij jullie aan tafel te kunnen schuiven om te genieten van het heerlijke eten.
 
Mijn allerliefste Wu. Jouw liefde, geduld en steun geven mij de kracht om door te 
gaan en doelen te bereiken. Ik bewonder je om het vermogen mij tot rust te kun-
nen brengen met je aanwezigheid en je humor. Jouw hulp en betrokkenheid in de 
afgelopen moeilijke periode hebben ons samen nog veel sterker gemaakt. Ik weet 
zeker dat wij alle verloren momenten in de toekomst zullen inhalen. Ik hou van je.
Mijn lieve zussen, Lisa en Malou, ik ben jullie ontzettend dankbaar voor de steun 
de afgelopen jaren, maar vooral de laatste maanden. Ingrijpende gebeurtenis-
sen laten ons nog dichter naar elkaar toe groeien en bewijzen maar weer hoe 
belangrijk jullie voor me zijn. Ik, als middelste van de drie, kan oprecht zeggen 
dat ik super trots op jullie beiden ben. Lieve Lisa, mijn ‘grote’ zus, toen ik klein 
was heb jij mij mijn eerste woordjes en sommetjes geleerd, nu leer je mij hoe te 
‘overleven’ in de kliniek. Ik ben ervan overtuigd dat je een deskundige en begrip-
volle huisarts wordt! Lieve Malou, mijn ‘kleine’ zusje, ik kijk met plezier terug naar 
ons hardloopweekend in Maastricht met de rugzak. Dit was de basis voor alle 
sportevenementen waar we samen aan hebben deelgenomen. Het is mooi om te 
zien dat deze bevlogenheid ook terug te vinden is in je eigen promotieonderzoek 
wat ongetwijfeld tot een mooi proefschrift zal leiden. Ik ben trots dat ik jou mijn 
paranimf mag noemen. 
Allerliefste papa en mama, het is fijn om op te groeien in zo’n warm en hecht 
gezin. Dankzij jullie onvoorwaardelijke liefde, steun en vertrouwen heb ik alle 
mogelijkheden in het leven gekregen om mezelf te ontwikkelen zoals ik nu ben en 
te bereiken wat ik nu heb. Ik ben jullie intens dankbaar. Papa, in deze moeilijke tijd 
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heb je nog meer laten zien hoe bijzonder, waardevol en liefdevol jij bent. Mama, 
verzorgend en lief, jij blijft voor altijd in mijn hart.
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